<SUBMISSION>
<ACCESSION-NUMBER>0000950152-06-000434
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>4
<PERIOD>20060122
<ITEMS>1.01
<ITEMS>9.01
<FILING-DATE>20060124
<DATE-OF-FILING-DATE-CHANGE>20060124
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ALBERTSONS INC /DE/
<CIK>0000003333
<ASSIGNED-SIC>5411
<IRS-NUMBER>820184434
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>0131
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-06187
<FILM-NUMBER>06547390
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>250 PARKCENTER BLVD
<STREET2>P O BOX 20
<CITY>BOISE
<STATE>ID
<ZIP>83726
<PHONE>2083956200
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>250 PARKCENTER BLVD
<STREET2>P O BOX 20
<CITY>BOISE
<STATE>ID
<ZIP>83726
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>l18113ae8vk.htm
<DESCRIPTION>ALBERTSON'S, INC.             8-K/425
<TEXT>
<HTML>
<HEAD>
<TITLE>ALBERTSON'S, INC.             8-K/425</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of the<BR>
Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of report (Date of earliest event reported): January&nbsp;22, 2006</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>ALBERTSON&#146;S, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt"><B>(Exact Name of Registrant as Specified in Charter)</B></DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware<BR>
(State or Other Jurisdiction<BR>
of Incorporation)</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>1-6187<BR>
(Commission File Number)</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>82-0184434<BR>
(IRS Employer<BR>
Identification Number)</B></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>250 Parkcenter Blvd., PO Box 20<BR>
Boise, Idaho</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B><BR>83726</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>(Address of Principal Executive Offices)</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>(Zip Code)</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>(208)&nbsp;395-6200<BR>
Registrant&#146;s telephone number, including area code</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>n/a<BR>
(Former Name and Address,<BR>
If Changed Since Last Report)</B></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><FONT face="Wingdings">&#254;</FONT> Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD><FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<!-- link2 "Item&nbsp;1.01 Entry into Material Definitive Agreement" -->
<DIV align="left"><A NAME="000"></A></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;1.01 Entry into Material Definitive Agreement</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
January&nbsp;22, 2006, Albertson&#146;s, Inc.
(&#147;Albertson&#146;s&#148;), CVS Corporation, (&#147;CVS&#148;) a consortium of
investors including Cerberus Capital Management, L.P., Kimco Realty Corporation, Lubert-Adler
Management, Inc. and Schottenstein Stores Corporation (such investors collectively, the &#147;Cerberus
Group&#148;), and SUPERVALU INC. (&#147;Supervalu&#148;) agreed to enter into a series of transactions pursuant to
which, among other things, Albertson&#146;s would transfer assets and certain liabilities that relate to
its standalone drug stores to CVS Pharmacy, Inc. (&#147;CVS Pharmacy&#148;), a wholly owned subsidiary of CVS (the &#147;Standalone Drug Sale&#148;) and would
transfer assets and liabilities associated with its other operations in specified metropolitan
areas to the Cerberus Group (the &#147;Core Separation&#148;), after which Albertson&#146;s remaining business
would be combined with Supervalu&#146;s business pursuant to a merger (the &#147;Supervalu Merger&#148;,
and, together with the Standalone Drug Sale and Core Separation, the &#147;Transactions&#148;). The
Transactions are conditioned upon one another.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The proposed Standalone Drug Sale is subject to that certain Asset Purchase Agreement (the
&#147;Standalone Drug Sale Agreement&#148;) by and among CVS, CVS Pharmacy, Supervalu, Albertson&#146;s, New Aloha Corporation, a wholly-owned subsidiary of Albertson's (&#147;New Diamond&#148;)
and certain other entities affiliated with Albertson&#146;s. Under the Standalone Drug Sale Agreement,
CVS Pharmacy has agreed to purchase specified assets primarily related to Albertson&#146;s
standalone drug business, including, among other things,
approximately 700&nbsp;standalone drugstore, certain related owned
real estate interests and a distribution center in La&nbsp;Habra, California. In connection with the transaction, CVS Pharmacy has also agreed to assume
certain related liabilities. In addition to being conditioned on the other Transactions, the
Standalone Drug Sale is subject to the satisfaction of other customary conditions, including
governmental and regulatory approvals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The proposed Core Separation is subject to that certain Purchase and Separation Agreement (the
&#147;Separation Agreement&#148;) by and among Albertson&#146;s, New Diamond, Supervalu and AB Acquisition LLC, an affiliate of the Cerberus
Group (&#147;AB&#148;). The Separation Agreement provides for, among other things, causing New Diamond to
become a holding company for Albertsons and the division of Albertson&#146;s assets and liabilities
(other than those to be purchased and assumed, respectively, by CVS Pharmacy as described above) between
those associated with Albertson&#146;s core business (which would be transferred to New Diamond) and those associated with Albertson&#146;s non-core business (which would remain with
Albertson&#146;s).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The core business includes approximately 1124 stores and related support operations for Acme
Markets, Bristol Farms, Jewel-Osco, Shaw&#146;s, and Star Markets, as well as all Albertsons banner
stores in Idaho, Southern Nevada, Utah, Southern California, and the Northwestern US. The non-core
business includes approximately 655 Albertsons and Super Saver banner stores and related
distribution centers and offices in Albertsons&#146; Dallas/Fort Worth division, and in the Florida,
Northern California, Rocky Mountain and Southwestern regions. Both the core and non-core
businesses include, among other things, grocery stores with in-store pharmacies as well as those
without. After the consummation of the transactions contemplated by the Separation Agreement, the
Cerberus Group would own the equity interests of Albertson&#146;s, which would own the non-core
business, and New Diamond would own the core business. New
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Diamond would thereafter be acquired by Supervalu pursuant to the merger described below. In
addition to being conditioned on the other Transactions, the Core Separation is subject to the
satisfaction of other customary conditions, including governmental and regulatory approvals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The proposed Supervalu Merger is subject to that certain Agreement and Plan of Merger (the
&#147;Merger Agreement&#148; together with the Standalone Drug Sale Agreement and the Separation Agreement,
the &#147;Agreements&#148;), by and among Albertson&#146;s, New Diamond, New Diamond Sub, Inc., a wholly-owned
subsidiary of New Diamond (&#147;New Diamond Sub&#148;), Supervalu and Emerald Acquisition Sub, Inc., a
newly-organized wholly-owned subsidiary of Supervalu (&#147;Merger Sub&#148;). Under the Merger Agreement,
New Diamond would become a wholly owned subsidiary of Supervalu as a result of the Supervalu
Merger, in which each share of Albertson&#146;s common stock would be converted into the right to
receive (1)&nbsp;0.182 shares of common stock of Supervalu and (2) $20.35 in cash. In addition to being conditioned on the other Transactions, the
Supervalu Merger is subject to the approval of the stockholders of Supervalu and Albertson&#146;s and the satisfaction of other customary conditions, including
governmental and regulatory approvals. The Transactions are not subject to a financing condition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prior to the entry into the Agreements, Supervalu sold its retail grocery stores operating
under the &#147;Cub&#148; banner in the Chicago and Bloomington, Illinois metropolitan areas to an affiliate
of Cerberus Capital Management, L.P.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition, the board of directors of Albertson&#146;s approved
 an amendment to the Albertson&#146;s, Inc. Change in Control Severance Benefit Trust, which provides that Albertson&#146;s
entry into the Merger Agreement will not constitute a &#147;Potential Change in Control&#148; for the purpose of such trust.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Agreements are filed pursuant to Item&nbsp;9.01 as Exhibits 2.01, 2.02, and 2.03. The
foregoing description of the Agreements and the transactions contemplated therein does not purport
to be complete and is qualified in its entirety by reference to the Agreements which are filed as
an exhibit hereto, and is incorporated herein by reference.
</DIV>


<!-- link2 "Item&nbsp;9.01.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Statements and Exhibits" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01.</B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B>Financial Statements and Exhibits</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(a)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Not applicable.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(b)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Not applicable.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(c)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Not applicable.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(d)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exhibits</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 0px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Document Designation</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.01
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Agreement and Plan of Merger, among Albertson&#146;s, Inc., New Aloha Corporation,
New Diamond Sub, Inc., SUPERVALU INC., and Emerald Acquisition Sub, Inc., dated as of
January&nbsp;22, 2006.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.02
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Purchase and Separation Agreement, by and among Albertson&#146;s, Inc., New Aloha
Corporation, SUPERVALU, INC. and AB Acquisition LLC, dated as of January&nbsp;22, 2006.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.03
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Asset Purchase Agreement, among CVS Corporation, CVS Pharmacy, Inc.,
Albertson&#146;s, Inc., SUPERVALU INC., New Aloha</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">


</TABLE>
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="88%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;Corporation, and the other sellers thereto, dated as of January&nbsp;22,
2006.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "SIGNATURE" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SIGNATURE
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dated: January&nbsp;24, 2006
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ALBERTSON&#146;S, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/
John&nbsp;R. Sims</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John R. Sims&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President &#038;<BR> General
Counsel&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "EXHIBIT INDEX" -->

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT INDEX
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="90%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">Exhibit</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Number</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">2.01
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Agreement and Plan of Merger, among Albertson&#146;s, Inc., New Aloha Corporation,
New Diamond Sub, Inc., SUPERVALU INC., and Emerald Acquisition Sub, Inc., dated as of
January&nbsp;22, 2006.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">2.02
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Purchase and Separation Agreement, by and among Albertson&#146;s, Inc., New Aloha
Corporation, SUPERVALU, INC. and AB Acquisition LLC, dated as of January&nbsp;22, 2006.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">2.03
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Asset Purchase Agreement, among CVS Corporation, CVS Pharmacy, Inc.,
Albertson&#146;s, Inc., SUPERVALU INC., New Aloha Corporation, and the other sellers
thereto, dated as of January&nbsp;22, 2006.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.01
<SEQUENCE>2
<FILENAME>l18113aexv2w01.htm
<DESCRIPTION>EX-2.01 AGREEMENT AND PLAN OF MERGER
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-2.01 Agreement and Plan of Merger</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U><B>Exhibit&nbsp;2.01</B></U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AGREEMENT AND PLAN OF MERGER</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>among</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>ALBERTSON&#146;S, INC.,</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>NEW ALOHA CORPORATION,</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>NEW DIAMOND SUB, INC.,</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>SUPERVALU INC.,</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>and</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>EMERALD ACQUISITION SUB, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>Dated as of January&nbsp;22, 2006</B>
</DIV>


<P align="center" style="font-size: 10pt">
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE I DEFINITIONS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 1.1 Certain Defined Terms</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 1.2 Other Defined Terms</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE II MERGERS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 2.1 The Diamond Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 2.2 The Emerald Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 2.3 Closing; Effective Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 2.4 Effects of the Mergers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 2.5 Certificate of Incorporation; By-Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 2.6 Directors and Officers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE III EFFECT OF THE MERGERS ON CAPITAL STOCK OF THE CONSTITUENT CORPORATIONS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 3.1 Effect of the Diamond Merger on Capital Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 3.2 Effect of the Emerald Merger on Capital Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 3.3 Treatment of Options and Other Equity Awards</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 3.4 Adjustment of Merger Consideration</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 3.5 Dissenting Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 3.6 Payment and Exchange of Certificates</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">

<TD><DIV style="margin-left:78px; text-indent:-78px; margin-right: 0px">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY, NEW DIAMOND, AND NEW DIAMOND
MERGER SUB</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.1 Organization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.2 Authority; Enforceability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.3 Non-Contravention</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-i-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.4 Governmental Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.5 Capitalization of the Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.6 Company Subsidiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.7 SEC Reports; Financial Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.8 No Undisclosed Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.9 Absence of Certain Changes or Events</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.10 Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.11 Compliance with Law and Reporting Requirements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.12 Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.13 Employee Compensation and Benefit Plans; ERISA</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.14 Labor Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.15 Properties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.16 Tangible Personal Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.17 Intellectual Property; IT Systems</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.18 Environmental Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.19 Taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.20 Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.21 Rights Plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.22 HITS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.23 Affiliate Transactions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.24 Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.25 State Takeover Statutes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 4.26 Fairness Opinion</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT AND ACQUISITION SUB</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.1 Organization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-ii-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.2 Authority; Enforceability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.3 Non-Contravention</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.4 Governmental Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.5 Capitalization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.6 SEC Reports; Financial Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.7 No Undisclosed Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.8 Absence of Certain Changes or Events</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.9 Compliance with Law and Reporting Requirements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.10 Litigation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.11 Financing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.12 Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.13 Company Stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.14 Acquisition Sub</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.15 Fairness Opinion</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 5.16 Cub Stores Divestiture</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VI ADDITIONAL AGREEMENTS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.1 Conduct of Business Prior to the Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.2 Stockholders Meetings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.3 Proxy Statement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.4 Access to Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.5 Acquisition Proposals</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.6 Further Action; Reasonable Best Efforts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.7 Resignations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.8 Directors&#146; and Officers&#146; Indemnification and Insurance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">59</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.9 Public Announcements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-iii-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.10 Cooperation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.11 Notification</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.12 Third-Party Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">63</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.13 Employment and Employee Benefits Matters; Section&nbsp;16</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">63</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.14 Board Representation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.15 Available Cash</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.16 Coordination of Dividends</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.17 The Diamond Reorganization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 6.18 Boise Operations and Community Involvement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VII CONDITIONS OF MERGER</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 7.1 Mutual Conditions to Effect the Mergers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 7.2 Conditions to Obligations of Parent and Acquisition Sub</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 7.3 Conditions to Obligations of the Company, New Diamond and New Diamond
Merger Sub</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VIII TERMINATION, AMENDMENT AND WAIVER</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 8.1 Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 8.2 Effect of Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">70</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 8.3 Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 8.4 Amendment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 8.5 Waiver</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE IX GENERAL PROVISIONS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.1 Non-Survival of Representations, Warranties and
Agreements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.1 Company Disclosure Letter; Parent Disclosure Letter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">73</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.3 Notices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">74</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.4 Severability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">75</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.5 Entire Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">75</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-iv-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.6 Assignment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.7 No Third Party Beneficiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.8 No Responsibility for Other Parties</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.9 Governing Law</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.10 Specific Performance; Jurisdiction</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">76</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.11 Waiver of Jury Trial</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">77</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.12 Interpretation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">77</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">SECTION 9.13 Counterparts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">77</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>INDEX OF EXHIBITS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="14%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="81%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A-1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Restated Certificate of Incorporation of Old Albertson&#146;s, Inc.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A-2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of By-Laws of Old Albertson&#146;s, Inc.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Amended and Restated Certificate of Incorporation of New
Aloha Corporation</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;C
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of By-Laws of New Aloha Corporation</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;D
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Amended and Restated Certificate of Incorporation of New
Albertson&#146;s Inc.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;E
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of By-Laws of New Albertson&#146;s Inc.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;F
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Separation Agreement</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;G
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Standalone Drug Sale Agreement</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;H
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Separate Operations Data</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;I
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Separate Balance Sheet Data</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">-v-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This AGREEMENT AND PLAN OF MERGER, dated as of January&nbsp;22, 2006 (this &#147;<U>Agreement</U>&#148;), is
entered into by and among SUPERVALU INC., a Delaware corporation (&#147;<U>Parent</U>&#148;), Emerald
Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent
(&#147;<U>Acquisition Sub</U>&#148;), Albertson&#146;s, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;), New
Aloha Corporation, a Delaware corporation and a wholly owned subsidiary of the Company (&#147;<U>New
Diamond</U>&#148;), and New Diamond Sub, Inc., a Delaware corporation and a wholly owned subsidiary of
New Diamond (&#147;<U>New Diamond Merger Sub</U>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>W I T N E S S E T H:</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Board of Directors of the Company (the &#147;<U>Company Board of Directors</U>&#148;) has
(i)&nbsp;determined that it is in the best interests of the Company and the stockholders of the Company,
and declared it advisable, to enter into this Agreement providing for the merger (the &#147;<U>Diamond
Merger</U>&#148;) of New Diamond Merger Sub with and into the Company, with the Company as the surviving
corporation, in accordance with the General Corporation Law of the State of Delaware (the
&#147;<U>DGCL</U>&#148;) and upon the terms and subject to the conditions set forth herein, (ii)&nbsp;determined
that it is in the best interests of the Company, New Diamond and the stockholders thereof, and
declared it advisable, to enter into this Agreement providing for the merger (the &#147;<U>Emerald
Merger</U>,&#148; and together with the Diamond Merger, the &#147;<U>Mergers</U>&#148;) of Acquisition Sub with
and into New Diamond, with New Diamond as the surviving corporation, in accordance with the DGCL
and upon the terms and conditions set forth herein, (iii)&nbsp;approved this Agreement in accordance
with the DGCL, and (iv)&nbsp;resolved to recommend adoption of this Agreement by the stockholders of the
Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, (i)&nbsp;the Board of Directors of Parent (the &#147;<U>Parent Board of Directors</U>&#148;), the
Board of Directors of Acquisition Sub, the Board of Directors of New Diamond, and the Board of
Directors of New Diamond Merger Sub have each determined that it is in the best interests of
Parent, Acquisition Sub, New Diamond and New Diamond Merger Sub and their respective stockholders,
and declared it advisable, to enter into this Agreement, and have approved this Agreement in
accordance with the DGCL, and (ii)&nbsp;Parent, as the sole stockholder of Acquisition Sub, will adopt
this Agreement in accordance with the DGCL;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, concurrently with the execution of this Agreement, (i)&nbsp;the Company, New Diamond,
Parent and AB Acquisition LLC are entering into that certain Purchase and Separation Agreement,
dated as of the date hereof and attached as <U>Exhibit&nbsp;F</U> hereto (the &#147;<U>Separation
Agreement</U>&#148;), and (ii)&nbsp;the Company, New Diamond, Parent, CVS Corporation (&#147;<U>CVS</U>&#148;) and
certain additional parties are entering into that certain Asset Purchase Agreement, dated as of the
date hereof and attached as <U>Exhibit&nbsp;G</U> hereto (the &#147;<U>Standalone Drug Sale
Agreement</U>&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, it is intended that, after the Diamond Merger, the Company will convert into a
Delaware limited liability company (such limited liability company, &#147;<U>Diamond LLC</U>,&#148; and such
conversion, the &#147;<U>Diamond LLC Conversion</U>&#148;), and that Diamond LLC will then distribute its
core business to New Diamond, pursuant to the terms of the Separation Agreement; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, for federal income tax purposes, it is intended that the Diamond Merger and the
Diamond LLC Conversion, taken together, will qualify as a reorganization under the
</DIV>

<P align="center" style="font-size: 10pt">-1-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">provisions of Section&nbsp;368(a)(1)(F) of the Code, and that this Agreement shall constitute a
&#147;plan of reorganization&#148; with respect thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements
herein contained, and intending to be legally bound hereby, New Diamond, New Diamond Merger Sub,
Parent, Acquisition Sub and the Company hereby agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE I</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>DEFINITIONS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1.1 <U>Certain Defined Terms</U> . As used in this Agreement, the following terms
have the following meanings:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Action</U>&#148; means any claim, action, suit, proceeding or investigation by or before any
Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affiliate</U>&#148; means, with respect to any specified Person, any other Person that
directly, or indirectly through one or more intermediaries, Controls, is Controlled by, or is under
common Control with, such specified Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ASC</U>&#148; means American Stores Company LLC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Average Closing Price</U>&#148; means the average of the closing prices for a Parent Share as
reported on the NYSE Composite Transactions Reports (as reported in <U>The Wall Street Journal</U>
or, if not reported thereby, any other authoritative source) for the ten trading days prior to, but
not including, the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Day</U>&#148; means any day that is not a Saturday, a Sunday or other day that is a
statutory holiday under the federal Laws of the United States.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Cash Consideration</U>&#148; means $20.35 in cash, without interest, per New Diamond Share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and the rules and
regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Material Adverse Effect</U>&#148; means any effect that is materially adverse to the
business, financial condition or results of operations of the Company and the Company Subsidiaries
(or, following the Separation, New Diamond and its Subsidiaries) taken as a whole in relation to
the New Diamond Business, other than any effect to the extent resulting proximately from (i)
general economic conditions or developments or changes therein, (ii)&nbsp;conditions in the industries
in which the Company and the Company Subsidiaries operate or developments or changes therein,
except to the extent that such conditions, developments or changes impact the Company in a
materially disproportionate adverse manner relative to similarly situated competitors of the
Company, (iii)&nbsp;conditions in the stock markets or other capital markets or developments or changes
therein, (iv)&nbsp;the announcement of the Transaction Agreements or the Transactions, (v)&nbsp;the
performance by the Company of its obligations pursuant
to the Transaction Agreements (except the obligations of the Company to obtain the consents
</DIV>

<P align="center" style="font-size: 10pt">-2-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">contemplated by Section&nbsp;4.3 and Section&nbsp;4.4), (vi)&nbsp;the announcement, consummation, termination or
abandonment of the Standalone Drug Sale, (vii)&nbsp;any actions taken or omitted to be taken by or at
the request or with the written consent of Parent or Acquisition Sub, (viii)&nbsp;any changes in any
Laws or any accounting regulations or principles, (ix)&nbsp;any union organizing activities, labor
disputes, strikes, work stoppages or similar labor unrest or disruption, or (x)&nbsp;any acts of God,
war or terrorism, except to the extent that such acts impact the Company in a materially
disproportionate adverse manner relative to similarly situated competitors of the Company. A
failure by the Company to meet any projections, estimates or budgets for any period prior to, on or
after the date of this Agreement shall not in itself constitute a Company Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Proposal</U>&#148; means any Acquisition Proposal relating to the acquisition of, or a
business combination transaction with, the Company, any of its Subsidiaries or some or all of their
respective assets, securities or other ownership interests.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Subsidiaries</U>&#148; means the Subsidiaries of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Confidentiality Agreements</U>&#148; means the reciprocal confidentiality agreements dated
September&nbsp;22, 2005 and November&nbsp;17, 2005, between Parent and the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Control</U>&#148; (including the terms &#147;<U>Controlled by</U>&#148; and &#147;<U>under common Control
with</U>&#148;), with respect to the relationship between or among two or more Persons, means the
possession, directly or indirectly, of the power to direct or cause the direction of the affairs or
management of a Person, whether through the ownership of voting securities, by contract or
otherwise, including the ownership, directly or indirectly, of securities having the power to elect
a majority of the board of directors or similar body governing the affairs of such Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Coordination Agreement</U>&#148; means that certain Coordination Agreement by and among the
Company, Parent, AB Acquisition LLC, and CVS, dated as of the date hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Cub Sale Agreement</U>&#148; means that certain Asset Purchase Agreement by and among Parent
and Hawk Acquisition LLC, dated as of the date hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Data</U>&#148; means all information and data, whether in printed or electronic form and
whether contained in a database or otherwise, that is used in or held for use in the operation of
the respective businesses of the Company or the Company Subsidiaries, or that is otherwise material
to or necessary for the operation of the respective businesses of the Company or the Company
Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Deferred Compensation Plans</U>&#148; means the Company&#146;s 2000 Deferred Compensation Plan; the
Company&#146;s 1990 Deferred Compensation Plan; the Company&#146;s Executive Deferred Compensation Plan; the
Company&#146;s Senior Executive Deferred Compensation Plan; any supplemental retirement benefit provided
in any employment agreement; the Company&#146;s Non-Employees Directors&#146; Deferred Compensation Plan;
Shaw&#146;s Supermarkets, Inc. Deferred Compensation Plan; the Company&#146;s Executive ASRE Makeup Plan; the
Company&#146;s Executive Pension Makeup Plan; Shaw&#146;s Supermarkets, Inc. Supplemental Savings Plan;
Shaw&#146;s Supermarkets, Inc. Supplemental Executive Retirement Plan; American Stores Company
Supplemental Executive Retirement Plan; American Stores Company
Retirement Plan for Non-
</DIV>

<P align="center" style="font-size: 10pt">-3-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Employee Directors; and American Stores Company Supplemental Long Range Retirement Plan, as any
of the foregoing may have been amended or restated, and any other plan, program, agreement or
arrangement providing substantially similar benefits to the Company&#146;s current or former directors,
officers or employees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Encumbrance</U>&#148; means any security interest, pledge, mortgage, lien, charge,
hypothecation, option or right of first refusal to purchase or lease or otherwise acquire any
interest, conditional sales agreement, adverse claim of ownership or use, title defect, easement,
right of way, or other encumbrance of any kind, other than any obligation to accept returns of
inventory in the ordinary course of business consistent with past practice and other than those
arising by reason of restrictions on transfers under federal, state and foreign securities Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Equity Interest</U>&#148; means (a)&nbsp;with respect to a corporation, any and all classes or
series of shares of capital stock, (b)&nbsp;with respect to a partnership, limited liability company,
trust or similar Person, any and all classes or series of partnership, limited liability company,
trust or similar interests or units, and (c)&nbsp;with respect to any other Person, any other security
representing any direct equity ownership or participation in such Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended, and the
rules and regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934 and the rules and regulations
promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>GAAP</U>&#148; means United States generally accepted accounting principles.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Governmental Authority</U>&#148; means any federal, state, local or foreign government
(including any political or other subdivision or judicial, legislative, executive or administrative
branch, agency, commission, authority or other body of any of the foregoing).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Governmental Order</U>&#148; means any order, writ, judgment, injunction, decree or award
entered by or with any Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
and the rules and regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indebtedness</U>&#148; means, with respect to any Person, (i)&nbsp;indebtedness of such Person for
borrowed money, (ii)&nbsp;other indebtedness of such Person evidenced by notes, bonds or debentures,
(iii)&nbsp;capitalized leases classified as indebtedness of such Person under GAAP, (iv)&nbsp;all
indebtedness created or arising under any conditional sale or other title retention agreement with
respect to property acquired by such Person (even though the rights and remedies of the seller or
lender under such agreement in the event of default are limited to repossession or sale of such
property), (v)&nbsp;any obligation of such Person for the deferred purchase price of property or
services (other than trade payables and other current liabilities), (vi)&nbsp;all Indebtedness of
another Person referred to in clauses (i)&nbsp;through (v)&nbsp;above guaranteed directly or indirectly,
jointly or severally, in any manner by such Person, (vii)&nbsp;all Indebtedness referred to in clauses
(i)&nbsp;through (v)&nbsp;above secured by (or for which the holder of such Indebtedness has an existing
right,
contingent or otherwise, to be secured by) any Encumbrance on property (including, without
</DIV>

<P align="center" style="font-size: 10pt">-4-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">limitation, accounts and contract rights) owned by such Person, even though such Person has not
assumed or become liable for the payment of such Indebtedness, and (viii)&nbsp;all reimbursement
obligations of such Person with respect to letters of credit, bankers&#146; acceptance or similar
facilities issued for the account of such Person. Notwithstanding anything to the contrary herein,
the Indebtedness of the Company and the Company Subsidiaries shall not include (a)&nbsp;any indebtedness
or obligation owed by the Company to any Company Subsidiary, by any Company Subsidiary to the
Company, or between any Company Subsidiaries, or (b)&nbsp;any guarantee by the Company or any Company
Subsidiary of any indebtedness or obligation described in clause (a)&nbsp;of this sentence.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Intellectual Property</U>&#148; means United States or foreign intellectual property,
including (i)&nbsp;patents and patent applications, together with all reissues, continuations,
continuations-in-part, divisionals, extensions and reexaminations thereof, (ii)&nbsp;trademarks, service
marks, logos, trade names, corporate names, Internet domain names, trade dress, including all
goodwill associated therewith, and all applications, registrations and renewals in connection
therewith, (iii)&nbsp;copyrights and copyrightable works and all applications and registrations in
connection with any of the foregoing, (iv)&nbsp;inventions and discoveries (whether patentable or not),
industrial designs, trade secrets, confidential information and know-how, (v)&nbsp;computer software
(including databases and related documentation), (vi)&nbsp;moral and economic rights of authors and
inventors, and (vii)&nbsp;all other proprietary rights whether now known or hereafter recognized in any
jurisdiction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>IT Systems</U>&#148; means all electronic data processing, information, recordkeeping,
communications, telecommunications, account management, inventory management and other computer
systems (including all computer programs, software, databases, firmware, hardware and related
documentation) and Internet websites.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Knowledge</U>&#148; means (i)&nbsp;with respect to Parent, the actual knowledge after reasonable
inquiry of the officers of Parent listed in Section&nbsp;1.1 of the Parent Disclosure Letter and (ii)
with respect to the Company, the actual knowledge after reasonable inquiry of the officers of the
Company listed in Section&nbsp;1.1 of the Company Disclosure Letter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Law</U>&#148; means any statute, law, ordinance, regulation, rule, code or other requirement
of law of a Governmental Authority or any Governmental Order.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Company Subsidiary</U>&#148; shall mean a Company Subsidiary that qualifies as a
&#147;significant subsidiary&#148; of the Company as such term is defined in Rule&nbsp;1-02(w) of Regulation&nbsp;S-X
promulgated under the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Business</U>&#148; has the meaning given to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Employee</U>&#148; has the meaning given to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Entities</U>&#148; has the meaning given to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>NYSE</U>&#148; means the New York Stock Exchange.
</DIV>

<P align="center" style="font-size: 10pt">-5-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Option</U>&#148; means, subject to Section&nbsp;3.3(a), each option granted by the Company to
purchase Company Shares pursuant to any of the Stock Plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Material Adverse Effect</U>&#148; means any effect that is materially adverse to the
business, financial condition or results of operations of Parent and its Subsidiaries taken as a
whole, other than any effect to the extent resulting proximately from (i)&nbsp;general economic
conditions or developments or changes therein, (ii)&nbsp;conditions in the industries in which Parent
operates or developments or changes therein, except to the extent that such conditions,
developments or changes impact Parent in a materially disproportionate adverse manner relative to
similarly situated competitors of Parent, (iii)&nbsp;conditions in the stock markets or other capital
markets or developments or changes therein, (iv)&nbsp;the announcement of the Transaction Agreements or
the Transactions, (v)&nbsp;the performance by the Parent of its obligations pursuant to the Transaction
Agreements (except the obligations of Parent to obtain the consents contemplated by Section&nbsp;5.3 and
Section&nbsp;5.4), (vi)&nbsp;any actions taken or omitted to be taken by or at the request or with the
written consent of the Company or (vii)&nbsp;any changes in any Laws or any accounting regulations or
principles, any union organizing activities, labor disputes, strikes, work stoppages or similar
labor unrest or disruption, or (ix)&nbsp;any acts of God, war or terrorism, except to the extent that
such acts impact Parent in a materially disproportionate adverse manner relative to similarly
situated competitors of Parent. A failure by Parent to meet any projections, estimates or budgets
for any period prior to, on or after the date of this Agreement shall not in itself constitute a
Parent Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Proposal</U>&#148; means any Acquisition Proposal relating to the acquisition of, or a
business combination transaction with, Parent, any of its Subsidiaries or some or all of their
respective assets, securities or other ownership interests.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>PCX</U>&#148; means the Pacific Stock Exchange.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Per Share Merger Consideration</U>&#148; means the Cash Consideration and the Stock
Consideration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Permitted Encumbrances</U>&#148; means: (i)&nbsp;Encumbrances that relate to taxes, assessments
and governmental charges or levies imposed upon the Company or a Company Subsidiary that are not
yet due and payable or that are being contested in good faith by appropriate proceedings and for
which reserves have been established in accordance with GAAP on the most recent financial
statements included in the Company SEC Reports filed prior to the date hereof, (ii)&nbsp;Encumbrances
imposed by Law that relate to obligations that are not yet due and have arisen in the ordinary
course of business and consistent with past practice, (iii)&nbsp;pledges or deposits to secure
obligations under workers&#146; compensation laws or similar legislation or to secure public or
statutory obligations, (iv)&nbsp;mechanics&#146;, carriers&#146;, workers&#146;, repairers&#146; and similar Encumbrances
imposed upon the Company or a Company Subsidiary arising or incurred in the ordinary course of
business and consistent with past practice and (v)&nbsp;other Encumbrances on assets which, in the case
of each of clause (iv)&nbsp;and (v)&nbsp;above are, either individually or in the aggregate, not material in
amount and would not reasonably be expected to materially impair the continued use, utility or
value of the property to which they relate in the conduct of the business currently conducted
thereon.
</DIV>

<P align="center" style="font-size: 10pt">-6-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Person</U>&#148; means any individual, partnership, firm, corporation, association, trust,
unincorporated organization, Governmental Authority, joint venture, limited liability company or
other entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Public Proposal</U>&#148; means an Acquisition Proposal (provided that all percentages
included in the definition of &#147;Acquisition Proposal&#148; shall be increased to 50%) that shall have
been publicly announced and not publicly withdrawn.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Qualifying Parent Proposal</U>&#148; means any Parent Proposal that contemplates, and would
not materially delay, the consummation of the Transactions and the Standalone Drug Sale and that is
not otherwise inconsistent with the provisions of the Transaction Agreements and the Standalone
Drug Sale Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Reorganization</U>&#148; has the meaning given to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Business</U>&#148; has the meaning given to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Business Purchase</U>&#148; has the meaning given to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933 and the rules and regulations
promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Separation</U>&#148; has the meaning given to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Site</U>&#148; means each location where the Company or any Company Subsidiary conducts
business, including each Owned Real Property and Leased Real Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug Business</U>&#148; has the meaning given to the term &#147;Business&#148; in the
Standalone Drug Sale Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug Employee</U>&#148; has the meaning given to the word &#147;Employee&#148; in the
Standalone Drug Sale Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug RE Purchase</U>&#148; has the meaning given to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug Sale</U>&#148; means the sale of the Standalone Drug Business pursuant to the
Standalone Drug Sale Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Stock Consideration</U>&#148; means 0.182 Parent Shares for each New Diamond Share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Stock Plans</U>&#148; means the following plans, in each case as amended through the date
hereof: (i)&nbsp;the Albertson&#146;s, Inc. 1995 Amended and Restated Stock-Based Incentive Plan, (ii)&nbsp;the
Albertson&#146;s, Inc. 2004 Equity and Performance Incentive Plan, (iii)&nbsp;the Albertson&#146;s, Inc. 1995
Stock Option Plan for Non-Employee Directors, (iv)&nbsp;the ASC 1997 Stock Option and Stock Award Plan,
(v)&nbsp;the ASC 1997 Stock Plan for Non-Employee Directors, (vi)&nbsp;the ASC 1997A Stock Option and Stock
Award Plan, (vii)&nbsp;the ASC Amended and Restated 1989 Stock Option
</DIV>

<P align="center" style="font-size: 10pt">-7-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">and Stock Award Plan, and (viii)&nbsp;the ASC Amended and Restated 1985 Stock Option and Stock
Award Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Stock Unit</U>&#148; means, subject to Section&nbsp;3.3(d), a right to receive Company Shares
pursuant to a stock unit award under any of the Stock Plans.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Subsidiaries</U>&#148; of a Person means any and all corporations, partnerships, limited
liability companies, trusts and other entities, whether incorporated or unincorporated, with
respect to which such Person, directly or indirectly, legally or beneficially, owns (i)&nbsp;a right to
a majority of the profits of such entity or (ii)&nbsp;securities having the power to elect a majority of
the board of directors or similar body governing the affairs of such entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means all federal, state, provincial, local, territorial and
foreign income, profits, franchise, license, capital, capital gains, transfer, ad valorem, wage,
severance, occupation, import, custom, gross receipts, payroll, sales, employment, use, property,
real estate, excise, value added, goods and services, stamp, alternative or add-on minimum,
environmental, withholding and any other like governmental tax charges, together with all interest,
penalties and additions imposed with respect to such amounts, whether disputed or not and including
any obligations to indemnify or otherwise assume or succeed to the Tax liability of any other
Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Authority</U>&#148; and &#147;<U>Taxing Authority</U>&#148; means any Governmental Authority
responsible for the administration or imposition of any Tax.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Return</U>&#148; or &#147;<U>Tax Returns</U>&#148; means all returns, declarations, reports, claims
for refund or statements relating to Taxes, including any schedule or attachment thereto, and
including any amendment thereof filed or to be filed with any Tax Authority in connection with the
determination, assessment or collection of Taxes.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transaction Agreements</U>&#148; means this Agreement and the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transactions</U>&#148; means the transactions contemplated by the Transaction Agreements,
including the Mergers, the Reorganization, the Separation and the Retained Business Purchase.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 1.2 <U>Other Defined Terms</U>. The following terms have the meanings defined for
such terms in the Sections set forth below:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Term</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Section</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ACM</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.18(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Acquisition Proposal</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Acquisition Sub</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Preamble</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Adjusted Option</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.3(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Advance Contract</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.10(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Preamble</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Benefits Continuation Period</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.13(a)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-8-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Term</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Section</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Blackstone</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.24</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Board of Directors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Capitalization Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash Fraction</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.3(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash-Out Amount</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.3(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Cash-Out Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.3(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Certificate</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.6(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Charter Amendment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2(a)(i)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3(d)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Closing Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3(d)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Preamble</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Balance Sheet Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.8</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Board of Directors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Board Recommendation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2(a)(ii)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Disclosure Letter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Article IV</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Employees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.13(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Form&nbsp;10-K</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Article IV</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Intellectual Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.17(a)(i)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.13(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company SEC Reports</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.7(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.1(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Stockholders Meeting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2(a)(i)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Company Termination Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.2(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Compensation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.13(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current Employee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.13(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">CVS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Debt and Purchase Contract Assumption</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6(h)(ii)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Deferred Compensation Distribution</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.13(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">DGCL</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diamond Certificate of Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diamond LLC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-9-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Term</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Section</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diamond LLC Conversion</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diamond Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Diamond Reorganization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.17</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Dissenting Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.5(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Effective Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3(e)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Emerald Certificate of Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3(e)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Emerald Merger</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Environmental Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.18(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Environmental Permits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.18(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Financing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.11</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Financing Commitment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.11</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">First Operating Year</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.10(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Form&nbsp;S-4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.3(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">F Reorg</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.17</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Goldman Sachs</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.24</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HITS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HITS Indenture</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.22(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HITS Purchase Contract Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.22(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">HSR Clearance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6(d)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Indemnified Directors and Officers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.8(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Initial Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Initial Closing Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Initial Effective Time</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.3(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">IRS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.13(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Leased Real Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.15(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Lucky Delaware</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.17</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">LYONs</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Material Contract</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.10(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Materials of Environmental Concern</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.18(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Mergers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Multiemployer Plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.13(a)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-10-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Term</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Section</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">New Diamond</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Preamble</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">New Diamond Merger Sub</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Preamble</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">New Diamond Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.1(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Objection</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6(d)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Owned Real Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.15(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Preamble</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Balance Sheet Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.7</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Board of Directors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Board Recommendation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Disclosure Letter</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Article V</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Form&nbsp;10-K</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Article V</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.13(d)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Rights Plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent SEC Reports</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.6(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Shares</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Stockholders Meeting</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.2(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Parent Termination Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.2(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Paying Agent</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">3.6(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">PBGC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.13(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Pledge Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6(h)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Proxy Statement/Prospectus</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.3(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Real Property Lease</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.15(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Regulatory Termination Fee</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.2(d)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Remarketing Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.6(h)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Representatives</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Requisite Company Stockholder Vote</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.2(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Requisite Parent Stockholder Vote</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.2(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Rights Plan</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">SEC</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.7(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Separate Balance Sheet Data</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.7(b)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Separate Operations Data</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.7(b)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">-11-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="77%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="18%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Term</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Section</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Separation Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Share Issuance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">5.2(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Standalone Drug Sale Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Recitals</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Superior Proposal</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">6.5(a)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Surviving Corporation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2.2</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Termination Date</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">8.1(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Third Party Use and Occupancy Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.15(c)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Withdrawal Liability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">4.13(d)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE II</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>MERGERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.1 <U>The Diamond Merger</U>. Upon the terms and subject to the conditions of this
Agreement and in accordance with the DGCL, at the Initial Effective Time (as defined below), New
Diamond Merger Sub shall be merged with and into the Company. As a result of the Diamond Merger,
the separate corporate existence of New Diamond Merger Sub shall cease and the Company shall
continue as the surviving corporation in the Diamond Merger and as a wholly owned subsidiary of New
Diamond.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.2 <U>The Emerald Merger</U>. Upon the terms and subject to the conditions of this
Agreement and in accordance with the DGCL, at the Effective Time (as defined below), Acquisition
Sub shall be merged with and into New Diamond. As a result of the Emerald Merger, the separate
corporate existence of Acquisition Sub shall cease and New Diamond shall continue as the surviving
corporation in the Emerald Merger (the &#147;<U>Surviving Corporation</U>&#148;) and as a wholly owned
subsidiary of Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.3 <U>Closing; Effective Time</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to the provisions of Article&nbsp;VII, the closing of the Diamond Merger (the
&#147;<U>Initial Closing</U>&#148;) shall take place at the offices of Jones Day, 222 West 41st Street, New
York, New York 10017, at 9:00 a.m. local time, as soon as practicable, but in no event later than
the second Business Day after the satisfaction or waiver of the conditions set forth in Article&nbsp;VII
(excluding conditions that, by their terms, cannot be satisfied until the Closing, as defined
below, but the Closing shall be subject to the satisfaction or waiver of those conditions), or at
such other place or at such other date or time as Parent and the Company may mutually agree. The
date on which the Initial Closing actually occurs is hereinafter referred to as the &#147;<U>Initial
Closing Date</U>.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Subject to the provisions of this Agreement, as soon as practicable after 9:00 a.m. local
time on the Initial Closing Date, the parties hereto shall cause the Diamond Merger to be
consummated by filing a certificate of merger (the &#147;<U>Diamond Certificate of Merger</U>&#148;) with
the Secretary of State of the State of Delaware, in such form as required by, and executed in
</DIV>

<P align="center" style="font-size: 10pt">-12-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">accordance with, the relevant provisions of the DGCL (the date and time of the filing of the
Diamond Certificate of Merger
with the Secretary of State of the State of Delaware, or such later
time as is specified in the Diamond Certificate of Merger and as is agreed to by Parent and the
Company, being the &#147;<U>Initial Effective Time</U>&#148;) and shall make all other filings or recordings
required under the DGCL in connection with the Diamond Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As soon as practicable after the Initial Effective Time, but in any event before the
Effective Time (as defined below), the parties hereto shall effect the Diamond LLC Conversion and
then shall effect the other transactions set forth in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Subject to the provisions of Article&nbsp;VII, the closing of the Emerald Merger (the
&#147;<U>Closing</U>&#148;) shall take place at the offices of Jones Day, 222 West 41st Street, New York,
New York 10017, at 10:00&nbsp;a.m. local time, on the Initial Closing Date or as promptly as practicable
thereafter (and in no case more than two Business Days thereafter), or at such other place or at
such other date or time as Parent and the Company may mutually agree. The date on which the
Closing actually occurs is hereinafter referred to as the &#147;<U>Closing Date</U>.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Subject to the provisions of this Agreement, as soon as practicable after 10:00&nbsp;a.m. local
time on the Closing Date, the parties hereto shall cause the Emerald Merger to be consummated by
filing a certificate of merger (the &#147;<U>Emerald Certificate of Merger</U>&#148;) with the Secretary of
State of the State of Delaware, in such form as required by, and executed in accordance with, the
relevant provisions of the DGCL (the date and time of the filing of the Emerald Certificate of
Merger with the Secretary of State of the State of Delaware, or such later time as is specified in
the Emerald Certificate of Merger and as is agreed to by Parent and New Diamond, being the
&#147;<U>Effective Time</U>&#148;) and shall make all other filings or recordings required under the DGCL in
connection with the Emerald Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.4 <U>Effects of the Mergers</U>. The Mergers shall have the effects set forth in
this Agreement and the applicable provisions of the DGCL. Without limiting the generality of the
foregoing and subject thereto, (i)&nbsp;at the Initial Effective Time, all the property, rights,
privileges, immunities, powers and franchises of the Company and New Diamond Merger Sub shall vest
in the Company as the surviving corporation in the Diamond Merger and all debts, liabilities and
duties of the Company and New Diamond Merger Sub shall become the debts, liabilities and duties of
the Company as the surviving corporation in the Diamond Merger, and (ii)&nbsp;at the Effective Time, all
the property, rights, privileges, immunities, powers and franchises of New Diamond and Acquisition
Sub shall vest in the Surviving Corporation and all debts, liabilities and duties of New Diamond
and Acquisition Sub shall become the debts, liabilities and duties of the Surviving Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.5 <U>Certificate of Incorporation; By-Laws</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;At the Initial Effective Time, (i)&nbsp;the restated certificate of incorporation of the
Company, as in effect immediately prior to the Initial Effective Time, shall be amended in its
entirety in the form attached hereto as <U>Exhibit&nbsp;A-1</U> and as so amended shall be the restated
certificate of incorporation of the Company, as the surviving corporation in the Diamond Merger,
and (ii)&nbsp;the by-laws of the Company shall be amended and
restated to read in their entirety in the
form attached hereto as <U>Exhibit&nbsp;A-2</U> and, as so amended, shall be the amended and
</DIV>

<P align="center" style="font-size: 10pt">-13-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">restated
by-laws of the Company until thereafter amended in accordance with their terms, the restated
certificate of incorporation of the Company and applicable law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Immediately prior to the Initial Effective Time, the certificate of incorporation and the
by-laws of New Diamond shall be amended and restated to read in their entirety in the form attached
hereto as <U>Exhibits B</U> and <U>C</U>, respectively.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;At the Effective Time, (i)&nbsp;the amended and restated certificate of incorporation of New
Diamond shall be amended so as to read in its entirety in the form annexed hereto as <U>Exhibit
D</U>, and, as so amended, shall be the amended and restated certificate of incorporation of the
Surviving Corporation until thereafter amended in accordance with its terms and applicable Law, and
(ii)&nbsp;the restated by-laws of New Diamond shall be amended so as to read in their entirety in the
form annexed hereto as <U>Exhibit&nbsp;E</U>, and, as so amended, shall be the amended and restated
by-laws of the Surviving Corporation until thereafter amended in accordance with their terms, the
amended and restated certificate of incorporation of the Surviving Corporation and applicable Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 2.6 <U>Directors and Officers</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company and New Diamond shall take the necessary actions to cause the directors and
officers of the Company immediately prior to the Initial Effective Time to be the directors and
officers of New Diamond from and after the Initial Effective Time. Immediately prior to the
Retained Business Purchase, the directors of the Company shall submit resignations to be effective
as of the consummation of the Retained Business Purchase.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Immediately prior to the Effective Time, the directors of New Diamond shall submit their
resignations to be effective as of the Effective Time. Parent shall take the necessary actions to
cause the directors of Acquisition Sub immediately prior to the Effective Time to be the directors
of the Surviving Corporation from and after the Effective Time, each to hold office in accordance
with the restated certificate of incorporation and by-laws of the Surviving Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The officers of New Diamond immediately prior to the Effective Time shall be the officers
of the Surviving Corporation, each to hold office until the earlier of his or her resignation or
removal.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE III</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EFFECT OF THE MERGERS ON CAPITAL STOCK OF THE CONSTITUENT<BR>
CORPORATIONS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.1 <U>Effect of the Diamond Merger on Capital Stock</U>. At the Initial Effective
Time, by virtue of the Diamond Merger and without any action on the part of any party hereto or any
holder of any of the following securities:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each share (or fraction of a share) of Common Stock, par value $1.00 per share, of the
Company (the &#147;<U>Company Shares</U>&#148;) issued and outstanding immediately prior to the Initial
Effective Time (other than any Company Shares to be canceled pursuant to Section&nbsp;3.1(b) and
</DIV>

<P align="center" style="font-size: 10pt">-14-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any
Dissenting Shares (as defined in Section&nbsp;3.5(b))) shall be converted into the right to receive one
(1)&nbsp;fully paid and nonassessable share (or an equal fraction of a share, if applicable) of Common
Stock, par value $0.01 per share, of New Diamond (the &#147;<U>New Diamond Shares</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each Company Share held in the treasury of the Company immediately prior to the Initial
Effective Time shall be canceled without any conversion thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each New Diamond Share held by the Company immediately prior to the Initial Effective Time
shall be canceled.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each share of common stock of New Diamond Merger Sub issued and outstanding immediately
prior to the Initial Effective Time shall be converted into one share of Common Stock of the
Company as the surviving corporation of the Diamond Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.2 <U>Effect of the Emerald Merger on Capital Stock</U>. At the Effective Time, by
virtue of the Emerald Merger and without any action on the part of Parent, Acquisition Sub, New
Diamond or the holders of any of the following securities:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each New Diamond Share issued and outstanding immediately prior to the Effective Time
(other than any Shares to be canceled pursuant to Section&nbsp;3.2(b)) shall be converted into the right
to receive the Per Share Merger Consideration from Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each New Diamond Share held in the treasury of New Diamond, or owned by Parent, the
Company, New Diamond or any wholly owned direct or indirect Subsidiary of the Company, Parent or
New Diamond, in each case immediately prior to the Effective Time, shall be canceled without any
conversion thereof and no consideration shall be paid with respect thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each share of common stock of Acquisition Sub issued and outstanding immediately prior to
the Effective Time shall be converted into one share of common stock of the Surviving Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.3 <U>Treatment of Options and Other Equity Awards</U>. Prior to the Initial
Effective Time, the Company and New Diamond, and the Company Board
of Directors and the New Diamond Board of Directors, as applicable, shall take all action
necessary, including a resolution of such boards (or a committee thereof), such that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each Option that is outstanding and unexercised as of immediately prior to the Initial
Effective Time shall be assumed by New Diamond at the Initial Effective Time, and shall continue to
have, and be subject to, the same terms and conditions (and shall have the same date of grant) as
were applicable under the Stock Plans and any applicable agreements thereunder immediately before
the Initial Effective Time, except that each Option will be exercisable for a number of New Diamond
Shares equal to the number of Company Shares that were issuable upon exercise of such option
immediately prior to the Initial Effective Time. For the avoidance of doubt, the term &#147;Option&#148;
after the Initial Effective Time shall mean an option to purchase New Diamond Shares pursuant to
any of the Stock Plans, as assumed by New Diamond at the Initial Effective Time.
</DIV>

<P align="center" style="font-size: 10pt">-15-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each Option that is outstanding and unexercised as of immediately prior to the Effective
Time, whether or not vested or exercisable, and that is not held by a New Diamond Employee shall be
canceled by New Diamond, and the holder of such Option shall receive, in full settlement thereof,
an amount of cash (the &#147;<U>Cash-Out Amount</U>&#148;), without interest, equal to the product of (i)
the total number of New Diamond Shares subject to such Option multiplied by (ii)&nbsp;the excess, if
any, of the sum of (x) (A)&nbsp;the number of Parent Shares represented by the Stock Consideration
multiplied by (B)&nbsp;the Average Closing Price plus (y)&nbsp;the Cash Consideration (such sum, the
&#147;<U>Cash-Out Price</U>&#148;) over the exercise price per New Diamond Share subject to such Option
(with the aggregate amount of such payment to the holder to be rounded to the nearest cent), less
applicable Taxes, if any, required to be withheld with respect to such payment; <U>provided</U>,
<U>however</U>, that if the holder of such Option is a non-employee director of New Diamond, such
holder shall not receive the full Cash-Out Amount in cash, but shall instead receive (x)&nbsp;an amount
in cash (rounded to the nearest cent) equal to the product of (1)&nbsp;the Cash-Out Amount multiplied by
(2)&nbsp;a fraction (the &#147;<U>Cash Fraction</U>&#148;), the numerator of which is the Cash Consideration and
the denominator of which is the sum of (a)&nbsp;the Cash Consideration plus (b)&nbsp;the product of (i)&nbsp;the
Stock Consideration multiplied by (ii)&nbsp;the Average Closing Price, and (y)&nbsp;a number of Parent Shares
(rounded to the nearest share) equal to a fraction, the numerator of which is the product of (1)
the Cash-Out Amount multiplied by (2) (a)&nbsp;1.0 minus (b)&nbsp;the Cash Fraction, and the denominator of
which is the Average Closing Price.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each Option that is outstanding and unexercised as of immediately prior to the Effective
Time and that is held by a New Diamond Employee (whether or not vested or exercisable) shall be
assumed by Parent at the Effective Time. To the extent permitted under the Stock Plans, all such
outstanding Options shall accelerate and become immediately exercisable in connection with the
Mergers in accordance with the terms of the Stock Plans and any applicable agreements thereunder.
Except for the acceleration of the Options in accordance with the terms of the Stock Plans and any
applicable agreements thereunder, at the Effective Time, each Option so assumed by Parent under
this Agreement (an &#147;<U>Adjusted Option</U>&#148;) shall continue to have, and be subject to, the same
terms and conditions as were applicable under the Stock Plans and any applicable agreements
thereunder immediately before the Initial Effective Time, except that (i)&nbsp;each Adjusted Option will
be exercisable for that number of Parent Shares (rounded up or down to the nearest share, and
rounded up in the case of half a share) equal to the product of (x)&nbsp;the number of New Diamond
Shares that were issuable upon exercise of such
option immediately prior to the Effective Time multiplied by (y)&nbsp;the sum of (A)&nbsp;the Stock
Consideration, plus (B) (1)&nbsp;the Cash Consideration divided by (2)&nbsp;the Average Closing Price, and
(ii)&nbsp;the per share exercise price for the Parent Shares issuable upon exercise of such Adjusted
Option will be equal to the quotient (rounded up or down to the nearest cent) determined by
dividing (x)&nbsp;the per share exercise price of such Option immediately prior to the Effective Time by
(y)&nbsp;the sum of (A)&nbsp;the Stock Consideration plus (B) (1)&nbsp;the Cash Consideration, divided by (2)&nbsp;the
Average Closing Price. The date of grant of each Adjusted Option will be the date on which the
corresponding Option was granted. In the event that the holder of an Adjusted Option would be
precluded by applicable securities laws from disposing of Parent Shares acquired upon exercise of
such option during the 60-day period beginning on the Closing Date, Parent will (to the extent
permitted by applicable Law) make available a &#147;cashless exercise&#148; opportunity to such holder during
such period unless such cashless exercise would result in an accounting impact for Parent that is
both adverse to Parent and likely to continue beyond the 60-day period beginning on the Closing
Date.
</DIV>

<P align="center" style="font-size: 10pt">-16-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each Stock Unit that is outstanding as of immediately prior to the Initial Effective Time
shall be assumed by New Diamond at the Initial Effective Time, and shall continue to have, and be
subject to, the same terms and conditions as were applicable immediately before the Initial
Effective Time, except that each Stock Unit will become a right to receive a number of New Diamond
Shares equal to the number of Company Shares that would be received for such Stock Unit immediately
prior to the Initial Effective Time. Each Stock Unit that is outstanding as of immediately prior
to the Effective Time (other than Stock Units granted pursuant to the exception provided in Section
6.1 of the Company Disclosure Letter), whether or not vested, will, as of the Effective Time,
entitle the holder thereof to receive the Per Share Merger Consideration and shall continue to
have, and be subject to, the same terms and conditions as were applicable immediately before the
Effective Time, provided that each holder of a Stock Unit that is outstanding as of immediately
prior to the Effective Time, whether or not vested, may elect, prior to the Effective Time, to
receive payment of such Stock Unit upon the earlier of (1)&nbsp;the existing payment date under the
current terms of the Stock Units (subject to any change in the existing payment date that is
required to comply with Section&nbsp;409A of the Code) or (2)&nbsp;the later of (x)&nbsp;the Effective Time or (y)
January&nbsp;1, 2007. The Company may adopt such amendments to the Stock Units as it deems necessary or
appropriate to effectuate the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Prior to the Initial Effective Time, the Company shall use its reasonable best efforts to
take or cause to be taken all actions necessary to effectuate the foregoing treatment in this
Section&nbsp;3.3 to the extent such treatment is not expressly provided for by the terms of the
applicable equity compensation plans and related award agreements. All payments under this Section
3.3 shall be made no later than five (5)&nbsp;Business Days following the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Parent shall take all corporate action necessary to reserve for issuance a sufficient
number of Parent Shares for delivery upon exercise of Adjusted Options pursuant to the terms set
forth in Section&nbsp;3.3(c). As soon as practicable following the Effective Time, Parent shall cause
the Parent Shares subject to the Adjusted Options to be covered by an effective registration
statement on Form S-8 (or any successor form) or another appropriate form and Parent shall use its
reasonable best efforts to maintain the effectiveness of such registration statement for so long
as any Adjusted Options remain outstanding. In addition, Parent shall use its reasonable best
efforts to cause the Parent Shares subject to the Adjusted Options to be listed on the NYSE.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The parties will make good faith efforts to make equitable adjustments if necessary to
ensure that the provisions of this Section&nbsp;3.3 comply with Section&nbsp;409A of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.4 <U>Adjustment of Merger Consideration</U>. Notwithstanding anything in this
Agreement to the contrary, if, (a)&nbsp;between the date of this Agreement and the Closing Date, the
issued and outstanding Company Shares (prior to the Initial Effective Time) or New Diamond Shares
(after the Initial Effective Time), or the issued and outstanding Parent Shares, shall have been
changed into a different number of shares or a different class by reason of any stock split,
reverse stock split, stock dividend (other than dividend equivalents paid to members of the Company
Board of Directors under the terms of Stock Units outstanding on the date hereof),
reclassification, or redenomination, or (b)&nbsp;at the Initial Effective Time, the Company&#146;s
representation and warranties in Section&nbsp;4.5 (Capitalization of the Company) or Parent&#146;s
</DIV>

<P align="center" style="font-size: 10pt">-17-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">representations and warranties in Section&nbsp;5.5 (Capitalization) are not true in any non-de minimis
respect relating to the number of fully diluted shares outstanding, then the Per Share Merger
Consideration, the Cash-Out Price and any other dependent items (1)&nbsp;shall be appropriately
adjusted, in the case of (a)&nbsp;above, to provide to the holders of New Diamond Shares the same
economic effect as contemplated by this Agreement prior to such action and as so adjusted shall,
from and after the date of such event, be the Per Share Merger Consideration, the Cash-Out Price or
other dependent item, subject to further adjustment in accordance with this sentence, and/or (2)
shall be appropriately adjusted, in the case of (b)&nbsp;above, to provide to New Diamond and Parent and
their respective stockholders the same economic effect as contemplated by this Agreement assuming
such representations and warranties are true and correct in all such respects as written and as so
adjusted shall be the Per Share Merger Consideration, the Cash-Out Price or other dependent item,
subject to further adjustment in accordance with this sentence.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.5 <U>Dissenting Shares</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;No appraisal rights shall be available to holders of New Diamond Shares in connection with
the Emerald Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the event the Charter Amendment is approved and the Effective Time occurs, Company
Shares that are issued and outstanding immediately prior to the Initial Effective Time and which
are held by holders of Company Shares who have not voted in favor of or consented to the adoption
of this Agreement and who have properly taken the steps required in order to demand and perfect
their rights to appraisal in connection with the Diamond Merger, in accordance with Section&nbsp;262 of
the DGCL (the &#147;<U>Dissenting Shares</U>&#148;) shall not be converted into the right to receive New
Diamond shares in accordance with Section&nbsp;3.1(a), and the holders thereof instead shall be entitled
to only such rights as are granted by Section&nbsp;262 of the DGCL and the restated certificate of
incorporation of the Company; <U>provided</U>, <U>however</U>, that if any such stockholder of
the Company shall fail to perfect or shall effectively waive, withdraw or lose such stockholder&#146;s
rights under Section&nbsp;262 of the DGCL, such stockholder&#146;s Company Shares in
respect of which the stockholder would otherwise be entitled to receive fair value under
Section&nbsp;262 of the DGCL shall thereupon be deemed to have been converted, at the Initial Effective
Time, into New Diamond Shares in accordance with Section&nbsp;3.1(a) (which New Diamond Shares shall be
converted into the Per Share Merger Consideration in the Emerald Merger in accordance with Section
3.2(a)). In the event the Charter Amendment is not approved or the Effective Time does not occur,
no appraisal rights shall be available to holders of Company Shares in connection with the Diamond
Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Company shall give Parent (i)&nbsp;prompt notice of any notice received by Company of the
intent of any holder of Company Shares to demand the fair value of any Company Shares in the
Diamond Merger, any written demand for appraisal, any withdrawals thereof and any instruments
served pursuant to Section&nbsp;262 of the DGCL and received by the Company, and (ii)&nbsp;the opportunity to
direct all negotiations and proceedings with respect to the exercise of dissenters&#146; rights under
Section&nbsp;262 of the DGCL. The Company shall not, except with the prior written consent of Parent or
as otherwise required by an order, decree, ruling or injunction of a court of competent
jurisdiction, make any payment with respect to any such exercise of dissenters&#146; rights or offer to
settle or settle any such rights.
</DIV>

<P align="center" style="font-size: 10pt">-18-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The parties shall cooperate to take any reasonable steps requested by another party that
may be necessary to (i)&nbsp;provide appraisal rights to holders of Company Shares as contemplated by
Section&nbsp;3.5(b), and (ii)&nbsp;ensure that no appraisal rights are available in connection with the
Emerald Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 3.6 <U>Payment and Exchange of Certificates</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Following the date of this Agreement and in any event not less than three Business Days
prior to the mailing of the Proxy Statement/Prospectus to the stockholders of the Company, Parent
or Acquisition Sub shall designate a bank or trust company reasonably acceptable to the Company to
act as Paying Agent in connection with the Mergers (the &#147;<U>Paying Agent</U>&#148;). At or prior to
the Effective Time, Parent will cause to be deposited in trust with the Paying Agent the aggregate
consideration to which stockholders of the Company are contemplated to become entitled under this
Article&nbsp;III. Until used for that purpose, the portion of such aggregate consideration consisting
of cash shall be invested by the Paying Agent, as directed by Parent or the Surviving Corporation,
in obligations of or guaranteed by the United States of America or obligations of an agency of the
United States of America which are backed by the full faith and credit of the United States of
America, or in commercial paper obligations rated A-1 or P-1 or better by Moody&#146;s Investors
Service, Inc. or Standard &#038; Poor&#146;s Corporation; <U>provided</U> that no such investment or losses
thereon shall affect the Per Share Merger Consideration payable to former stockholders of New
Diamond, and Parent shall promptly provide, or shall cause the Surviving Corporation to promptly
provide, additional funds to the Paying Agent for the benefit of the former stockholders of New
Diamond in the amount of any shortfall in funds payable to the former stockholders of New Diamond
pursuant to this Article&nbsp;III.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;From and after the Initial Effective Time, (i)&nbsp;each stock certificate which immediately
prior to the Initial Effective Time represented Company Shares (other than
Dissenting Shares) shall be deemed to represent an equal number of New Diamond Shares (each
such stock certificate, a &#147;<U>Certificate</U>&#148;), and (ii)&nbsp;each holder of record of Company Shares
(other than Dissenting Shares) immediately prior to the Initial Effective Time shall be deemed to
be a holder of record of the same number of New Diamond Shares.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Promptly after the Effective Time (and in any event within two Business Days following the
Effective Time), the Surviving Corporation shall cause the Paying Agent to mail to each Person who
was a record holder of New Diamond Shares immediately prior to the Effective Time, whose New
Diamond Shares were converted pursuant to this Article&nbsp;III into the right to receive the Per Share
Merger Consideration, (i)&nbsp;a form of letter of transmittal for use in effecting the surrender of
Certificates in order to receive payment of the Per Share Merger Consideration (which shall specify
that delivery shall be effected, and risk of loss and title to the Certificate shall pass, only
upon actual delivery of the Certificates to the Paying Agent, and shall otherwise be in customary
form), and (ii)&nbsp;instructions for use in effecting the surrender of the Certificates in exchange for
payment of the Per Share Merger Consideration. When the Paying Agent receives a Certificate,
together with a properly completed and executed letter of transmittal and any other required
documents, the Paying Agent shall deliver to the holder of the New Diamond Shares represented by
the Certificate, or as otherwise directed in the letter of transmittal, (A)&nbsp;a cash amount in
immediately available funds equal to the aggregate Cash Consideration into
</DIV>

<P align="center" style="font-size: 10pt">-19-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">which all of the New
Diamond Shares represented by such Certificate shall have been converted pursuant to the Emerald
Merger, (B)&nbsp;a certificate representing that number of whole Parent Shares into which the New
Diamond Shares represented by such Certificate shall have been converted pursuant to the Emerald
Merger, (C)&nbsp;any cash in lieu of a fractional Parent Share to which such holder shall be entitled
pursuant to Section&nbsp;3.6(h), and (D)&nbsp;any dividends or other distributions to which such holder shall
be entitled pursuant to Section&nbsp;3.6(i). Any payment hereunder shall be less any required Tax
withholdings in accordance with Section&nbsp;3.6(d) below, and the Certificate shall be canceled. No
interest shall be paid or accrued on the Per Share Merger Consideration payable upon the surrender
of Certificates. If payment is to be made to a Person other than the Person in whose name a
surrendered Certificate is registered, it shall be a condition of payment that the Certificate so
surrendered must be properly endorsed or otherwise be in proper form for transfer, and the Person
who surrenders the Certificate must provide funds for payment of any transfer or other Taxes
required by reason of the payment to a Person other than the registered holder of the surrendered
Certificate or establish to the satisfaction of the Surviving Corporation that the Tax has been
paid or is not applicable. After the Effective Time, a Certificate shall represent only the right
to receive the Per Share Merger Consideration in respect of the New Diamond Shares represented by
such Certificate, without any interest thereon.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Paying Agent may withhold from the sum payable to any Person as a result of the
Emerald Merger, and pay to the appropriate Taxing Authorities, any amounts that the Paying Agent or
the Surviving Corporation may be required (or may reasonably believe it is required) to withhold
under the Code, or any provision of state, local or foreign Tax Law. Any sum that is withheld and
paid to a Taxing Authority as permitted by this Section will be deemed to have been paid to the
Person from whom it is withheld.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In the event that any Certificate shall have been lost, stolen or destroyed, upon the
holder&#146;s compliance with the reasonable replacement requirements established by the Paying
Agent, the Paying Agent shall deliver in exchange for the lost, stolen or destroyed
Certificate the applicable Per Share Merger Consideration payable in respect of the New Diamond
Shares represented by the Certificate pursuant to this Article&nbsp;III.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;At any time which is more than 180&nbsp;days after the Effective Time, Parent shall be entitled
to require the Paying Agent to deliver to it any funds and shares which had been deposited with the
Paying Agent and have not been disbursed in accordance with this Article&nbsp;III (including interest
and other income received by the Paying Agent in respect of the funds made available to it), and
after the funds and shares have been delivered to Parent, Persons entitled to payment in accordance
with this Article&nbsp;III shall be entitled to look solely to Parent (subject to abandoned property,
escheat or other similar Laws) for payment of the Per Share Merger Consideration upon surrender of
the Certificates held by them, without any interest thereon. Any Per Share Merger Consideration
remaining unclaimed as of a date which is immediately prior to such time as such amounts would
otherwise escheat to or become property of any government entity shall, to the extent permitted by
applicable Law, become the property of Parent free and clear of any claims or interest of any
Person previously entitled thereto. Neither the Surviving Corporation, Parent nor the Paying Agent
will be liable to any Person entitled to payment under this Article&nbsp;III for any consideration which
is properly delivered to a public official pursuant to any abandoned property, escheat or similar
Law.
</DIV>

<P align="center" style="font-size: 10pt">-20-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;At the Effective Time, the stock transfer books of New Diamond shall be closed and
thereafter there shall be no further registration of transfers of New Diamond Shares that were
outstanding prior to the Effective Time. After the Effective Time, Certificates presented to the
Surviving Corporation for transfer shall be canceled and exchanged for the Per Share Merger
Consideration in respect of the New Diamond Shares represented thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;No certificates or scrip representing fractional Parent Shares will be issued upon the
surrender for exchange of Certificates, no dividend or distribution of Parent will relate to such
fractional share interests and such fractional share interests will not entitle the owner thereof
to vote or to any rights of a stockholder of Parent. Notwithstanding any other provision of this
Agreement, each holder of New Diamond Shares converted pursuant to the Emerald Merger who would
otherwise be entitled to receive a fraction of a Parent Share (after taking into account all New
Diamond Shares held at the Effective Time by such holder) shall receive, in lieu thereof and in
accordance with Section&nbsp;3.6(i), an amount in cash (without interest), rounded to the nearest cent,
equal to the product obtained by multiplying (i)&nbsp;the fractional share interest to which such former
holder would otherwise be entitled by (ii)&nbsp;the Average Closing Price.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;No cash payment in lieu of fractional shares and no dividends or other distributions with
respect to Parent Shares with a record date after the Effective Time will be paid to any holder of
an unsurrendered Certificate until the surrender of such Certificate in accordance with this
Article&nbsp;III. Subject to the effect of applicable escheat or similar Laws, following the surrender
of any such Certificate in accordance herewith, there will be paid to the holder of the New Diamond
Shares represented by such Certificate or as otherwise directed by the related letter of
transmittal, without interest, (i)&nbsp;at the time of such surrender, the amount of any cash payable in
lieu of a fractional Parent Share to which such holder is entitled pursuant to Section&nbsp;3.6(h) and
the amount of dividends or other distributions with a record date after the Effective Time
theretofore paid with respect to whole Parent Shares to which such holder is
entitled pursuant to Section&nbsp;3.6(c), and (ii)&nbsp;at the appropriate payment date, the amount of
dividends or other distributions with a record date after the Effective Time but prior to such
surrender and with a payment date subsequent to such surrender payable with respect to such whole
Parent Shares. Pending such payment, all such amounts shall be deposited by Parent, as promptly as
practicable, with the Paying Agent, to be held in trust by the Paying Agent for the benefit of the
applicable holders of unsurrendered Certificates.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;Holders of unsurrendered Certificates shall be entitled to vote after the Effective Time
at any meeting of Parent stockholders the number of whole Parent Shares the holder of such
Certificates would be entitled to receive in the Emerald Merger, regardless of whether such holders
have exchanged their Certificates.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IV</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY, NEW DIAMOND, AND NEW DIAMOND MERGER SUB</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in the corresponding sections of the disclosure letter (subject to the
provisions of Section&nbsp;9.2) delivered by the Company to Parent on or prior to the execution of this
Agreement (the &#147;<U>Company Disclosure Letter</U>&#148;) and except as disclosed in the Form 10-K of the
</DIV>

<P align="center" style="font-size: 10pt">-21-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company for the fiscal period ended February&nbsp;3, 2005, as amended through the date hereof (as
amended, the &#147;<U>Company Form&nbsp;10-K</U>&#148;), the Proxy Statement for the Company&#146;s 2005 Annual
Meeting of Shareholders, and the Form 10-Qs and Form 8-Ks filed or furnished from the date of the
filing of the Company Form 10-K to the date of this Agreement (and any amendments to any such
filings which amendments are filed with the SEC prior to the date hereof) to the extent such
qualifications are reasonably apparent (and which in no event shall include risk factors or other
factors identified in general cautionary statements regarding reliance on forward looking
statements in either case included in the Company SEC Reports); and <U>provided</U> that in this
Article&nbsp;IV, except for this sentence and the representations and warranties contained in Section
4.1 (Organization), Section&nbsp;4.2(a) and (c) (Authority; Enforceability), Section&nbsp;4.5 (Capitalization
of the Company), Section&nbsp;4.7 (SEC Reports; Financial Information), Section&nbsp;4.10(a)(iv), (x)&nbsp;and
(xi) (Contracts), Section&nbsp;4.13 (Employee Compensation and Benefit Plans; ERISA), Section&nbsp;4.14
(Labor Matters), Section&nbsp;4.19 (Tax) and Section&nbsp;4.20 (Insurance), all references to the &#147;Company&#148;
or to the &#147;Company Subsidiaries&#148; shall (1)&nbsp;prior to the Separation, be deemed to refer to the
Company or to the Company Subsidiaries, as applicable, in relation to the New Diamond Business, and
(2)&nbsp;following the Separation, be deemed to refer to New Diamond or to its Subsidiaries, as
applicable, in relation to the New Diamond Business; the Company hereby represents and warrants to
Parent and Acquisition Sub that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.1 <U>Organization</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of the Company and the Company Subsidiaries is duly organized, validly existing and
in good standing under the laws of its respective jurisdiction of organization, and has the
requisite corporate or similar power and authority to own its properties and to carry on its
business as presently conducted and is duly qualified to do business and is in good standing

(where such concept exists) as a foreign corporation or other entity in each jurisdiction in
which the nature of its business or the ownership or leasing of its properties makes such
qualification necessary, except where the failure to be so organized, qualified or in good standing
or have such power or authority would not reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect. Complete and correct copies of the certificate of
incorporation and by-laws of the Company and of the certificate of incorporation and the by-laws or
the equivalent organizational documents of each of the Material Company Subsidiaries as currently
in effect have been made available to Parent and, as so made available, are in full force and
effect, and no other organizational documents are applicable to or binding upon the Company or such
Material Company Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;New Diamond is a Delaware corporation and, as of the date hereof, a wholly owned
subsidiary of the Company. It was formed solely for the purpose of engaging in the Transactions
and, prior to the Initial Effective Time, has engaged in no business activities and has conducted
no operations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;New Diamond Merger Sub is a Delaware corporation and, as of the date hereof, a wholly
owned subsidiary of New Diamond. It was formed solely for the purpose of engaging in the
transactions contemplated hereby and, prior to the Initial Effective Time, has engaged in no
business activities and has conducted no operations.
</DIV>

<P align="center" style="font-size: 10pt">-22-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.2 <U>Authority; Enforceability</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company has all necessary corporate power and authority to execute and deliver this
Agreement, to perform its obligations hereunder and to consummate the transactions contemplated
hereby. The execution, delivery and performance by the Company of this Agreement and the
consummation by the Company of the transactions contemplated hereby have been duly and validly
authorized by all necessary corporate action on the part of the Company and no other corporate
proceedings on the part of the Company are necessary pursuant to its governing documents or the
DGCL to authorize this Agreement or to consummate the transactions contemplated hereby (other than,
with respect to the Diamond Merger, the adoption of this Agreement and the Charter Amendment by the
holders of a majority of the outstanding Company Shares) (the &#147;<U>Requisite Company Stockholder
Vote</U>&#148;)). The Company Board of Directors has (i)&nbsp;approved this Agreement and the transactions
contemplated hereby, (ii)&nbsp;determined that the terms of this Agreement are fair to and in the best
interests of the Company and its stockholders, and (iii)&nbsp;declared the advisability of this
Agreement. This Agreement has been duly executed and delivered by the Company and, assuming due
authorization, execution and delivery by the other parties hereto, constitutes a legal, valid and
binding agreement of the Company enforceable against the Company in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
and other similar Laws relating to or affecting creditors&#146; rights generally and general equitable
principles (whether considered in a proceeding in equity or at law).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Attached as <U>Exhibit&nbsp;G</U> hereto is a true and correct copy of the Standalone Drug
Sale Agreement. The Company has all requisite power and authority to enter into the Standalone
Drug Sale Agreement and consummate the Standalone Drug Sale, and such agreement has been
duly and validly executed by the Company and, to the Company&#146;s Knowledge (without any inquiry
by any officers of the Company), any other party thereto, and constitutes the valid and binding
obligation of the Company and, to the Company&#146;s Knowledge (without any inquiry by any officers of
the Company), each party thereto, enforceable against such party in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
and other similar Laws relating to or affecting creditors&#146; rights generally and general equitable
principles (whether considered in a proceeding in equity or at law).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Attached as <U>Exhibit&nbsp;F</U> hereto is a true and correct copy of the Separation
Agreement. The Company has all requisite power and authority to enter into the Separation
Agreement and consummate the transactions contemplated thereby, and such agreement has been duly
and validly executed by the Company and, to the Company&#146;s Knowledge (without any inquiry by any
officers of the Company), any other party thereto, and constitutes the valid and binding obligation
of the Company and, to the Company&#146;s Knowledge (without any inquiry by any officers of the
Company), each party thereto, enforceable against such party in accordance with its terms, subject
to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and
other similar Laws relating to or affecting creditors&#146; rights generally and general equitable
principles (whether considered in a proceeding in equity or at law).
</DIV>

<P align="center" style="font-size: 10pt">-23-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each of New Diamond and New Diamond Merger Sub has all necessary corporate power and
authority to execute and deliver this Agreement, to perform its obligations hereunder and to
consummate the transactions contemplated hereby. The execution, delivery and performance by New
Diamond and New Diamond Merger Sub of this Agreement and the consummation of the transactions
contemplated hereby have been duly and validly authorized by all necessary corporate action on the
part of New Diamond and New Diamond Merger Sub, and no other corporate proceedings on the part of
New Diamond or New Diamond Merger Sub are necessary pursuant to their governing documents or the
DGCL to authorize this Agreement or to consummate the transactions contemplated hereby (other than,
with respect to the Diamond Merger, the adoption of this Agreement by New Diamond as the sole
stockholder of New Diamond Merger Sub and, with respect to the Emerald Merger, the adoption of this
Agreement by the Company as the sole stockholder of New Diamond). The Company has caused the
directors of each of New Diamond and New Diamond Merger Sub to approve and declare advisable, and
such directors have approved and declared advisable, this Agreement and the transactions
contemplated hereby. This Agreement has been duly executed and delivered by New Diamond and New
Diamond Merger Sub and, assuming due authorization, execution and delivery by the other parties
hereto, constitutes a legal, valid and binding agreement of each of New Diamond and New Diamond
Merger Sub enforceable against New Diamond and New Diamond Merger Sub in accordance with its terms,
subject to the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
and other similar Laws relating to or affecting creditors&#146; rights generally and general equitable
principles (whether considered in a proceeding in equity or at law).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.3 <U>Non-Contravention</U>. The execution, delivery and performance of the
Transaction Agreements by each of the Company, New Diamond, and New Diamond Merger Sub does not and
will not (a)&nbsp;conflict with
or violate its respective organizational documents, (b)&nbsp;conflict with or violate the
organizational documents of any Company Subsidiary, (c)&nbsp;assuming that all consents, approvals and
authorizations contemplated by Section&nbsp;4.4 have been obtained and all filings described therein
have been made, conflict with or violate any Law applicable to the Company or any of the Company
Subsidiaries or by which its or any of their respective properties are bound, or (d)&nbsp;result in any
breach or violation of or constitute a default (or an event which with notice or lapse of time or
both would become a default) or result in the loss of a benefit under, or give rise to any right of
termination, cancellation, recapture, amendment or acceleration of, or performance under, any note,
bond, mortgage, indenture, contract, agreement, lease, license, permit or other instrument or
obligation (which, in any case, is not a contract, agreement or other arrangement pursuant to which
the Company or any Company Subsidiary leases real property, including the Real Property Leases) to
which the Company or any of the Company Subsidiaries is a party or by which the Company or any of
the Company Subsidiaries or its or any of their respective properties are bound, except in the case
of clauses (b), (c)&nbsp;and (d)&nbsp;of this Section&nbsp;4.3, for any such conflict, violation, breach, default,
loss, right or other occurrence which would not (i)&nbsp;prevent or materially delay the Company from
performing its obligations under this Agreement in any material respect, or (ii)&nbsp;reasonably be
expected to have, individually or in the aggregate, a Company Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.4 <U>Governmental Consents</U>. The execution, delivery and performance of the
Transaction Agreements by the Company, New Diamond, and New Diamond Merger Sub and the consummation
of the Transactions does not and will not require any consent, approval,
</DIV>

<P align="center" style="font-size: 10pt">-24-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">authorization or permit
of, action by, filing with or notification to, any Governmental Authority, except as required under
or pursuant to (a)&nbsp;the HSR Act, (b)&nbsp;the Securities Act and the Exchange Act, (c)&nbsp;state securities,
takeover and &#147;blue sky&#148; Laws, (d)&nbsp;the rules and regulations of the NYSE or the PCX, (e)&nbsp;the DGCL,
(f)&nbsp;the applicable requirements of antitrust or other competition Laws of other jurisdictions or
investment Laws relating to foreign ownership, and (g)&nbsp;any other consent, approval, authorization,
permit, action, filing or notification the failure of which to be made or obtained would not (i)
prevent or materially delay the Company from performing its obligations under this Agreement in any
material respect, or (ii)&nbsp;reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.5 <U>Capitalization of the Company</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The authorized capital stock of the Company consists of 1,200,000,000 Company Shares and
10,000,000 shares of preferred stock. As of the close of business on January&nbsp;19, 2006 (the
&#147;<U>Capitalization Date</U>&#148;), (i)&nbsp;368,970,767 Company Shares were issued and outstanding, (ii)&nbsp;no
Company Shares were held in the treasury of the Company or by Company Subsidiaries, (iii)
49,868,600 Company Shares were reserved for issuance upon or otherwise deliverable in connection
with the conversion of the Company&#146;s 7.25% Hybrid Income Term Security Units (&#147;<U>HITS</U>&#148;), (iv)
62,300,123 Company Shares were reserved for issuance upon or otherwise deliverable in connection
with the grant of equity-based awards (including Stock Units) or the exercise of outstanding
Options issued pursuant to the Company Plans and (v)&nbsp;no shares of preferred stock were outstanding.
Section&nbsp;4.5 of the Company Disclosure Letter sets forth, as of the date specified thereon, a
complete and accurate list of the Options granted under each Stock
Plan and the exercise price of each such Option and the number of underlying Shares. As of
the Capitalization Date, the Company had outstanding (1)&nbsp;Options to purchase 35,840,443 Company
Shares, (2)&nbsp;6,051,892 Company Shares underlying Stock Units, and (3)&nbsp;46,000,000 HITS obligating the
holders thereof to purchase Company Shares in accordance with the terms thereof. From the close of
business on the Capitalization Date until the date of this Agreement, no Company Shares, Options,
Stock Units or HITS have been granted or issued except for Company Shares issued pursuant to the
exercise of Options, the settlement of Stock Units (and dividend equivalents thereon) or the
settlement of HITS in accordance with their present terms. All of the outstanding securities of
the Company are duly authorized and validly issued, and, to the extent such concepts are applicable
thereto, fully paid and nonassessable. Except for the Rights Agreement, dated as of December&nbsp;9,
1996, between the Company and American Stock Transfer &#038; Trust Company, as successor to ChaseMellon
Shareholder Services, LLC, as subsequently amended on August&nbsp;2, 1998, March&nbsp;16, 1999 and September
26, 2003 (as so amended, the &#147;<U>Rights Plan</U>&#148;) and the Rights (as defined in the Rights Plan)
and except as set forth above, there are no outstanding shares, options, warrants, calls, stock
appreciation rights, or other Equity Interests, rights or commitments or any other agreements of
any character relating to dividend rights or to the sale, issuance or voting of, or the granting of
rights to acquire, any shares of capital stock or securities of the Company, or any securities or
obligations convertible into, exchangeable for or evidencing the right to purchase any shares of
capital stock or securities of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as set forth in Section&nbsp;4.5(a), (i)&nbsp;there are no preemptive rights of any kind
which obligate the Company or any Company Subsidiary to issue or deliver any shares of capital
stock or securities of the Company or any securities or obligations convertible or exchangeable
</DIV>

<P align="center" style="font-size: 10pt">-25-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">into or exercisable for, or giving any Person a right to subscribe for or acquire from the Company
or any Company Subsidiary, any shares of capital stock or securities of the Company, and (ii)&nbsp;there
is no agreement, contract, commitment or arrangement pursuant to which the Company or any Company
Subsidiary is or may become obligated to repurchase or redeem any shares of capital stock or
securities of the Company or any securities or obligations convertible or exchangeable into or
exercisable for any shares of capital stock or securities of the Company. Except for the HITS,
neither the Company nor any Company Subsidiary has outstanding any bonds, debentures, notes or
other obligations the holders of which have the right to vote (or which are convertible,
exchangeable, exercisable or can be settled for or into securities having the right to vote) with
the stockholders of the Company on any matter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As of the date hereof, the authorized capital stock of New Diamond consists of 1,000 New
Diamond Shares. Immediately prior to the Initial Effective Time, the certificate of incorporation
of New Diamond will be amended to provide that the authorized capital stock of New Diamond will
consist of 1,200,000,000 New Diamond Shares. As of the date hereof, 100 New Diamond Shares are
issued and outstanding, all of which New Diamond Shares have been issued to and are held by the
Company. Except for the New Diamond Shares, there are no securities of New Diamond authorized,
issued or outstanding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The authorized capital stock of New Diamond Merger Sub consists of 1,000 shares of Common
Stock, 100 of which shares have been issued to and are held by New Diamond. Except for such shares
of Common Stock, there are no securities of New Diamond Merger Sub authorized, issued or
outstanding.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.6 <U>Company Subsidiaries</U>. All of the outstanding Equity Interests, as
applicable, of each Company Subsidiary are validly issued, fully paid and nonassessable and are
owned, directly or indirectly, by the Company free and clear of any Encumbrances. There are no
outstanding options, warrants, calls, stock appreciation rights, or other rights or commitments or
any other agreements of any character (other than agreements between the Company and any Company
Subsidiary) relating to the sale, issuance or voting of, or the granting of rights to acquire any
Equity Interests of any such Company Subsidiary, or any securities or other instruments convertible
into, exchangeable for or evidencing the right to purchase any Equity Interests of any such Company
Subsidiary. Section&nbsp;4.6 of the Company Disclosure Letter sets forth each Company Subsidiary. No
Subsidiary of the Company owns any stock, or any option or other instrument convertible into or
calculated by reference to any stock, in the Company or any HITS.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.7 <U>SEC Reports; Financial Information</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company has timely filed or furnished, as applicable, all forms, reports, statements,
certifications and other documents (including all exhibits, supplements and amendments thereto)
required to be filed or furnished by it with the Securities and Exchange Commission (&#147;<U>SEC</U>&#148;)
since January&nbsp;1, 2003 (collectively, with any amendments thereto, the &#147;<U>Company SEC
Reports</U>&#148;), each of which, including any financial statements or schedules included therein, as
finally amended prior to the date hereof, has complied as to form in all material respects with the
applicable requirements of the Securities Act and the Exchange Act, each as in effect on the date
so filed. None of the Company SEC Reports contained, when filed
</DIV>

<P align="center" style="font-size: 10pt">-26-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">as finally amended prior to the
date hereof, any untrue statement of a material fact or omitted to state a material fact required
to be stated or incorporated by reference therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. Each of (i)
the consolidated balance sheets included in the Company SEC Reports (including the related notes
and schedules) was prepared in accordance with GAAP in all material respects applied on a
consistent basis throughout the periods covered and fairly presents, in all material respects, the
consolidated financial position of the Company and the Company Subsidiaries at the respective dates
thereof and (ii)&nbsp;the related consolidated statements of earnings, cash flows and stockholders&#146;
equity included in the Company SEC Reports (including the related notes and schedules) were
prepared in accordance with GAAP in all material respects applied on a consistent basis throughout
the periods covered and fairly present, in all material respects, the results of operations and
cash flows of the Company and the Company Subsidiaries for the periods indicated (subject, in the
case of each of clause (i)&nbsp;and (ii), to normal and/or recurring year-end adjustments and the
absence of full footnote disclosure in the case of unaudited financial statements).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Attached hereto are (i)&nbsp;unaudited selected results of operations data for each of the New
Diamond Business, the Standalone Drug Business and the Retained Business for the 52&nbsp;weeks ended
January&nbsp;29, 2004, the 53&nbsp;weeks ended February&nbsp;3, 2005 and the 39&nbsp;weeks ended November&nbsp;3, 2005
(collectively, the &#147;<U>Separate Operations Data</U>,&#148; attached hereto as <U>Exhibit&nbsp;H</U>) and
(ii)&nbsp;unaudited selected balance sheet data for the Company and each of the Company&#146;s operating
regions as of February&nbsp;3, 2005 (the &#147;<U>Separate Balance Sheet Data</U>,&#148; attached hereto as
<U>Exhibit&nbsp;I</U>). The Separate Operations Data and the Separate Balance Sheet Data have been
compiled from source books, records and financial reports of the Company and its Subsidiaries.
Such source books, records and financial reports were prepared by the Company in the ordinary
course of its business, are accurate in all material respects and were subject to the Company&#146;s
internal controls. The allocations of the Separate Operations Data among the New Diamond Business,
the Standalone Drug Business and the Retained Business are consistent with Section&nbsp;4.7(b)(i) of the
Company Disclosure Letter and the allocations of the Separate Balance Sheet Data are allocated in
the manner described in Section&nbsp;4.7(b)(ii) of the Company Disclosure Letter. The Separate Balance
Sheet Data and the Separate Operations Data reconcile to the Company&#146;s historical financial
statements filed with the SEC and, in the Company&#146;s opinion, present fairly, in all material
respects, the information presented in the Separate Balance Sheet Data and the Separate Operations
Data, respectively. Subject to the changes in accounting principles and methodologies effected by
the Company as described in the Company SEC Reports, the accounting principles and methodologies
used in the preparation of the Separate Operations Data were applied on a consistent basis, in all
material respects, for each of the periods presented therein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company has designed and maintains a system of internal control over financial
reporting (as defined in Rules&nbsp;13a-15(f) and 15d-15(f) of the Exchange Act) sufficient to provide
reasonable assurances regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP. The Company (i)&nbsp;has designed
and maintains disclosure controls and procedures (as defined in Rules&nbsp;13a-15(e) and 15d-15(e) of
the Exchange Act) that provide reasonable assurance that material information required to be
disclosed by the Company in the reports that it files or submits under the Exchange Act is
recorded, processed, summarized and reported within the time periods
</DIV>

<P align="center" style="font-size: 10pt">-27-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">specified in the SEC&#146;s rules
and forms, and (ii)&nbsp;has disclosed and reported, based on its most recent evaluation of its internal
control over financial reporting prior to the date hereof, to the Company&#146;s auditors and the audit
committee of the Company Board of Directors (A)&nbsp;any significant deficiencies and material
weaknesses in the design or operation of its internal control over financial reporting that are
reasonably likely to adversely affect in any material respect the Company&#146;s ability to record,
process, summarize and report financial information and (B)&nbsp;any fraud, whether or not material,
that involves management or other employees who have a significant role in the Company&#146;s internal
control over financial reporting. The Company has heretofore furnished to Parent complete and
correct copies of the Company&#146;s final report to the audit committee of the Company Board of
Directors for fiscal 2004 and all subsequent regular quarterly updates, in each case in respect of
the matters described in clause (ii)&nbsp;of the immediately preceding sentence.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Except for matters resolved prior to the date hereof, since January&nbsp;1, 2003, (i)&nbsp;to the
Knowledge of the Company neither the Company nor any Company Subsidiary nor any director, officer,
employee, auditor, accountant or representative of the Company or of any Company Subsidiary has
received or otherwise had or obtained Knowledge of any material complaint, allegation, assertion or
claim, whether written or oral, regarding the accounting or auditing practices, procedures,
methodologies or methods of the Company or any Company Subsidiary or their respective internal
accounting controls, including any material complaint, allegation, assertion or claim that the
Company or any Company Subsidiary has engaged in questionable accounting or auditing practices, and
(ii)&nbsp;no attorney representing the Company or any Company Subsidiary, whether or not employed by the
Company or any Company
Subsidiary, has reported evidence of a material violation of securities Laws, breach of
fiduciary duty or similar violation by the Company or any of its officers, directors, employees or
agents to the Company Board of Directors or any committee thereof or to the General Counsel or
Chief Executive Officer of the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.8 <U>No Undisclosed Liabilities</U>. Neither the Company nor any of the Company
Subsidiaries has any liabilities, claims or indebtedness of any kind whatsoever, whether accrued,
contingent, absolute, determined, determinable or otherwise, whether due or to become due, in each
case, that are required by GAAP to be accrued, reserved against, or disclosed in a consolidated
balance sheet or the notes thereto, except liabilities that (i)&nbsp;are accrued or reserved against in
the financial statements included in the Company Form 10-K or Quarterly Report on Form 10-Q most
recently filed prior to the date hereof or are disclosed in the notes thereto, (ii)&nbsp;were incurred
in the ordinary course of business and consistent with past practice since the date of the most
recent balance sheet included in the most recent quarterly report on Form 10-Q filed by the Company
with the SEC prior to the date of this Agreement (the &#147;<U>Company Balance Sheet Date</U>&#148;) and
would not reasonably be expected to have, individually or in the aggregate, (A)&nbsp;a Company Material
Adverse Effect or (B)&nbsp;a Material Adverse Effect as that term is defined in the Standalone Drug Sale
Agreement, (iii)&nbsp;are incurred pursuant to the transactions contemplated by this Agreement, (iv)
have been discharged or paid in full prior to the date of this Agreement in the ordinary course of
business consistent with past practice or (v)&nbsp;were incurred outside the ordinary course of business
since the Company Balance Sheet Date, but which are, and would reasonably be expected to be,
individually or in the aggregate, immaterial in amount or nature.
</DIV>

<P align="center" style="font-size: 10pt">-28-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.9 <U>Absence of Certain Changes or Events</U>. Since the Company Balance Sheet
Date, except as expressly contemplated by this Agreement, the Company and the Company Subsidiaries
have conducted their businesses in the ordinary course in all material respects consistent with
past practice, and, since such date, there has not been any change, event or occurrence which has
had or would reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect. Except as set forth in Section&nbsp;4.9 of the Company Disclosure Letter, since the
Company Balance Sheet Date to the date hereof, neither the Company nor any Company Subsidiary has
taken any action that, if taken after the date of this Agreement, would constitute a breach of the
covenants set forth in Sections&nbsp;6.1(a)(i), (ii), (iv)(B), (v)(A), (v)(B), (v)(C), (v)(D) (other
than any Real Property Leases), (viii)&nbsp;or (xi)&nbsp;hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.10 <U>Contracts</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As of the date hereof, none of the Company nor any Company Subsidiary is a party to or
bound by any: (i)&nbsp;contract (other than this Agreement) that would be required to be filed by the
Company as a material contract pursuant to Item&nbsp;601(b)(10) of Regulation&nbsp;S-K of the SEC; (ii)
except as contemplated by this Agreement, contract containing covenants of the Company or any
Company Subsidiary not to compete in any line of business, industry or geographical area (in each
case, other than agreements with respect to real property) in any manner that is material to the
Company and the Company Subsidiaries, taken as a whole; (iii)&nbsp;contract which creates a partnership
or joint venture or similar arrangement that is material to the
Company and the Company Subsidiaries, taken as a whole; (iv)&nbsp;contract (other than purchase
orders) for the purchase of merchandise for resale with the Company&#146;s top ten suppliers of
merchandise for resale (measured by dollar volume during the fiscal year ended February&nbsp;3, 2005),
or requirements or output contract or any contract containing an exclusive arrangement or agreement
with a Company supplier under which, in each case, the Company and the Company Subsidiaries have
made or reasonably expect to make $20,000,000 of payments in any 12&nbsp;month period; (v)&nbsp;indenture,
credit agreement, loan agreement, security agreement, note, mortgage or other evidence of
Indebtedness or agreement providing for Indebtedness, or capital lease or sublease of real or
personal property (including synthetic leases and similar financing arrangements), in excess of
$25,000,000; (vi)&nbsp;contract (other than the Transaction Agreements and the Standalone Drug Sale
Agreement) for the sale of any of its assets after the date hereof in excess of $35,000,000 (other
than in the ordinary course of business consistent with past practice); (vii)&nbsp;collective bargaining
or employee association agreement covering in excess of 50 employees; (viii)&nbsp;except for HITS,
contract that contains a put, call, right of first refusal or similar right pursuant to which the
Company or any Company Subsidiary would be required to purchase or sell, as applicable, any Equity
Interests of any Person (other than a Company Subsidiary); (ix)&nbsp;settlement or conciliation
agreement or similar agreement with a Governmental Authority or order or consent of a Governmental
Authority to which the Company or any of the Company Subsidiaries is a party involving future
performance by the Company or any Company Subsidiary which is material to the Company and Company
Subsidiaries taken as a whole; (x)&nbsp;distribution, supply, inventory purchase or private label
products purchase contract under which the Company and the Company Subsidiaries are obligated to
make payments in the future in excess of $10,000,000 per annum during the life of the contract and
which is not cancelable (without material penalty, cost or other liability) within one year; and
(xi)&nbsp;other contract (other than the Transaction Agreements, the Standalone Drug Sale Agreement,
purchase orders for the purchase of inventory or supplies or agreements with respect to real
property made in the
</DIV>

<P align="center" style="font-size: 10pt">-29-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ordinary course of business consistent with past practice) under which the
Company and the Company Subsidiaries have made payments in the past 12&nbsp;months or are obligated to
make payments in the future in excess of (A) $5,000,000 per annum or $10,000,000 during the life of
the contract in the case of licenses or contracts for the provision of agency, advisory or
consulting services, and (B) $20,000,000 per annum or $50,000,000 during the life of the contract
in the case of any other contracts. Each such contract described in clauses (i)-(xi), together
with any contract of the type described in clauses (i)-(xi) above and entered into on or after the
date hereof and prior to the Closing Date, is referred to herein as a &#147;<U>Material Contract</U>.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;(i)&nbsp;Neither the Company nor any Company Subsidiary is (and, to the Company&#146;s Knowledge, no
other party is) in default under any Material Contract in any material respect, (ii)&nbsp;each of the
Material Contracts is, in all material respects, in full force and effect, and is the valid,
binding and enforceable obligation of the Company and the Company Subsidiaries, and to the
Company&#146;s Knowledge, of the other parties thereto, and (iii)&nbsp;the Company and the Company
Subsidiaries have performed all respective material obligations required to be performed by them to
date under the Material Contracts and are not (with or without the lapse of time or the giving of
notice, or both) in material breach thereunder. The Company has made available to Parent true and
complete copies of each Material Contract, including all material amendments thereto, except to the
extent such disclosure would violate the confidentiality provisions of such Material Contract.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Section&nbsp;4.10(c) of the Company Disclosure Letter is a complete and correct list of all
distribution, supply, inventory purchase or private label products purchase contracts under which
the Company has received any advance of money in excess of $10,000,000 (including advances
characterized as advance payments, inducements, incentives, rebates, fees or promotional funds)
subject to repayment, in whole or in part, for reasons relating to purchase volume (including
minimum volume requirements, minimum number of participating stores, or repayment for early
cancellation) (such contracts, &#147;<U>Advance Contracts</U>&#148;). The consummation of the Transactions
and the Standalone Drug Sale will not cause any advances under the Advance Contracts to be
repayable within one year of the Closing Date (the &#147;<U>First Operating Year</U>&#148;), assuming the
Company&#146;s and its Subsidiaries&#146; business consisted only of the New Diamond Business and generated a
sales volume during the course of the First Operating Year that is consistent with the sales volume
of the New Diamond Business over that past year.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.11 <U>Compliance with Law and Reporting Requirements</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company and the Company Subsidiaries are not (and have not been since the Company
Balance Sheet Date) in material violation of any Law, and have not received any written notice of
any material violation of Law. The Company and the Company Subsidiaries have, and are (and have
been since the Company Balance Sheet Date) in compliance with, all permits, licenses,
authorizations, exemptions, orders, consents, approvals and franchises from Governmental
Authorities required to conduct their respective businesses as now being conducted, except for any
such permit, license, authorization, exemption, order, consent, approval or franchise the absence
of, or the non-compliance with which, would not reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect.
</DIV>

<P align="center" style="font-size: 10pt">-30-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;None of the Company Subsidiaries is, or has at any time since January&nbsp;1, 2003 been,
subject to the reporting requirements of Sections 13(a) or 15(d) under the Exchange Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.12 <U>Litigation</U>. There are no Actions pending or, to the Knowledge of the
Company, threatened against the Company or any Company Subsidiary or, to the Knowledge of the
Company, any officer, director or employee of the Company or any Company Subsidiary in such
capacity, which would reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect. Neither the Company nor any Company Subsidiary is a party or subject to
or in default under any material Governmental Order.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.13 <U>Employee Compensation and Benefit Plans; ERISA</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Section&nbsp;4.13(a) of the Company Disclosure Letter sets forth a correct and complete list of
each material &#147;employee benefit plan&#148; (within the meaning of Section&nbsp;3(3) of ERISA but excluding
any plan that is a &#147;multiemployer plan,&#148; as defined in Section&nbsp;3(37) of ERISA (&#147;<U>Multiemployer
Plan</U>&#148;)) and each other material director and employee plan, program, agreement or arrangement,
vacation or sick pay policy, fringe benefit plan, compensation,
severance or employment agreement, stock bonus, stock purchase, stock option, restricted
stock, stock appreciation right or other equity-based plan, and bonus or other incentive
compensation or salary continuation plan or policy contributed to, sponsored or maintained by or
with respect to which the Company or any Company Subsidiary has any liability (contingent or
otherwise) as of the date hereof for the benefit of any current, former or retired employee,
officer, consultant, independent contractor or director of the Company or any Company Subsidiary
(collectively, the &#147;<U>Company Employees</U>&#148;; such plans, programs, policies, agreements and
arrangements, collectively, being the &#147;<U>Company Plans</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;With respect to each Company Plan, the Company has made available to the Parent a current,
accurate and complete copy thereof (or, if a plan is not written, a written description thereof)
and, to the extent applicable, (i)&nbsp;any related trust or custodial agreement or other funding
instrument, (ii)&nbsp;the most recent determination letter, if any, received from the Internal Revenue
Service (&#147;<U>IRS</U>&#148;), (iii)&nbsp;any current summary plan description or employee handbook, (iv)&nbsp;for
the most recent year (A)&nbsp;the Form&nbsp;5500 and attached schedules, (B)&nbsp;audited financial statements,
and (C)&nbsp;actuarial valuation reports, if any, and (v)&nbsp;copies of any correspondence from the IRS,
SEC, Pension Benefit Guaranty Corporation (the &#147;<U>PBGC</U>&#148;) or Department of Labor (or any
agency thereof) relating to any material compliance issues with respect to any Company Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as would not, individually or in the aggregate, reasonably be expected to result in
a Company Material Adverse Effect, each Company Plan has been established and is being administered
in accordance with its terms and in compliance with the applicable provisions of ERISA, the Code,
and other Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;With respect to any Multiemployer Plan with respect to which the Company or any Company
Subsidiary has any liability or contributes (or has at any time contributed) or has an obligation
to make a contribution, (i)&nbsp;neither the Company nor any Company Subsidiary has incurred any
withdrawal liability under Subtitle E of Title IV of ERISA (&#147;<U>Withdrawal Liability</U>&#148;) that
remains unsatisfied as would reasonably be expected to have, individually or in the
</DIV>

<P align="center" style="font-size: 10pt">-31-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">aggregate, a
Company Material Adverse Effect, and (ii)&nbsp;neither the Company nor any Company Subsidiary has
received any notification, nor has any reason to believe, that any such Multiemployer Plan is in
reorganization, has been terminated, is insolvent, or prior to the Effective Time is reasonably
likely to be in reorganization, to be insolvent, or to be terminated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, no actions, suits or claims (other than routine claims for
benefits in the ordinary course) are pending or, to the Knowledge of the Company, threatened with
respect to any Company Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i)&nbsp;neither the Company nor any Company Subsidiary has incurred
any liability under Subtitle C or D of Title IV of ERISA that has not been satisfied in full, and
(ii)&nbsp;no condition exists that presents a risk to the Company or any Company Subsidiary of incurring
any such liability other than liability for premiums due the PBGC. With respect to each Company
Plan that is subject to Title IV or Section&nbsp;302 of ERISA or Section&nbsp;412 or 4971 of the Code: (A)
there does not exist any accumulated funding
deficiency within the meaning of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, whether or
not waived, (B)&nbsp;the fair market value of the assets of such plan equals or exceeds the actuarial
present value of all accrued benefits under such plan (whether or not vested), (C)&nbsp;since January&nbsp;1,
2003, no reportable event within the meaning of Section 4043(c) of ERISA for which the 30-day
notice requirement has not been waived has occurred, and the consummation of the transactions
contemplated by this agreement will not result in the occurrence of any such reportable event, (D)
all premiums to the PBGC have been timely paid in full, and (E)&nbsp;the PBGC has not instituted
proceedings to terminate any such plan and, to the Company&#146;s Knowledge, no condition exists that
presents a risk that such proceedings will be instituted or which would constitute grounds under
Section&nbsp;4042 of ERISA for the termination of, or the appointment of a trustee to administer, any
such plan and the Company has not received any notice from the PBGC regarding the Transactions
and/or the funded status of any Company Plan subject to Title IV of ERISA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, each Company Plan which is intended to be qualified under Section
401(a) of the Code is so qualified and has received a determination letter to that effect from the
IRS and, to the Knowledge of the Company, no circumstances exist which would reasonably be expected
to materially adversely affect such qualification or exemption.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;The Company and the Company Subsidiaries have reserved the right to amend, terminate or
modify at any time all plans or arrangements providing for retiree health or life insurance
coverage, and there has been no communication to current or former employees of the Company and
Company Subsidiaries which could reasonably be interpreted to promise or guarantee such individuals
or their dependents retiree health or life insurance or other retiree death benefits on a permanent
basis.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;All Company Plans subject to the laws of any jurisdiction outside of the United States (i)
have been maintained in accordance with all applicable requirements, (ii)&nbsp;if
</DIV>

<P align="center" style="font-size: 10pt">-32-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">they are intended to
qualify for special tax treatment, meet all requirements for such treatment, and (iii)&nbsp;if they are
intended to be funded and/or book-reserved, are fully funded and/or book-reserved, as appropriate,
based upon reasonable actuarial assumptions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.14 <U>Labor Matters</U>. Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, neither the Company nor any
Company Subsidiary has received notice during the past two years of the intent of any Governmental
Authority responsible for the enforcement of labor, employment, occupational health and safety or
workplace safety and insurance/workers compensation laws to conduct an investigation of or
affecting the Company or a Company Subsidiary and, to the Knowledge of the Company, no such
investigation is in progress. Except as would not reasonably be expected to have, individually or
in the aggregate, a Company Material Adverse Effect, there are no (and have not since June&nbsp;30, 2003
been any) labor disputes, strikes, organizing activities or work stoppages against the Company or
Company Subsidiaries pending, or to the Knowledge of the Company, threatened. No labor
organization or group of 50 or more employees of the Company or any Company Subsidiary has made a
pending formal demand for recognition or certification, and there are no representation or
certification proceedings or petitions seeking a representation
proceeding presently pending or, to the Company&#146;s Knowledge, threatened to be brought. The
Company and each of the Company Subsidiaries is in compliance with all collective bargaining
agreements respecting employment and employment practices, terms and conditions of employment,
wages and hours and occupational safety and health (including, without limitation, classifications
of service providers as employees and/or independent contractors).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.15 <U>Properties</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Section&nbsp;4.15(a) of the Company Disclosure Letter contains a true and complete list of all
real property owned by the Company or any Company Subsidiary (other than immaterial real property
that is not currently used (or currently identified for future use) in connection with the
operation of a grocery store, drug store and/or distribution center) (each, an &#147;<U>Owned Real
Property</U>,&#148; and collectively, the &#147;<U>Owned Real Properties</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Section&nbsp;4.15(b) of the Company Disclosure Letter contains a true and complete list of all
real property leased or subleased (whether as tenant or subtenant) by the Company or any Company
Subsidiary (other than immaterial real property that is not currently used (or currently identified
for future use) in connection with the operation of a grocery store, drug store and/or distribution
center) (each, including the improvements thereon, a &#147;<U>Leased Real Property</U>,&#148; and
collectively, the &#147;<U>Leased Real Properties</U>&#148;). With respect to the Leased Real Properties and
the Real Property Leases (as defined below), there are no non-disturbance agreements and
declarations of covenants, restrictions, reciprocal and/or operating easements, development
agreements, or agreements with municipal authorities with respect to zoning or planning, including
amendments relating thereto, that would reasonably be expected to have, individually or in the
aggregate, a Company Material Adverse Effect. Substantially accurate (to the Company&#146;s Knowledge)
summaries prepared in the ordinary course of business of the principal economic terms of each of
the leases pursuant to which the Company leases (as a lessee) real property for the operation of a
grocery or drug store, distribution center, or other material operation center, as such leases have
been amended to date (each lease, including all amendments thereto, a &#147;<U>Real Property
Lease</U>&#148;) have been made available to Parent.
</DIV>

<P align="center" style="font-size: 10pt">-33-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, the Company or one of the Company Subsidiaries has good and
marketable fee simple title to all Owned Real Properties and valid leasehold estates in all Leased
Real Properties free and clear of all Encumbrances. The Company or one of the Company Subsidiaries
has exclusive use and possession of each Leased Real Property and Owned Real Property, other than
any use or occupancy rights granted to third-party owners, tenants or licensees pursuant to
agreements with respect to such real property entered in the ordinary course of business (each
agreement, including all amendments thereto, a &#147;<U>Third Party Use and Occupancy Agreement</U>&#148;),
none of which would reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, each Real Property Lease and each Third Party Use and Occupancy
Agreement is in full force and effect and is valid and enforceable in accordance with its terms,
and there is no material default under any Real Property Lease or any Third Party Use and Occupancy
Agreement either by the Company or the Company Subsidiaries
party thereto or, to the Company&#146;s Knowledge, by any other party thereto, and no event has
occurred that, with the lapse of time or the giving of notice or both, would constitute a default
by the Company or the Company Subsidiaries thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, there are no pending or, to the Company&#146;s Knowledge, threatened
condemnation or eminent domain proceedings that affect any Owned Real Property or Leased Real
Property, and neither the Company nor the Company Subsidiaries have received any written notice of
the intention of any Governmental Authority or other Person to take any Owned Real Property or
Leased Real Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.16 <U>Tangible Personal Property</U>. Other than with respect to the Owned Real
Properties and the Leased Real Properties and except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, the Company or one of the
Company Subsidiaries has good, valid and indefeasible title to or, in the case of leased assets, a
valid, binding and enforceable leasehold interest in, all tangible assets reflected on the most
recent consolidated balance sheet included in Company SEC Reports filed prior to the date hereof as
being owned by the Company or one of the Company Subsidiaries or purchased or acquired by the
Company or a Company Subsidiary after the date of such most recent balance sheet, in each case free
and clear of any Encumbrance other than Permitted Encumbrances.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.17 <U>Intellectual Property; IT Systems</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i)&nbsp;the Company and the Company Subsidiaries own all right, title,
and interest in, or have the right to use, pursuant to a license or otherwise, in each case, free
and clear of all Encumbrances, all Intellectual Property required to operate their respective
businesses as presently conducted (the &#147;<U>Company Intellectual Property</U>&#148;), (ii)&nbsp;Section&nbsp;4.17
of the Company Disclosure Letter lists all registrations and applications for Intellectual Property
owned by the Company and/or any of the Company Subsidiaries and material to the Company&#146;s business,
and (iii)&nbsp;as of the date hereof, (x)&nbsp;neither the Company nor any Company
</DIV>

<P align="center" style="font-size: 10pt">-34-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiary has received
any written notice of any actual or threatened Actions alleging a violation, misappropriation or
infringement of the Intellectual Property of any other Person, except for any of the foregoing that
have since been resolved, (y)&nbsp;to the Company&#146;s Knowledge, the operation of the business of the
Company and each Company Subsidiary does not violate, misappropriate or infringe and has not
previously violated, misappropriated or infringed the Intellectual Property of any other Person
(except for any previous violation, misappropriation or infringement which has been fully and
conclusively resolved with such other Person), and (z)&nbsp;to the Company&#146;s Knowledge, no other Person
has violated, misappropriated or infringed any Intellectual Property owned by the Company or any
Company Subsidiary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i)&nbsp;the IT Systems of the Company and the Company Subsidiaries are
adequate for the operation of their respective businesses as presently conducted and (ii)&nbsp;there has
not been any material malfunction with respect to any of the material
IT Systems of the Company or the Company Subsidiaries since January&nbsp;31, 2002 that has not been
remedied or replaced in all material respects.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Company Material Adverse Effect, (i)&nbsp;the use of the Data by the Company or the Company Subsidiaries
in the operation of their business does not infringe or violate the privacy rights of any Person or
otherwise violate any Law or regulation, (ii)&nbsp;the Company and the Company Subsidiaries have taken
reasonable and customary measures consistent with generally accepted industry practices to protect
the privacy of the Data of their respective customers, and (iii)&nbsp;to the Company&#146;s Knowledge, since
January&nbsp;31, 2002 there have been no security breaches with respect to the privacy of such Data.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.18 <U>Environmental Laws</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;(i)&nbsp;Except as would not reasonably be expected to have a Company Material Adverse Effect,
to the Company&#146;s Knowledge, the Company and each Company Subsidiary comply and have complied with
all applicable Environmental Laws (as defined below), and possess and comply, and have complied,
with all applicable Environmental Permits (as defined below) required under such laws to operate as
it currently operates; (ii)&nbsp;except as would not reasonably be expected to have a Company Material
Adverse Effect, to the Company&#146;s Knowledge, there are no, and there have not been any, Materials of
Environmental Concern (as defined below) at any property currently or formerly owned or operated by
the Company or a Company Subsidiary, under circumstances that have resulted in or are reasonably
likely to result in liability of the Company or a Company Subsidiary under any applicable
Environmental Laws; (iii)&nbsp;except as would not reasonably be expected to have a Company Material
Adverse Effect, neither the Company nor any Company Subsidiary has received any written
notification alleging that it is liable for, or request for information pursuant to section 104(e)
of the Comprehensive Environmental Response, Compensation and Liability Act or similar foreign,
state or local Law concerning, any release or threatened release of Materials of Environmental
Concern at any location except, with respect to any such notification or request for information
concerning any such release or threatened release, to the extent such matter has been fully
resolved such that no further action is required with the appropriate foreign, federal, state or
local regulatory authority or otherwise; and (iv)&nbsp;the reports of environmental assessments, audits
and similar investigations
</DIV>

<P align="center" style="font-size: 10pt">-35-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">previously made available to Parent are all material such reports in the
possession of the Company and conducted since January&nbsp;30, 2003 on any property currently or
formerly owned or operated by the Company or any Company Subsidiary. There are no Actions arising
under Environmental Laws pending or, to the Knowledge of the Company, threatened against the
Company or any Company Subsidiary which would reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect. Except as would not reasonably be expected to
have a Company Material Adverse Effect, at each property where Asbestos-Containing Material
(&#147;<U>ACM</U>&#148;) has been identified, all ACM is non-friable, encapsulated or abated and no ACM is
present in any property where the Company has not implemented an Asbestos Operation and Management
Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding any other representations and warranties in this Agreement, the
representations and warranties in this Section&nbsp;4.18 are the only representations and warranties in
this Agreement with respect to Environmental Laws, Environmental Permits or Materials of
Environmental Concern.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For purposes of this Agreement, the following terms have the meanings assigned below:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Laws</U>&#148; means all Laws relating to the protection of the environment,
including the ambient air, soil, surface water or groundwater, or relating to the protection of
human health from exposure to Materials of Environmental Concern.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Permits</U>&#148; means all permits, licenses, registrations, and other
authorizations required under applicable Environmental Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Materials of Environmental Concern</U>&#148; means any hazardous, acutely hazardous, or toxic
substance or waste defined or regulated as such under Environmental Laws, including the federal
Comprehensive Environmental Response, Compensation and Liability Act and the federal Resource
Conservation and Recovery Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.19 <U>Taxes</U>. (a)&nbsp;Except as would not reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect, (1)&nbsp;all Tax Returns required
to be filed by, or with respect to any activities of, the Company and the Company Subsidiaries have
been filed (except those under valid extension), (2)&nbsp;all Taxes of the Company and the Company
Subsidiaries have been paid or adequately provided for on the most recent financial statements
included in the Company SEC Reports filed prior to the date hereof other than those Taxes accrued
in the ordinary course of business since February&nbsp;3, 2005, (3)&nbsp;neither the Company nor any Company
Subsidiary has received notice in writing of any action, suit, proceeding, investigation, claim or
audit against, or with respect to, any Taxes of the Company or any Company Subsidiary, (4)&nbsp;there
are no liens for Taxes (other than Taxes not yet due and payable) upon any of the assets of the
Company or any Company Subsidiary, (5)&nbsp;the Company and each Company Subsidiary has withheld and
paid all Taxes required to have been withheld and paid in connection with amounts paid or owing to
any employee, independent contractor, creditor, stockholder, or other third party, (6)&nbsp;neither the
Company nor any Company Subsidiary (A)&nbsp;has been a member of an affiliated group filing a
consolidated federal income tax return (other than a group the common parent of which was the
Company) or (A)&nbsp;has any liability for
</DIV>

<P align="center" style="font-size: 10pt">-36-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Taxes of any Person (other than the Company, or any
Company Subsidiary) under Treasury Regulation&nbsp;Section&nbsp;1.1502-6 (or any similar provision of state,
local or foreign law), (7)&nbsp;neither the Company nor any Company Subsidiary has engaged in any
&#147;listed transaction&#148; for purposes of Treasury Regulation&nbsp;Sections&nbsp;1.6011-4(b)(2) and (c)(3), and
(8)&nbsp;neither the Company nor any Company Subsidiary has waived any statute of limitations with
respect to Taxes which has not since expired or agreed to any extension of time with respect to a
Tax assessment or deficiency which has not since expired.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the Company nor any Company Subsidiary has distributed the stock of another
company in a transaction (occurring within the past two years or that otherwise is part of the same
plan or series of transactions, within the meaning of Section&nbsp;355 of the Code, as the Mergers) that
was purported or intended to be governed by Section&nbsp;355 or Section&nbsp;361 of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each of American Stores Company, LLC and American Stores Realty Company, LLC is a
&#147;disregarded&#148; entity within the meaning of Treasury Regulation&nbsp;Section&nbsp;301.7701-3. American
Partners, LP is a partnership within the meaning of the Code. Except as set forth in Section
4.19(c) of the Company Disclosure Letter, each other Subsidiary of the Company is a corporation
within the meaning of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.20 <U>Insurance</U>. All material insurance policies maintained by the Company and
the Company Subsidiaries are listed in Section&nbsp;4.20 of the Company Disclosure Letter. Except as
would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, all such insurance policies are in full force and effect, all premiums due and
payable thereon have been paid, and no written notice of cancellation or termination has been
received with respect to such policy.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.21 <U>Rights Plan</U>. The Company Board of Directors has amended the Rights Plan
so that (a)&nbsp;neither the execution, delivery or performance of this Agreement nor the consummation
of the transactions contemplated hereby will (i)&nbsp;cause the Rights to become exercisable, (ii)&nbsp;cause
New Diamond, Parent or any of its Affiliates or Associates (as each such term is defined in the
Rights Plan) to become an Acquiring Person (as such term is defined in the Rights Plan) or (iii)
give rise to a Stock Acquisition Date or a Distribution Date (as each such term is defined in the
Rights Plan), and (b)&nbsp;the Rights will expire immediately prior to the Initial Effective Time
without any payment being made in respect thereof. The Company has made available to Parent a true
and complete copy of such amendment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.22 <U>HITS</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Complete and correct copies of the following documents relating to the HITS have been made
available to the Parent and, as so made available, are in full force and effect: (i)&nbsp;the Purchase
Contract Agreement dated May&nbsp;7, 2004 and relating to the HITS, between the Company and U.S. Bank
Trust National Association, as Purchase Contract Agent (the &#147;<U>HITS Purchase Contract
Agreement</U>&#148;); (ii)&nbsp;the Pledge Agreement; (iii)&nbsp;the Remarketing Agreement; and (iv)&nbsp;the
Indenture, dated as of May&nbsp;1, 1992, between the Company and U.S. Bank Trust National Association,
as successor Trustee, as supplemented by Supplemental Indenture No.&nbsp;1, dated May&nbsp;7, 2004, between
the Company and U.S. Bank Trust National Association, as Trustee
</DIV>

<P align="center" style="font-size: 10pt">-37-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(as supplemented, the &#147;<U>HITS
Indenture</U>&#148;). For purposes of this Section&nbsp;4.22, all capitalized terms not defined in this
Agreement shall have the meaning given to them in the HITS Purchase Contract Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If the Surviving Corporation enters into such supplemental agreements in form reasonably
satisfactory to the Purchase Contract Agent and Collateral Agent, so as to cause all obligations of
the Company under the HITS Purchase Contract Agreement, the Purchase Contracts, the HITS Pledge
Agreement, the HITS Remarketing Agreement, and the HITS Indenture, to become obligations of the
Surviving Corporation upon consummation of the Mergers (which supplemental agreements to the HITS
Purchase Contract Agreement shall provide that each Holder of a Purchase Contract shall have the
rights provided by Section&nbsp;5.04(b)(i) of the HITS Purchase Agreement), then the consummation of the
Transactions shall
not cause a breach of the covenant contained in Section&nbsp;9.01 of the HITS Purchase Contract
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Neither the Company nor the Surviving Corporation shall, immediately after any of the
Transactions, (i)&nbsp;be in default of payment obligations under the HITS Purchase Contract Agreement,
the Purchase Contracts, the HITS Pledge Agreement, the HITS Remarketing Agreement or the HITS
Indenture, or (ii)&nbsp;be in material default in the performance of any other covenants under any of
the foregoing agreements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;If the Transactions are consummated and on the Purchase Contract Settlement Date, the
Surviving Corporation, in exchange for the Purchase Price, delivers or causes the Collateral Agent
to deliver to a Holder of a Purchase Contract on such date with respect to each Purchase Contract,
utilizing the Settlement Rate in effect at such time based upon the Applicable Market Value of the
Per Share Merger Consideration, (i)&nbsp;an amount in cash equal to the product obtained by multiplying
the Cash Consideration by such Settlement Rate and (ii)&nbsp;a number of Parent Shares equal to the
product obtained by multiplying the Stock Consideration by such Settlement Rate, such delivery
shall be in compliance with Article&nbsp;5 of the HITS Purchase Contract Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;If the Transactions are consummated and any Holder of a Purchase Contract effects a Cash
Merger Early Settlement with respect to any Purchase Contract in accordance with Section
5.04(b)(ii) of the HITS Purchase Contract Agreement, and if the Surviving Corporation delivers or
causes the Collateral Agent to deliver with respect to each Purchase Contract on the Cash Merger
Early Settlement Date utilizing the Settlement Rate in effect at such time based upon the
Applicable Market Value of the Per Share Merger Consideration: (i) (x)&nbsp;an amount in cash equal to
the product obtained by multiplying the Cash Consideration by such Settlement Rate and (y)&nbsp;a number
of Parent Shares equal to the product obtained by multiplying the Stock Consideration by such
Settlement Rate; (ii)&nbsp;the Senior Notes, the Applicable Ownership Interests in the Treasury
Portfolio or Treasury Securities, as the case may be, related to such Purchase Contract; and (iii)
any prospectus required to be delivered by Section&nbsp;5.04(b)(ii) of the HITS Purchase Contract
Agreement, then such delivery shall be in compliance with Section&nbsp;5.04(b)(ii) of the HITS Purchase
Contract Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.23 <U>Affiliate Transactions</U>. There are no transactions, agreements,
arrangements or understandings between (i)&nbsp;the Company or any of the Company Subsidiaries,
</DIV>


<P align="center" style="font-size: 10pt">-38-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">on the
one hand, and (ii)&nbsp;any Affiliate, stockholder, officer or director of the Company (other than the
Company Subsidiaries), on the other hand, of the type that would be required to be disclosed under
Item&nbsp;404 of Regulation&nbsp;S-K under the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.24 <U>Brokers</U>. Except for Goldman, Sachs &#038; Co. (&#147;<U>Goldman Sachs</U>&#148;) and
The Blackstone Group, L.P. (&#147;<U>Blackstone</U>&#148;), no agent, broker, finder or investment banker is
entitled to any brokerage, finder&#146;s or other fee or commission from the Company in connection with
the Transactions. The amount of such fees and commissions payable to each of Goldman Sachs and
Blackstone is set forth in Section&nbsp;4.24 of the Company Disclosure Letter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.25 <U>State Takeover Statutes</U>. No &#147;fair price&#148;, &#147;moratorium&#148;, &#147;control share
acquisition&#148; or other similar antitakeover statute or regulation enacted under state or federal
laws in the United States (with the exception of Section&nbsp;203 of the DGCL) applicable to the
Company, New Diamond or New Diamond Merger Sub is applicable to the transactions contemplated by
this Agreement. Assuming the accuracy of the representations and warranties set forth in Section
5.13, the action of the Company Board of Directors in approving this Agreement (and the
transactions contemplated hereby) is sufficient to render inapplicable to this Agreement (and the
transactions contemplated hereby) the restrictions on &#147;business combinations&#148; (as defined in
Section&nbsp;203 of the DGCL) as set forth in Section&nbsp;203 of the DGCL. The Company has delivered to
Parent a true and complete copy of all resolutions of the Company Board of Directors relating to
the applicability of such antitakeover statute or regulation to the Company or to this Agreement or
the other transactions contemplated hereby. The original certificate of incorporation of each of
New Diamond and New Diamond Merger Sub contains a provision expressly electing not to be governed
by Section&nbsp;203 of the DGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 4.26 <U>Fairness Opinion</U>. Goldman Sachs, Blackstone and Houlihan Lokey Howard &#038;
Zukin have each delivered to the Company Board of Directors its written opinion (or oral opinion to
be confirmed in writing), dated as of the date hereof, that, as of such date, the Per Share Merger
Consideration is fair, from a financial point of view, to the holders of New Diamond Shares (as the
former holders of Company Shares).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE V</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF PARENT AND ACQUISITION SUB</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth in the corresponding sections of the disclosure letter (subject to the
provisions of Section&nbsp;9.2) delivered by Parent to the Company on or prior to the execution of this
Agreement (the &#147;<U>Parent Disclosure Letter</U>&#148;) and except as disclosed in the Form 10-K of
Parent for the fiscal period ended December&nbsp;31, 2004, as amended through the date hereof (as
amended, the &#147;<U>Parent Form&nbsp;10-K</U>&#148;), the Proxy Statement for the Parent&#146;s 2005 Annual Meeting
of Stockholders, and the Form 10-Qs and Form 8-Ks filed or furnished from the date of the filing of
the Parent Form 10-K to the date of this Agreement (and any amendments to any such filings which
amendments are filed with the SEC prior to the date hereof) to the extent such qualifications are
reasonably apparent (and which in no event shall include risk factors or other factors identified
in general cautionary statements regarding reliance on forward looking statements in either case
included in the Parent SEC Reports), Parent and Acquisition Sub hereby, jointly and severally,
represent and warrant to the Company that:
</DIV>

<P align="center" style="font-size: 10pt">-39-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.1 <U>Organization</U>. Each of Parent and Acquisition Sub is duly organized,
validly existing and in good standing under the laws of its respective jurisdiction of
organization, and has the requisite corporate or similar power and authority to own its properties
and to carry on its business as presently conducted and is duly qualified to do business and is in
good standing (where such concept exists) as a foreign
corporation in each jurisdiction in which the nature of its business or the ownership or
leasing of its properties makes such qualification necessary. Complete and correct copies of the
certificate of incorporation and by-laws (or equivalent organizational documents) of Parent and
Acquisition Sub as currently in effect, have been made available to the Company, and as so made
available, are in full force and effect and no other organizational documents are applicable to or
binding upon Parent and Acquisition Sub. Acquisition Sub is a direct wholly owned Subsidiary of
Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.2 <U>Authority; Enforceability</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of Parent and Acquisition Sub has the corporate or other power and authority to
execute and deliver this Agreement, to perform its obligations hereunder and to consummate the
transactions contemplated hereby. The execution, delivery and performance by each of Parent and
Acquisition Sub of this Agreement and the consummation by each of Parent and Acquisition Sub of the
transactions contemplated hereunder have been duly authorized by all necessary action on the part
of each of Parent and Acquisition Sub, and no other corporate proceedings on the part of Parent or
Acquisition Sub are necessary pursuant to its governing documents or the DGCL to authorize this
Agreement or to consummate the transactions contemplated hereby (other than (i)&nbsp;the adoption of
this Agreement by Parent as the sole stockholder of Acquisition Sub and (ii)&nbsp;the approval of the
issuance of Parent Shares in connection with the consummation of the Merger (the &#147;<U>Share
Issuance</U>&#148;) by the holders of a majority of the votes cast by the holders of outstanding Parent
Shares present (in person or by proxy) and entitled to vote on such matter at the Parent
Stockholder Meeting, where a quorum is present (the &#147;<U>Requisite Parent Stockholder Vote</U>&#148;)).
The boards of directors of Parent and Acquisition Sub have determined that it is in the best
interests of Parent and Acquisition Sub and their respective stockholders, and declared it
advisable, to enter into this Agreement, and have approved this Agreement in accordance with the
DGCL. This Agreement has been duly executed and delivered by each of Parent and Acquisition Sub
and, assuming due authorization, execution and delivery by the other parties hereto, constitutes a
legal, valid and binding agreement of each of Parent and Acquisition Sub, enforceable against each
of them in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors&#146;
rights generally and general equitable principles (whether considered in a proceeding in equity or
at law).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Parent has all requisite power and authority to enter into the Separation Agreement and to
consummate the transactions contemplated thereby, and such agreement has been duly and validly
executed by Parent and, to Parent&#146;s Knowledge (without any inquiry by any officers of Parent), any
other party thereto, and constitutes the valid and binding obligation of Parent and, to Parent&#146;s
Knowledge (without any inquiry by any officers of Parent), each party thereto, enforceable against
such party in accordance with its terms, subject to the effects of bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other similar
</DIV>

<P align="center" style="font-size: 10pt">-40-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Laws relating to or affecting
creditors&#146; rights generally and general equitable principles (whether considered in a proceeding in
equity or at law).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.3 <U>Non-Contravention</U>. The execution, delivery and performance of the
Transaction Agreements, as applicable, by each of Parent and Acquisition Sub does not and will not
(a)&nbsp;conflict with or violate its certificate of incorporation or by-laws or comparable governing
documents, (b)&nbsp;conflict with or violate the governing documents of any other Subsidiary of Parent,
(c)&nbsp;assuming that all consents, approvals and authorizations contemplated by Section&nbsp;5.4 have been
obtained and all filings described therein have been made, conflict with or violate any Law
applicable to Parent, Acquisition Sub or any of their Subsidiaries or by which it or any of its
properties are bound or (d)&nbsp;result in any breach or violation of or constitute a default (or an
event which with notice or lapse of time or both would become a default) or result in the loss of a
benefit under, or give rise to any right of termination, cancellation, recapture, amendment or
acceleration of, or performance under, any note, bond, mortgage, indenture, contract, agreement,
lease, license, permit or other instrument or obligation to which Parent, Acquisition Sub or any of
their Subsidiaries is a party or by which Parent, Acquisition Sub or any of their Subsidiaries or
its or any of their properties are bound, except, in the case of clauses (b), (c), and (d)&nbsp;of this
Section&nbsp;5.3 for any such conflict, violation, breach, default, loss, right or other occurrence
which would not (i)&nbsp;prevent or materially delay the consummation of the transactions contemplated
by the Transaction Agreements, or (ii)&nbsp;reasonably be expected to have, individually or in the
aggregate, a Parent Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.4 <U>Governmental Consents</U>. The execution, delivery and performance of this
Agreement by each of Parent and Acquisition Sub and the consummation by each of Parent and
Acquisition Sub of the Transactions do not and will not require any consent, approval,
authorization or permit of, action by, filing with or notification to, any Governmental Authority,
except as required under or pursuant to (a)&nbsp;the HSR Act, (b)&nbsp;the Exchange Act, (c)&nbsp;state
securities, takeover and &#147;blue sky&#148; Laws, (d)&nbsp;the rules and regulations of the NYSE and the PCX,
(e)&nbsp;the DGCL, (f)&nbsp;the applicable requirements of antitrust or other competition Laws of other
jurisdictions or investment Laws relating to foreign ownership, and (g)&nbsp;any other consent,
approval, authorization, permit, action, filing or notification the failure of which to be made or
obtained would not reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.5 <U>Capitalization</U>. (a)&nbsp;The authorized capital stock of Parent consists of
400,000,000 shares of Common Stock, par value $1.00 per share (&#147;<U>Parent Shares</U>&#148;), and
1,000,000 shares of preferred stock. As of the close of business on the Capitalization Date, (i)
136,318,661 Parent Shares were issued and outstanding, (ii)&nbsp;14,312,549 Parent Shares were held in
the treasury of Parent or by Parent Subsidiaries, (iii)&nbsp;10,159,743 Parent Shares were reserved for
issuance upon or otherwise deliverable in connection with the grant of equity-based awards
(including Retention Stock Units) or the exercise of outstanding stock options and (iv)&nbsp;1,341
shares of preferred stock were outstanding. As of the Capitalization Date, Parent had outstanding
(1)&nbsp;options to purchase 12,088,125 Parent Shares at a weighted average exercise price of $26.74 per
share and (2)&nbsp;810,750 Liquid Yield Option Notes (&#147;<U>LYONs</U>&#148;) which may be convertible into
Parent Shares under certain circumstances in accordance with the terms thereof. From the close of
business on the Capitalization Date until the date of this Agreement, no Parent Shares have been
issued except for Parent Shares issued pursuant to the exercise of Options or to
</DIV>

<P align="center" style="font-size: 10pt">-41-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the settlement of
the LYONs in accordance with their terms. Except for the Rights Agreement, dated as of April&nbsp;12,
2000, between Parent and Wells
Fargo Bank Minnesota, N.A. (formerly Norwest Bank Minnesota, N.A.) as Rights Agent (the
&#147;<U>Parent Rights Plan</U>&#148;) and the Rights (as defined in the Parent Rights Plan) and except as
set forth above, there are no outstanding shares, options, warrants, calls, stock appreciation
rights, or other Equity Interests, rights or commitments or any other agreements of any character
relating to dividend rights or to the sale, issuance or voting of, or the granting of rights to
acquire, any shares of capital stock or voting securities of Parent, or any securities or
obligations convertible into, exchangeable for or evidencing the right to purchase any shares of
capital stock or voting securities of Parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as set forth in Section&nbsp;5.5(a), (i)&nbsp;there are no preemptive rights of any kind
which obligate Parent or any Subsidiary of Parent to issue or deliver any shares of capital stock
or voting securities of Parent or any securities or obligations convertible or exchangeable into or
exercisable for, or giving any Person a right to subscribe for or acquire from Parent or any
Subsidiary of Parent, any shares of capital stock or voting securities of Parent, and (ii)&nbsp;there is
no agreement, contract, commitment or arrangement pursuant to which Parent or any Subsidiary of
Parent is or may become obligated to repurchase or redeem any shares of capital stock or voting
securities of Parent or any securities or obligations convertible or exchangeable into or
exercisable for, any shares of capital stock or voting securities of Parent. Parent does not have
outstanding any bonds, debentures, notes or other obligations the holders of which have the right
to vote (or which are convertible, exchangeable or exercisable for or into securities having the
right to vote) with the stockholders of the Parent on any matter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.6 <U>SEC Reports; Financial Information</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Parent has timely filed or furnished, as applicable, all forms, reports, statements,
certifications and other documents (including all exhibits, supplements and amendments thereto)
required to be filed or furnished by it with the SEC since January&nbsp;1, 2003 (collectively, with any
amendments thereto, the &#147;<U>Parent SEC Reports</U>&#148;), each of which, including any financial
statements or schedules included therein, as finally amended prior to the date hereof, has complied
as to form in all material respects with the applicable requirements of the Securities Act and the
Exchange Act, each as in effect on the date so filed. None of the Parent SEC Reports contained,
when filed as finally amended prior to the date hereof, any untrue statement of a material fact or
omitted to state a material fact required to be stated or incorporated by reference therein or
necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. Each of (i)&nbsp;the consolidated balance sheets included in the Parent
SEC Reports (including the related notes and schedules) was prepared in accordance with GAAP in all
material respects applied on a consistent basis throughout the periods covered and fairly presents,
in all material respects, the consolidated financial position of Parent and the Parent Subsidiaries
at the respective dates thereof and (ii)&nbsp;the related consolidated statements of earnings, cash
flows and stockholders&#146; equity included in the Parent SEC Reports (including the related notes and
schedules) were prepared in accordance with GAAP in all material respects applied on a consistent
basis throughout the periods covered and fairly present in all material respects the results of
operations and cash flows of Parent and the Parent Subsidiaries for the periods indicated (subject,
in the case of each of clause (i)&nbsp;and (ii), to normal and/or recurring year-end adjustments and the
absence of full footnote disclosure in the case of unaudited financial statements).
</DIV>

<P align="center" style="font-size: 10pt">-42-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Parent has designed and maintains a system of internal controls over financial reporting
(as defined in Rules&nbsp;13a-15(f) and 15d-15(f) of the Exchange Act) sufficient to provide reasonable
assurances regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with GAAP. Parent (i)&nbsp;has designed and maintains
disclosure controls and procedures (as defined in Rules&nbsp;13a-15(e) and 15d-15(e) of the Exchange
Act) that provide reasonable assurance that material information required to be disclosed by Parent
in the reports that it files or submits under the Exchange Act is recorded, processed, summarized
and reported within the time periods specified in the SEC&#146;s rules and forms, and (ii)&nbsp;has disclosed
and reported, based on its most recent evaluation of such internal control over financial reporting
prior to the date hereof, to Parent&#146;s auditors and the audit committee of the Parent Board of
Directors (A)&nbsp;any significant deficiencies and material weaknesses in the design or operation of
its internal control over financial reporting which are reasonably likely to adversely affect in
any material respect Parent&#146;s ability to record, process, summarize and report financial
information and (B)&nbsp;any fraud, whether or not material, that involves management or other employees
who have a significant role in Parent&#146;s internal control over financial reporting. Parent has
heretofore furnished to the Company complete and correct copies of all such reports (if any).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except for matters resolved prior to the date hereof, since January&nbsp;1, 2003, (i)&nbsp;to the
Knowledge of Parent neither Parent nor any Parent Subsidiary nor any director, officer, employee,
auditor, accountant or representative of Parent or of any Parent Subsidiary has received or
otherwise had or obtained Knowledge of any material complaint, allegation, assertion or claim,
whether written or oral, regarding the accounting or auditing practices, procedures, methodologies
or methods of Parent or any Parent Subsidiary or their respective internal accounting controls,
including any material complaint, allegation, assertion or claim that the Parent or any Parent
Subsidiary has engaged in questionable accounting or auditing practices, and (ii)&nbsp;no attorney
representing the Parent or any Parent Subsidiary, whether or not employed by Parent or any Parent
Subsidiary, has reported evidence of a material violation of securities Laws, breach of fiduciary
duty or similar violation by Parent or any of its officers, directors, employees or agents to the
Parent Board of Directors or any committee thereof or to the General Counsel or Chief Executive
Officer of Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.7 <U>No Undisclosed Liabilities</U>. Neither Parent nor any of the Parent
Subsidiaries has any liabilities, claims or indebtedness of any kind whatsoever, whether accrued,
contingent, absolute, determined, determinable or otherwise, whether due or to become due, in each
case, that are required by GAAP to be accrued, reserved against or disclosed in a consolidated
balance sheet or the notes thereto, except liabilities that (i)&nbsp;are accrued or reserved against in
the most recent financial statements included in the Parent Form 10-K or Quarterly Report on Form
10-Q most recently filed prior to the date hereof or are disclosed in the notes thereto, (ii)&nbsp;were
incurred in the ordinary course of business and consistent with past practice since the date of the
most recent balance sheet included in the most recent quarterly report on Form 10-Q filed by Parent
with the SEC prior to the date of this Agreement (the &#147;<U>Parent Balance Sheet Date</U>&#148;) and
would not reasonably be expected to have, individually or in the aggregate, a Parent Material
Adverse Effect, (iii)&nbsp;are incurred pursuant to the transactions contemplated by this Agreement,
(iv)&nbsp;have been discharged or paid in full prior to the date of this Agreement in the ordinary
course of business consistent with past practice or (v)&nbsp;were incurred outside the
</DIV>

<P align="center" style="font-size: 10pt">-43-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">ordinary course
of business since the Company Balance Sheet Date, but which are, and would reasonably be expected
to be, individually or in the aggregate, immaterial in amount or nature.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.8 <U>Absence of Certain Changes or Events</U>. Since the Parent Balance Sheet
Date, except as contemplated by this Agreement, Parent and the Parent Subsidiaries have conducted
their businesses in the ordinary course in all material respects consistent with past practice,
and, since such date, there has not been any change, event or occurrence which has had or would
reasonably be likely to have, individually or in the aggregate, a Parent Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.9 <U>Compliance with Law and Reporting Requirements</U>. Parent and the Parent
Subsidiaries are not (and have not been since the Parent Balance Sheet Date) in violation of any
Law, and have not received any written notice of any violation of Law, in each case except for any
violation or possible violation that would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect. Parent and the Parent Subsidiaries have, and are
(and have been since the Parent Balance Sheet Date) in compliance with, all permits, licenses,
authorizations, exemptions, orders, consents, approvals and franchises from Governmental
Authorities required to conduct their respective businesses as now being conducted, except for any
such permit, license, authorization, exemption, order, consent, approval or franchise the absence
of, or the non-compliance, with which would not reasonably be expected to have, individually or in
the aggregate, a Parent Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.10 <U>Litigation</U>. There are no Actions pending or, to the knowledge of Parent,
threatened against Parent or any Parent Subsidiary or, to the knowledge of Parent, any officer,
director or employee of Parent or any Parent Subsidiary in such capacity, which would, individually
or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. Neither
Parent nor any Parent Subsidiary is a party or subject to or in default under any material
Governmental Order.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.11 <U>Financing</U>. Attached hereto as Section&nbsp;5.11 of the Parent Disclosure
Letter is a true and complete copy of the Commitment Letter dated the date hereof, between
Supervalu Inc., The Royal Bank of Scotland plc and RBS Securities Corporation (the &#147;<U>Financing
Commitment</U>&#148;), pursuant to which The Royal Bank of Scotland plc has agreed, subject to the terms
and conditions set forth therein, to lend the amounts set forth therein for the purposes of
financing the transactions contemplated hereby (the &#147;<U>Financing</U>&#148;). As of the date hereof,
the Financing Commitment has not been amended, modified, withdrawn or rescinded, and is in full
force and effect. Assuming the receipt of the proceeds of the Standalone Drug Sale, and the
consummation of the transactions contemplated by the Separation Agreement, Parent and Acquisition
Sub will have at and after the Closing funds sufficient to consummate the Emerald Merger on the
terms and conditions set forth in this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.12 <U>Brokers</U>. No agent, broker, finder or investment banker is entitled to
any brokerage, finder&#146;s or other fee or
commission in connection with the transactions contemplated by this Agreement based upon
arrangements made by or on behalf of Parent or Acquisition Sub for which the Company could have any
liability.
</DIV>

<P align="center" style="font-size: 10pt">-44-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.13 <U>Company Stock</U>. Neither Parent nor Acquisition Sub is, and at no time
during the last three years has either Parent or Acquisition Sub been, an &#147;interested stockholder&#148;
of the Company as defined in Section&nbsp;203 of the DGCL. Neither Parent nor Acquisition Sub owns
(directly or indirectly, beneficially or of record), or is a party to any agreement, arrangement or
understanding for the purpose of acquiring, holding, voting or disposing of, any shares of capital
stock of the Company (other than as contemplated by this Agreement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.14 <U>Acquisition Sub</U>. Acquisition Sub was formed solely for the purpose of
engaging in the transactions contemplated hereby, has engaged in no business activities and has
conducted no operations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.15 <U>Fairness Opinion</U>. Lazard Fr&#232;res has delivered to the Parent Board of
Directors its written opinion (or oral opinion to be confirmed in writing) that, as of the date
hereof, the Per Share Merger Consideration to be paid by Parent is fair, from a financial point of
view, to Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 5.16 <U>Cub Stores Divestiture</U>. Parent has closed, or simultaneously with the
execution and delivery of this Agreement will close, the sale, pursuant to the Cub Sale Agreement,
of all of Parent&#146;s direct or indirect right, title and interest in and to all of the retail grocery
stores that, immediately prior to the date hereof, were operated directly or indirectly by Parent
in the Chicago, Illinois and Bloomington, Illinois metropolitan areas under the &#147;Cub&#148; or &#147;Cub
Foods&#148; banners. Parent has delivered to the Company correct and complete copies of the Cub Sale
Agreement and the Ancillary Agreements referred to therein, all of which constitute legal, valid
and binding obligations of Parent and its Affiliates that are parties thereto, enforceable against
them in accordance with their terms, subject to the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors&#146;
rights generally and general equitable principles (whether considered in a proceeding in equity or
at law).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VI</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>ADDITIONAL AGREEMENTS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.1 <U>Conduct of Business Prior to the Closing</U>. (a)&nbsp;The Company covenants and
agrees that, during the period from the date hereof until the Closing Date, except as contemplated
by this Agreement, as set forth in Section&nbsp;6.1 of the Company Disclosure Letter or as required by
Law, or unless Parent shall otherwise consent in writing (which consent shall not be unreasonably
withheld, conditioned or delayed), the business of the Company and the Company Subsidiaries (in
each case, with respect to the New Diamond
Business or to the extent affecting New Diamond and/or the New Diamond Entities in a non-de
minimis respect) and the use, operation, maintenance and repair of the Owned Real Properties and
the Leased Real Properties, shall be conducted in the ordinary course of business, consistent with
past practice, and the Company shall use its reasonable best efforts to preserve substantially
intact its business organization and operations, including material insurance policies, material
Company Intellectual Property and goodwill, and to preserve its present relationships with
suppliers, lessors, licensees, distributors, wholesalers, franchisees and other Persons with which
it has material business relations. Between the date of this Agreement and the Closing Date,
subject to
</DIV>

<P align="center" style="font-size: 10pt">-45-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">applicable Law and except as otherwise contemplated by this Agreement, as set forth in
Section&nbsp;6.1 of the Company Disclosure Letter or as required by Law or the Transaction Agreements
(or, with respect to clauses (vi)&nbsp;or (vii)&nbsp;below, as required by any Material Contract disclosed in
Section&nbsp;4.10 of the Company Disclosure Letter), neither the Company nor any Company Subsidiary (in
each case, with respect to the New Diamond Business or to the extent affecting New Diamond and/or
the New Diamond Entities in a non-de minimis respect) shall, without the prior written consent of
Parent (which consent shall not be unreasonably withheld, conditioned or delayed):
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) amend or otherwise change its certificate of incorporation or by-laws (or other
comparable governing documents);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) issue, deliver, sell, pledge, transfer, convey, dispose of or encumber any Equity
Interests of the Company or any Company Subsidiary or securities convertible into or
exchangeable for any such Equity Interests, or any options, warrants, convertible securities
or other rights of any kind to acquire any Equity Interests of the Company or any Company
Subsidiary, or any other ownership interest or security, of the Company or any Company
Subsidiary (other than (A)&nbsp;the issuance of Shares (and the associated Rights) upon the
exercise of Options, the settlement of Stock Units (and dividend equivalents thereon), or
the settlement of HITS, in each case in accordance with their present terms, (B)&nbsp;issuances
by a wholly owned Company Subsidiary of capital stock to such Company Subsidiary&#146;s parent,
and (C)&nbsp;issuances in accordance with the Rights Plan);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) declare, set aside, make or pay any dividend or other distribution payable in
cash, stock, property or otherwise with respect to any Equity Interests or any options,
warrants, convertible securities or other rights to acquire any Equity Interest (except for
any dividend or distribution of cash by a wholly owned Company Subsidiary, required payments
made by the Company in respect of its HITS in accordance with their present terms, dividend
equivalents paid by the Company or accrued on Stock Units in accordance with their present
terms and regular quarterly dividends paid to holders of the Company Shares in an amount not
in excess of $0.19 per share of Common Stock);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) (A)&nbsp;reclassify, combine, split, subdivide, redeem, purchase or otherwise acquire
any Equity Interests of the Company or any Company Subsidiary or any options, warrants,
convertible securities or other rights to acquire any Equity Interest of the Company or any
Company Subsidiary (other than the acquisition of shares tendered by directors, employees or
former employees in order to pay Taxes in connection with the exercise of Options or the
settlement of Stock Units pursuant to the terms of any of the
Stock Plans or any redemption of the Rights pursuant to the terms of the Rights Plan),
or (B)&nbsp;redeem, repurchase, prepay, defease or otherwise acquire any of the Company&#146;s or the
Company Subsidiaries&#146; Indebtedness set forth on Section&nbsp;6.1(a)(iv)(B) of the Company
Disclosure Letter;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) (A)&nbsp;acquire, lease or license from any Person (by merger, consolidation,
acquisition of stock or assets or otherwise) or sell, dispose of, abandon, encumber (other
than through the creation of a Permitted Encumbrance), lease or license (by merger,
</DIV>

<P align="center" style="font-size: 10pt">-46-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">consolidation, sale of stock or assets or otherwise) to any corporation, partnership or
other business organization or division thereof, any Equity Interests therein or any assets,
including Intellectual Property, in each case, which are material to the Company and the
Company Subsidiaries taken as a whole, other than acquisitions, leases, licenses, sales,
dispositions and encumbrances of inventory, non-merchandise supplies, media and advertising
and other assets in the ordinary course of business, (B)&nbsp;enter into any material joint
venture, partnership or similar agreement, (C)&nbsp;incur or guarantee, or modify in any material
respect, any Indebtedness or make any loans, advances or capital contributions to, or
investments in, any other Person (other than a Company Subsidiary), in each case, other than
in the ordinary course of business and consistent with past practice, (D)&nbsp;enter into, renew,
terminate or amend in any material respect (1)&nbsp;any contract or agreement which is or would
be a Material Contract, other than in the ordinary course of business consistent with past
practice, (2)&nbsp;any Real Property Lease which provides for rental payments over the primary
term of the lease (including percentage sales and other variable payments, as estimated by
the Company in good faith) in excess of $1,200,000 in any one year (<U>provided</U>, that
neither the Company nor any Company Subsidiary shall, without first consulting with Parent
in writing, enter into, renew, terminate or amend in any material respect any Real Property
Lease which provides for such rental payments in excess of $500,000 in any one year), or (3)
any Advance Contract, or (E)&nbsp;notwithstanding anything to the contrary set forth in Section
6.1(a)(v)(D) of the Company Disclosure Letter, authorize, or enter into any commitment to
make, any new capital expenditures which are, in the aggregate, in excess of the Company&#146;s
capital expenditure budget insofar as it relates to the New Diamond Business set forth on
Section&nbsp;6.1(a)(v)(D) of the Company Disclosure Letter or which are, individually, in excess
of $15,000,000 (<U>provided</U>, that neither the Company nor any Company Subsidiary shall,
without first consulting with Parent in writing, authorize, or enter into any commitment to
make, any new capital expenditures which are, individually, in excess of $10,000,000);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;except (A)&nbsp;to the extent required under any Company Plan, or (B)&nbsp;as necessary to
conform to the requirements of any applicable Law that absent such conformance would impose
a penalty of an additional Tax on the Company, any Company Subsidiary or any current or
former director, officer, employee or consultant of the Company or any Company Subsidiary,
(1)&nbsp;increase or decrease the compensation or fringe benefits of, or pay any bonus to, any
current or former director, officer, employee or consultant of the Company or any Company
Subsidiary (except in the ordinary course of business and consistent with past practice),
(2)&nbsp;grant any severance or termination pay not required under any Company Plan (except in
the ordinary course of business and consistent with past practice) or grant any equity or
equity-based awards, (3)&nbsp;exercise any discretion to accelerate the vesting or payment or any
compensation or benefit under any
Company Plan, (4)&nbsp;except as required by GAAP, materially change any actuarial or other
assumption used to calculate funding obligations with respect to any Company Plan or change
the manner in which contributions to any Company Plan are made or the basis on which such
contributions are determined, (5)&nbsp;enter into any (A)&nbsp;employment agreement with any present
directors or employees, (B)&nbsp;consulting agreement or arrangement with any present directors
or executive officers (as defined by Rule&nbsp;3b-7 of the Exchange Act) or (C)&nbsp;except in the
ordinary course of business consistent with past practice, consulting agreement or
arrangement or change in control or severance agreement with any present
</DIV>

<P align="center" style="font-size: 10pt">-47-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">employee, (6)
without limiting the scope of the preceding clause (5), establish, adopt, enter into any
new, or amend in any material respect or terminate any existing Company Plan, (7)&nbsp;without
limiting the scope of Section&nbsp;6.1(a)(v)(D), enter into, renew, or materially amend any
collective bargaining or similar agreement covering in excess of 500 employees or (8)
provide any funding to any rabbi trust or similar arrangement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;enter into any transaction, agreement, arrangement or understanding between (A)
the Company or any Company Subsidiary, on the one hand, and (B)&nbsp;any Affiliate of the Company
(other than the Company Subsidiaries), on the other hand, of the type that would be required
to be disclosed under Item&nbsp;404 of Regulation&nbsp;S-K;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;(A)&nbsp;make any material Tax election (in a manner inconsistent with past
practices), change any method of accounting or make any election with respect to the Company
or any Company Subsidiary under Treasury Regulation&nbsp;Section&nbsp;301.7701-3, (B)&nbsp;enter into any
settlement or compromise of any material Tax liability for an amount in excess of the amount
reserved for such Tax liability in the financial statements included in the Company SEC
Reports as of the date hereof, (C)&nbsp;change any annual Tax accounting period, (D)&nbsp;enter into
any closing agreement relating to any material Tax or (E)&nbsp;surrender any right to claim a
material Tax refund;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix)&nbsp;make any material changes in accounting policies or procedures other than as
required by GAAP or a Governmental Authority;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)&nbsp;subject to the fiduciary duties of the Company Board of Directors (as determined in
good faith after consultation with outside legal counsel), amend, waive, terminate or fail
to enforce its Rights Agreement or any confidentiality agreement, standstill clause or
agreement or similar agreement, arrangement or understanding;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi)&nbsp;settle any litigation or other proceedings before or threatened to be brought
before a Governmental Authority or arbitral proceeding for an amount payable by or on behalf
of the Company or any Company Subsidiary in excess of $2,500,000 (exclusive of (A)&nbsp;any
amounts to be received by the Company in reimbursement of such settlement amount, whether
under any insurance policy or indemnity, other than such amounts that are contested, and (B)
any amounts accrued or reserved for in respect of such matter in the financial statements
included in the Company 10-K or the Quarterly Report on Form 10-Q most recently filed prior
to the date hereof) or which would be reasonably likely to have a material adverse impact on
the operations of the Company or any Company Subsidiary or on any current or future
litigation or other proceeding of the Company or any Company Subsidiary;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xii)&nbsp;except to the extent required for cash management in the ordinary course of
business consistent with past practice, enter into, perform or undergo any internal
restructuring, merger, liquidation, change in organizational status (such as conversion of
any corporation to a limited liability company), intercompany transfer of assets or
assumption or guarantee of liability, distribution, contribution, or creation, elimination,
increase or decrease in intercompany debt or liabilities;
</DIV>

<P align="center" style="font-size: 10pt">-48-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiii) cause any Company Subsidiary that is a captive insurance company to underwrite
any insurance other than in respect of the New Diamond Business;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiv) take any action prohibited by the restrictions described in clause (5)&nbsp;of Section
6.8(c) of the Separation Agreement or Section&nbsp;5.01(f) of the Drug Sale Agreement; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xv) agree to take any of the actions described in clauses (i)&nbsp;through (xiii)&nbsp;above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Parent covenants and agrees that, during the period from the date hereof until the Closing
Date, except as contemplated by this Agreement, as set forth in Section&nbsp;6.1 of the Parent
Disclosure Letter or as required by Law, or unless Company shall otherwise consent in writing
(which consent shall not be unreasonably withheld, conditioned or delayed), the business of the
Parent and the Parent Subsidiaries shall be conducted in the ordinary course of business and
consistent with past practice, and Parent shall use its reasonable best efforts to preserve
substantially intact its business organization and operations, including material insurance
policies, material intellectual property and goodwill, and to preserve its present relationships
with suppliers, lessors, licensees, distributors, wholesalers, franchisees and other Persons with
which it has material business relations. Between the date of this Agreement and the Closing Date,
subject to applicable Law and except as otherwise contemplated by this Agreement, as set forth in
Section&nbsp;6.1 of the Parent Disclosure Letter or as required by Law, neither Parent nor any Parent
Subsidiary shall, without the prior written consent of the Company (which consent shall not be
unreasonably withheld, conditioned or delayed):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) amend or otherwise change its certificate of incorporation or by-laws (or other
comparable governing documents);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) declare, set aside, make or pay any dividend or other distribution payable in
cash, stock, property or otherwise with respect to any Equity Interests of Parent (except
for any dividend or distribution by a wholly owned Subsidiary of Parent, and any regular
quarterly dividend paid to holders of Parent Shares in an amount not in excess of the amount
set forth in Section&nbsp;6.1(b)(ii) of the Parent Disclosure Letter);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) reclassify, combine, split, subdivide or redeem, purchase or otherwise acquire
any Parent Shares or any options, warrants, convertible securities or other rights to
acquire any Parent Shares (other than (A)&nbsp;the acquisition of shares tendered by directors,
employees or former employees to pay Taxes in connection with the exercise of options issued
under any Parent Employee Plans and (B)&nbsp;open-market purchases of Parent Shares to fund
Parent Employee Plans consistent with past practice);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) except for any such transactions that would not materially impair or delay the
consummation of the transactions contemplated by this Agreement, (A)&nbsp;acquire, lease or
license from any Person (by merger, consolidation, acquisition of stock or assets or
otherwise) or sell, dispose of, encumber (other than through the creation of a Permitted
Encumbrance), lease or license (by merger, consolidation, sale of stock or assets or
otherwise) any corporation, partnership or other business organization or division thereof,
</DIV>

<P align="center" style="font-size: 10pt">-49-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">any Equity Interests therein or any assets, including Intellectual Property, in each case,
which are material to the Parent and Parent Subsidiaries taken as a whole, other than
acquisitions, leases, licenses, sales, dispositions and encumbrances of inventory,
non-merchandise supplies, media and advertising and other assets in the ordinary course of
business and consistent with past practice, (B)&nbsp;incur or guarantee, or modify in any
material respect, any Indebtedness or make any loans, advances or capital contributions to,
or investments in, any other Person (other than a Parent Subsidiary), in each case, other
than loans, advances and indebtedness incurred in the ordinary course of business and
consistent with past practice, or (C)&nbsp;enter into, renew or amend in any material respect any
material contract, other than in the ordinary course of business and consistent with past
practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) enter into any transaction, agreement, arrangement or understanding between (A)
Parent or any Parent Subsidiary, on the one hand, and (B)&nbsp;any Affiliate of Parent (other
than the Parent Subsidiaries), on the other hand, of the type that would be required to be
disclosed under Item&nbsp;404 of Regulation&nbsp;S-K;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) make any material changes in accounting policies or procedures other than as
required by GAAP or a Governmental Authority; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) agree to take any of the actions described in clauses (i)&nbsp;through (vi), above.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company will not, without the prior written consent of Parent, agree to any
modification of any term or condition of, or give any consent or waiver or exercise any right of
termination under, the Standalone Drug Sale Agreement, if such modification, consent, waiver or
exercise would reasonably be expected to adversely affect, or impose any cost or liability on,
Parent or its Subsidiaries (including their interests following the consummation of the
transactions contemplated by the Standalone Drug Sale Agreement) or adversely affect the ability to
consummate the transactions contemplated hereby in a timely manner. The Company shall comply with
the terms of the Standalone Drug Sale Agreement in all material respects. The Company will use
reasonable best efforts to cause the conditions to the consummation of the Standalone Drug Sale to
be satisfied (or waived by the other party thereto).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company agrees that between the date hereof and the Closing Date it will take all
actions it has affirmatively committed to take pursuant to Section&nbsp;6.1(a)(v) or Section&nbsp;6.1(a)(vi)
of the Company Disclosure Letter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.2 <U>Stockholders Meetings</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As soon as reasonably practicable following the date of this Agreement (and subject to the
Company&#146;s using its reasonable best efforts to hold the Company Stockholders Meeting on the same
day as the Parent Stockholders Meeting), the Company, acting through the Company Board of
Directors, and in accordance with applicable Law, shall (i)&nbsp;duly call, give notice of, convene and
hold a meeting of its stockholders for the purpose of (A)&nbsp;approving an amendment (the &#147;<U>Charter
Amendment</U>&#148;) to the Company&#146;s restated certificate of incorporation providing for appraisal
rights to holders of Company Shares for the Diamond Merger if the
</DIV>

<P align="center" style="font-size: 10pt">-50-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Effective Time occurs and (B)
with respect to the Diamond Merger, adopting this Agreement (the &#147;<U>Company Stockholders
Meeting</U>&#148;) to be held as soon as reasonably practicable after such notice, and (ii) (A)&nbsp;include
in the Proxy Statement/Prospectus the Company Board of Directors&#146; determination that the terms of
this Agreement are fair to and in the best interest of the stockholders of the Company, the Company
Board of Directors&#146; determination that this Agreement is advisable, and the Company Board of
Directors&#146; recommendation that the stockholders of the Company, with respect to the Diamond Merger,
vote in favor of the adoption of this Agreement (collectively, the &#147;<U>Company Board
Recommendation</U>&#148;) and the Company Board of Directors&#146; recommendation that the stockholders of
the Company vote in favor of the adoption of the Charter Amendment and (B)&nbsp;use its reasonable best
efforts to obtain the necessary approval of the transactions contemplated by this Agreement by the
stockholders of the Company and New Diamond, as applicable; <U>provided</U>, that if the Company
Board of Directors determines in good faith, after consultation with outside counsel, that any of
the foregoing actions in clause (ii)&nbsp;would be inconsistent with their fiduciary duties under
applicable Law, the Company Board of Directors may fail to take any of such actions and/or may
withdraw, modify or change in a manner adverse to Parent all or any portion of the Company Board
Recommendation. The Company shall call and hold the Company Stockholders Meeting in accordance
with clause (i)&nbsp;of the preceding sentence regardless of any failure to make the Company Board
Recommendation pursuant to clause (ii), and regardless of any change in the Company Board
Recommendation; <U>provided</U>, <U>however</U>, that nothing in this sentence shall affect the
Company&#146;s right to terminate the agreement in accordance with Section&nbsp;8.1. In the event that the
Requisite Company Stockholder Vote is obtained, the Company, as sole stockholder of New Diamond,
shall, prior to the Initial Effective Time, adopt this Agreement in favor of the Emerald Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As soon as reasonably practicable following the date of this Agreement (and subject to
Parent&#146;s using its reasonable best efforts to hold the Parent Stockholders Meeting on the same day
as the Company Stockholders Meeting), Parent, acting through the Parent Board of Directors, and in
accordance with applicable Law, shall (i)&nbsp;duly call, give notice of, convene and hold a meeting of
its stockholders for the purpose of adopting this Agreement (the &#147;<U>Parent Stockholders
Meeting</U>&#148;) to be held as soon as reasonably practicable after such notice and (ii)(A) include in
the Proxy Statement/Prospectus the Parent Board of Directors&#146; recommendation that Parent&#146;s
stockholders approve the issuance of Parent Shares pursuant to this Agreement (the &#147;<U>Parent
Board Recommendation</U>&#148;) and (B)&nbsp;use its reasonable best efforts to obtain the necessary approval
of the transactions contemplated by this Agreement by the stockholders of Parent<U> provided</U>,
that if the Parent Board of Directors determines in good faith, after consultation with outside
counsel, that any of the foregoing actions in clause (ii)&nbsp;would be inconsistent with their
fiduciary duties under applicable Law, the Parent Board of Directors may fail to take any of
such actions and/or may withdraw, modify or change in a manner adverse to the Company all or any
portion of the Parent Board Recommendation. Parent shall call and hold the Parent Stockholders
Meeting in accordance with clause (i)&nbsp;of the preceding sentence regardless of any failure to make
the Parent Board Recommendation pursuant to clause (ii), and regardless of any change in the Parent
Board Recommendation made at any time prior to the meeting.
</DIV>

<P align="center" style="font-size: 10pt">-51-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.3 <U>Proxy Statement</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As promptly as reasonably practicable following the date of this Agreement, (i)&nbsp;the
Company and Parent shall prepare a proxy statement to be sent to the stockholders of the Company
and Parent in connection with the Company Stockholder Meeting and the Parent Stockholder Meeting
(such proxy statement, as amended or supplemented, the &#147;<U>Proxy Statement/Prospectus</U>&#148;), and
(ii)&nbsp;Parent (and, if necessary, New Diamond) shall prepare and file with the SEC a registration
statement on Form S-4 (together with all amendments thereto, the &#147;<U>Form&nbsp;S-4</U>&#148;), in which the
Proxy Statement/Prospectus will be included as a prospectus, in connection with the registration
under the Securities Act of the New Diamond shares to be issued to the stockholders of the Company
in connection with the Diamond Merger and the Parent Shares to be issued to the stockholders of New
Diamond in connection with the payment of the aggregate Stock Consideration. Parent, New Diamond
and the Company will cooperate with each other in the preparation of the Proxy Statement/Prospectus
and Form S-4. Without limiting the generality of the foregoing, each of Parent, New Diamond and
the Company will provide the other with a reasonable opportunity to review drafts of, and revisions
to, the Proxy Statement/Prospectus and Form S-4 prepared by such party, and shall use its
reasonable best efforts to furnish to the other party information relating to it and its affiliates
as necessary to prepare the Proxy Statement/Prospectus and Form S-4. All of the parties hereto
shall cause the Proxy Statement/Prospectus and Form S-4 to comply as to form and substance as to
such party in all material respects with the applicable requirements of (i)&nbsp;the Exchange Act, (ii)
the Securities Act and (iii)&nbsp;the rules and regulations of the NYSE and the PCX. The Company or New
Diamond, as appropriate, shall provide audited financial statements for inclusion in the Proxy
Statement/Prospectus and Form S-4 as and to the extent required under applicable Law and SEC
regulations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each of the Company and Parent shall use reasonable best efforts to have the Form S-4
declared effective under the Securities Act as promptly as practicable after such filing and to
maintain the effectiveness of the Form S-4 through the Effective Time and to ensure that it
complies in all material respects with the applicable provisions of the Exchange Act and the
Securities Act until such time. The Company shall use its reasonable best efforts to cause the
Proxy Statement/Prospectus to be mailed to the Company&#146;s stockholders, and Parent shall use its
reasonable best efforts to cause the Proxy Statement/Prospectus to be mailed to Parent&#146;s
stockholders, in each case as promptly as practicable after the Form S-4 is declared effective
under the Securities Act. Parent and New Diamond shall also take any action required to be taken
under any applicable state securities laws in connection with the issuance of New Diamond Shares in
the Diamond Merger and Parent Shares in the Emerald Merger, as applicable, and the Company shall
furnish all information concerning the Company and the holders of the Company Shares as may be
reasonably requested in connection with any such action.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;No filing of, or amendment or supplement to, the Form S-4 will be made by New Diamond or
Parent, and no filing of, or amendment or supplement to the Proxy Statement/ Prospectus will be
made by the Company or Parent, in each case, without providing the other party and its respective
counsel a reasonable opportunity to review and comment thereon.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each of the parties agrees that none of the information supplied or to be supplied by it
for inclusion or incorporation by reference in the Proxy Statement/Prospectus or the Form
</DIV>

<P align="center" style="font-size: 10pt">-52-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">S-4 will,
at the date such document is first mailed to the stockholders of the relevant party and at the time
of such party&#146;s meeting of stockholders relating to the Mergers, contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances under which they are made,
not misleading. For purposes of the foregoing, it is understood and agreed that information
concerning or related to the Company or any Company Subsidiary will be deemed to have been supplied
by the Company and information concerning or related to Parent or Acquisition Sub will be deemed to
have been supplied by Parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Each of Parent and the Company agree to correct any information provided by it for use in
the Proxy Statement/Prospectus or Form S-4 which shall have become false or misleading. The
parties shall as soon as reasonably practicable notify each other of the receipt of any comments
from or other correspondence with the SEC staff with respect to the Proxy Statement/Prospectus or
Form S-4 and any request by the SEC for any amendment to the Proxy Statement/Prospectus or Form S-4
or for additional information (and promptly deliver a copy of such comments, correspondence or
request to each other). Parent will advise the Company, promptly after it receives notice thereof,
of the time when the Form S-4 has become effective, the issuance of any stop order or the
suspension of the qualification of the Parent Shares issuable in connection with the Mergers for
offering or sale in any jurisdiction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Each of the Company and Parent shall use its reasonable best efforts to cause to be
delivered to the other party a letter of its independent auditors, dated (i)&nbsp;the date on which the
Form S-4 shall become effective and (ii)&nbsp;the Closing Date, and addressed to the other party, in
form and substance customary for &#147;comfort&#148; letters delivered by independent public accountants in
connection with registration statements similar to the Form S-4.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.4 <U>Access to Information</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;During the period from the date of this Agreement through the earlier of the termination
of this Agreement pursuant to its terms and the Closing, the Company shall, and shall cause each
Company Subsidiary to, subject to reasonable restrictions imposed from time to time upon advice of
counsel respecting applicable Law or the Confidentiality Agreements, afford representatives of
Parent, following notice from Parent to the Company in accordance with this Section&nbsp;6.4(a),
reasonable access during normal business hours to all properties, offices, books, contracts,
commitments and records and such financial (including all working papers) and operating data of the
Company and the Company Subsidiaries and all other information concerning its business, properties,
personnel, vendors, landlords/sublandlords, tenants, licensees and franchisees as Parent may
reasonably request. Notwithstanding the foregoing, neither Parent nor any of its representatives
shall (i)&nbsp;contact or have any discussions with any of the Company&#146;s
employees, agents, or representatives, unless in each case Parent obtains the prior written
consent of the Company, which shall not be unreasonably withheld, conditioned or delayed, (ii)
contact or have any discussions with any of the vendors, landlords/sublandlords,
tenants/subtenants, licensees or franchisees of the Company or the Company Subsidiaries, unless in
each case Parent obtains the prior written consent of the Company, which shall not be unreasonably
withheld, conditioned or delayed, (iii)&nbsp;damage any property or any portion thereof, or (iv)&nbsp;perform
any onsite procedure or investigation (including any onsite environmental investigation or study)
without the Company&#146;s prior written consent. Parent shall schedule and coordinate all
</DIV>

<P align="center" style="font-size: 10pt">-53-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">inspections
with the Company and shall give the Company at least three Business Days prior written notice
thereof, setting forth the inspection or materials that Parent or its representatives intend to
conduct. The Company shall be entitled to have representatives present at all times during any
such inspection. Notwithstanding the foregoing, neither the Company nor any Company Subsidiary
shall be required to provide access to or to disclose information where such access or disclosure
would jeopardize the attorney-client privilege of the Company or any Company Subsidiary or
contravene any Law or binding agreement entered into prior to the date of this Agreement. All
information obtained pursuant to this Section&nbsp;6.4(a) shall continue to be governed by the
Confidentiality Agreements.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;During the period from the date of this Agreement through the earlier of the termination
of this Agreement pursuant to its terms and the Closing, Parent shall, and shall cause each Parent
Subsidiary to, subject to reasonable restrictions imposed from time to time upon advice of counsel
respecting applicable Law, afford representatives of the Company, following notice from Company to
the Parent in accordance with this Section&nbsp;6.4(b), reasonable access during normal business hours
to all properties, offices, books, contracts, commitments and records and such financial (including
all working papers) and operating data of Parent and the Parent Subsidiaries and all other
information concerning its business, properties, personnel, vendors, landlords/sublandlords,
tenants, licensees and franchisees as the Company may reasonably request. Notwithstanding the
foregoing, neither the Company nor any of its representatives shall (i)&nbsp;contact or have any
discussions with any of Parent&#146;s or the Parent Subsidiaries&#146; employees, agents, or representatives,
unless in each case the Company obtains the prior written consent of Parent, which shall not be
unreasonably withheld, conditioned or delayed, (ii)&nbsp;contact or have any discussions with any of the
vendors, landlords/sublandlords, tenants/subtenants, licensees or franchisees of Parent or the
Parent Subsidiaries, unless in each case the Company obtains the prior written consent of Parent,
which shall not be unreasonably withheld, conditioned or delayed, (iii)&nbsp;damage any property or any
portion thereof, or (iv)&nbsp;perform any onsite procedure or investigation (including any onsite
environmental investigation or study) without Parent&#146;s prior written consent. The Company shall
schedule and coordinate all inspections with Parent and shall give Parent at least three Business
Days prior written notice thereof, setting forth the inspection or materials that the Company or
its representatives intend to conduct. Parent shall be entitled to have representatives present at
all times during any such inspection. Notwithstanding the foregoing, neither Parent nor any Parent
Subsidiary shall be required to provide access to or to disclose information where such access or
disclosure would jeopardize the attorney-client privilege of Parent or any Parent Subsidiary or
contravene any Law or binding agreement entered into prior to the date of this Agreement. The
Company will keep confidential all non-public information provided to it pursuant to this Section
6.4(b), except for disclosures required by applicable Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.5 <U>Acquisition Proposals</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of the Company and Parent shall not, and shall not permit its Subsidiaries to, and
shall direct its and its Subsidiaries&#146; directors, officers, investment bankers, financial advisors,
attorneys, accountants and other representatives not to, (A)&nbsp;directly or indirectly, initiate or
solicit or knowingly encourage or facilitate any inquiries or the making or submission of any
proposal or offer with respect to a tender offer or exchange offer, merger, reorganization, share
exchange, consolidation or other business combination involving it or any proposal or offer
</DIV>

<P align="center" style="font-size: 10pt">-54-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to
acquire in any manner 20% or more of its Equity Interests, or the assets, securities or other
ownership interests of or in it or any Subsidiary representing 20% or more of the consolidated
assets, revenues or earnings of the Company and the Company Subsidiaries or of the Parent and the
Parent Subsidiaries, as the case may be, other than the transactions contemplated by the
Transaction Agreements and the Standalone Drug Sale Agreement (any such proposal or offer being
hereinafter referred to as an &#147;<U>Acquisition Proposal</U>&#148;) or (B)&nbsp;directly or indirectly, engage
in any negotiations or discussions concerning, or provide any confidential information or data to,
any Person relating to an Acquisition Proposal or execute or enter into any agreement,
understanding, letter of intent or arrangement with respect to any Acquisition Proposal (other than
a confidentiality agreement described below). Subject to Section&nbsp;6.5(b), neither the Company nor
Parent, nor the Company Board of Directors nor the Parent Board of Directors (each, a &#147;<U>Board of
Directors</U>&#148;) nor any committee thereof shall recommend to its stockholders any Acquisition
Proposal or approve any agreement with respect to an Acquisition Proposal. Notwithstanding the
foregoing, nothing contained in this Agreement shall prevent either of the Company or Parent or its
Board of Directors from (i)&nbsp;taking and disclosing to its stockholders a position contemplated by
Rule&nbsp;14d-9 and Rule&nbsp;14e-2(a) promulgated under the Exchange Act or from making any other legally
required disclosure to stockholders with regard to an Acquisition Proposal (provided that neither
the Company nor the Parent nor the Board of Directors thereof may recommend any Acquisition
Proposal unless permitted by Section&nbsp;6.5(b) below and may not fail to include or make, or withdraw,
modify or change in a manner adverse to the other party all or any portion of, the Company Board
Recommendation or Parent Board Recommendation, as the case may be, unless permitted by Section&nbsp;6.2
(in which case Parent or the Company shall have the right to terminate this Agreement as set forth
in Section&nbsp;8.1(e)(ii) or Section&nbsp;8.1(d)(ii), as applicable), and provided further that,
notwithstanding anything herein to the contrary, any &#147;stop-look-and-listen&#148; communication to its
stockholders pursuant to Rule&nbsp;14d-9(f) promulgated under the Exchange Act shall not be considered a
failure to make, or a withdrawal, modification or change in any manner adverse to the other party
of, all or a portion of the Company Board Recommendation or the Parent Board Recommendation, as
applicable) or (ii) (A)&nbsp;prior to obtaining the requisite vote of its stockholders at the Company
Stockholders Meeting, in the case of a Company Proposal, providing access to its properties, books
and records and providing information or data in response to a request therefor by a Person who has
made a bona fide, unsolicited Acquisition Proposal that does not involve an intentional, material
breach of this Section&nbsp;6.5(a), if (1)&nbsp;the Board of Directors receives from the Person so requesting
such information an executed confidentiality agreement on terms substantially similar to those
contained in the Confidentiality Agreements (except for such changes specifically necessary in
order for such party to be able to comply with its obligations under this Agreement and it being
understood that either party may enter into a confidentiality agreement without a standstill
provision or with a standstill provision less favorable to it if it waives or similarly modifies
the standstill provision in the relevant Confidentiality Agreement in favor of the other party),
and (2)&nbsp;in the case of a Parent Proposal, such Parent Proposal is, or is reasonably likely to
result in, a Qualifying Parent Proposal, or (B)&nbsp;prior to obtaining
 the requisite vote of its
stockholders at the Company Stockholders Meeting, in the case of a Company Proposal, engaging in
any negotiations or discussions with any Person who has made a bona fide unsolicited Acquisition
Proposal that does not involve an intentional, material breach of this Section&nbsp;6.5(a) and, in
addition, in the case of a Parent Proposal, such Parent Proposal is a Qualifying Parent Proposal,
if and only to the extent, in the case of a Company Proposal, that prior to taking any of the
</DIV>



<P align="center" style="font-size: 10pt">-55-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">actions set forth in clauses (A)&nbsp;or (B)&nbsp;of clause (ii), the Company Board of Directors shall have
determined in good faith (after consultation with its outside legal and financial advisors) that
such Acquisition Proposal constitutes or is reasonably likely to result in a Superior Proposal from
the Person that made the applicable Acquisition Proposal, and the Company shall have informed
Parent promptly following (and in no event later than 24 hours after) the taking by it of any such
action. A &#147;<U>Superior Proposal</U>&#148; means, with respect to a Company Proposal, an Acquisition
Proposal (with all percentages included in the definition of &#147;Acquisition Proposal,&#148; increased to
50% for purposes of this definition) that the Company Board of Directors determines in good faith
(taking into account such factors as it deems appropriate, including any legal, financial and
regulatory aspects of the proposal and the Person making the proposal) is reasonably capable of
being consummated and, if consummated, would result in a transaction more favorable to the
Company&#146;s stockholders from a financial point of view than the transactions contemplated by this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If either the Company Board of Directors or the Parent Board of Directors determines in
good faith, in response to an Acquisition Proposal, that such proposal is a Superior Proposal (in
the case of a Company Proposal) or a Qualifying Parent Proposal (in the case of a Parent Proposal),
the Company or Parent, as the case may be, shall notify the other party in writing of such
determination promptly following (and in no event later than 24 hours after) the making of such
determination. Prior to obtaining the requisite vote of its stockholders at the Company
Stockholders Meeting, in the case of a Company Proposal, the Company Board of Directors or the
Parent Board of Directors, as the case may be, may approve or recommend such Superior Proposal or
Qualifying Parent Proposal, as the case may be, to its stockholders and enter into any agreement,
understanding, letter of intent or arrangement with respect to such Superior Proposal or Qualifying
Parent Proposal, as applicable, and the Company may terminate this Agreement; <U>provided</U>,
<U>however</U>, that the Company shall not recommend any such Superior Proposal to its
stockholders, enter into any definitive agreement providing for any such Superior Proposal or
terminate this Agreement pursuant to this sentence (and any purported termination pursuant to this
sentence shall be void and of no force or effect), unless and until (1)&nbsp;it has given Parent prior
written notice of its intention to enter into such agreement at least two Business Days before
doing so, (2)&nbsp;the Company Board of Directors has considered in good faith any proposed changes to
this Agreement proposed by Parent, (3)&nbsp;the Company Board of Directors has determined in good faith,
after consultation with its outside legal counsel, that the failure to make such recommendation or
enter into such agreement would be inconsistent with its fiduciary duties under applicable Law, (4)
prior to entering into such agreement, it has terminated this Agreement, and (5)&nbsp;concurrently with
such termination pursuant to this Section&nbsp;6.5(b), the Company pays to Parent the Company
Termination Fee (as defined below) payable pursuant to Section&nbsp;8.2(b).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each of the Company and Parent shall immediately cease and cause to be terminated any
existing discussions or negotiations with any Persons conducted heretofore with respect to any
Acquisition Proposal. Each of the Company and Parent also shall, if it has not already done so,
promptly request, to the extent it has a contractual right to do so, that each Person, if any, that
has heretofore executed a confidentiality agreement within the 12&nbsp;months prior to the date of this
Agreement in connection with its consideration of any Acquisition Proposal return or destroy all
confidential information or data heretofore furnished to it by or on behalf of the Company or
Parent, as the case may be.
</DIV>

<P align="center" style="font-size: 10pt">-56-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Each of the Company and Parent shall promptly (and in no event later than 48 hours after
receipt of an Acquisition Proposal) notify (which notice shall be provided orally and in writing
and shall identify the Person making the Acquisition Proposal and set forth in reasonable detail
its material terms and conditions) the other party after receipt of an Acquisition Proposal and
thereafter shall keep the other party reasonably informed of the status and material terms and
conditions of any proposals or offers. Each of the Company and Parent shall make available to the
other party (to the extent it has not already done so) all material non-public information made
available to any Person making an Acquisition Proposal at substantially the same time and in
substantially the same form as it provides it to such other Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.6 <U>Further Action; Reasonable Best Efforts</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to the terms and conditions of this Agreement, Company and Parent will use their
reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done,
and assist and cooperate with the other parties in doing, all things necessary or desirable under
applicable Laws and regulations to consummate, in the most expeditious manner practicable, the
transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Company and Parent will use reasonable best efforts to: (i)&nbsp;prepare, as soon as
practicable, all filings and other presentations in connection with seeking any regulatory
approval, exemption or other authorization from any Governmental Authority necessary to consummate
the transactions contemplated hereby; (ii)&nbsp;prosecute such filings and other presentations with
diligence; and (iii)&nbsp;oppose any objections to, appeals from or petitions to reconsider or reopen
any such approval by Persons not party to this Agreement. Company and Parent will use reasonable
best efforts to facilitate obtaining any final order or orders approving such transactions,
consistent with this Agreement and/or to remove any impediment to the consummation of the
transactions contemplated hereby. Company and Parent will use reasonable best efforts to furnish
all information in connection with the approvals of or filings with any Governmental Authority and
will promptly cooperate with and furnish information in connection with any such requirements
imposed upon Parent or any of its Affiliates in connection with this Agreement and the transactions
contemplated hereby. Subject to Section&nbsp;6.6(c), Parent will use reasonable best efforts to obtain
any consent, authorization, order or approval of, or any exemption by, and to remove any impediment
imposed by any Governmental Authority to allow the consummation of the transactions contemplated
hereby. Parent and Company will each advise the other party promptly of any material communication
received by such party or any of its Affiliates from the Federal Trade Commission, Department of
Justice, any state attorney general or any other Governmental Authority regarding any of the
transactions
contemplated hereby, and of any understandings, undertakings or agreements (oral or written)
such party proposes to make or enter into with the Federal Trade Commission, Department of Justice,
any state attorney general or any other Governmental Authority in connection with the transactions
contemplated hereby. Parent and Company will each consult with the other in advance of any
material meetings with the Federal Trade Commission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In furtherance and not in limitation of Sections&nbsp;6.6(a) and (b), each of Parent and
Company shall make an appropriate filing of a Notification and Report Form pursuant to the HSR Act
with respect to the transactions contemplated hereby as promptly as practicable and thereafter make
any other required submissions with respect to the transactions contemplated
</DIV>

<P align="center" style="font-size: 10pt">-57-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">hereby under the HSR
Act and to take all other appropriate actions reasonably necessary, proper or advisable to cause
the expiration or termination of the applicable waiting periods under the HSR Act as soon as
practicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Notwithstanding the foregoing, Parent shall promptly take, in order to consummate the
Transactions, all actions necessary (i)&nbsp;to secure the expiration or termination of any applicable
waiting period under the HSR Act (the &#147;<U>HSR Clearance</U>&#148;) and/or to resolve any objections
asserted by any Governmental Authority with respect to the Transactions under any antitrust Law or
the Federal Trade Commission Act (each, an &#147;<U>Objection</U>&#148;), and (ii)&nbsp;to prevent the entry of,
and to have vacated, lifted, reversed or overturned, any decree, judgment, injunction or other
order that would prevent, prohibit, restrict or delay the consummation of the Transactions, in each
case including (A)&nbsp;executing settlements, undertakings, consent decrees, stipulations or other
agreements with any such party and (B)&nbsp;selling, divesting or otherwise conveying particular assets
or categories of assets or businesses of Parent and its Affiliates and/or constituting part of the
New Diamond Assets (as such term is defined in the Separation Agreement) or New Diamond Business.
Such efforts shall include, in addition to the consummation of the transactions contemplated by the
Cub Sale Agreement and the Ancillary Agreements referred to therein, taking all additional actions
contemplated by the preceding sentence, subject only to a limitation that those additional actions
not result in a divestiture of additional assets or businesses that, in the aggregate, produce
annual revenues in excess of $4&nbsp;billion. Parent shall respond to and seek to resolve as promptly
as practicable any Objections that are raised. No actions taken pursuant to this Section&nbsp;6.6(d)
shall be considered for purposes of determining whether a Company Material Adverse Effect has
occurred.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Notwithstanding the foregoing or any other provision of this Agreement, nothing in this
Section&nbsp;6.6 shall limit a party&#146;s right to terminate this Agreement pursuant to Section&nbsp;8.1 so long
as such party has up to then complied in all material respects with its obligations under this
Section&nbsp;6.6.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Parent shall use reasonable best efforts to cause the Parent Shares issuable to New
Diamond&#146;s stockholders as contemplated by this Agreement to be approved for listing on the NYSE,
subject to official notice of issuance, as promptly as practicable after the date of this
Agreement, and in any event prior to the Closing Date. The Company and New Diamond shall use
reasonable best efforts to cause the New Diamond Shares issuable to the Company&#146;s stockholders in
the Diamond Merger as contemplated by this Agreement to be approved for listing on a national
securities exchange, subject to official notice of issuance, prior to the Initial Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The Company shall deliver to Parent prior to the Closing Date a letter identifying all
Persons who are, at the time this Agreement is submitted for adoption by the stockholders of the
Company, &#147;affiliates&#148; of the Company for purposes of Rule&nbsp;145 of the rules and regulations
promulgated under the Securities Act. The Company shall use reasonable best efforts to cause each
such Person to deliver to Parent on or prior to the Closing Date a written affiliate letter
agreement in a form to be agreed by the parties.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;The Company shall provide, and shall cause the Company Subsidiaries to provide, and shall
use commercially reasonable efforts to cause the respective officers,
</DIV>

<P align="center" style="font-size: 10pt">-58-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">employees and
Representatives, including legal and accounting, of the Company and its Subsidiaries to provide,
all cooperation reasonably requested by Parent or New Diamond in connection with the Mergers and
the transactions contemplated by the Separation Agreement and Standalone Drug Sale Agreement to
effect the ultimate assumption by New Diamond of, and the release of the Company from, all of the
rights and obligations under, (i)&nbsp;that certain Indenture, as supplemented, dated as of May&nbsp;1, 1992,
by and between the Company and U.S. Bank Trust National Association, as successor trustee, and each
series of notes issued thereunder, and (ii) (w)&nbsp;the HITS Purchase Contract Agreement, (x)&nbsp;that
certain Pledge Agreement dated as of May&nbsp;7, 2004, by and between the Company and U.S. Bank Trust
National Association, as collateral agent, custodial agent, securities intermediary and purchase
contract agent (&#147;<U>Pledge Agreement</U>&#148;), (y)&nbsp;that certain Remarketing Agreement, dated as of
May&nbsp;7, 2004, by and between the Company, Banc of America Securities LLC, as the remarketing agent,
and U.S. Bank Trust National Association, as purchase contract agent and as attorney-in-fact of the
holders of purchase contracts (the &#147;<U>Remarketing Agreement</U>&#148;), and (z)&nbsp;each other agreement
related thereto (the foregoing clauses (i)&nbsp;and (ii)&nbsp;together, the &#147;<U>Debt and Purchase Contract
Assumption</U>&#148;). In furtherance of the foregoing, the Company shall (1)&nbsp;take all necessary
corporate action to consummate the Debt and Purchase Contract Assumption immediately prior to or
substantially simultaneous with the Closing, (2)&nbsp;obtain any consent of Banc of America Securities
LLC required under the terms of the Remarketing Agreement to effect the assignment to and
assumption by New Diamond of the rights and obligations of the Company under the Remarketing
Agreement, and (3)&nbsp;prepare and deliver other required opinions, certificates, documents,
supplemental indentures, supplemental agreements and other deliverables in connection with the Debt
and Purchase Contract Assumption.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.7 <U>Resignations</U>. To the extent requested by Parent in writing at least ten
Business Days prior to the Closing Date, on the Closing Date, the Company shall cause to be
delivered to Parent duly signed resignations, effective immediately after the Closing, of the
directors of the Company Subsidiaries designated by Parent and shall take such other action as is
necessary to accomplish the foregoing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.8 <U>Directors&#146; and Officers&#146; Indemnification and Insurance</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Without limiting any additional rights that any employee, officer or director may have
under any employment agreement or Company Plan or under the Company&#146;s or New Diamond&#146;s certificate
of incorporation or by-laws, after the Effective Time, Parent shall, and shall cause Surviving
Corporation to, indemnify and hold harmless each person who, as of the
Effective Time, is a present or former officer or director of the Company, New Diamond or any
Company Subsidiary or served as a fiduciary under or with respect to any employee benefit plan
(within the meaning of Section&nbsp;3(3) of ERISA) at any time maintained or contributed to by the
Company, New Diamond or any Company Subsidiaries (the &#147;<U>Indemnified Directors and
Officers</U>&#148;), against all claims, losses, liabilities, damages, judgments, fines and reasonable
fees, costs and expenses, including attorneys&#146; fees and disbursements, incurred in connection with
any claim, demand, action, suit, proceeding, inquiry or investigation, whether civil, criminal,
administrative or investigative, arising out of actions taken (or failure to take action) by any of
them in their capacities as officers, directors or fiduciaries at or prior to the Effective Time
(including in connection with this Agreement or the transactions or actions contemplated hereby),
whether asserted or claimed prior to, at or after the Effective Time, to the fullest extent
</DIV>

<P align="center" style="font-size: 10pt">-59-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">permitted under applicable Law. Parent shall, and shall cause the Surviving Corporation to,
advance the cost of any expenses incurred by each Indemnified Director and Officer in the defense
of any claim, demand, action, suit, proceeding, inquiry or investigation arising out of such
Indemnified Director or Officer&#146;s service as a director, officer or fiduciary within three Business
Days of receipt by the Surviving Corporation from the Indemnified Director or Officer of a request
therefor; provided only that any Person to whom expenses are to be advanced provides an
undertaking, if and only to the extent required by the DGCL, to repay such advances if it is
determined that such person is not entitled to indemnification in a final, nonappealable
determination by a Governmental Authority of competent jurisdiction. Neither Parent nor the
Surviving Corporation shall settle, compromise or consent to the entry of any judgment in any
actual or threatened claim, demand, action, suit, proceeding, inquiry or investigation in respect
of which indemnification has been or could be sought by such Indemnified Director or Officer
hereunder unless such settlement, compromise or judgment includes an unconditional release of such
Indemnified Director or Officer from all liability arising out of such claim, demand, action, suit,
proceeding, inquiry or investigation or such Indemnified Director or Officer otherwise consents
thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The certificate of incorporation and by-laws of the Surviving Corporation shall continue
to contain provisions no less favorable with respect to indemnification, advancement of expenses
and exculpation of the Indemnified Directors and Officers and former or present directors and
officers than are presently set forth in the Company&#146;s certificate of incorporation and by-laws,
which provisions shall not be amended, repealed or otherwise modified in any manner that would
adversely affect the rights thereunder of any such individuals. The resolutions adopted by the
Company Board of Directors on October&nbsp;7, 2005 relating to the indemnification of certain benefit
plan fiduciaries, which resolutions are set forth in Section&nbsp;6.8(b) of the Company Disclosure
Letter, shall continue in effect and shall not be amended, repealed or otherwise modified in any
manner that would adversely affect the rights thereunder of any Fiduciary (as such term is defined
therein) and the Surviving Corporation shall, and Parent shall cause the Surviving Corporation to,
indemnify and pay any and all expenses incurred by each Fiduciary in accordance with the term of
such resolutions and otherwise honor and comply with the provisions of such resolutions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Prior to the Effective Time, the Company and/or New Diamond shall (and if it is unable to,
Parent shall cause the Surviving Corporation as of the Effective Time to) obtain and fully pay for
&#147;tail&#148; insurance policies (providing only for the Side A coverage for Indemnified Directors and
Officers where the existing policies also include Side B coverage for the
Company) with a claims period of at least six years from the Effective Time from an insurance
carrier with the same or better credit rating as the Company&#146;s current insurance carrier with
respect to directors&#146; and officers&#146; liability insurance and fiduciary liability insurance with
benefits and levels of coverage at least as favorable as the Company&#146;s existing policies as of the
date hereof with respect to matters existing or occurring at or prior to the Effective Time
(including in connection with this Agreement or the transactions or actions contemplated hereby),
<U>provided</U>, <U>however</U>, that in no event shall the Company expend for such policies an
amount in excess of the amounts set forth in Section&nbsp;6.8(c) of the Company Disclosure Letter; and,
provided further that if the premiums of such insurance coverage exceeds such amount, the Company
shall obtain a policy with the greatest coverage available for a cost not exceeding such amount.
If the Company and the Surviving Corporation for any reason fail to obtain such &#147;tail&#148;
</DIV>

<P align="center" style="font-size: 10pt">-60-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">insurance
policies as of the Effective Time, the Surviving Corporation shall, and Parent shall cause the
Surviving Corporation to, continue to maintain in effect for a period of at least six years from
the Effective Time the directors&#146; and officers&#146; liability insurance and fiduciary liability
insurance in place as of the date hereof covering the Indemnified Directors and Officers with
benefits and levels of coverage at least as favorable as provided in the Company&#146;s existing
policies as of the date hereof, or the Surviving Corporation shall, and Parent shall cause the
Surviving Corporation to, purchase comparable directors&#146; and officers&#146; liability insurance and
fiduciary liability insurance for such six-year period with benefits and levels of coverage at
least as favorable as provided in the Company&#146;s existing policies as of the date hereof covering
the Indemnified Directors and Officers; <U>provided</U>, <U>however</U>, that in no event shall
the Parent or Surviving Corporation be required to expend for such policies an annual premium
amount in excess of the amounts set forth in Section&nbsp;6.8(c) of the Company Disclosure Letter; and,
provided further that if the annual premiums of such insurance coverage exceed such amount, the
Surviving Corporation shall obtain a policy with the greatest coverage available for a cost not
exceeding such amount. Parent shall, and shall cause the Surviving Corporation to, honor and
perform under all indemnification agreements entered into by the Company or any Company Subsidiary
set forth in Section&nbsp;6.8(c) of the Company Disclosure Letter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;This covenant is intended to be for the benefit of, and shall be enforceable by, each of
the Indemnified Directors and Officers and their respective heirs and legal representatives. The
indemnification provided for herein shall not be deemed exclusive of any other rights to which an
Indemnified Director or Officer is entitled, whether pursuant to Law, contract or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In the event that Parent or the Surviving Corporation or any of its successors or assigns
(i)&nbsp;consolidates with or merges into any other Person and shall not be the continuing or surviving
corporation or entity of such consolidation or merger or (ii)&nbsp;transfers or conveys all or
substantially all of its properties and assets as an entirety in one or a series of related
transactions to any Person(s), then, and in each such case, proper provision shall be made so that
such continuing or surviving corporation or entity or such Persons(s), as the case may be, shall
assume the obligations set forth in this Section&nbsp;6.8; <U>provided</U> that neither Parent nor the
Surviving Corporation shall be relieved from such obligation. In addition, neither Parent nor the
Surviving Corporation shall distribute, sell, transfer or otherwise dispose of any of its assets in
a manner that would reasonably be expected to render the Parent or Surviving Corporation unable to
satisfy its obligations under this Section&nbsp;6.8.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.9 <U>Public Announcements</U>. The initial press release relating to this
Agreement shall be a joint press release the text of which has been agreed to by each of Parent and
the Company. Thereafter, each of Parent and Acquisition Sub, on the one hand, and the Company, New
Diamond, and New Diamond Merger Sub, on the other hand, shall consult with each other before
issuing any press release or otherwise making any public statements with respect to the Transaction
Agreements or the transactions contemplated thereby, except to the extent public disclosure is
required by applicable Law or the requirements of the NYSE or the PCX, in which case the issuing
party shall use its reasonable best efforts to consult with the other party before issuing any such
release or making any such public statement.
</DIV>

<P align="center" style="font-size: 10pt">-61-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.10 <U>Cooperation</U>. (a)&nbsp;Parent shall use its commercially reasonable efforts
to obtain the Financing pursuant to the terms and conditions set forth in the Financing
Commitments. Parent shall notify the Company if at any time prior to the Closing Date the
Financing Commitment shall expire or be terminated, modified or amended for any reason. The
Company shall provide, and shall cause the Company Subsidiaries to, and shall use commercially
reasonable efforts to cause the respective officers, employees and Representatives, including legal
and accounting, of the Company and its Subsidiaries to provide, all cooperation reasonably
requested by Parent in connection with (i)&nbsp;the Financing, including providing such access and
documentation and taking such action as is customary for transactions such as the Financing and
(ii)&nbsp;the satisfaction of the conditions in the Financing Commitment that require action by the
Company, including those set forth in Section&nbsp;3 of the Financing Commitment and Exhibit&nbsp;B thereto.
Parent shall promptly, upon request by the Company, reimburse the Company for all reasonable
out-of-pocket third party costs incurred by the Company or any of the Company Subsidiaries in
connection with such cooperation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If the Financing Commitment expires, is terminated or otherwise become unavailable prior
to the Closing, in whole or in part, for any reason, Parent shall (i)&nbsp;immediately notify the
Company of such expiration, termination or other unavailability and the reasons therefor and (ii)
use its reasonable best efforts promptly to arrange for alternative financing to replace the
financing contemplated by such expired, terminated or otherwise unavailable commitments or
agreements in an amount sufficient to consummate the transactions contemplated by this Agreement.
Without limiting the effect of the preceding sentence, if Parent is unable to obtain replacement
financing from alternative sources within 25 Business Days after any expiration, termination or
other unavailability of any of the Financing Commitment (<U>provided</U>, that in the event such
25-day period would delay the Closing, it shall be reduced to such period as would not delay the
Closing but in no event less than ten Business Days), alternative financing may be proposed for
Parent and Acquisition Sub by the Company (or, at the request of the Company, the Company&#146;s
advisors) with one or more financing sources and Parent shall use its reasonable best efforts to
consummate such alternative financing, unless such alternative financing is on terms and conditions
that are (x)&nbsp;materially less favorable to Parent than the terms of the Financing Commitment that
expired, was terminated, or otherwise became unavailable or (y)&nbsp;not commercially reasonable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.11 <U>Notification</U>. During the period commencing upon the execution and
delivery of this Agreement by all of the parties hereto and terminating upon the earlier to occur
of the Effective Time and the termination of this
Agreement pursuant to and in accordance with Section&nbsp;8.1, the Company shall promptly notify
Parent, and Parent shall promptly notify the Company, in writing of any event, condition, fact or
circumstance that would cause any of the conditions set forth in Section&nbsp;7.1, Section&nbsp;7.2 or
Section&nbsp;7.3 not to be met. Each such notification shall include a certification of an officer of
the Company or Parent, as applicable, that such notification is being delivered in accordance with
this Section&nbsp;6.11. No such notification shall be deemed to supplement or amend the Company
Disclosure Letter or the Parent Disclosure Letter for the purpose of (i)&nbsp;determining the accuracy
of any of the representations and warranties made by the Company in this Agreement, or (ii)
determining whether any of the conditions set forth in Section&nbsp;7.1, Section&nbsp;7.2 and Section&nbsp;7.3 has
been satisfied.
</DIV>

<P align="center" style="font-size: 10pt">-62-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.12 <U>Third-Party Consents</U>. Without limiting the effect of Section&nbsp;6.6, each
of the Company and Parent shall use reasonable best efforts to promptly obtain all authorizations,
consents, approvals and waivers of, and give all notices to, each third party that may be necessary
for the consummation of the Mergers and are material to such party; <U>provided</U>,
<U>however</U>, that, except as expressly contemplated hereby, neither the Company nor Parent
shall materially amend or agree to materially amend, or waive any material right or material
economic benefit under, any Material Contract in connection with obtaining such consents, approvals
and waivers without the other party&#146;s consent (which shall not be unreasonably withheld,
conditioned or delayed); <U>provided</U>, <U>further</U>, that, in connection with obtaining such
authorizations, consents, approvals and waivers, or the giving of such notices, the Company shall
not be required to incur any out-of-pocket costs or any other obligation or liability unless de
minimis in nature and amount.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.13 <U>Employment and Employee Benefits Matters; Section&nbsp;16</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Without limiting any additional rights that any Company Employee may have under any
Company Plan, Parent shall cause the Surviving Corporation and each of its Subsidiaries, for a
period commencing at the Effective Time and ending on December&nbsp;31, 2007 (the &#147;<U>Benefits
Continuation Period</U>&#148;), to maintain the severance-related provisions of existing Company Plans
not subject to termination pursuant to the express terms hereof and to provide 100% of the
severance payments and benefits required thereunder to be provided to any Current Employee whose
employment is terminated during that period. For purposes of this Section&nbsp;6.13 only, the term
&#147;Company Employee&#148; shall be deemed to refer to any current, former or retired employee, officer,
consultant, independent contractor or director of the Company or any Company Subsidiary, excluding
employees of the Standalone Drug Business and the Retained Business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company shall allow each participant in the Deferred Compensation Plans to elect,
prior to the Effective Time, to receive his or her account balances (in the case of account balance
plans) and the present value of all accrued benefits (in the case of non-account balance plans,
with the present value in the case of benefits payable pursuant to an individual agreement being
determined using the assumptions required to be used in such agreement and in all other cases being
determined by using the average yield to maturity for 30-year US Government Bonds and the unloaded
94 GAR mortality rates, blended 50% male and 50% female, projected
to 2002), upon the earlier of (1)&nbsp;the existing payment date under the current terms relating
to such deferred compensation (subject to any change in the existing payment date that is required
to comply with Section&nbsp;409A of the Code) or (2)&nbsp;the later of (x)&nbsp;the Effective Time or (y)&nbsp;January
1, 2007. The Company may adopt such amendments to the Deferred Compensation Plans as it deems
necessary or appropriate to effectuate the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Without limiting any additional rights that any Company Employee not covered by a
collective bargaining agreement and employed by the Company or any Company Subsidiary at the
Effective Time (&#147;<U>Current Employee</U>&#148;) may have under any Company Plan, Parent shall cause the
Surviving Corporation and each of its Subsidiaries, for the Benefits Continuation Period, to
maintain for any Current Employees (i)&nbsp;salary or hourly wage rate, commissions and target cash
bonus opportunities under annual and long-term incentive programs (collectively,
&#147;<U>Compensation</U>&#148;), that in the aggregate are no less favorable than, and (ii)&nbsp;benefits
provided
</DIV>

<P align="center" style="font-size: 10pt">-63-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">under Company Plans (other than those covered by (i)&nbsp;above) that in the aggregate are no
less favorable than, the Compensation and benefits maintained for and provided to such Current
Employees immediately prior to the Effective Time; <U>provided</U>, <U>however</U>, subject to
the foregoing, that nothing herein shall prevent the amendment or termination of any Company Plan
or interfere with the Surviving Corporation&#146;s right or obligation to make such changes as are
necessary to conform with applicable Law. Nothing in this Section&nbsp;6.13 shall limit the right of
Parent, the Surviving Corporation or any of their Subsidiaries to terminate the employment of any
Current Employee at any time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;As of and after the Effective Time, Parent will, or will cause the Surviving Corporation
to, give Current Employees full credit for purposes of eligibility and vesting (but not benefit
accruals, except for vacation and severance, if applicable, under the Company Plans), under any
employee compensation and incentive plans, benefit (including vacation) plans, programs, policies
and arrangements maintained for the benefit of Current Employees as of and after the Effective Time
by Parent, its Subsidiaries or the Surviving Corporation for the Company Employees&#146; service with
the Company, its Subsidiaries and their predecessor entities (each, a &#147;<U>Parent Plan</U>&#148;) to the
same extent recognized under the Company Plans immediately prior to the Effective Time, provided
that no such credit shall be granted to the extent that it would result in a duplication of
benefits or to the extent that it is not similarly granted to similarly situated employees of
Parent and its Affiliates. With respect to each Parent Plan that is a &#147;welfare benefit plan&#148; (as
defined in Section&nbsp;3(1) of ERISA), the Parent or its Subsidiaries shall (i)&nbsp;cause to be waived any
pre-existing condition or eligibility limitations to the extent waived or satisfied under the
applicable Company Plan in which the Current Employee participates immediately prior to the
Effective Time and (ii)&nbsp;give effect, for the fiscal year in which the Closing occurs, in
determining any deductible and maximum out-of-pocket limitations, to claims incurred and amounts
paid by, and amounts reimbursed to, Current Employees under similar plans maintained by the Company
and its Subsidiaries immediately prior to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;From and after the Effective Time, Parent will cause the Surviving Corporation and all of
its Subsidiaries to honor, in accordance with its terms (including any right to amend or
terminate), (i)&nbsp;each existing employment, change in control, severance and termination plan, policy
or agreement of or between the Company or any Company Subsidiary and any officer, director or
employee of that company, and (ii)&nbsp;bonus plans or programs, bonus deferral plans,
vested and accrued benefits under any employee benefit plan, program or arrangement of the
Company or any Company Subsidiary and similar employment compensation and benefit arrangements and
agreements in effect as of the Effective Time. Without limiting the generality of the foregoing,
in the event that the annual bonus for fiscal year 2005 is not yet paid to participants at the
Effective Time, any participant who was employed by the Company at the end of fiscal year 2005 will
be entitled to a bonus if earned pursuant to the 2005 bonus program, regardless of whether such
participant is employed at the time of the payment of 2005 bonuses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Prior to the Effective Time, (i)&nbsp;the Company shall take all steps reasonably necessary to
cause the transactions contemplated hereby and any other dispositions of Equity Interests of the
Company (including derivative securities), in connection with this Agreement by each individual who
is subject to the reporting requirements of Section 16(a) of the Exchange Act to be approved by the
Company Board of Directors or a committee of two or more Non-
</DIV>

<P align="center" style="font-size: 10pt">-64-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Employee Directors of the Company (as
such term is defined in Rule&nbsp;16b-3 promulgated under the Exchange Act) and (ii)&nbsp;Parent shall take
all steps reasonably necessary to cause the transactions contemplated hereby and any other
acquisitions of Parent equity securities (including derivative securities) in connection with this
Agreement by each individual who is subject to the reporting requirements of Section 16(a) of the
Exchange Act to be approved by Parent Board of Directors or a committee of two or more Non-Employee
Directors of Parent (as such term is defined in Rule&nbsp;16b-3 promulgated under the Exchange Act).
Such approvals shall specify: (A)&nbsp;the name of each officer or director, (B)&nbsp;the number of
securities to be disposed of or acquired for each named person, and (C)&nbsp;that the approval is
granted for purposes of exempting the transaction under Rule&nbsp;16b-3 of the Exchange Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;The parties hereto will treat the consummation of the Transactions and the Standalone Drug
Sale, both individually and collectively, and regardless of the order in which they actually occur,
as a &#147;change in control,&#148; &#147;change of control&#148; or similar event under each of the Company Plans (to
the extent such Company Plans contain provisions relating to &#147;change in control,&#148; &#147;change of
control&#148; or similar event).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;The parties will make good faith efforts to make equitable adjustments if necessary to
ensure that the provisions of this Section&nbsp;6.13 comply with Section&nbsp;409A of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;Without limiting the generality of Section&nbsp;9.7, nothing in this Section&nbsp;6.13, express or
implied, is intended to or shall confer upon any employee or service provider of Parent, the
Company, or their respective Subsidiaries any right, benefit or remedy of any nature whatsoever.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.14 <U>Board Representation</U>. Parent shall take any and all actions necessary or
appropriate to cause, effective immediately following the Effective Time, the number of directors
comprising the Parent Board of Directors to be no more than fourteen (14)&nbsp;and for there to be three
(3)&nbsp;vacancies on such board. Parent shall use its reasonable best efforts to cause three of the
independent members of the Company Board of Directors to be elected to the Parent Board of
Directors. In furtherance thereto, Parent shall refer the names of three or more mutually
agreeable nominees to the Director Affairs Committee of the Parent Board of Directors for
nomination to fill such vacancies immediately following the Effective Time and to serve on the
Parent Board of Directors, one in each of the three classes of the Parent Board of Directors.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.15 <U>Available Cash</U>. No less than two Business Days and no earlier than five
Business Days prior to the Closing Date, the Company shall provide Parent with a good faith
estimate, together with reasonable supporting documentation, of the amount of immediately available
funds, in U.S. dollars, that the Company has available to it to be used to fund Parent&#146;s obligation
to pay the Merger Consideration without restriction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.16 <U>Coordination of Dividends</U>. From the date of this Agreement until the
Effective Time, Parent and the Company shall coordinate with each other regarding the declaration
and payment of dividends in respect of the Company Shares and the Parent Shares and the record
dates and payment dates relating thereto, it being the intention of the parties hereto that holders
of Company Shares or Parent Shares shall not receive two dividends, or fail
</DIV>

<P align="center" style="font-size: 10pt">-65-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to receive one
dividend, for any single calendar quarter, including the quarter in which the Effective Time
occurs, with respect to their Company Shares or Parent Shares, as the case may be. New Diamond and
New Diamond Merger Sub shall not declare or pay any dividends in respect of their Common Stock.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.17 <U>The Diamond Reorganization</U>. The parties acknowledge and agree that they
desire and intend to (i)&nbsp;cause the Diamond Merger and the Diamond LLC Conversion, taken together
(the &#147;<U>Diamond Reorganization</U>&#148;), to qualify as a &#147;reorganization&#148; within the meaning of
Section&nbsp;368(a)(1)(F) of the Code (an &#147;<U>F Reorg</U>&#148;), (ii)&nbsp;treat the Retained Business Purchase
(other than the purchase of Lucky Stores, Inc., a Delaware corporation (&#147;<U>Lucky Delaware</U>&#148;)
and its Subsidiaries) and the Standalone Drug Sale as purchases of assets for federal income Tax
purposes, (iii)&nbsp;treat the purchase of Lucky Delaware as a purchase of stock for federal income Tax
purposes and (iv)&nbsp;effect the Separation in a manner that does not result in any gain, including any
deferred intercompany gain, for federal income Tax purposes (other than with respect to the
distribution of certain New Diamond Assets from Lucky Delaware and its Subsidiaries pursuant to the
Separation Agreement). The Company shall, and shall cause New Diamond to, (x)&nbsp;use best efforts to
cause the Diamond Reorganization to qualify as an F Reorg, (y)&nbsp;consult with Parent prior to taking
any action that could affect the qualification of the Diamond Reorganization as an F Reorg and
take, or refrain from taking, any actions reasonably requested by Emerald in order to qualify the
Diamond Reorganization as an F Reorg and (z)&nbsp;consult with Parent prior to taking any action in
connection with the Separation, the Retained Business Purchase or the Standalone Drug Sale and
take, or refrain from taking, any action reasonably requested by Parent in connection with the
Separation, the Retained Business Purchase or the Standalone Drug Sale in furtherance of the
intentions described above in this Section&nbsp;6.17. Any capitalized term used in this paragraph, but
not defined in this Agreement, shall have the meaning ascribed to it in the Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 6.18 <U>Boise Operations and Community Involvement</U>. Parent intends to maintain a
significant presence in Boise, Idaho for a period of not less than three years following the
Effective Time.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VII</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS OF MERGER</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7.1 <U>Mutual Conditions to Effect the Mergers</U>. The respective obligations of
each party to consummate the Mergers shall be subject to the satisfaction or waiver at or prior to
the Closing of the following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;This Agreement shall have been adopted by the stockholders of the Company by the Requisite
Company Stockholder Vote in accordance with the Company&#146;s certificate of incorporation and the DGCL
and the Share Issuance shall have been approved by the stockholders of Parent by the Requisite
Parent Stockholder Vote in accordance with the Parent&#146;s certificate of incorporation or other
governing documents, the DGCL and applicable stock
exchange regulations;
</DIV>

<P align="center" style="font-size: 10pt">-66-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Form S-4 shall have become effective under the Securities Act and not be the subject
of any stop order or proceedings seeking a stop order;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Parent Shares issuable to the New Diamond stockholders as contemplated by this
Agreement in connection with the payment of the aggregate Stock Consideration shall have been
approved for listing on the NYSE, subject to official notice of issuance;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;With respect to the Emerald Merger only, each of the Standalone Drug Sale, the Separation
and the Retained Business Purchase shall have occurred;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;No Law, temporary restraining order, preliminary or permanent injunction or other legal
restraint shall have been enacted, entered, promulgated or enforced and no action or decision shall
have been taken and remain in effect by any United States or state Governmental Authority, or any
Governmental Authority of the jurisdictions listed in Section&nbsp;7.1(e) of the Company Disclosure
Letter, which seeks to or in fact prohibits, restrains or enjoins the consummation of the
transactions contemplated by this Agreement; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The waiting period (and any extension thereof) applicable to the transactions contemplated
by this Agreement under the HSR Act shall have been terminated or shall have expired.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7.2 <U>Conditions to Obligations of Parent and Acquisition Sub</U>. The obligations
of Parent and Acquisition Sub to consummate the Mergers shall be further subject to the
satisfaction or waiver at or prior to the Closing of the following conditions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The representations and warranties of the Company contained in this Agreement
(disregarding any Company Material Adverse Effect, materiality or similar qualifiers therein)
shall be true and correct as of the date hereof and the Closing Date as though made on and as
of such date (unless any such representation or warranty is made only as of a specific date, in
which event such representation and warranty shall be true and correct as of such specified date),
except where any failure of any such representation or warranty to be so true and correct has not
had and would not reasonably be expected to have a Company Material Adverse Effect;
<U>provided</U>, <U>however</U>, that the representations and warranties of the Company in
Section&nbsp;4.2 (Authority; Enforceability) shall be true in all but de minimis respects;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each of the Company, New Diamond and New Diamond Merger Sub shall have performed in all
material respects the obligations, and complied in all material respects with the agreements and
covenants, required to be performed by or complied with by it under this Agreement at or prior to
the Effective Time; <U>provided</U>, that the Company&#146;s failure to comply with the notification
requirements in Section&nbsp;6.11 shall not cause the condition set forth in this Section&nbsp;7.2(b) to fail
to be satisfied; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent shall have received a certificate of the Chief Executive Officer and the Chief
Financial Officer of the Company, certifying that the conditions set forth in Sections&nbsp;7.2(a) and
(b)&nbsp;have been satisfied.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 7.3 <U>Conditions to Obligations of the Company, New Diamond and New Diamond Merger
Sub</U>. The obligations of the Company, New Diamond and New Diamond
</DIV>

<P align="center" style="font-size: 10pt">-67-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Merger Sub to consummate the
Mergers shall be further subject to the satisfaction or waiver at or prior to the Closing of the
following conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The representations and warranties of Parent and Acquisition Sub contained in this
Agreement (disregarding any Parent Material Adverse Effect, materiality or similar qualifiers
therein) shall be true and correct in all material respects, in each case as of the date hereof and
the Closing Date as though made on and as of such date (unless any such representation or warranty
is made only as of a specific date, in which event such representation and warranty shall be true
and correct in all material respects as of such specified date), except where any failure of any
such representation or warranty to be so true and correct has not had and would not reasonably be
expected to have a Parent Material Adverse Effect; <U>provided</U>, <U>however</U>, that the
representations and warranties of Parent in Section&nbsp;5.2 (Authority; Enforceability) shall be true
in all but de minimis respects;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each of Parent and Acquisition Sub shall have performed in all material respects the
material obligations, and complied in all material respects with the material agreements and
covenants, required to be performed by or complied with by it under this Agreement at or prior to
the Effective Time; <U>provided</U>, that the Parent&#146;s failure to comply with the notification
requirements in Section&nbsp;6.11 shall not cause the condition set forth in this Section&nbsp;7.3(b) to fail
to be satisfied;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The New Diamond Shares issuable to the Company&#146;s stockholders as contemplated by this
Agreement in connection with the Diamond Merger shall have been approved for listing on a national
securities exchange, subject to official notice of issuance; <U>provided</U>, that the obligations
of the Company, New Diamond and New Diamond Merger Sub to
consummate the Mergers shall be subject to the condition in this Section&nbsp;7.3(c) only if (i)
the Company and New Diamond have complied in all respects with Section&nbsp;6.6(f) and (ii)&nbsp;it is
reasonably likely that the Emerald Merger will not be consummated; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The Company shall have received a certificate of the Chief Executive Officer and the Chief
Financial Officer of Parent, certifying that the conditions set forth in Sections&nbsp;7.3(a) and (b)
have been satisfied.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VIII</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>TERMINATION, AMENDMENT AND WAIVER</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.1 <U>Termination</U>. This Agreement may be terminated and the transactions
contemplated hereby may be abandoned at any time prior to the Closing, whether before or after
adoption of this Agreement by stockholders of the Company or of New Diamond:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;by mutual written consent of each party hereto;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;by Parent or the Company if any United States or state Governmental Authority shall have
issued a final order, decree or ruling or taken any other final action permanently restraining,
enjoining or otherwise prohibiting the transactions contemplated by this Agreement and such
decision, order, decree, ruling or other action is or shall have become final and nonappealable;
</DIV>

<P align="center" style="font-size: 10pt">-68-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;by Parent or the Company if the Closing shall not have occurred on or before September&nbsp;22,
2006 (the &#147;<U>Termination Date</U>&#148;); <U>provided</U>, that the right to terminate this Agreement
pursuant to this Section&nbsp;8.1(c) shall not be available to the party seeking to terminate if any
action of such party or the failure of such party to perform any of its obligations under this
Agreement required to be performed at or prior to the Closing has been the cause of, or resulted
in, the failure of the Closing to occur on or before the applicable termination date and such
action or failure to perform constitutes a breach of this Agreement; <U>provided</U>,
<U>further</U>, that the right to terminate this Agreement pursuant to this Section&nbsp;8.1(c) shall
not be available to the Company if neither the Company nor CVS shall have exercised its termination
right under Section&nbsp;12.01(b) of the Standalone Drug Sale Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;by the Company
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;if there shall have been a material failure of any representation or warranty of Parent or
Acquisition Sub to be true, or a material breach of any covenant or agreement of Parent or
Acquisition Sub contained in this Agreement such that the condition set forth in Section&nbsp;7.3(a) or
7.3(b) would not be satisfied and which shall not have been cured (if curable) prior to the earlier
of (A)&nbsp;20 Business Days following notice of such breach (it being understood that such 20 Business
Day period shall not be applicable to covenants or agreements that by their terms are intended to
be satisfied at the Closing) and (B)&nbsp;the Termination Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;if the Parent Board of Directors (A)&nbsp;shall have failed to include or make or shall have
publicly withdrawn, modified or changed (it being understood and agreed that any
&#147;stop-look-and-listen&#148; communication by the Parent Board of Directors to the stockholders of the
Parent pursuant to Rule&nbsp;14d-9(f) of the Exchange Act shall not be deemed to constitute a
withdrawal, modification or change of its recommendation of this Agreement), in a manner adverse to
Company, the Parent Board Recommendation either (1)&nbsp;due in any meaningful respect to antitrust
concerns or (2)&nbsp;for any other reason, or (B)&nbsp;shall have recommended to the stockholders of Parent
an Acquisition Proposal other than the transactions contemplated by this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;if Parent fails to duly call or convene the Parent Stockholders Meeting in accordance
with Section&nbsp;6.2; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;prior to obtaining the requisite vote of its stockholders at the Company Stockholders
Meeting, in accordance with, and subject to the terms and conditions of, Section&nbsp;6.5(b);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;by Parent
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;if there shall have been a material failure of any representation or warranty of the
Company to be true, or a material breach of any covenant or agreement of the Company contained in
this Agreement such that the condition set forth in Section&nbsp;7.2(a) or 7.2(b) would not be satisfied
and which shall not have been cured (if curable) prior to the earlier of (A)&nbsp;20 Business Days
following notice of such breach (it being understood that such 20 Business Day period shall not be
applicable to covenant or agreements that by their terms are intended to be satisfied at the
Closing) and (B)&nbsp;the Termination Date;
</DIV>


<P align="center" style="font-size: 10pt">-69-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;if the Company Board of Directors (A)&nbsp;shall have failed to include or make or shall have
publicly withdrawn, modified or changed (it being understood and agreed that any
&#147;stop-look-and-listen&#148; communication by the Company Board of Directors to the stockholders of the
Company pursuant to Rule&nbsp;14d-9(f) of the Exchange Act shall not be deemed to constitute a
withdrawal, modification or change of its recommendation of this Agreement), in a manner adverse to
Parent, the Company Board Recommendation, or (B)&nbsp;shall have recommended to the stockholders of the
Company an Acquisition Proposal other than the transactions contemplated by this Agreement; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;if the Company fails to duly call or convene the Company Stockholders Meeting in
accordance with Section&nbsp;6.2;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;by Parent or the Company if, (i)&nbsp;upon a vote thereon at the Company Stockholders Meeting
or any postponement or adjournment thereof, this Agreement shall not have been adopted by the
Requisite Company Stockholder Vote, or (ii)&nbsp;upon a vote thereon at the Parent Stockholders Meeting
or any postponement or adjournment thereof, the Share Issuance shall not have been approved by the
Requisite Parent Stockholder Vote; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;by Parent or the Company if the Separation Agreement or the Standalone Drug Sale Agreement
shall have been terminated in accordance with the terms thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.2 <U>Effect of Termination</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;In the event of the termination of this Agreement pursuant to Section&nbsp;8.1, this Agreement
shall forthwith become void and there shall be no liability or obligation on the part of any party
hereto, except with respect to Section&nbsp;6.4(b), this Section&nbsp;8.2, Section&nbsp;8.3, or Article&nbsp;IX, which
shall survive such termination; <U>provided</U>, <U>however</U>, that nothing herein shall
relieve any party from liability for any willful or intentional material breach hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company shall pay Parent, by wire transfer of immediately available funds to such
accounts as Parent may designate, the sum of $276,000,000 (the &#147;<U>Company Termination Fee</U>&#148;)
if this Agreement is terminated as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;if Parent shall terminate this Agreement pursuant to Section&nbsp;8.1(e)(iii), then the
Company shall pay the Company Termination Fee on the business day following such
termination;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;if the Company shall terminate this Agreement pursuant to Section&nbsp;8.1(d)(iv), the
Company shall pay the Company Termination Fee concurrently with such termination;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;if (A)&nbsp;either party shall terminate this Agreement pursuant to Section&nbsp;8.1(f)(i)
and (B)&nbsp;at any time after the date hereof and at or before the date of the Company
Stockholders Meeting there shall have been a Public Proposal with respect to the Company,
and if (C)&nbsp;within twelve months of the date of such termination of this Agreement, the
Company or any of the Company Subsidiaries enters into any definitive agreement with respect
to, or consummates, any Acquisition Proposal (<U>provided</U> that, in this instance, all
percentages included in the definition of &#147;Acquisition Proposal&#148; shall be
</DIV>

<P align="center" style="font-size: 10pt">-70-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">increased to 50%),
then the Company shall pay the Company Termination Fee upon the date of such execution or
consummation, whichever is earlier;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) if (A)&nbsp;either party shall terminate this Agreement pursuant to Section&nbsp;8.1(c) and
(B)&nbsp;at any time after the date hereof and before such termination there shall have been a
Public Proposal with respect to the Company, and if (C)&nbsp;within twelve months of the date of
such termination of this Agreement, the Company or any of the Company Subsidiaries enters
into any definitive agreement with respect to, or consummates, any Acquisition Proposal
(<U>provided</U> that, in this instance, all percentages included in the definition of
&#147;Acquisition Proposal&#148; shall be increased to 50%), then the Company shall pay the Company
Termination Fee upon the date of such execution or consummation, whichever is earlier; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) if Parent shall terminate this Agreement pursuant to Section&nbsp;8.1(e)(ii) within 10
calendar days following the occurrence of the event giving rise to such termination right,
then the Company shall pay the Company Termination Fee on the Business Day following such
termination.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary, if the Company fails to pay all
amounts due to Parent on the dates specified, then the Company shall pay all costs and
expenses (including legal fees and expenses) incurred by Parent in connection with any action
or proceeding (including the filing of any lawsuit) taken by it to collect such unpaid amounts,
together with interest on such unpaid amounts at the prime lending rate prevailing at such time, as
published in The Wall Street Journal, from the date such amounts were required to be paid until the
date actually received by Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent shall pay the Company, by wire transfer of immediately available funds to such
accounts as the Company may designate, the sum of $135,000,000 (the &#147;<U>Parent Termination
Fee</U>&#148;) if this Agreement is terminated as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;if the Company shall terminate this Agreement pursuant to Section&nbsp;8.1(d)(iii) then
Parent shall pay the Parent Termination Fee on the business day following such termination;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;if (A)&nbsp;either party shall terminate this Agreement pursuant to Section&nbsp;8.1(f)(ii)
and (B)&nbsp;at any time after the date hereof and before such termination there shall have been
a Public Proposal with respect to the Parent, and if (C)&nbsp;within twelve months of the date of
such termination of this Agreement, Parent or any of Parent Subsidiaries enters into any
definitive agreement with respect to, or consummates, any Acquisition Proposal
(<U>provided</U> that, in this instance, all percentages included in the definition of
&#147;Acquisition Proposal&#148; shall be increased to 50%), then Parent shall pay the Parent
Termination Fee upon the date of such execution or consummation, whichever is earlier;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;if (A)&nbsp;either party shall terminate this Agreement pursuant to Section&nbsp;8.1(c),
except in the circumstances described in Section&nbsp;8.2(d)(i), and (B)&nbsp;at any time after the
date hereof and before such termination there shall have been a Public Proposal with respect
to the Parent, and if (C)&nbsp;within twelve months of the date of such termination
</DIV>

<P align="center" style="font-size: 10pt">-71-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">of this
Agreement, Parent or any of Parent Subsidiaries enters into any definitive agreement with
respect to, or consummates, any Acquisition Proposal (<U>provided</U> that, in this
instance, all percentages included in the definition of &#147;Acquisition Proposal&#148; shall be
increased to 50%), then Parent shall pay the Parent Termination Fee upon the date of such
execution or consummation, whichever is earlier; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) if the Company shall terminate this Agreement pursuant to Section&nbsp;8.1(d)(ii)
within 10 calendar days following the occurrence of the event giving rise to such
termination right, except in the circumstances described in Section&nbsp;8.2(d)(ii), then Parent
shall pay the Parent Termination Fee on the Business Day following such termination.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary, if Parent fails to pay all amounts
due to the Company on the dates specified, then Parent shall pay all costs and expenses (including
legal fees and expenses) incurred by the Company in connection with any action or proceeding
(including the filing of any lawsuit) taken by it to collect such unpaid amounts, together with
interest on such unpaid amounts at the prime lending rate prevailing at such time, as published in
The Wall Street Journal, from the date such amounts were required to be paid until the date
actually received by the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Parent shall pay the Company by wire transfer of immediately available funds to such
accounts as the Company may designate, the sum of $250,000,000 (the &#147;<U>Regulatory Termination
Fee</U>&#148;), and shall not pay the Company the Parent Termination Fee, if this Agreement is
terminated as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) if (A)&nbsp;either party shall terminate this Agreement pursuant to Section&nbsp;8.1(c), (B)
as of the date of such termination the HSR Clearance shall not have occurred or any decree,
judgment, injunction, or other order (in each case that relates to antitrust Laws) that
prevents, prohibits or delays the consummation of the Transactions exists or is in effect,
(C)&nbsp;immediately prior to such termination, the conditions set forth in Sections&nbsp;7.1(a) (to
the extent relating to the Requisite Company Stockholder Vote), 7.1(b) and 7.2(a) shall have
been satisfied, and (D)&nbsp;each of the Company, New Diamond and New Diamond Merger Sub shall
have performed in all material respects the obligations, and complied in all material
respects with the agreements and covenants, required to be performed by or complied with by
it under this Agreement prior to such termination (other than obligations, agreements and
covenants set forth in Section&nbsp;6.11), then Parent shall pay the Regulatory Termination Fee
on the business day following such termination; <U>provided</U>, that if (1)&nbsp;this Agreement
is terminated pursuant to Section&nbsp;8.1(g) and (2)&nbsp;at the time of such termination this
Agreement may also be terminated pursuant to Section&nbsp;8.1(c), then for purposes of this
Section&nbsp;8.2(d)(i) this Agreement shall be deemed to have been terminated pursuant to Section
8.1(c); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) if the Company shall terminate this Agreement pursuant to Section&nbsp;8.1(d)(ii)(A)(1)
within 10 calendar days following the occurrence of the event giving rise to such
termination right, Parent shall pay the Regulatory Termination Fee on the business day
following such termination,
</DIV>

<P align="center" style="font-size: 10pt">-72-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything in this Agreement to the contrary, if Parent fails to pay all amounts
due to the Company on the dates specified, then Parent shall pay all costs and expenses (including
legal fees and expenses) incurred by the Company in connection with any action or proceeding
(including the filing of any lawsuit) taken by it to collect such unpaid amounts, together with
interest on such unpaid amounts at the prime lending rate prevailing at such time, as published in
The Wall Street Journal, from the date such amounts were required to be paid until the date
actually received by the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.3 <U>Expenses</U>. Except as otherwise specifically provided in this Agreement,
each party shall bear its own expenses in connection with this Agreement and the transactions
contemplated hereby; <U>provided</U>, that expenses incurred in connection with the filing fee for
the Proxy Statement/Prospectus and printing and mailing the Proxy Statement/Prospectus shall be
shared equally by Parent and the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.4 <U>Amendment</U>. Subject to applicable Law, this Agreement may be amended by
the parties hereto by action taken by or on behalf of their respective boards of directors, at any
time prior to the Closing Date, whether before or after adoption of this Agreement by the
stockholders of the Company, New Diamond
and Acquisition Sub. This Agreement may not be amended except by an instrument in writing
signed by the parties hereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 8.5 <U>Waiver</U>. At any time prior to the Effective Time, any party hereto may (i)
extend the time for the performance of any of the obligations or other acts of the other parties
hereto, (ii)&nbsp;waive any inaccuracies in the representations and warranties contained herein or in
any document delivered pursuant hereto, and (iii)&nbsp;subject to the requirements of applicable Law,
waive compliance with any of the agreements or conditions contained herein. Any such extension or
waiver shall be valid only if set forth in an instrument in writing signed by the party or parties
to be bound thereby.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IX</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>GENERAL PROVISIONS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.1 <U>Non-Survival of Representations, Warranties and Agreements</U>. None of the
representations, warranties, covenants and agreements in this Agreement or in any instrument
delivered pursuant to this Agreement, and the other agreements and documents contemplated to be
delivered in connection herewith, including any rights arising out of any breach of such
representations, warranties, covenants and agreements, shall, in the event Closing occurs, survive
the Effective Time, except for (i)&nbsp;those covenants and agreements contained herein that by their
terms apply or are to be performed in whole or in part at or after the Effective Time (including
Section&nbsp;6.8) and (ii)&nbsp;this Article&nbsp;IX.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.2 <U>Company Disclosure Letter; Parent Disclosure Letter</U>. There may have been
included in the Company Disclosure Letter and the Parent Disclosure Letter and may be included
elsewhere in this Agreement items which are not &#147;material,&#148; and such inclusion shall not be deemed
to be an acknowledgment or agreement by the Company or the Parent, as appropriate, that such items
are &#147;material&#148; or to affect the interpretation of such term for purposes of this Agreement.
Disclosures included in any Section of the Company Disclosure
</DIV>

<P align="center" style="font-size: 10pt">-73-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Letter or the Parent Disclosure
Letter shall be considered to be made for purposes of all other Sections of the Company Disclosure
Letter or of the Parent Disclosure Letter, as appropriate, to the extent that the relevance of any
such disclosure to any other Section of the Company Disclosure Letter or the Parent Disclosure
Letter, as appropriate, is reasonably apparent from the text of such disclosure. The inclusion of
any items or information in the Company Disclosure Letter or the Parent Disclosure Letter shall not
be construed as an admission that such item or information (or any non-disclosed item or
information of comparable or greater significance) is material or otherwise required to be
scheduled as an exception from any representation, warranty or covenant. Matters reflected in the
Company Disclosure Letter or the Parent Disclosure Letter are not necessarily limited to matters
required by the Agreement to be disclosed in the Company Disclosure Letter or the Parent Disclosure
Letter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.3 <U>Notices</U>. Any and all notices or other communications or deliveries
required or permitted to be provided hereunder shall be in writing and shall be deemed given and
effective on the earliest of (i)&nbsp;the date of
transmission, if such notice or communication is delivered via facsimile at the facsimile
telephone number specified in this Section&nbsp;9.3 prior to 5:00 p.m. (New York time) on a Business
Day, (ii)&nbsp;the Business Day after the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile telephone number specified in this Agreement later than
5:00 p.m. (New York time) on any date and earlier than 11:59&nbsp;p.m. (New York time) on such date,
(iii)&nbsp;when received, if sent by nationally recognized overnight courier service, or (iv)&nbsp;upon
actual receipt by the party to whom such notice is required to be given. The address for such
notices and communications shall be as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;if to the Company, New Diamond Merger Sub, or New Diamond:
</DIV>
<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">Albertson&#146;s, Inc.<BR>
250 East Parkcenter Boulevard<BR>
Boise, Idaho 83706<BR>
Facsimile: (208)&nbsp;395-6349<BR>
Attention: Corporate Secretary
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">with a copy to (which shall not constitute notice):
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">Jones Day<BR>
North Point<BR>
901 Lakeside Avenue<BR>
Cleveland, Ohio 44114<BR>
Facsimile: (216)&nbsp;579-0212<BR>
Attention: Lyle G. Ganske, Esq.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 9%; margin-top: 6pt">and to:
</DIV>



<P align="center" style="font-size: 10pt">-74-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="83%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Jones Day</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">2727 North Harwood Street</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Dallas, Texas 75201</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Facsimile: (214)&nbsp;969-5100</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Attention: Mark E. Betzen, Esq.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">and to:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Sullivan &#038; Cromwell LLP</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">125 Broad Street</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">New York, New York 10004</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(212) 558-3588</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">James C. Morphy, Esq.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Audra D. Cohen, Esq.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if to Parent, Acquisition Sub or the Surviving Corporation:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="83%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">SUPERVALU INC.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">11840 Valley View Road</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Eden Prairie, MN 55344</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(952) 828-8900</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Secretary</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">with a copy to (which shall not constitute notice):</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Wachtell, Lipton, Rosen &#038; Katz</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">51 West 52nd Street</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">New York, New York 10019</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(212) 403-2233</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attention:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Andrew R. Brownstein, Esq.</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Igor Kirman, Esq.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.4 <U>Severability</U>. Whenever possible, each provision of this Agreement shall
be interpreted in such manner as to be valid, legal and enforceable under applicable Law. If any
provision of this Agreement or the application of any such provision to any Person or circumstance
shall be held invalid, illegal or unenforceable in any respect by a court of competent
jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision
hereof, and this Agreement shall be reformed, construed and enforced as if such invalid, illegal or
unenforceable provision had never been contained herein and there had been contained herein instead
such valid, legal and enforceable provisions as would most nearly accomplish the intent and purpose
of such invalid, illegal or unenforceable provision.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.5 <U>Entire Agreement</U>. This Agreement, the Company Disclosure Letter, the
Parent Disclosure Letter, the Coordination Agreement and the Confidentiality Agreements constitute
the entire agreement of the parties hereto with respect to the subject matter hereof and supersede
all prior agreements and undertakings, both written and oral, between the parties hereto with
respect to the subject matter hereof.
</DIV>

<P align="center" style="font-size: 10pt">-75-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.6 <U>Assignment</U>. This Agreement may not be assigned by any party or by
operation of law or otherwise without the prior written consent of each of the other parties (which
consent may be granted or withheld in the sole discretion of such other party). Any attempted
assignment in violation of this Section&nbsp;9.6 shall be void.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.7 <U>No Third Party Beneficiaries</U>. Except for Section&nbsp;6.8, this Agreement
shall be binding upon and inure solely to the benefit of the parties hereto and their permitted
assigns and nothing herein, express or implied, is intended to or shall confer upon any other
Person any legal or equitable right, benefit or remedy of any nature whatsoever under or by reason
of this Agreement. The representations and warranties in this Agreement are the product of
negotiations among the
parties hereto and are for the sole benefit of the parties hereto. Any inaccuracies in such
representations and warranties are subject to waiver by the parties hereto in accordance with
Section&nbsp;8.5 without notice or liability to any other Person. In some instances, the
representations and warranties in this Agreement may represent an allocation among the parties
hereto of risks associated with matters as to which the party making such representations and
warranties has no knowledge or only incomplete knowledge. Consequently, Persons other than the
parties hereto may not rely upon the representations and warranties in this Agreement as
characterizations of actual facts or circumstances as of the date of this Agreement or as of any
other date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.8 <U>No Responsibility for Other Parties</U>. Each party to each of the
Transaction Agreements shall be responsible only for its own representations, warranties,
covenants, actions or omissions under each of the Transaction Agreements. The Company, New
Diamond, New Diamond Merger Sub, Parent and Acquisition Sub each acknowledges that none of the
other parties shall be held liable in any way for any representation, warrant, covenant, action or
omission of any other party to the Transaction Agreements. Notwithstanding anything to the
contrary in this Section&nbsp;9.8, however, (i)&nbsp;Parent shall be responsible for the representations,
warranties, covenants, actions and omissions under each of the Transaction Agreements of
Acquisition Sub, and (ii)&nbsp;the Company shall be responsible for the representations, warranties,
covenants, actions and omissions, in each case prior to the Effective Time, under each of the
Transaction Agreements of New Diamond and New Diamond Merger Sub.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.9 <U>Governing Law</U>. This Agreement shall be governed by, and construed in
accordance with, the laws of the State of Delaware (without giving effect to choice of law
principles thereof).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.10 <U>Specific Performance; Jurisdiction</U>. The parties agree that irreparable
damage would occur in the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached. It is accordingly agreed that the
parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and
to enforce specifically the terms and provisions of this Agreement in the Court of Chancery of the
State of Delaware, this being in addition to any other remedy to which such party is entitled at
law or in equity. In addition, each of the parties hereto (i)&nbsp;consents to submit itself to the
personal jurisdiction of the Court of Chancery of the State of Delaware (and, with respect to
claims in which the exclusive subject matter jurisdiction of such claims is federal, the federal
district court for the District of Delaware) in the event any dispute arises out of this
</DIV>

<P align="center" style="font-size: 10pt">-76-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Agreement
or any of the transactions contemplated by this Agreement, (ii)&nbsp;agrees that it will not attempt to
deny or defeat such personal jurisdiction by motion or other request for leave from such court,
(iii)&nbsp;agrees that it will not bring any action relating to this Agreement or any of the
transactions contemplated by this Agreement in any court other than the Court of Chancery of the
State of Delaware (or, with respect to claims in which the exclusive subject matter jurisdiction of
such claims is federal, the federal district court for the District of Delaware) and (iv)&nbsp;to the
fullest extent permitted by Law, consents to service being made through the notice procedures set
forth in Section&nbsp;9.3. Each party hereto hereby agrees that, to the fullest extent permitted by
Law, service of any process, summons, notice or document by U.S. registered mail to the respective
addresses set forth in
Section&nbsp;9.3 shall be effective service of process for any suit or proceeding in connection
with this Agreement or the transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.11 <U>Waiver of Jury Trial</U>. EACH PARTY HERETO ACKNOWLEDGES AND AGREES THAT ANY
CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE SEPARATION AGREEMENT IS LIKELY TO INVOLVE
COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE, IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES
ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY
ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE SEPARATION AGREEMENT AND ANY OF THE AGREEMENTS
DELIVERED IN CONNECTION HEREWITH OR THEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY.
EACH PARTY HERETO CERTIFIES AND ACKNOWLEDGES THAT (I)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY
OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT
OF LITIGATION, SEEK TO ENFORCE EITHER OF SUCH WAIVERS, (II)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE
IMPLICATIONS OF SUCH WAIVERS, (III)&nbsp;IT MAKES SUCH WAIVERS VOLUNTARILY, AND (IV)&nbsp;IT HAS BEEN INDUCED
TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS
SECTION 9.11.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.12 <U>Interpretation</U>. When reference is made in this Agreement to a Section,
such reference shall be to a Section of this Agreement unless otherwise indicated. The table of
contents and headings contained in this Agreement are for convenience of reference purposes only
and shall not affect in any way the meaning or interpretation of this Agreement. Whenever the
words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to be
followed by the words &#147;without limitation.&#148; This Agreement shall be construed without regard to
any presumption or rule requiring construction or interpretation against the party drafting or
causing any instrument to be drafted. The meanings given to terms defined herein shall be equally
applicable to both the singular and plural forms of such terms.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SECTION 9.13 <U>Counterparts</U>. This Agreement may be executed in one or more
counterparts, and by the different parties hereto in separate counterparts, each of which when
executed shall be deemed to be an original but all of which taken together shall constitute one and
the same agreement.
</DIV>

<P align="center" style="font-size: 10pt">-77-
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the Company, New Diamond, New Diamond Merger Sub, Acquisition Sub and
Parent have caused this Agreement to be executed as of the date first written above by their
respective officers thereunto duly authorized.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="34%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">ALBERTSON&#146;S, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ John R. Sims</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">John R. Sims</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Executive Vice President and</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General Counsel</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">NEW ALOHA CORPORATION</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Paul G. Rowan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Paul G. Rowan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">NEW DIAMOND SUB, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Paul G. Rowan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Paul G. Rowan</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">SUPERVALU INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Jeff Noddle</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jeff Noddle</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chairman &#038; CEO</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">EMERALD ACQUISITION SUB, INC.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" align="left" valign="top">/s/ David Boehnen</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Name:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">David Boehnen</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Title:</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt">-78-
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.02
<SEQUENCE>3
<FILENAME>l18113aexv2w02.htm
<DESCRIPTION>EX-2.02 PURCHASE AND SEPARATION AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-2.02 Purchase and Separation Agreement</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Exhibit&nbsp;2.02</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">PURCHASE AND SEPARATION AGREEMENT
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">by and among
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">ALBERTSON&#146;S, INC.,
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">NEW ALOHA CORPORATION,
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">SUPERVALU INC.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">and
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">AB ACQUISITION LLC
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">Dated as of January&nbsp;22, 2006
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">TABLE OF CONTENTS
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U><B>Page</B></U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE I</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">DEFINITIONS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;1.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">General</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">2</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE II</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TRANSFER OF NEW DIAMOND ASSETS AND NEW DIAMOND LIABILITIES;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="bottom"></TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">PURCHASE AND SALE OF THE COMPANY AND THE RETAINED ENTITIES&#146;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">STOCK</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transfer of New Diamond Assets and New Diamond Entities</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transfer and Assumption of New Diamond Liabilities</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Purchase and Sale of the Company&#146;s and the Retained Entities&#146; Stock;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Retained Assets and Retained Liabilities</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reorganization; Consummation of the Mergers and New Diamond Liability</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transfer; Retained Business Price </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.5</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Closing </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.6</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Indebtedness of the Company; Succession and Release;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indemnification </TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.7</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Current Accounts</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.8</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Retained Business Price Allocation; Retained Property Proceeds</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">22</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;2.9.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Insurance Proceeds</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE III</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">REPRESENTATIONS AND WARRANTIES</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;3.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Representations and Warranties of Onyx</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;3.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Representations and Warranties of the Company</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;3.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Representations and Warranties of SV</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE IV</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">TAX MATTERS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.1.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Liability for Taxes</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.2.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filing Responsibility</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.3.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cooperation and Exchange of Information</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.4.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Proceedings</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.5.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Sharing Agreements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.6.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Benefits</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.7.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transfer Taxes</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.8.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Taxes Governed by Article IV</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">i
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.9</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Survival</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.10.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Post-Closing Dispositions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.11.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reorganization Treatment</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.12.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&#091;Intentionally Omitted&#093;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;4.13.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Treatment of Payments</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE V</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">INDEMNIFICATION</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SV&#146;s and New Diamond&#146;s Agreement to Indemnify</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Onyx&#146;s and the Company&#146;s Agreement to Indemnify</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reduction of Indemnifiable Losses for Insurance Benefits Received</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Procedure for Indemnification</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">40</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.5</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Pending Litigation; New Litigation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.6</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Remedies Exclusive</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.7</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Retained Business Price Adjustment</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;5.8</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exclusion of Tax Indemnities</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VI</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CERTAIN ADDITIONAL MATTERS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Further Assurances; Subsequent Transfers</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Use of Names; Cross-License</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Settlement of Intercompany Accounts</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merger Agreement Provisions</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">46</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.5</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Further Action; Reasonable Best Efforts</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">49</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.6</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Ancillary Agreements</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.7</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sharing of Certain Payments</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.8</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Restrictions Pending the Closing</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">51</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.9</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Payments by Onyx to the Exchange Fund</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.10</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Settlement of Appraisal Proceedings</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.11</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Standalone Drug Sale Matters</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">52</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.12</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proxy Statement</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;6.13</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merger Agreement Termination Fee</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VII</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">ACCESS TO INFORMATION AND SERVICES</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Access to Information</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Litigation Cooperation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Retention of Records</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">ii
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="87%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Confidentiality</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;7.5</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Publicity</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD nowrap><DIV style="margin-left:15px; text-indent:-15px">ARTICLE VIII</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">EMPLOYEE BENEFITS; LABOR MATTERS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Locus of Employees and Company Plans</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee Benefits</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Other Liabilities and Obligations</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Welfare Plans</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.5</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Retirement Plans; Savings Plans</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.6</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Preservation of Rights to Amend or Terminate Plans</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.7</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reimbursement; Indemnification</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;8.8</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Change In Control</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE IX</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">MISCELLANEOUS</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.1</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Conditions to Closing</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.2</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination Prior to the Closing</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.3</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effect of Termination</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">61</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.4</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Survival</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.5</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Entire Agreement; Third Party Beneficiaries</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.6</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Fees and Expenses</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.7</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Waiver</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.8</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendments</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">62</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.9.</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governing Law</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">63</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.10</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notices</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">63</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.11</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Interpretation</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">64</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.12</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Counterparts</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.13</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Specific Performance</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.14</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Successors and Assigns</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">65</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.15</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Severability</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.16</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jurisdiction; Venue; Consent to Service of Process</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.17</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Waiver of Jury Trial</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<TR><TD>&nbsp;</TD></TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Section&nbsp;9.18</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Disclosure Letter</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">67</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">iii
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">SCHEDULES
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.1 &#151; Separation Reorganization

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.2 &#151; New Diamond Assets

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.3 &#151; &#091;Intentionally Omitted&#093;

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.4 &#151; &#091;Intentionally Omitted&#093;

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.5 &#151; New Diamond Entities

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.6 &#151; New Diamond Scheduled Liabilities

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.7 &#151; Retained Assets

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.8 &#151; Retained Employees

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.9 &#151; &#091;Intentionally Omitted&#093;

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.10 &#151; Retained Scheduled Liabilities

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.11 &#151; Specified Standalone Drug Liabilities

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.12 &#151; Retained Actions

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.13 &#151; New Diamond Actions

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Schedule&nbsp;1.14 &#151; Retained Names

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">EXHIBITS
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit&nbsp;A &#151; Financing Commitment

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit&nbsp;B &#151; Form of Transition Services Agreement

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit&nbsp;C &#151; Onyx Disclosure Letter

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit&nbsp;D &#151; Company Disclosure Letter

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit&nbsp;E &#151; SV Disclosure Letter

</DIV>

<P align="center" style="font-size: 10pt">iv
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS PURCHASE AND SEPARATION AGREEMENT (this &#147;<U>Separation Agreement</U>&#148;), dated as of
January&nbsp;22, 2006, is entered into by and between Albertson&#146;s, Inc., a Delaware corporation (the
&#147;<U>Company</U>&#148;), New Aloha Corporation, a Delaware corporation and wholly owned subsidiary of
the Company (&#147;<U>New Diamond</U>&#148;), SUPERVALU INC., a Delaware corporation (&#147;<U>SV</U>&#148;), and AB
Acquisition LLC, a Delaware limited liability company (&#147;<U>Onyx</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, concurrently with the execution of this Separation Agreement, the Company has entered
into an Agreement and Plan of Merger (the &#147;<U>Merger Agreement</U>&#148;), dated as of the date hereof,
by and among the Company, New Diamond, New Diamond Sub, Inc., a Delaware corporation and
wholly-owned subsidiary of New Diamond, SV, and Emerald Acquisition Sub, Inc., a Delaware
corporation and wholly-owned subsidiary of SV, pursuant to which, among other things (1)&nbsp;the
Company shall merge with New Diamond Sub Inc., with the Company surviving (the &#147;<U>Diamond
Merger</U>&#148;), and (2)&nbsp;New Diamond shall merge with Emerald Acquisition Sub Inc., with New Diamond
surviving (the &#147;<U>Emerald Merger</U>,&#148; and together with the Diamond Merger, the
&#147;<U>Mergers</U>&#148;), in each case, in accordance with the General Corporation Law of the State of
Delaware (the &#147;<U>DGCL</U>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, upon the terms and subject to the conditions set forth herein (including as
contemplated by the Reorganization (as defined herein)), (1)&nbsp;pursuant to the Diamond Merger, New
Diamond shall acquire all of the issued and outstanding Equity Interests (as defined herein) of the
Company for stock of New Diamond, (2)&nbsp;the Company shall immediately thereafter convert into a
Delaware limited liability company, (3)&nbsp;the Company shall thereafter consummate the distribution
and transfer of all the New Diamond Assets (as defined herein) to New Diamond, subject to the
assumption by New Diamond of the New Diamond Liabilities (as defined herein), (4)&nbsp;thereafter the
Company and its Subsidiaries shall consummate the Standalone Drug Sale (as defined herein), upon
the terms and subject to the conditions set forth in the Standalone Drug Sale Agreement, (5)&nbsp;Onyx
shall immediately thereafter acquire all of the issued and outstanding Equity Interests of the
Company from New Diamond for the Retained Business Price (as defined below) and (6)&nbsp;thereafter the
Emerald Merger shall be consummated; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, concurrently with the execution of this Separation Agreement, and as a condition to
the willingness of each of the Company and SV to enter into this Separation Agreement, Cerberus
Capital Management, L.P., on behalf of one or more affiliated funds or managed accounts to be
designated by it (the &#147;<U>Sponsor</U>&#148;), has provided a financing commitment pursuant to which the
Sponsor has committed, subject to the terms and conditions set forth therein, to invest the amount
set forth therein to purchase Equity Interests of Onyx and to provide debt financing to the
Retained Business (as defined herein), in the form attached hereto as <U>Exhibit&nbsp;A</U> (the
&#147;<U>Financing Commitment</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements
herein contained, and intending to be legally bound hereby, the parties hereto hereby agree as
follows:
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE I
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>DEFINITIONS</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.1 <U>General</U>. As used in this Separation Agreement, the following terms shall
have the following meanings:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>338(h)(10) Election Subsidiaries</U>&#148; has the meaning set forth in Section&nbsp;4.1(c).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>338(h)(10) Elections</U>&#148; has the meaning set forth in Section&nbsp;4.1(c).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ABS Indenture</U>&#148; has the meaning set forth in the definition of Company Indentures.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Accountant</U>&#148; has the meaning set forth in Section&nbsp;2.8(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Action</U>&#148; means any claim, action, suit, proceeding or investigation by or before any
Authority.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affected Party</U>&#148; has the meaning set forth in Section&nbsp;4.2(d).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affiliate</U>&#148; means, with respect to any specified person, any other person that
directly, or indirectly through one or more intermediaries, Controls, is Controlled by, or is under
common Control with, such specified person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Affiliated Group</U>&#148; means the consolidated group for Income Tax purposes of which New
Diamond or the Company is or was the common parent, which group terminates as a result of the
Mergers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Albertson&#146;s Inc. Guarantee</U>&#148; has the meaning set forth in Section&nbsp;2.6(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>American Stores</U>&#148; has the meaning set forth in the definition of Company Indentures.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Ancillary Agreements</U>&#148; means (i)&nbsp;the Transition Services Agreement substantially in
the form attached as <U>Exhibit&nbsp;B</U> and (ii)&nbsp;the Cross-License Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ASC Indenture</U>&#148; has the meaning set forth in the definition of Company Indentures.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Asset</U>&#148; means, with respect to any person, except as otherwise provided herein, any
and all of its right, title and interest in and to all of the rights, properties, assets,
inventories, claims, contracts and businesses of every kind, character and description, whether
real, personal or mixed, tangible and intangible, whether accrued, contingent or otherwise, of
every kind and description and wherever located, owned or used by such person (including in the
possession of owners or third parties or elsewhere), including (i)&nbsp;all cash, cash equivalents,
notes and accounts receivable (whether current or non-current), deposit accounts, securities
accounts and other banks accounts; (ii)&nbsp;all certificates of deposit, banker&#146;s acceptances and other
investment
</DIV>


<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">securities; (iii)&nbsp;all patents, patent rights, trade dress, trademarks, service marks,
trademark and service mark rights, trade names, trade name rights, domain names, copyrights,
banners, logos, data rights, privacy rights, publicity rights, registrations or applications for
any of the foregoing, trade secrets, works of authorship, technology and know-how (including all
data bases, customer lists, confidential information, discoveries, inventions and improvements),
and other proprietary rights and information; (iv)&nbsp;all rights existing under leases, contracts,
licenses, service agreements, sales and purchase agreements, other agreements and business
arrangements and all policies of insurance and proceeds, benefits and rights to coverage under
insurance policies; (v)&nbsp;all real estate and all buildings and other improvements thereon; (vi)&nbsp;all
leasehold improvements and all equipment (including all office equipment), fixtures, trade fixtures
and furniture; (vii)&nbsp;all office supplies, other miscellaneous supplies and other tangible property
of any kind; (viii)&nbsp;all computer hardware, software, computer programs and systems and
documentation relating thereto, including all databases and reference and resource materials; (ix)
all prepayments or prepaid expenses; (x)&nbsp;all claims, causes of action, rights of recovery, rights
to sue for past, present and future infringement of any intellectual property rights and rights of
set-off of any kind; (xi)&nbsp;the right to receive mail, accounts receivable payments and other
communications; (xii)&nbsp;all customer lists and records pertaining to customers and accounts,
personnel records, all lists and records pertaining to suppliers and agents, and all books,
ledgers, files and business records of every kind and all minute books, stock ledgers and other
corporate books and records; (xiii)&nbsp;all advertising materials and all other printed or written
materials; (xiv)&nbsp;all permits, waivers, licenses, approvals and authorizations of governmental
authorities or third parties relating to the ownership, possession or operation of the Assets; (xv)
all goodwill as a going concern and all other intangible properties; and (xvi)&nbsp;all employee
contracts, including the right thereunder to restrict the employee from competing in certain
respects.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Assumed Benefit Plans</U>&#148; means any (i)&nbsp;Company Plan maintained by the Retained Entities
solely for the benefit of current and former employees of the Retained Business (including, for the
avoidance of doubt, any such plan in which New Diamond Employees participate by virtue of past
service to the Retained Business), and (ii)&nbsp;any Company Plan that is an employment,
change-of-control, severance or similar individual agreement between the Company, a New Diamond
Entity or one of their respective Affiliates and any Retained Employee, other than any such
agreement providing for equity or equity-based compensation. For purposes of the preceding
sentence, any award (whether a cash, restricted stock unit, or retention award) made pursuant to
Section&nbsp;6.1(a)(ii) of the Company Disclosure Letter to the Merger Agreement and made to a Retained
Employee (and any agreement in respect of such award) shall not be considered an award and/or
agreement providing for equity or equity-based compensation and shall be considered an Assumed
Benefit Plan for all purposes of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Authority</U>&#148; means any court, arbitrator, administrative or other governmental
authority, agency, commission, tribunal, authority or instrumentality, domestic (including federal,
state or local) or foreign or any other authority, which has authority or jurisdiction over any
party hereto or any of their respective properties or assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Day</U>&#148; means any day that is not a Saturday, a Sunday or other day that is a
statutory holiday under the federal Laws of the United States.
</DIV>


<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Description Presentation</U>&#148; has the meaning set forth in the definition of New
Diamond Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Buyer Tax Indemnitee</U>&#148; has the meaning set forth in Section&nbsp;4.1(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Casualty</U>&#148; has the meaning set forth in Section&nbsp;2.9(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing</U>&#148; has the meaning set forth in Section&nbsp;2.5(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Date</U>&#148; means the date on which the Closing occurs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, and the rules and
regulations promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company</U>&#148; has the meaning set forth in the Preamble.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Disclosure Letter</U>&#148; has the meaning set forth in Section&nbsp;3.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Form&nbsp;10-K</U>&#148; has the meaning set forth in Section&nbsp;3.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Headquarters</U>&#148; has the meaning set forth in the definition of New Diamond
Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Indemnitees</U>&#148; has the meaning set forth in Section&nbsp;5.1.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Indentures</U>&#148; mean (i)&nbsp;that certain Indenture, dated as of May&nbsp;1, 1992, by and
between Albertson&#146;s, Inc. and Morgan Guaranty Trust Company of New York, as trustee (the &#147;<U>ABS
Indenture</U>&#148;) and (ii)&nbsp;that certain Indenture, dated as of May&nbsp;1, 1995 (as supplemented), by and
between American Stores Company, LLC (&#147;<U>American Stores</U>&#148;) and J.P. Morgan Trust Company,
National Association, as successor trustee (the &#147;<U>ASC Indenture</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Material Adverse Effect</U>&#148; means any effect that is materially adverse to the
business, financial condition or results of operations of the Company and the Company Subsidiaries
taken as a whole in relation to the current and expected performance and value of the Retained
Business, Retained Assets and Retained Liabilities, other than any effect to the extent resulting
proximately from (i)&nbsp;general economic conditions or developments or changes therein, (ii)
conditions in the industries in which the Company and the Company Subsidiaries operate or
developments or changes therein, except to the extent that such conditions, developments or changes
impact the Company in a materially disproportionate adverse manner relative to similarly situated
competitors of the Company, (iii)&nbsp;conditions in the stock markets or other capital markets or
developments or changes therein, (iv)&nbsp;the announcement of the Transaction Agreements or the
Transactions (each as defined in the Merger Agreement), (v)&nbsp;the performance by the Company of its
obligations pursuant to the Transaction Agreements (except the obligations of the Company to obtain
the consents contemplated by Section&nbsp;4.3 and Section&nbsp;4.4 of the Merger Agreement as incorporated by
reference <I>mutatis mutandis </I>into this Separation Agreement pursuant to Section&nbsp;3.2 hereof), (vi)&nbsp;the
announcement, consummation, termination or abandonment of the Standalone Drug Sale, (vii)&nbsp;any
actions taken or omitted to be taken by or at the request or with the written consent of the other
parties hereto, (viii)&nbsp;any changes in any
</DIV>


<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Laws or any accounting regulations or principles, (ix)&nbsp;any union organizing activities, labor
disputes, strikes, work stoppages or similar labor unrests or disruption, or (x)&nbsp;any acts of God,
war or terrorism, except to the extent that such acts impact the Company in a materially
disproportionate manner relative to similarly situated competitors of the Company. A failure by
the Company to meet any projections, estimates or budgets for any period prior to, on or after the
date of this Separation Agreement shall not in itself constitute a Company Material Adverse Effect.
The parties hereto acknowledge their awareness of the matters set forth in Section&nbsp;4.9 of the
Company Disclosure Letter with respect to decline in business and financial performance.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Percentage</U>&#148; means 15%.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Plans</U>&#148; has the meaning set forth in the Merger Agreement, but determined
without application of any materiality standard under Section&nbsp;4.13(a) of the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Subsidiaries</U>&#148; means the Subsidiaries of the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Condemnation</U>&#148; has the meaning set forth in Section&nbsp;2.9(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Confidentiality Agreement</U>&#148; means that certain Confidentiality Agreement, dated August
15, 2005, by and between Sponsor and the Company.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Control</U>&#148; (including the terms &#147;Controlled by&#148; and &#147;under common Control with&#148;), with
respect to the relationship between or among two or more persons, means the possession, directly or
indirectly, of the power to direct or cause the direction of the affairs or management of a person,
whether through the ownership of voting securities, by contract or otherwise, including the
ownership, directly or indirectly, of securities having the power to elect a majority of the board
of directors or similar body governing the affairs of such person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Controlling Party</U>&#148; has the meaning set forth in Section&nbsp;4.4(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Coordination Agreement</U>&#148; means that certain Coordination Agreement by and among the
Company, SV, Onyx, and CVS, dated as of the date hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Cross-Licensing Agreement</U>&#148; has the meaning set forth in Section&nbsp;6.2(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Cub Sale Agreement</U>&#148; means that certain Asset Purchase Agreement, dated as of the date
hereof, by and between Hawk Acquisition LLC and SV.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>CVS</U>&#148; has the meaning set forth in the definition of Standalone Drug Sale Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Designated Affiliate</U>&#148; means, with respect to any specified person, an Affiliate of
such person that (i)&nbsp;has been designated by such person for purposes of the appropriate section of
this Separation Agreement (with such designation subject to the prior written consent of Onyx, in
the case of a New Diamond Designated Affiliate, or SV, in the case of an Onyx Designated Affiliate,
which consent shall not be unreasonably withheld) and (ii)&nbsp;has agreed in writing for the benefit of
the other parties hereto to be bound by the terms of this Separation Agreement as if a
</DIV>


<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">party hereto; <U>provided</U>, <U>however</U>, any such designation by any person hereto
shall not relieve such person of any of its obligations or agreements hereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Determination</U>&#148; has the meaning set forth in Section&nbsp;2.8(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>DGCL</U>&#148; has the meaning set forth in the Recitals.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Diamond LLC Conversion</U>&#148; has the meaning set forth in Section&nbsp;2.1(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Diamond Merger</U>&#148; has the meaning set forth in the Recitals.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disregarded Entity</U>&#148; has the meaning set forth in Section&nbsp;4.1(c).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Disregarded Entity Treatment</U>&#148; has the meaning set forth in Section&nbsp;4.1(c).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>DOJ</U>&#148; means the Antitrust Division of the U.S. Department of Justice.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Effective Time</U>&#148; has the meaning provided for such term in the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Emerald Merger</U>&#148; has the meaning set forth in the Recitals.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Equity Interest</U>&#148; means (i)&nbsp;with respect to a corporation, any and all classes or
series of shares of capital stock, (ii)&nbsp;with respect to a partnership, limited liability company,
trust or similar person, any and all classes or series of partnership, limited liability company,
trust or similar interests or units, and (iii)&nbsp;with respect to any other person, any other security
representing any direct equity ownership or participation in such person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA</U>&#148; means Employee Retirement Income Security Act of 1974.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Excess Dissenting Shares Liability</U>&#148; has the meaning set forth in the definition of
Shared Transaction Litigation Liabilities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934 and the rules and regulations
promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Fund</U>&#148; has the meaning set forth in Section&nbsp;6.9.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exclusive Diamond Proceedings</U>&#148; has the meaning set forth in Section&nbsp;4.4(b)(i).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exclusive Onyx Proceedings</U>&#148; has the meaning set forth in Section&nbsp;4.4(b)(ii).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exclusive Tax Proceedings</U>&#148; has the meaning set forth in Section&nbsp;4.4(b)(ii).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Financing</U>&#148; has the meaning set forth in Section&nbsp;3.1(g).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Financing Commitment</U>&#148; has the meaning set forth in Section&nbsp;3.1(g).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Form&nbsp;S-4</U>&#148; has the meaning set forth in the Merger Agreement.
</DIV>


<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Former Retained Employees</U>&#148; means individuals who are Retained Employees by
application of clause (iii)&nbsp;of the definition of Retained Employees.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>FTC</U>&#148; means the U.S. Federal Trade Commission.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Future Debt Financing</U>&#148; has the meaning set forth in Section&nbsp;6.4(d).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Grantee</U>&#148; has the meaning set forth in Section&nbsp;6.1(d).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Grantor</U>&#148; has the meaning set forth in Section&nbsp;6.1(d).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Guarantee Release Date</U>&#148; has the meaning set forth in Section&nbsp;2.6(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
and the rules and regulations promulgated thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Income Taxes</U>&#148; means U.S. federal, state or local Taxes based upon or measured by net
income or capital gain (but not any gross income Taxes and not any withholding Taxes or payroll,
employment or employee Taxes).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnifiable Losses</U>&#148; means any and all losses, Liabilities, claims, damages,
obligations, payments, costs and expenses (including the Liabilities, costs and expenses of any and
all Actions, demands, assessments, Judgments, settlements and compromises relating thereto and
reasonable attorneys&#146; fees and expenses in connection therewith) suffered or incurred by an
Indemnitee; <U>provided</U>, that the foregoing does not include any losses, Liabilities, claims,
damages, obligations, payments, costs, fees or expenses arising out of or relating to any claim for
loss of profits or earnings, diminution in value or incidental, indirect, special or consequential
damages unless awarded against any Indemnitee in a Third Party Claim.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnified Amounts</U>&#148; has the meaning set forth in Section&nbsp;6.1(d)(2).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnified Directors or Officers</U>&#148; has the meaning set forth in the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnifying Party</U>&#148; means any party or other person who is required to indemnify any
other person pursuant to any indemnification provisions contained in this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnitee</U>&#148; means any party or other person who is entitled to receive
indemnification from an Indemnifying Party pursuant to any indemnification provisions contained in
this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Information</U>&#148; has the meaning set forth in Section&nbsp;7.1(a)(1).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Intercompany Accounts</U>&#148; has meaning set forth in Section&nbsp;6.3.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>IRS</U>&#148; has the meaning set forth in Section&nbsp;2.8(a).
</DIV>


<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Judgments</U>&#148; means any and all judgments, orders, writs, directives, rulings,
decisions, injunctions, decrees, assessments, settlement agreements (other than settlement
agreements under which there are no continuing obligations) or awards of any Authority.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Laws</U>&#148; means any and all applicable (i)&nbsp;federal, territorial, state, local and foreign
laws, ordinances and regulations, (ii)&nbsp;codes, standards, rules, requirements, orders and criteria
issued under any federal, territorial, state, local or foreign laws, ordinances or regulations,
(iii)&nbsp;rules, guidelines or published interpretations of any Authority and (iv)&nbsp;Judgments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Liabilities</U>&#148; means, with respect to any person, any and all liabilities and
obligations of such person, whether absolute, accrued, contingent, reflected on a balance sheet (or
in the notes thereto) or otherwise, including those arising under any Law or Action, and those
arising under any contract, commitment or undertaking.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Lien</U>&#148; means any lien, encumbrance, pledge, mortgage, security interest, claim under
bailment, or storage contract.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Lucky Delaware</U>&#148; has the meaning set forth in Section&nbsp;4.1(c).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Lucky Proprietary Name Rights</U>&#148; has the meaning set forth in Section&nbsp;6.2(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Merger Agreement</U>&#148; has the meaning set forth in the Recitals.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Mergers</U>&#148; has the meaning set forth in the Recitals.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond</U>&#148; has the meaning set forth in the Preamble.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Action</U>&#148; has the meaning set forth in Section&nbsp;5.5(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Asset Transfer</U>&#148; has the meaning set forth in Section&nbsp;2.1(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Assets</U>&#148; means (i)&nbsp;all the Assets of the Company and its Subsidiaries
primarily related to the New Diamond Business, (ii)&nbsp;Assets set forth on <U>Schedule&nbsp;1.2</U> of
this Separation Agreement whether or not any such Asset would fall within any category of Retained
Assets as set forth in the definition thereof and (iii)&nbsp;all cash and cash equivalents of the
Company and its Subsidiaries, other than cash and cash equivalents included in clause (iii)&nbsp;of the
definition of Retained Assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Assumption Price</U>&#148; means an amount of cash equal to the difference between
(i) $625,000,000 in respect of certain Liabilities to be assumed by New Diamond including
Liabilities that, but for such assumption, would be Retained Liabilities and (ii)&nbsp;the Option
Adjustment Amount.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Business</U>&#148; means (i)&nbsp;the business of the Company reflected as the &#147;Core
Food&#148; business of the Company and its Subsidiaries as reflected in that certain Presentation, dated
September&nbsp;2005 (the &#147;<U>Business Description Presentation</U>&#148;), by The Blackstone Group L.P. and
Goldman Sachs &#038; Co. (which presentation describes the Company&#146;s &#147;Core Food&#148;, &#147;Standalone Drug&#148; and
&#147;Underperforming Metro Areas&#148; (or &#147;Non-Core&#148;)
</DIV>


<P align="center" style="font-size: 10pt">8
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">businesses), and (ii)&nbsp;the Company&#146;s headquarters in Boise, Idaho, Phoenix, Arizona (the
Scottsdale and Glendale facilities) and Salt Lake City, Utah (collectively, the &#147;<U>Company
Headquarters</U>&#148;); <U>provided</U>, that the New Diamond Business shall not include the
Springfield Stores.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Employees</U>&#148; means:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) all employees of the New Diamond Business as of immediately prior to the
Separation;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) all employees of the Company Headquarters other than those set forth on
<U>Schedule&nbsp;1.8</U> of this Separation Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) all former employees of the New Diamond Business (other than Standalone Drug
Employees) who were, immediately prior to termination of employment (with such termination
occurring prior to the Closing), employed primarily in connection with the New Diamond
Business;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Entities</U>&#148; means each of the entities set forth on <U>Schedule&nbsp;1.5</U>
of this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Indemnitees</U>&#148; has the meaning set forth in Section&nbsp;5.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Liabilities</U>&#148; means, without duplication:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the obligations of New Diamond to perform and comply with its covenants and
agreements contained in this Separation Agreement and Liabilities arising from or relating
to any breach by New Diamond of such covenants and agreements;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) all of the Liabilities of the Company and the New Diamond Entities primarily
related to the New Diamond Business; <U>provided</U>, <U>however</U>, that Liabilities
primarily related to the Company Headquarters shall be deemed to be only Liabilities that
relate directly to the assets physically located there;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) all Liabilities directly relating to all New Diamond Actions;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) all obligations for dividends declared by the Company after the date hereof but
not paid prior to the Effective Time;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) all Liabilities of Shaw&#146;s Supermarkets, Inc., Star Markets Company, Inc., Shaw
Equipment Corporation, Clifford W. Perham, Inc., Shaw&#146;s Realty Co., Gorham Markets LLC,
Shaw&#146;s Realty Trust., Acme Markets, Inc, Jewel Food Stores, Inc., Jetco Properties, Inc.,
Bristol Farms Inc., Lazy Acres Market, Inc., U.S. Satellite Corporation, Lucky Stores, Inc.
(NV), Scolari&#146;s Stores Inc., Food Basket Inc., Albertson&#146;s Liquors, Inc., American
Procurement and Logistics Co., APLC Procurement, Inc., Brockton Corporation, Jewel
Companies, Inc., JOAH, Inc., Meadowlane, Inc., MFC-Livonia Properties, Inc., SSM Holdings
Company, Star Markets Holdings, Inc.,
</DIV>

<P align="center" style="font-size: 10pt">9
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">Shaw&#146;s North Attleboro, Corp., Shaw&#146;s Securities Corporation I, and Shaw&#146;s Securities
Corporation II;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) 85% of Unallocated Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) New Diamond Scheduled Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) 50% of the Shared Transaction Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) 85% of the Shared Transaction Litigation Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) all of the Specified Standalone Drug Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi) Liabilities that arise from or relate to the Company Indentures and Liabilities in
respect of commercial paper, revolving credit debt and long-term debt for borrowed money
(other than mortgages for borrowed money secured by real estate and all capital leases and
industrial revenue bonds to the extent, in each case, such matters relate to the Retained
Assets) of the Company or its Subsidiaries, including any costs associated with the
defeasance or prepayment of debt and release of collateral directly related thereto;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xii) all Liabilities for Actions to the extent arising from or relating to information
supplied by SV or its Affiliates specified for inclusion (or incorporation by reference) in
the Proxy Statement/Prospectus (as defined in the Merger Agreement);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiii) all Liabilities that are express post-Closing obligations of SV, New Diamond or
their Affiliates under the Standalone Drug Sale Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiv) Liabilities that arise from or relate to the conduct of the New Diamond Business
following the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Liability Transfer</U>&#148; has the meaning set forth in Section&nbsp;2.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Merger</U>&#148; has the meaning set forth in the Recitals.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Names</U>&#148; has the meaning set forth in Section&nbsp;6.2(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Percentage</U>&#148; means 85%.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Proprietary Name Rights</U>&#148; has the meaning set forth in Section&nbsp;6.2(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Scheduled Liabilities</U>&#148; means the Liabilities set forth on <U>Schedule
1.6</U> of this Separation Agreement (it being understood that such Liabilities shall be deemed to
be New Diamond Liabilities and not Retained Liabilities irrespective of whether or not any such
Liabilities would fall within any category of Retained Liabilities as set forth in the definition
thereof).
</DIV>


<P align="center" style="font-size: 10pt">10
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Diamond Seller Group</U>&#148; means New Diamond or any New Diamond Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Welfare Plans</U>&#148; has the meaning set forth in Section&nbsp;8.4.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Non-Controlling Party</U>&#148; has the meaning set forth in Section&nbsp;4.4(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Non-Income Tax</U>&#148; means any Tax that is not an Income Tax.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>NYSE</U>&#148; means the New York Stock Exchange.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Objection</U>&#148; has the meaning set forth in Section&nbsp;6.5(d).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Old Welfare Plans</U>&#148; has the meaning set forth in Section&nbsp;8.4.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Onyx</U>&#148; has the meaning set forth in the Preamble.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Onyx Disclosure Letter</U>&#148; has the meaning set forth in Section&nbsp;3.1.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Onyx Real Estate Dropdowns</U>&#148; shall mean the transfer by a Retained Entity to a
wholly-owned subsidiary (treated as a disregarded entity within the meaning of Treasury Regulatory
Section&nbsp;301.7701-3) of such Retained Entity of any real estate ground lease in which the Retained
Entity is the lessee and any real property owned by the Retained Entity, in each case, associated
with the Retained Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Onyx Termination Fee</U>&#148; has the meaning set forth in Section&nbsp;9.3(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Option Adjustment Amount</U>&#148; means, in the event that the fair market value of the Per
Share Merger Consideration (as defined in the Merger Agreement), valuing the Stock Consideration
(as defined in the Merger Agreement) at the Average Closing Price (as defined in the Merger
Agreement), is less than $24.71, an amount equal to 40% of the aggregate reduction of the Per Share
Merger Consideration payable to holders of Options and Stock Units (each as defined in the Merger
Agreement) as a result of the Per Share Merger Consideration being less than $24.71 per share (as
compared to being $24.71 per share).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Board Recommendation</U>&#148; has the meaning set forth in the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Material Adverse Effect</U>&#148; has the meaning set forth in the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>PCX</U>&#148; means the Pacific Stock Exchange.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Post-Closing Period</U>&#148; has the meaning set forth in Section&nbsp;4.1(a)(7).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Post-Standalone Drug Sale Cash Sweep</U>&#148; has the meaning set forth in Section&nbsp;2.1.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Pre-Closing Period</U>&#148; has the meaning set forth in Section&nbsp;4.1(a)(3).
</DIV>


<P align="center" style="font-size: 10pt">11
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Pre-Existing Title Policy</U>&#148; has the meaning set forth in Section&nbsp;6.1(d)(2).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Prior Transferors</U>&#148; has the meaning set forth in Section&nbsp;6.1(d)(2).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Proxy Statement/Prospectus</U>&#148; has the meaning set forth in the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Reorganization</U>&#148; means the Separation and the Retained Business Purchase pursuant to a
series of transaction steps, substantially as reflected on <U>Schedule&nbsp;1.1</U> of this Separation
Agreement, that are intended to further the parties&#146; efforts to accomplish the Separation and the
Retained Business Purchase, in the manner contemplated by Section&nbsp;2.4(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Representatives</U>&#148; has the meaning set forth in Section&nbsp;5.1.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Action</U>&#148; has the meaning set forth in Section&nbsp;5.5(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Assets</U>&#148; means, following the consummation of the Standalone Drug Sale, (i)
all of the Assets of the Company and its Subsidiaries, other than the New Diamond Assets, (ii)
Assets set forth on <U>Schedule&nbsp;1.7</U> of this Separation Agreement whether or not any such Asset
would fall within any category of New Diamond Assets as set forth in the definition thereof and
(iii)&nbsp;cash and cash equivalents held directly at the store level by stores included in the Retained
Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Assets Transfer</U>&#148; has the meaning set forth in Section&nbsp;2.3(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Business</U>&#148; means all present and past businesses of the Company and its
Subsidiaries (and their respective predecessors) other than (i)&nbsp;the Standalone Drug Business and
(ii)&nbsp;the New Diamond Business, and specifically includes the Springfield Stores.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Business Allocation</U>&#148; has the meaning set forth in Section&nbsp;2.8(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Business Entities</U>&#148; means Onyx, the Retained Entities and any Designated
Affiliates of Onyx.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Business Price</U>&#148; means (i) $325,000,000 <U>plus</U> (ii)&nbsp;the New Diamond
Assumption Price <U>minus</U> (iii)&nbsp;the Retained Property Proceeds.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Business Purchase</U>&#148; has the meaning set forth in Section&nbsp;2.3(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Employees</U>&#148; means:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) employees of the Retained Business as of immediately prior to the Separation, other
than the New Diamond Employees;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the individuals listed on <U>Schedule&nbsp;1.8</U> of this Separation Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) all former employees of the Company and its Subsidiaries (other than Standalone
Drug Employees) who were, immediately prior to termination of
</DIV>

<P align="center" style="font-size: 10pt">12
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">employment (with such termination occurring prior to the Closing), employed <SUP style="font-size: 85%; vertical-align: text-top">
</SUP>primarily in connection with the Retained Business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Entities</U>&#148; means the Company and all of the direct and indirect Subsidiaries
of the Company, excluding New Diamond and the New Diamond Entities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Entities Transfer</U>&#148; has the meaning set forth in Section&nbsp;2.3(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Liabilities</U>&#148; means, without duplication:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the obligations of the Company to perform and comply with its respective covenants
and agreements contained in this Separation Agreement and the Transition Services Agreement
and Liabilities arising from or relating to any breach by the Company of such covenants and
agreements;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) all Liabilities of the Company and its Subsidiaries (including Liabilities that
arise from or relate to mortgages for borrowed money secured by real estate and all capital
leases and industrial revenue bonds to the extent that, in each case, such matters relate to
the Retained Assets, including the Springfield Stores) other than the New Diamond
Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) all Liabilities directly relating to all Retained Actions;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) 15% of Unallocated Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) Retained Scheduled Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) 50% of the Shared Transaction Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) 15% of the Shared Transaction Litigation Liabilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) all Liabilities for Actions to the extent arising from or relating to
information supplied by Onyx or its Affiliates specified for inclusion (or incorporation by
reference) in the Proxy Statement/Prospectus (as defined in the Merger Agreement);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) all Liabilities that are express post-Closing obligations of the Company or its
Affiliates under the Standalone Drug Sale Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) Liabilities that arise from or relate to the conduct of the Retained Business
following the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Names</U>&#148; has the meaning set forth in Section&nbsp;6.2(a)(2).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Property Proceeds</U>&#148; has the meaning set forth in Section&nbsp;2.8(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Proprietary Name Rights</U>&#148; has the meaning set forth in Section&nbsp;6.2(a)(2).
</DIV>


<P align="center" style="font-size: 10pt">13
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Retained Scheduled Liabilities</U>&#148; means the Liabilities set forth on <U>Schedule
1.10</U> of this Separation Agreement (it being understood that such Liabilities shall be deemed to
be Retained Liabilities and not New Diamond Liabilities irrespective of whether or not any such
Liabilities would fall within any category of New Diamond Liabilities set forth in the definition
thereof).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Return Preparer</U>&#148; has the meaning set forth in Section&nbsp;4.2(d).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Section&nbsp;4.6 Liability</U>&#148; means:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any New Diamond Scheduled Liability;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any Liability under Company Plans that are not Assumed Benefit Plans and any Liability
that New Diamond is responsible for under Section&nbsp;8.4 (other than any Liability under the
Transition Services Agreement);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any obligation to make payments with respect to Options and Stock Units issued by the
Company or New Diamond, in each case, to the extent set forth in the Merger Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) any Tax Liability set forth in Section&nbsp;4.1(a)(4).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Seller Tax Indemnitee</U>&#148; has the meaning set forth in Section&nbsp;4.1(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Separation</U>&#148; has the meaning set forth in Section&nbsp;2.2.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Separation Agreement</U>&#148; has the meaning set forth in the Preamble.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Shared Non-Income Taxes</U>&#148; means Non-Income Taxes for any Pre-Closing Period
attributable to neither the New Diamond Business, the New Diamond Assets, the Retained Business,
the Retained Assets, the Standalone Drug Business nor the Standalone Drug Assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Shared Transaction Liabilities</U>&#148; means, without duplication, Liabilities incurred by
the Company and its Subsidiaries for fees and expenses of investment bankers, attorneys,
accountants and other consultants and advisors and their out-of-pocket costs and expenses, in each
case, to the extent incurred in connection with the transactions contemplated by this Separation
Agreement, the Merger Agreement and the Standalone Drug Sale that are incurred on or prior to
Closing or arise from or relate to arrangements, agreements or commitments entered into or made by
the Company or its Subsidiaries prior to the Effective Time, including Liabilities for filing fees
and printing and mailing costs and other expenses incurred in connection with the Proxy
Statement/Prospectus and other out-of-pocket costs and expenses incurred in connection with the
Company&#146;s and its Subsidiaries&#146; efforts to comply with the pre-closing covenants and agreements
contained in the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Shared Transaction Litigation Liabilities</U>&#148; means Liabilities incurred by the Company
and its Subsidiaries and arising from or relating to any Actions that arise from or relate to the
execution of this Separation Agreement, the Merger Agreement or the Standalone Drug
</DIV>


<P align="center" style="font-size: 10pt">14
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Sale Agreement, or the consummation of the transactions contemplated hereby and thereby,
whether brought before or after the Closing and whether brought by current or former stockholders
or option holders of the Company or New Diamond, any Authority or third parties, including any
obligation of the Company or New Diamond to make payments to any of its dissenting stockholders
(but only to the extent such Liabilities to dissenting stockholders are in excess (such excess
amount, the &#147;<U>Excess Dissenting Shares Liability</U>&#148;) of the amount of Per Share Merger
Consideration that would have been payable in respect of the Dissenting Shares (as defined in the
Merger Agreement) held by such dissenting stockholders at the Effective Time if such appraisal
proceeding had not been brought). Notwithstanding anything to the contrary in this Separation
Agreement, &#147;Shared Transaction Litigation Liabilities&#148; shall not include Liabilities for Actions to
the extent arising from or relating to information supplied by Onyx or New Diamond specifically for
inclusion (or incorporation by reference) in the Proxy Statement/Prospectus.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Solvent</U>&#148; has the meaning set forth in Section&nbsp;3.1(h).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Specified Standalone Drug Liabilities</U>&#148; means the Liabilities set forth on
<U>Schedule&nbsp;1.11</U> of this Separation Agreement (it being understood that such Liabilities shall
be deemed New Diamond Liabilities irrespective of whether or not any such Liabilities would fall
under any category of Retained Liabilities set forth in the definition thereof), to the extent not
paid or assumed by CVS pursuant to the Standalone Drug Sale Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Sponsor</U>&#148; has the meaning set forth in the Recitals.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Springfield Stores</U>&#148; means the Jewel-Osco stores of the Company located at (i)&nbsp;1903
West Monroe, Springfield, Illinois (Company store number 3031), and (ii)&nbsp;277 South 6th Street,
Springfield, Illinois (Company store number 3180).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Springfield Stores Date</U>&#148; has the meaning set forth in Section&nbsp;6.14.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug Assets</U>&#148; means the Purchased Assets (as defined in the Standalone Drug
Sale Agreement).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug Business</U>&#148; has the meaning set forth in the Standalone Drug Sale
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug Employees</U>&#148; means all employees of Standalone Drug at the time of the
Standalone Drug Sale and all former employees of Standalone Drug.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug Sale</U>&#148; means the purchase and sale of the Standalone Drug Business, on
the terms and subject to the conditions set forth in the Standalone Drug Sale Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Standalone Drug Sale Agreement</U>&#148; means that certain Asset Purchase Agreement, dated as
of the date hereof, by and among the Company, New Diamond, SV, and CVS Corporation (&#147;<U>CVS</U>&#148;)
and certain other Sellers (as defined in the Standalone Drug Sale Agreement).
</DIV>


<P align="center" style="font-size: 10pt">15
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Straddle Period</U>&#148; has the meaning set forth in Section&nbsp;4.1(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Subsidiary</U>&#148; of a person means any and all corporations, partnerships, limited
liability companies, trusts and other entities, whether incorporated or unincorporated, with
respect to which such person, directly or indirectly, legally or beneficially, owns (i)&nbsp;a right to
a majority of the profits of such entity or (ii)&nbsp;securities having the power to elect a majority of
the board of directors or similar body governing the affairs of such entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SV</U>&#148; has the meaning set forth in the Preamble.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SV Disclosure Letter</U>&#148; has the meaning set forth in Section&nbsp;3.3.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax</U>&#148; means all (i)&nbsp;taxes imposed by any U.S. federal, state or local, foreign or
other governmental entity or political subdivision thereof, including all income, gross receipts,
gains, profits, windfall profits, gift, severance, ad valorem, capital, social security,
unemployment disability, premium, recapture, credit, excise, property, sales, use, occupation,
service, service use, leasing, leasing use, value added, transfer, payroll, employment,
withholding, estimated, license, stamp, franchise or other taxes of any kind whatsoever, including
interest, penalties or additions thereto and (ii)&nbsp;liabilities of a person for the payment of any
amounts pursuant to any tax-sharing, tax allocation or similar agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Authority</U>&#148; means, with respect to any Tax, the governmental entity or political
subdivision thereof that imposes such Tax, and the agency (if any) charged with the collection of
such Tax for such entity or subdivision.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Benefit</U>&#148; means the Tax effect of any item of loss, deduction or credit or any
other item which decreases Taxes paid or payable or increases Tax basis.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Detriment</U>&#148; means the Tax effect of any item of income or gain or other item that
increases Taxes paid or payable or decreases Tax basis.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Item</U>&#148; means any item of income, gain, loss, deduction, credit, recapture of
credit or any other item which increases or decreases Taxes paid or payable, including an
adjustment under Section&nbsp;481 of the Code resulting from a change in accounting method.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Proceeding</U>&#148; means any Tax audit, contest, litigation, defense or other proceeding
with or against any Tax Authority.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Return</U>&#148; or &#147;<U>Return</U>&#148; means any report, return, documents, declaration or
other information (and any supporting schedules or attachments thereto) required to be supplied to
any Tax Authority or jurisdiction with respect to Taxes (including any returns or reports filed on
a consolidated, unitary, or combined basis, amended returns and claims for refund).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Termination Date</U>&#148; has the meaning set forth in the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Third Party Claim</U>&#148; has the meaning set forth in Section&nbsp;5.4(a).
</DIV>


<P align="center" style="font-size: 10pt">16
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transactions</U>&#148; means the Mergers, the Standalone Drug Sale and the transactions
contemplated by this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transfer Document</U>&#148; has the meaning set forth in Section&nbsp;6.1(d)(1).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transfer Taxes</U>&#148; has the meaning set forth in Section&nbsp;4.7.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transferred Real Property</U>&#148; means all real property Assets (including any fee or
leasehold) to be transferred or assigned pursuant to the Separation Agreement, to New Diamond, the
New Diamond Entities, Onyx or the Retained Entities, and/or one or more of the respective
Designated Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Unallocated Action</U>&#148; has the meaning set forth in Section&nbsp;5.5(b).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Unallocated Liabilities</U>&#148; means, without duplication:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Unallocated Actions;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any Liabilities incurred by the Company and/or SV under Section&nbsp;6.8(a) of the
Merger Agreement in respect of the Company; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Liabilities of the Company arising out of the operation of the Standalone Drug
Business prior to the Closing (other than Specified Standalone Drug Liabilities and any such
Liabilities to the extent paid or assumed by CVS pursuant to the Standalone Drug Sale
Agreement);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) other Liabilities of the Company to the extent such Liabilities are not (a)
Liabilities of the type described in any clause of the definition of New Diamond Liabilities
(other than clause (vi)&nbsp;thereof) or (b)&nbsp;Liabilities of the type described in any clause of
the definition of Retained Liabilities (other than clause (iv)&nbsp;thereof).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Welfare Plans</U>&#148; has the meaning set forth in Section&nbsp;8.4.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE II
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>TRANSFER OF NEW DIAMOND ASSETS AND NEW DIAMOND LIABILITIES;<BR>
PURCHASE AND SALE OF THE COMPANY AND THE RETAINED ENTITIES&#146; STOCK</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.1 <U>Transfer of New Diamond Assets and New Diamond Entities</U>. (a)&nbsp;Subject to
the terms and conditions of this Separation Agreement, each of the Company, Onyx, SV and New
Diamond and their respective Affiliates shall consummate, or cause to be consummated immediately
following the satisfaction or waiver of the conditions to the consummation of this Separation
Agreement as set forth in Section&nbsp;9.1 (excluding conditions that, by their terms, cannot be satisfied until the Closing), (i)&nbsp;the acquisition by New
Diamond of all of the capital stock of the Company in exchange for stock of New Diamond in
accordance with the Merger Agreement, followed immediately by (ii)&nbsp;the conversion of the Company
into a limited liability company (the &#147;<U>Diamond LLC Conversion</U>&#148;).
</DIV>


<P align="center" style="font-size: 10pt">17
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Immediately thereafter, (1)&nbsp;the Company shall (i)&nbsp;convey, assign, transfer and deliver,
directly or indirectly, to New Diamond and/or one or more of its Designated Affiliates, subject to
all Liens, all of the Company&#146;s right, title and interest in and to all the New Diamond Assets of
the Company and (ii)&nbsp;deliver, directly or indirectly, to New Diamond and/or one or more of its
Designated Affiliates legal and beneficial ownership of all of the Equity Interests of the New
Diamond Entities, and (2)&nbsp;New Diamond and/or one or more of its Designated Affiliates shall (i)
acquire and accept from the Company, subject to all Liens in place with respect to such Assets
immediately prior to the Closing Date, all of the Company&#146;s right, title and interest in and to all
the New Diamond Assets of the Company and (ii)&nbsp;acquire and accept from the Company legal and
beneficial ownership of all of the Equity Interests of the New Diamond Entities directly
transferred to New Diamond (such transactions, the &#147;<U>New Diamond Asset Transfer</U>&#148;). In
addition to the foregoing, immediately following the consummation of the Standalone Drug Sale, the
Company shall, and shall cause each of its Subsidiaries to, convey, assign, transfer or otherwise
distribute all of the cash proceeds from the Standalone Drug Sale to New Diamond (the
&#147;<U>Post-Standalone Drug Sale Cash Sweep</U>&#148;). By virtue of the New Diamond Asset Transfer and
the Post-Standalone Drug Sale Cash Sweep, pursuant to this Separation Agreement, after the Closing,
New Diamond will directly or indirectly own all of the capital stock of the New Diamond Entities
and the Assets of such entities (other than the Retained Assets) as well as other Assets, including
the New Diamond Proprietary Name Rights, and such Assets of the New Diamond Entities will be
considered New Diamond Assets for purposes of this Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.2 <U>Transfer and Assumption of New Diamond Liabilities</U>. Subject to the terms
and conditions of this Separation Agreement, concurrently with the New Diamond Asset Transfer, (a)
the Company shall convey, assign and transfer, directly or indirectly, to New Diamond and/or one or
more of its Designated Affiliates, all of the New Diamond Liabilities of the Company and (b)&nbsp;New
Diamond and/or one or more of its Designated Affiliates shall assume and agree to pay, perform and
discharge when due, or cause to be assumed, paid, performed and discharged, in due course, all of
the New Diamond Liabilities of the Company and the New Diamond Entities (the &#147;<U>New Diamond
Liability Transfer</U>,&#148; and together with the New Diamond Asset Transfer, the
&#147;<U>Separation</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.3 <U>Purchase and Sale of the Company&#146;s and the Retained Entities&#146; Stock; Retained
Assets and Retained Liabilities</U>. (a)&nbsp;Subject to the terms and conditions of this Separation
Agreement, at the Closing and following the Separation and the Standalone Drug Sale, New Diamond
shall (or shall cause one or more of its Subsidiaries to) sell and deliver, directly or indirectly,
to Onyx and/or one or more of its Designated Affiliates, and Onyx and/or one or more of its
Designated Affiliates shall (1)&nbsp;purchase, acquire and accept from New Diamond, or the applicable
Subsidiary or Subsidiaries of New Diamond, legal and beneficial ownership of all of the Equity
Interests of the Company (such purchase, the &#147;<U>Retained Entities Transfer</U>&#148;) and (2)&nbsp;assume and agree to pay,
perform and discharge when due, or cause to be assumed, paid, performed and discharged, in due
course, all of the Retained Liabilities. By virtue of the Company&#146;s retained ownership of all of
the capital stock of the other Retained Entities after the Closing, the Company will indirectly own
all of the Assets owned by such Retained Entities (other than the New Diamond Assets), including
the capital stock and the Assets of such entities and such Assets will be considered Retained
Assets for purposes of this Separation Agreement
</DIV>


<P align="center" style="font-size: 10pt">18
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Immediately following the Retained Entities Transfer, New Diamond shall (or shall cause
one or more of the New Diamond Entities to) sell, convey, assign, transfer and deliver, directly or
indirectly, to Onyx and/or one or more of its Designated Affiliates, subject to all Liens, all of
New Diamond&#146;s (or the New Diamond Entities&#146;, as applicable) right, title and interest in and to all
the Retained Assets of New Diamond or the New Diamond Entities, as applicable and Onyx and/or one
or more of its Designated Affiliates shall purchase, acquire and accept from New Diamond (or the
New Diamond Entities, as applicable) subject to all Liens in place with respect to such Asset
immediately prior to the Closing Date, all of New Diamond&#146;s (or the New Diamond Entities&#146;, as
applicable) right, title and interest in and to all the Retained Assets of New Diamond or the New
Diamond Entities, as applicable (such transactions, the &#147;<U>Retained Assets Transfer</U>&#148; and
together with the Retained Entities Transfer, the &#147;<U>Retained Business Purchase</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.4 <U>Reorganization; Consummation of the Mergers and New Diamond Liability
Transfer; Retained Business Price</U> . (a)&nbsp;Subject to the terms and conditions of this
Separation Agreement and in furtherance of Sections&nbsp;2.1, 2.2 and 2.3 hereof, and in furtherance of
the parties&#146; mutual desire and intent to transfer, directly or indirectly, the Retained Entities to
Onyx and/or one or more of its Designated Affiliates in a transaction treated for federal income
Tax purposes as a sale of assets (except with respect to the purchase of Lucky Delaware, which the
parties mutually desire and intend to be treated as a sale of stock for federal income Tax
purposes), each of the Company, Onyx, SV and New Diamond and their respective Affiliates shall
consummate, or cause to be consummated, the transactions contemplated by the Reorganization,
substantially as provided in <U>Schedule&nbsp;1.1</U> and in a manner consistent with Section&nbsp;4.1(c) of
this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Subject to the terms and conditions of this Separation Agreement, in consideration of the
New Diamond Asset Transfer, each of the Company and New Diamond shall consummate, or cause to be
consummated, the New Diamond Liability Transfer.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Subject to the terms and conditions of this Separation Agreement, in consideration of the
Retained Business Purchase, Onyx and/or one or more of its Designated Affiliates shall (1)&nbsp;pay to
New Diamond (or such New Diamond Entity as New Diamond may designate) an amount of cash equal to
the Retained Business Price and (2)&nbsp;assume and agree to pay, perform and discharge when due, or
cause to be assumed, paid, performed and discharged, in due course, all of the Retained Liabilities
assumed by Onyx and/or one or more of its Designated Affiliates pursuant to Section&nbsp;2.3.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.5 <U>The Closing</U>. (a)&nbsp;Subject to the satisfaction or waiver of the
conditions set forth in Section&nbsp;9.1 of this Separation Agreement, each of the Diamond LLC
Conversion, the Separation, the Standalone Drug Sale and the Retained Business Purchase shall take
place in succession as contemplated by the Coordination Agreement, in each case, at the offices of
Jones Day, 222 West 41st Street, New York, New York 10017 (the &#147;<U>Closing</U>&#148;). The parties
hereto agree that (i)&nbsp;the sale, conveyance, assignment and transfer of the New Diamond Assets and
New Diamond Entities or the Retained Assets and Retained Entities, as applicable, shall be effected
at the Closing by delivery by each of the parties (A)&nbsp;with respect to those Assets and Equity
Interests which are evidenced by capital stock certificates or similar instruments, certificates
duly endorsed in blank or accompanied by stock powers or other instruments of
</DIV>


<P align="center" style="font-size: 10pt">19
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">assignment executed in blank and (B)&nbsp;with respect to all other Assets, such good and sufficient instruments of transfer
and delivery as shall be necessary to vest in New Diamond or Onyx or their respective Designated
Affiliates, as the case may be, all of the right, title and interest of the Company in and to such
Assets, and (ii)&nbsp;the assumption of Liabilities shall be effected by delivery by New Diamond or Onyx
or their respective Designated Affiliates, as applicable, to the appropriate counterparty of such
good and sufficient instruments of assumption, as shall be necessary for the assumption by New
Diamond or Onyx or their respective Designated Affiliates, as applicable, of the Liabilities to be
assumed pursuant to this Separation Agreement. All of the foregoing transfer or assumption
instruments or other documents shall be in such form as are reasonably satisfactory to the parties
hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The parties hereto will cooperate with one another and with CVS in causing the Closing,
the &#147;Closing&#148; contemplated by the Standalone Drug Sale Agreement and the &#147;Closing&#148; contemplated by
the Merger Agreement to occur and be effected as promptly as practicable but in no event later than
two (2)&nbsp;Business Days after the Initial Closing Date (as defined in the Merger Agreement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.6 <U>Certain Indebtedness of the Company; Succession and Release;
Indemnification</U>. In connection with the transactions contemplated hereby, the parties agree
that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;In connection with the Separation and substantially concurrent with the New Diamond Asset
Transfer, with respect to the ABS Indenture, each of the Company and New Diamond shall take, or
cause to be taken, all those actions specified under the ABS Indenture to (1)&nbsp;cause New Diamond to
assume all obligations thereunder, including executing and delivering one or more supplemental
indentures in accordance with the terms thereof and (2)&nbsp;to cause the Company to be released and
discharged from any and all obligations thereunder. Following the Closing, New Diamond shall, or
shall cause one of its Affiliates to, pay, perform and discharge all obligation, covenants and
agreements under the ABS Indenture pursuant to the terms thereof. Any Liabilities of the Retained
Entities on account of the foregoing shall be deemed Indemnifiable Losses of the Company
Indemnitees under Article&nbsp;V of this Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Following the Closing, New Diamond shall, or shall cause one of its Affiliates to, pay,
perform and discharge all obligations, covenants and agreements under the ASC Indenture pursuant to
the terms thereof, subject only to the provisions in this Section&nbsp;2.6(b) relating to the Albertson&#146;s Inc. Guarantee. All Liabilities incurred by the Retained Entities
on account of the foregoing shall be deemed Indemnifiable Losses of the Company Indemnitees under
Article&nbsp;V of this Separation Agreement. Following the Closing and until the fifth (5<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>)
anniversary of the Closing Date (such date, the &#147;<U>Guarantee Release Date</U>&#148;), (i)&nbsp;Onyx shall
cause the Company to be duly organized, validly existing and in good standing under the laws of the
State of Delaware and (ii)&nbsp;each of Onyx and the Company shall cause to remain outstanding and in
full force and effect the guarantee entered pursuant to that certain Supplemental Indenture No.&nbsp;2,
dated as of July&nbsp;6, 2005 (the &#147;<U>Albertson&#146;s Inc. Guarantee</U>&#148;), whereby the Company guaranteed
all of the obligations under the ASC Indenture. On or prior to the Guarantee Release Date, New
Diamond shall, or shall cause one of its Affiliates to, cause the Company to be released and
discharged from the Albertson&#146;s Inc. Guarantee (and the Company shall, and shall cause the other
Retained Entities to, cooperate at New Diamond&#146;s expense in seeking such release and
</DIV>

<P align="center" style="font-size: 10pt">20
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">discharge). Any Liabilities of the Company or any other Retained Entities on account of any payments that are
required to be made under the Albertson&#146;s Inc. Guarantee (other than Liabilities arising out of a
breach by Onyx or the Company of this Section&nbsp;2.6(b) or the Albertson&#146;s Inc. Guarantee) shall be
deemed Indemnifiable Losses of the Company under Article&nbsp;V of this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Without limiting the generality of the foregoing, following the Closing, (1)&nbsp;with respect
to any other New Diamond Liabilities that constitute obligations for money borrowed, New Diamond
shall use its reasonable best efforts to cause the Company and the other Retained Entities and
their respective Equity Interests, properties and assets to be released and discharged from any and
all Liabilities, Liens, guarantees, and the like under such indebtedness (and Onyx and/or one of
its Designated Affiliates shall, and shall cause the Company and the other Retained Entities to,
cooperate in seeking such release and discharge), and New Diamond shall, or shall cause a New
Diamond Entity to, (to the extent permitted by the terms of New Diamond&#146;s financing) pay, perform
and discharge such indebtedness pursuant to the terms thereof, and perform and abide by all other
obligations, covenants and agreements therein, in each case, pending such release and discharge and
(2)&nbsp;with respect to any Retained Liabilities that constitute obligations for money borrowed, Onyx
and/or one of its Designated Affiliates shall, and shall cause the Company and the other Retained
Entities to, use its reasonable best efforts to cause New Diamond and the New Diamond Entities and
their respective Equity Interests, properties and assets to be released and discharged from any and
all Liabilities, Liens, guarantees and the like under such indebtedness (and New Diamond shall, and
shall cause the New Diamond Entities to, cooperate in seeking such release and discharge), and Onyx
and/or one of its Designated Affiliates shall, and shall cause the Company and the other Retained
Entities to (to the extent permitted by the terms of Onyx&#146;s financing), pay, perform and discharge
such indebtedness pursuant to the terms thereof, and perform and abide by all other obligations,
covenants and agreements therein, in each case, pending such release and discharge;
<U>provided</U>, that each of Onyx and New Diamond shall use commercially reasonable efforts to
obtain necessary approvals from their respective financing sources to permit such performance; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Following the Closing, (1)&nbsp;if the Company or any other Retained Entity is a party to or
bound by any agreement or instrument governing any New Diamond Liabilities contemplated by clause
(c)&nbsp;above that constitute obligations for money borrowed or any related guaranty, security
agreement or pledge, each of Onyx and/or one of its Designated Affiliates shall, or shall cause the Company or such Retained Entity to (to the extent
permitted by the terms of Onyx&#146;s financing), at the expense of New Diamond and/or one of its
Designated Affiliates, perform and abide by all obligations, covenants and agreements contained
therein pending the release and discharge contemplated by clause (c)(1) above and (2)&nbsp;if any New
Diamond Entity is a party to or bound by any agreement or instrument governing any Retained
Liabilities contemplated by clause (c)&nbsp;above that constitute obligations for money borrowed or any
related guaranty, security agreement or pledge, New Diamond and/or one of its Designated Affiliates
shall, or shall cause such New Diamond Entity to (to the extent permitted by the terms of New
Diamond&#146;s financing), at the expense of the Company and/or one of its Designated Affiliates,
perform and abide by all obligations, covenants and agreements contained therein pending the
release and discharge contemplated by clause (c)(2) above; <U>provided</U>, that each of Onyx and
New Diamond shall use commercially reasonable efforts to obtain necessary approvals
</DIV>

<P align="center" style="font-size: 10pt">21
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">from their respective financing sources to permit such performance. Any expenses (including reasonable
attorneys fees, administrative costs and amounts paid to third parties) incurred in connection with
this Section&nbsp;2.6(d) for the account of New Diamond and/or its Designated Affiliates, on the one
hand, and the Company and/or its Designated Affiliates on the other hand, shall be deemed
Indemnifiable Losses of the Company and New Diamond, respectively, under Article&nbsp;V of this
Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.7 <U>Current Accounts</U>. After the date hereof and prior to the Closing, (a)&nbsp;the
Company shall continue its general practices and policies relating to (1)&nbsp;the payment and
collection, as the case may be, of accounts payable and accounts receivable, (2)&nbsp;subject to the
provisions of Section&nbsp;6.1 of the Merger Agreement, the defense and settlement of Actions and (3)
maintenance of inventory of a quantity (accounting for seasonal variations), quality and mix, in
each case, in the ordinary course and consistent with past practice for the New Diamond Business
and the Retained Business and (b)&nbsp;no party hereto shall, nor shall any party permit any of its
Subsidiaries or Affiliates to, materially influence or otherwise alter such practices and policies.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.8 <U>Retained Business Price Allocation; Retained Property Proceeds</U>. (a)
Within sixty (60)&nbsp;days following the Closing Date, Onyx shall deliver to New Diamond for its review
and approval a proposed allocation of the Retained Business Price (including any adjustments made
thereto) and any liabilities assumed, for Tax purposes, which shall be prepared in a manner
consistent with fair market value and, as applicable, Sections&nbsp;338 and 1060 of the Code and the
Treasury Regulations promulgated thereunder (such allocation, as agreed by Onyx and New Diamond or
as resolved by the Accountant, the &#147;<U>Retained Business Allocation</U>&#148;). In the event that Onyx
and New Diamond are unable to reach an agreement on the Retained Business Allocation within fifty
(50)&nbsp;days of such delivery, Onyx and New Diamond shall each set forth in writing their positions
regarding any remaining disagreed items and such positions shall be submitted to a nationally
recognized public accounting firm mutually acceptable to both Onyx and New Diamond (the
&#147;<U>Accountant</U>&#148;) for resolution in the next forty-five (45)&nbsp;days. The Accountant shall be
instructed to resolve such disputed items so that the Retained Business Allocation is consistent
with fair market value and, as applicable, Sections&nbsp;338 and 1060 of the Code and the Treasury
Regulations promulgated thereunder. Each of Onyx and New Diamond shall bear all fees and costs
incurred by it in connection with such dispute, except that each of Onyx and New Diamond shall pay
one-half (50%) of the fees and expenses of the Accountant. The parties agree to use the Retained Business Allocation for all Tax
purposes and in all filings, declarations and reports with the Internal Revenue Service (the
&#147;<U>IRS</U>&#148;) in respect thereof, including any reports required to be filed under Sections&nbsp;1060
and 338 of the Code. The parties shall timely file, or cause to be timely filed, IRS Form&nbsp;8594 (or
any comparable form under state, local, or foreign Tax law) and any required attachments thereto in
accordance with the Retained Business Allocation. On any Tax Return and in any Tax Proceeding,
none of (x)&nbsp;Onyx, the Company, their Designated Affiliates and the other Retained Entities nor (y)
SV, New Diamond, their Designated Affiliates and the New Diamond Entities shall take any position
inconsistent with or represent that the Retained Business Allocation is not correct, unless
otherwise required to do so as a result of a determination (as defined in Section 1313(a) of the
Code or any similar state or local tax provision) (a &#147;<U>Determination</U>&#148;).
</DIV>


<P align="center" style="font-size: 10pt">22
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;(i)&nbsp;No less than five Business Days after each monthly anniversary of the first month end
after date hereof through no later than two Business Days prior to the Closing Date and (ii)&nbsp;on the
date that is two Business Days prior to the Closing Date, the Company shall deliver to Onyx in
writing a statement providing in reasonable detail the aggregate net cash proceeds (after Tax, any
reasonable transaction costs and assumption of Liabilities) actually received by the Company or any
of its Subsidiaries during the time period from and after the date hereof through the most recent
month end prior to the date such statement is delivered (or, in the case of the statement delivered
pursuant to clause (ii), from the date hereof through the date of such statement) directly related
to dispositions by the Company or any of its Subsidiaries after the date hereof (the &#147;<U>Retained
Property Proceeds</U>&#148;) of &#147;Non-Core&#148; stores (as described in the Business Description
Presentation) (or all or substantially all of the Assets located in any store in a liquidation of
such store) or any underlying real property or any non-operating real property (including, without
limitation, proceeds resulting from the exercise of any right of recapture by a landlord with
respect to any real property lease) that, if not disposed, would qualify as Retained Assets;
<U>provided</U>, <U>however</U>, that the Company shall not be required to deliver a report
pursuant to clause (i)&nbsp;of this sentence if the amount of Retained Property Proceeds that would be
set forth in such report would be less than $100,000 more than the amount of Retained Property
Proceeds set forth in the most recently delivered previous report; <U>provided</U>,
<U>further</U>, that nothing in this Separation Agreement shall prohibit the Company from selling
or otherwise transferring to a third party (other than SV) the Springfield Stores and in no event
shall any proceeds from such sale or transfer of the Springfield Stores be considered Retained
Property Proceeds; provided, further, that if the Company shall sell or otherwise transfer to a
third party (other than SV) the Springfield Stores at the Closing, it shall use commercially
reasonable best efforts to give 30&nbsp;days&#146; prior notice of such sale to Onyx (or such shorter period
of notice as may be practicable).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.9 <U>Insurance Proceeds</U>. (a)&nbsp;In the event that, after the execution of this
Agreement, but prior to the Closing Date, any New Diamond Asset or Retained Asset is subject to
loss, destruction or damage to the building or other improvements thereon (a &#147;<U>Casualty</U>&#148;) or
the exercise of eminent domain by a governmental authority (a &#147;<U>Condemnation</U>&#148;):
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Subject to Section&nbsp;2.9(a)(ii), at the Closing the Company shall (A)&nbsp;retain,
or shall transfer and convey to New Diamond or one or more of Onyx&#146;s Designated
Affiliates, as applicable, all net proceeds the Company or any of its Subsidiaries have received from any third party insurance claims,
condemnation awards, compensation or other reimbursements relating to such Casualty
or Condemnation (except as to proceeds of business interruption, rental and lost
profits insurance for periods up to and including the Effective Time, whenever
received, to the extent that such proceeds have not already been used by the Company
or any of its Subsidiaries to repair any such loss, destruction or damage) and
except to the extent such proceeds are used or intended to be used to reimburse the
Company or such Subsidiaries for any out-of-pocket costs, expenses, damages or
losses suffered or incurred by the Company or its Subsidiaries during the period up
to and including the Effective Time) and (B)&nbsp;to the extent such proceeds have not
already been used by the Company or its Subsidiaries to repair any such loss,
destruction or damage, assign to New Diamond (in the case of a Casualty relating to
a New Diamond Asset) or to one or
</DIV>

<P align="center" style="font-size: 10pt">23
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">more of Onyx&#146;s Designated Affiliates (in the case
of a Casualty relating to a Retained Asset) the right to receive any future proceeds
of such Casualty or Condemnation receivable after the Effective Time, including as
to business interruption insurance, rental and lost profits insurance for any period
after the Effective Time).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) If any such Casualty is not covered under the Company&#146;s or any of its
Subsidiaries&#146; third party insurance policies and in the event of a store that has
suffered a Casualty where the landlord is responsible for such repairs, loss or
destruction pursuant to the terms of the relevant Lease, the applicable the Company
or its Subsidiary, as applicable, shall assign the applicable lease to New Diamond
or one or more of Onyx&#146;s Designated Affiliates, as applicable, and, without any
additional payment from New Diamond or such Onyx Designated Affiliate(s), the
Company or such Subsidiary shall assign to New Diamond or such Onyx Designated
Affiliate(s) any claim they have under such lease with respect thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any party receiving a notice of Casualty or Condemnation shall notify all other
parties in accordance with Section&nbsp;9.10. Notwithstanding anything to the contrary contained
in this Separation Agreement, in no event will any Casualty or Condemnation constitute the
breach of any representation, warranty or covenant of the Company contained in this
Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Notwithstanding anything to the contrary in this Separation Agreement, under no
circumstances shall (1)&nbsp;the Company, New Diamond or any of their respective Affiliates be
responsible for any retention or deductible payable with respect to any Casualty or
Condemnation and (2)&nbsp;any payments on account of a Casualty or Condemnation or any other loss
be required after the Closing Date from Beryl American Corporation, or any other Subsidiary
or Affiliate of SV or the Company that has underwritten an insurance policy with respect to
any New Diamond Asset or Retained Asset.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE III
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>REPRESENTATIONS AND WARRANTIES</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.1 <U>Representations and Warranties of Onyx</U>. Except as set forth on the
corresponding sections of the disclosure letter delivered by Onyx to the Company and SV on or prior
to the execution of this Separation Agreement (the &#147;<U>Onyx Disclosure Letter</U>&#148;), Onyx hereby,
jointly and severally with each of its Designated Affiliates, represents and warrants to the
Company and SV that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Organization and Standing</U>. Each of Onyx and its Designated Affiliates is duly
organized, validly existing and in good standing under the laws of its respective jurisdiction of
organization, and has the requisite corporate or similar power and authority to own its properties
and to carry on its business as presently conducted and is duly qualified to do business and is in
good standing (where such concept exists) as a foreign corporation in each
</DIV>

<P align="center" style="font-size: 10pt">24
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">jurisdiction in which the nature of its business or the ownership or leasing of its properties makes such qualification
necessary. Complete and correct copies of the certificate of incorporation and by-laws (or
equivalent organizational documents) of Onyx and its Designated Affiliates (if and to the extend
actually designated), as currently in effect, have been made available to the Company, and as so
made available, are in full force and effect and no other organizational documents are applicable
to or binding upon Onyx and its Designated Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Authority; Enforceability</U>. Each of Onyx and its Designated Affiliates has the
corporate or other power and authority to execute and deliver this Separation Agreement and to
perform its obligations hereunder and to consummate the transactions contemplated hereby. The
execution and delivery by each of Onyx and its Designated Affiliates of this Separation Agreement
and the consummation by each of Onyx and its Designated Affiliates of the transactions contemplated
hereunder have been duly authorized by all necessary action on the part of each of Onyx and its
Designated Affiliates and the holders of any Equity Interests thereof and no other corporate or
similar proceeding on the part of Onyx or its Designated Affiliates are necessary pursuant to its
governing documents or applicable Law to authorize this Separation Agreement or to consummate the
transactions contemplated hereby. This Separation Agreement has been duly executed and delivered
by each of Onyx and, if and when applicable, its Designated Affiliates and, assuming due
authorization, execution and delivery by the other parties hereto, constitutes a legal, valid and
binding agreement of each of Onyx and its Designated Affiliates, enforceable against each of them
in accordance with its terms, subject to the effects of bankruptcy, insolvency, fraudulent
conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors&#146;
rights generally and general equitable principles (whether considered in a proceeding in equity or
at law).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Non-Contravention</U>. The execution, delivery and performance of this Separation
Agreement by each of Onyx and its Designated Affiliates does not and will not (1)&nbsp;conflict with or
violate its certificate of incorporation or by-laws or comparable governing documents, (2)&nbsp;assuming
that all consents, approvals and authorizations contemplated by Section&nbsp;3.1(d) have been obtained
and all filings described therein have been made, conflict with or violate any Law applicable to
Onyx, its Designated Affiliates or any of their Subsidiaries or by which it or any of its
properties are bound or (3)&nbsp;result in any breach or violation of or constitute
a default (or an event which with notice or lapse of time or both would become a default) or
result in the loss of a benefit under, or give rise to any right of termination, cancellation,
recapture, amendment or acceleration of, or performance under, any note, bond, mortgage, indenture,
contract, agreement, lease, license, permit or other instrument or obligation to which Onyx, its
Designated Affiliates or any of their Subsidiaries is a party or by which Onyx, its Designated
Affiliates or any of their Subsidiaries or its or any of their properties are bound, except, in the
case of clauses (2)&nbsp;and (3)&nbsp;of this Section&nbsp;3.1(c), for any such conflict, violation, breach,
default, loss, right or other occurrence which would not, individually or in the aggregate, prevent
or materially delay the consummation of the transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Governmental Consents</U>. The execution, delivery and performance of this Separation
Agreement by each of Onyx and its Designated Affiliates and the consummation by each of Onyx and
its Designated Affiliates of the transactions contemplated hereby do not and will not require any
consent, approval, authorization or permit of, action by, filing with or notification to, any
Governmental Authority, except as required under or pursuant
</DIV>


<P align="center" style="font-size: 10pt">25
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to (1)&nbsp;the HSR Act, (2)&nbsp;the Exchange Act, (3)&nbsp;state securities, takeover and &#147;blue sky&#148; Laws, (4)&nbsp;the rules and regulations of the NYSE
and the PCX, (5)&nbsp;the DGCL, (6)&nbsp;the applicable requirements of antitrust or other competition Laws
of other jurisdictions or investment Laws relating to foreign ownership, and (7)&nbsp;any other consent,
approval, authorization, permit, action, filing or notification the failure of which to be made or
obtained would not, individually or in the aggregate, prevent or materially delay the consummation
of the transactions contemplated hereby and by the Merger Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<U>Capitalization</U>. Section&nbsp;3.1(e) of the Onyx Disclosure Letter sets forth the
authorized, outstanding equity of Onyx as of the date hereof. There is no agreement, contract,
commitment or arrangement pursuant to which Onyx or any Subsidiary of Onyx is or may become
obligated to repurchase or redeem any shares of capital stock or voting securities of Onyx or any
securities or obligations convertible or exchangeable into or exercisable for, any shares of
capital stock or voting securities of Onyx. Onyx does not have outstanding any bonds, debentures,
notes or other obligations the holders of which have the right to vote (or which are convertible,
exchangeable or exercisable for or into securities having the right to vote) with the members of
Onyx on any matter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;<U>Litigation</U>. There are no Actions pending or, to the knowledge of Onyx, threatened
against Onyx or its Designated Affiliates or, to the knowledge of Onyx, any officer, director or
employee of Onyx or its Designated Affiliates in such capacity, which would, individually or in the
aggregate, prevent or materially delay Onyx or its Designated Affiliates from performing its
obligations under this Separation Agreement in any material respect. Neither Onyx nor its
Designated Affiliates is a party or subject to or in default under the order of any Authority which
would prevent or materially delay Onyx or its Designated Affiliates from performing its obligations
under this Separation Agreement in any material respect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;<U>Financing</U>. Attached hereto as <U>Exhibit&nbsp;A</U> is a true and complete copy of
the Financing Commitment (the &#147;<U>Financing Commitment</U>&#148;), pursuant to which the Sponsor
thereto has committed, subject to the terms and conditions set forth therein, to invest the amounts
set forth therein to purchase Equity Interests of Onyx and to provide debt financing to Onyx and
its Designated Affiliates (the &#147;<U>Financing</U>&#148;). The Financing Commitment has not been
amended or modified prior to the date of this Separation Agreement, no such amendment or
modification is contemplated, and the commitment contained in the Financing Commitment has not been
withdrawn or rescinded in any respect. The Financing Commitment is in full force and effect and is
the valid, binding and enforceable obligation of the parties thereto. There are no conditions
precedent or other contingencies related to the funding of the full amount of the Financing, other
than as set forth in or contemplated by the Financing Commitment. No event has occurred which,
with or without notice, lapse of time or both, would constitute a default on the part of Onyx or
its Designated Affiliates under the Financing Commitment, and Onyx has no reason to believe that
any of the conditions to the Financing contemplated by the Financing Commitment will not be
satisfied or that the Financing will not be made available to Onyx on the Closing Date. Onyx and
its Designated Affiliates will have at and after the Closing funds sufficient to pay the aggregate
Retained Business Price and any other amounts required to be paid in connection with the
consummation of the transactions contemplated hereby, and to pay all related fees and expenses.
</DIV>

<P align="center" style="font-size: 10pt">26
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;<U>Solvency</U>. Assuming satisfaction of the conditions to this Separation Agreement
and the Merger Agreement (other than the consummation of the transactions contemplated hereby), and
after giving effect to the transactions contemplated hereby and thereby, including the Financing
and Future Debt Financing, any alternative financing and the payment of the aggregate Per Share
Merger Consideration, the Reorganization, the assumption or retention (as applicable) of the
Retained Liabilities by the Company, Onyx and its Designated Affiliates, the assumption or
retention (as applicable) of the New Diamond Liabilities by New Diamond and its Designated
Affiliates, payment of all amounts required to be paid in connection with the consummation of the
transactions contemplated hereby and thereby, and payment of all related fees and expenses, each of
the Company, Onyx and its Designated Affiliates will be Solvent as of the Effective Time and
immediately after the consummation of the transactions contemplated hereby and thereby. For the
purposes of this Separation Agreement the term &#147;<U>Solvent</U>&#148; when used with respect to any
person, means that, as of any date of determination, (1)&nbsp;the amount of the &#147;fair saleable value&#148; of
the assets of such person will, as of such date, exceed (i)&nbsp;the value of all &#147;liabilities of such
person, including contingent and other liabilities,&#148; as of such date, as such quoted terms are
generally determined in accordance with applicable federal laws governing determinations of the
insolvency of debtors, and (ii)&nbsp;the amount that will be required to pay the probable liabilities of
such person on its existing debts (including contingent liabilities) as such debts become absolute
and matured, (2)&nbsp;such person will not have, as of such date, an unreasonably small amount of
capital for the operation of the businesses in which it is engaged or proposed to be engaged
following such date, and (3)&nbsp;such person will be able to pay its liabilities, including contingent
and other liabilities, as they mature. For purposes of this definition, &#147;not have an unreasonably
small amount of capital for the operation of the businesses in which it is engaged or proposed to
be engaged&#148; and &#147;able to pay its liabilities, including contingent and other liabilities, as they
mature&#148; means that such person will be able to generate enough cash from operations, asset
dispositions or refinancing, or a combination thereof, to meet its obligations as they become due.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;<U>Brokers</U>. No agent, broker, finder or investment banker is entitled to any
brokerage, finder&#146;s or other fee or commission in connection with the transactions contemplated by
this Separation Agreement based upon arrangements made by or on behalf of Onyx or its Designated Affiliates for which any party other than Onyx or its Designated
Affiliates could have any liability.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;<U>Company Stock</U>. Neither Onyx nor any of its Designated Affiliates is, and at no
time during the last three years has either Onyx or any of its Designated Affiliates been, an
&#147;interested stockholder&#148; of the Company as defined in Section&nbsp;203 of the DGCL. Neither Onyx nor
any of its Designated Affiliates owns (directly or indirectly, beneficially or of record), or is a
party to any agreement, arrangement or understanding for the purpose of acquiring, holding, voting
or disposing of, any shares of capital stock of the Company (other than as contemplated by this
Separation Agreement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;<U>Onyx Designated Affiliates</U>. Each of the Designated Affiliates of Onyx was formed
or will be formed, as the case may be, solely for the purpose of engaging in the transactions
contemplated hereby, has engaged in no other business activities and has conducted its operations
only as contemplated by this Separation Agreement.
</DIV>

<P align="center" style="font-size: 10pt">27
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.2 <U>Representations and Warranties of the Company</U>. Except as set forth in the
corresponding sections of the disclosure letter (subject to the provisions of Section&nbsp;9.18)
delivered by the Company to Onyx on or prior to the execution of this Separation Agreement (the
&#147;<U>Company Disclosure Letter</U>&#148;) and except as disclosed in the Form 10-K of the Company for
the fiscal period ended February&nbsp;3, 2005, as amended through the date hereof (as amended, the
&#147;<U>Company Form&nbsp;10-K</U>&#148;), the Proxy Statement for the Company&#146;s 2005 Annual Meeting of
Shareholders, and the Form 10-Qs and Form 8-Ks filed or furnished from the date of the filing of
the Company Form 10-K to the date of this Separation Agreement (and any amendments to any such
filings which amendments are filed with the SEC prior to the date hereof) to the extent such
qualifications are reasonably apparent (and which in no event shall include risk factors or other
factors identified in general cautionary statements regarding reliance on forward looking
statements in either case included in the Company SEC Reports), the Company hereby represents and
warrants to Onyx and its Designated Affiliates that the representations and warranties of the
Company set forth in Article&nbsp;IV of the Merger Agreement are true and correct; <U>provided</U>,
<U>however</U>, that (1)&nbsp;the representations and warranties contained in Article&nbsp;IV of the Merger
Agreement are made herein by the Company (<I>mutatis mutandis</I>) for the benefit of Onyx and its
Designated Affiliates, (2)&nbsp;except for purposes of the representations and warranties contained in
Section&nbsp;4.1 (Organization), Section&nbsp;4.2(a) and (c) (Authority; Enforceability), Section&nbsp;4.5
(Capitalization of the Company), Section&nbsp;4.7 (SEC Reports; Financial Information), Section
4.10(a)(iv), (x)&nbsp;and (xi) (Contracts), Section&nbsp;4.13 (Employee Compensation and Benefit Plans;
ERISA), Section&nbsp;4.14 (Labor Matters), Section&nbsp;4.19 (Tax) and Section&nbsp;4.20 (Insurance), of the
Merger Agreement, all references to the &#147;Company&#148; or to the &#147;Company Subsidiaries&#148; contained in
Article&nbsp;IV of the Merger Agreement shall be deemed to refer to the Company and its Subsidiaries in
respect of the Retained Business, Retained Assets and Retained Liabilities, (3)&nbsp;for the avoidance
of doubt, all reference to &#147;Company Material Adverse Effect&#148; therein shall be deemed to refer to
&#147;Company Material Adverse Effect&#148; as defined in this Separation Agreement and (4)&nbsp;all references to
&#147;Parent&#148; contained in Article&nbsp;IV of the Merger Agreement shall be deemed to refer to Onyx.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.3 <U>Representations and Warranties of SV</U>. Except as set forth on the
corresponding sections of the disclosure letter delivered by SV to the Company and Onyx on or prior
to the execution of this Separation Agreement (the &#147;<U>SV Disclosure Letter</U>&#148;), SV hereby,
jointly and severally with each of their respective Designated Affiliates, represents and warrants
to the Company and Onyx that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Organization</U>. Each of SV and its Designated Affiliates is duly organized, validly
existing and in good standing under the laws of its respective jurisdiction of organization, and
has the requisite corporate or similar power and authority to own its properties and to carry on
its business as presently conducted and is duly qualified to do business and is in good standing
(where such concept exists) as a foreign corporation in each jurisdiction in which the nature of
its business or the ownership or leasing of its properties makes such qualification necessary.
Complete and correct copies of the certificate of incorporation and by-laws (or equivalent
organizational documents) of SV and its Designated Affiliates (if and to the extend actually
designated) as currently in effect, have been made available to each of the Company and Onyx, and
as so made available, are in full force and effect and no other organizational documents are
applicable to or binding upon SV.
</DIV>

<P align="center" style="font-size: 10pt">28
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Authority; Enforceability</U>. Each of SV and its Designated Affiliates has the
corporate or other power and authority to execute and deliver this Separation Agreement and to
perform its obligations hereunder and to consummate the transactions contemplated hereby. The
execution and delivery by each of SV and its Designated Affiliates of this Separation Agreement and
the consummation by each of SV and its Designated Affiliates of the transactions contemplated
hereunder have been duly authorized by all necessary action on the part of each of SV and its
Designated Affiliates and no other corporate proceedings on the part of each of SV and its
Designated Affiliates are necessary pursuant to its governing documents or the DGCL to authorize
this Separation Agreement or to consummate the transactions contemplated hereby. The boards of
directors of each of SV and its Designated Affiliates have determined that it is in the best
interests of SV to enter into this Separation Agreement, and have approved this Separation
Agreement. This Separation Agreement has been duly executed and delivered by each of SV and its
Designated Affiliates and, assuming due authorization, execution and delivery by the other parties
hereto, constitutes a legal, valid and binding agreement of each of SV and its Designated
Affiliates, enforceable against each of them in accordance with its terms, subject to the effects
of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws
relating to or affecting creditors&#146; rights generally and general equitable principles (whether
considered in a proceeding in equity or at law).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Non-Contravention</U>. The execution, delivery and performance of this Separation
Agreement by each of SV and its Designated Affiliates does not and will not (1)&nbsp;conflict with or
violate its certificate of incorporation or by-laws or comparable governing documents, (2)&nbsp;conflict
with or violate the governing documents of any other Subsidiary of SV, (3)&nbsp;assuming that all
consents, approvals and authorizations contemplated by Section&nbsp;3.3(d) have been obtained and all
filings described therein have been made, conflict with or violate any Law applicable to each of SV
and its Designated Affiliates or any of their Subsidiaries or by which it or any of its properties
are bound or (4)&nbsp;result in any breach or violation of or constitute a default (or an event which
with notice or lapse of time or both would become a default) or result in the
loss of a benefit under, or give rise to any right of termination, cancellation, recapture,
amendment or acceleration of, or performance under, any note, bond, mortgage, indenture, contract,
agreement, lease, license, permit or other instrument or obligation to which SV and its Designated
Affiliates or any of their Subsidiaries is a party or by which SV and its Designated Affiliates or
any of their Subsidiaries or its or any of their properties are bound, except, in the case of
clauses (2), (3), and (4)&nbsp;of this Section&nbsp;3.3(c) for any such conflict, violation, breach, default,
loss, right or other occurrence which would not (i)&nbsp;prevent or materially delay SV or its
Designated Affiliates from performing its obligations under this Separation Agreement in any
material respect or (ii)&nbsp;reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Governmental Consents</U>. The execution, delivery and performance of this Separation
Agreement by each of SV and its Designated Affiliates and the consummation by each of SV and its
Designated Affiliates of the Transactions do not and will not require any consent, approval,
authorization or permit of, action by, filing with or notification to, any Governmental Authority,
except as required under or pursuant to (1)&nbsp;the HSR Act, (2)&nbsp;the Exchange Act, (3)&nbsp;state
securities, takeover and &#147;blue sky&#148; Laws, (4)&nbsp;the rules and regulations of the NYSE and the PCX,
(4)&nbsp;the DGCL, (5)&nbsp;the applicable requirements of antitrust or other competition Laws of other
jurisdictions or investment Laws relating to foreign ownership, and
</DIV>

<P align="center" style="font-size: 10pt">29
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(6)&nbsp;any other consent,
approval, authorization, permit, action, filing or notification the failure of which to be made or
obtained would not reasonably be expected to have, individually or in the aggregate, a Parent
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;<U>Solvency</U>. Assuming satisfaction of the conditions to this Separation Agreement
and the Merger Agreement (other than the consummation of the transactions contemplated hereby), and
after giving effect to the transactions contemplated hereby and thereby, the Reorganization, the
assumption or retention (as applicable) of the Retained Liabilities by the Company, Onyx and its
Designated Affiliates, the assumption or retention (as applicable) of the New Diamond Liabilities
by New Diamond and its Designated Affiliates, payment of all amounts required to be paid in
connection with the consummation of the transactions contemplated hereby and thereby, and payment
of all related fees and expenses, each of SV, New Diamond and its Designated Affiliates will be
Solvent as of the Effective Time and immediately after the consummation of the transactions
contemplated hereby and thereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;<U>Brokers</U>. No agent, broker, finder or investment banker is entitled to any
brokerage, finder&#146;s or other fee or commission in connection with the transactions contemplated by
this Separation Agreement based upon arrangements made by or on behalf of SV for which the Company
or Onyx could have any liability.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE IV
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>TAX MATTERS</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.1 <U>Liability for Taxes</U>. (a)&nbsp;New Diamond and SV shall (and New Diamond shall
cause the New Diamond Entities to) be responsible for, pay or cause to be paid, and shall (and New
Diamond shall cause the New Diamond Entities to) indemnify Onyx, its Designated
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affiliates and each of its Subsidiaries and Affiliates (including the Retained Entities after
the Closing Date) (each a &#147;<U>Buyer Tax Indemnitee</U>&#148;) and hold each Buyer Tax Indemnitee
harmless from and against any and all of the following (including reasonable fees and expenses in
connection therewith):
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) any and all Taxes of New Diamond and each New Diamond Entity ((i) other
than any Non-Income Taxes attributable to the Retained Business or the Retained
Assets and (ii)&nbsp;limited, in the case of Shared Non-Income Taxes, to the New Diamond
Percentage of such Non-Income Taxes);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) the New Diamond Percentage of any Shared Non-Income Taxes imposed on any
Retained Entity;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) any and all United States federal Income Taxes for any taxable period (or
portion thereof) that ends on or prior to the Closing Date (such a period, a
&#147;<U>Pre-Closing Period</U>&#148;) of the Affiliated Group;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) any and all state, local and foreign Income Taxes for all Pre-Closing
Periods of each Retained Entity;
</DIV>

<P align="center" style="font-size: 10pt">30
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) any and all liability for Taxes of the Affiliated Group imposed on the
Retained Entities as a result of the application of Treasury Regulation&nbsp;Section
1.1502-6 (or any similar provision of state, local or foreign law);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) any and all Non-Income Taxes for Pre-Closing Periods of, imposed upon, or
relating or attributable to the New Diamond Business, the New Diamond Assets or the
Standalone Drug Business (regardless of whether such Taxes are imposed on any New
Diamond Entity or any Retained Entity); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) any and all Taxes for any taxable period (or portion thereof) that begins
after the Closing Date (such a period, a &#147;<U>Post-Closing Period</U>&#148;) of, imposed
upon or relating or attributable to the New Diamond Entities, the New Diamond
Business or the New Diamond Assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If, for any state, local or foreign Income Tax purposes, any Taxable period of any Retained
Entity includes but does not end on the Closing Date (any such period, a &#147;<U>Straddle
Period</U>&#148;), Income Taxes, if any, attributable to such Straddle Period shall be allocated to (A)
New Diamond and SV for the portion of such Straddle Period up to and including the Closing Date,
and (B)&nbsp;Onyx for the portion of such Straddle Period subsequent to the Closing Date. For purposes
of the preceding sentence, Income Taxes for the portion of each Straddle Period up to and including
the Closing Date and for the portion of such Straddle Period subsequent to the Closing Date shall
be determined on the basis of an interim closing of the books as of the close of business on the
Closing Date as if such Straddle Period consisted of one Taxable period ending on the Closing Date
followed by a Taxable period beginning on the day following the Closing Date, and exemptions,
allowances or deductions that are calculated on an annual basis, such as the deduction for
depreciation, shall be apportioned on a daily basis.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New Diamond and SV shall be entitled to any refund of (or credit of or against) Taxes to the
extent that such refund (or credit) relates to a Tax that is the responsibility of New Diamond or
SV under this Section&nbsp;4.1(a) and shall be entitled to any refund or credit to which New Diamond or
SV is entitled under Section&nbsp;4.6. For the avoidance of doubt, New Diamond and SV shall be entitled
to any deposits of Income Taxes with the Internal Revenue Service made by New Diamond, SV, any New
Diamond Entity or, prior to the Closing, the Company or any Retained Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each of Onyx and the Company shall (and shall cause each of the Retained Entities to), be
responsible for, pay or cause to be paid, and shall (and shall cause each of the Retained Entities
to) indemnify New Diamond and its Subsidiaries and Affiliates (other than the Retained Entities)
(each a &#147;<U>Seller Tax Indemnitee</U>&#148;) and hold each Seller Tax Indemnitee harmless from and
against any and all of the following (including reasonable fees and expenses in connection
therewith):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) any and all Non-Income Taxes of each Retained Entity ((i) other than any Non-Income
Taxes attributable to the New Diamond Business, the New Diamond Assets or the Standalone
Drug Business and (ii)&nbsp;limited, in the case of Shared Non-Income Taxes, to the Company
Percentage of such Non-Income Taxes);
</DIV>

<P align="center" style="font-size: 10pt">31
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) the Company Percentage of any Shared Non-Income Taxes imposed on New Diamond or a
New Diamond Entity;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) any and all Non-Income Taxes for Pre-Closing Periods of, imposed upon, or relating
or attributable to the Retained Business or the Retained Assets (regardless of whether such
Non-Income Taxes are imposed on any Retained Entity or New Diamond or any New Diamond
Entity);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) any and all Taxes for any Post-Closing Period of, imposed upon, or relating or
attributable to the Retained Entities, the Retained Business or the Retained Assets and any
and all Taxes of Onyx (or any Affiliate of Onyx that purchases a Retained Entity or Retained
Asset pursuant hereto); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) notwithstanding Section&nbsp;4.1(a), any Taxes resulting from any extraordinary
transaction taken by or with respect to the Retained Entities, the Retained Business or the
Retained Assets on the Closing Date but after the Retained Business Purchase and any and all
Taxes resulting from any Onyx Real Estate Dropdowns (or of any wholly-owned subsidiary
referred to in the definition thereof), the Financing or any Future Debt Financing (and New
Diamond and SV shall not be responsible for such Taxes described in this clause (5)).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each of Onyx, its Designated Affiliates and the Company shall be entitled to any refund of (or
credit of or against) Taxes to the extent that such refund (or credit) relates to a Tax that is the
responsibility of Onyx, its Designated Affiliates, any Retained Entity or the Company under this
Section&nbsp;4.1(b), except for refunds (or credits) to which New Diamond may be entitled under Section
4.1(a).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The parties acknowledge and agree that they desire and intend to treat (x)&nbsp;the Retained
Business Purchase (other than the purchase of Lucky Stores, Inc., a Delaware corporation
(&#147;<U>Lucky Delaware</U>&#148;), and its Subsidiaries) as a purchase of assets for federal income Tax
purposes, (y)&nbsp;the purchase of Lucky Delaware as a purchase of stock for federal income Tax purposes
and (z)&nbsp;the Separation as a transaction that does not result in any gain, including any deferred
intercompany gain, for federal income Tax purposes (other than with respect to the distribution of
certain New Diamond Assets from Lucky Delaware and its Subsidiaries pursuant to this Separation
Agreement). In furtherance of the parties&#146; desire and intention, at the option of SV: New Diamond
and Onyx shall (i)&nbsp;jointly make timely and irrevocable elections under Section&nbsp;338(h)(10) of the
Code (and any corresponding elections under state or local tax law) (the &#147;<U>338(h)(10)
Elections</U>&#148;) with respect to any Retained Entities designated by New Diamond (such entities, the
&#147;<U>338(h)(10) Election Subsidiaries</U>&#148;) (<U>provided</U> that this clause (i)&nbsp;shall not be
available with respect to any Retained Entity designated by Onyx in writing no later than 60&nbsp;days
after the execution of this Separation Agreement as a Retained Entity to be purchased by an entity
that is not a corporation for federal income Tax purposes), (ii)&nbsp;jointly cause any Retained
Entities designated by New Diamond (such entities, the &#147;<U>Disregarded Entities</U>&#148;) to be
treated as &#147;disregarded&#148; entities within the meaning of Treasury Regulation&nbsp;Section&nbsp;301.7701-3,
including by way of conversion of such Retained Entities into Delaware limited liability companies
on or prior to the Closing Date (such treatment, the &#147;<U>Disregarded Entity Treatment</U>&#148;), and
(iii)&nbsp;take such other actions as may be necessary or appropriate to further
</DIV>

<P align="center" style="font-size: 10pt">32
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">such desire and intention while transferring directly or indirectly the Retained Entities to Onyx and/or its
Designated Affiliates. New Diamond and Onyx shall, and shall cause their respective Subsidiaries
and Affiliates to, (i)&nbsp;treat the 338(h)(10) Elections and Disregarded Entity Treatment as valid,
(ii)&nbsp;file all Tax Returns in a manner consistent with such 338(h)(10) Elections and Disregarded
Entity Treatment and (iii)&nbsp;take no position or action contrary thereto, except to the extent
required to do otherwise pursuant to a Determination. New Diamond and Onyx shall jointly prepare
or cause to be prepared, in a manner consistent with the Retained Business Allocation, any form or
document required to effect a valid and timely 338(h)(10) Election or Disregarded Entity Treatment.
New Diamond and Onyx and any of their respective Subsidiaries and Affiliates shall take any and
all actions reasonably necessary to effectuate the 338(h)(10) Elections and Disregarded Entity
Treatment. Except as may be required by a Determination, consistent with the provisions above in
this Section&nbsp;4.1(c), New Diamond, Onyx and their respective Subsidiaries and Affiliates shall file,
or cause to be filed, all Tax Returns in a manner consistent with the 338(h)(10) Elections and
Disregarded Entity Treatment and shall treat the Retained Business Purchase (other than the
purchase of Lucky Delaware and its Subsidiaries) as a purchase of assets for federal income Tax
purposes, the purchase of Lucky Delaware as a purchase of stock for federal income Tax purposes and
the Separation as a transaction that does not result in any gain, including any deferred
intercompany gain, for federal income Tax purposes (other than with respect to the distribution of
certain New Diamond Assets from Lucky Delaware and its Subsidiaries pursuant to this Separation
Agreement) (and take no position or action contrary thereto). The parties agree that no election
other than the 338(h)(10) Elections with respect to the 338(h)(10) Subsidiaries shall be made under
Section&nbsp;338 of the Code with respect to the purchase of any of the Retained Entities pursuant to
this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.2 <U>Filing Responsibility</U>. (a)&nbsp;New Diamond shall prepare and file, or cause
to be prepared and filed, when due: (1)&nbsp;all United States consolidated federal Income Tax Returns
for the Affiliated Group or the affiliated group of which SV is the common parent, (2)&nbsp;any Tax Return (whether
filed on a consolidated, combined, unitary, separate or other basis) of, or which includes, New
Diamond or any other New Diamond Entity, and (3)&nbsp;any Income Tax Return of any Retained Entity for
any Pre-Closing Period or a Straddle Period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Onyx, its Designated Affiliates or the Company shall, except to the extent that filing
such Tax Returns are the responsibility of New Diamond under Section&nbsp;4.2(a), prepare and file, or
cause to be prepared and filed, all Tax Returns with respect to each Retained Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The parties agree to prepare and file, or cause to be prepared and filed, all Pre-Closing
Period Tax Returns of the Company and its Subsidiaries in a manner consistent with past practices
of the Company and its Subsidiaries, except as otherwise required by Law or a Determination.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;In the case of any Straddle Period Income Tax Return of a Retained Entity or Non-Income
Tax Return of a New Diamond Entity or a Retained Entity, in each case, on which are reportable
Taxes for which both SV and New Diamond, on the one hand, and Onyx and the Company, on the other
hand, are responsible under Section&nbsp;4.1 (or any Non-Income Tax Return of a Retained Entity on which
are reportable only Taxes that are the responsibility of New Diamond and SV under Section&nbsp;4.1(a) or
any Non-Income Tax Return of a
</DIV>

<P align="center" style="font-size: 10pt">33
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">New Diamond Entity on which are reportable only Taxes that are the
responsibility of Onyx and the Company under Section&nbsp;4.1(b)), the party that is responsible for
preparing such Tax Return under this Section&nbsp;4.2 (the &#147;<U>Return Preparer</U>&#148;) shall furnish such
Tax Return required to be filed by the Return Preparer (together with making available any
associated workpapers prepared in connection with such Tax Return) to the other party (the
&#147;<U>Affected Party</U>&#148;) for its review and approval (which approval shall not be unreasonably
delayed or withheld) at least 30&nbsp;days prior to the due date for filing such Tax Return (taking into
account valid extensions) and (y)&nbsp;the Affected Party shall provide any good faith comments it may
have on such Return to the Return Preparer within 15&nbsp;days of the Affected Party&#146;s receipt of such
draft Tax Return from the Return Preparer (such comments to be limited to confirming that the Tax
Return is consistent with past practice as set forth in Section&nbsp;4.2(c) and with the Tax treatments
specified in this Separation Agreement); <U>provided</U>, <U>however</U>, that in the event that
such Tax Return is required to be filed (taking into account valid extensions) within four (4)
months after the Closing Date, then such time periods shall be reasonably reduced and the parties
shall act expeditiously so that such Tax Return may be filed on a timely basis; <U>provided</U><I>,</I>
<U>further</U><I>, </I><U>however</U>, that to the extent that the Return Preparer does not agree with
the Affected Party&#146;s comments, the Return Preparer and the Affected Party shall endeavor in good
faith to resolve such disagreement. In the event that the Return Preparer and the Affected Party
are unable to resolve such disagreement, and to the extent that the Affected Party objects that the
Return Preparer has not prepared the Tax Return in question in accordance with past practices as
set forth in Section&nbsp;4.2(c) or consistent with the Tax treatments specified in this Separation
Agreement, the Accountant shall resolve such dispute in accordance with past practices as set forth
in Section&nbsp;4.2(c) and consistent with the Tax treatments specified in this Separation Agreement.
In such case, the Return Preparer and the Affected Party shall each bear one-half (50%) of the fees
and expenses attributable to the Accountant&#146;s resolution of such dispute. Any Tax Return that is
furnished to an Affected Party pursuant to this Section&nbsp;4.2(d) shall be accompanied by a statement
setting forth the portion of the Tax due in connection with filing such Tax Return that is allocable to the Affected Party
pursuant to Section&nbsp;4.1, which statement will specify in reasonable detail the calculation of the
portion of such Tax so allocable. The Affected Party shall pay to the Return Preparer the portion
of such Tax so allocable no later than one Business Day prior to the date such Tax Return is to be
filed.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.3 <U>Cooperation and Exchange of Information</U>. (a)&nbsp;As soon as practicable,
from and after the Closing Date, SV, New Diamond and its Subsidiaries, on the one hand, and Onyx,
its Designated Affiliates, the Retained Entities and their respective Subsidiaries, on the other
hand, shall provide each other with such cooperation and shall deliver to each other such
information and data and make available such knowledgeable employees as Onyx, its Designated
Affiliates, the Retained Entities and their respective Subsidiaries, on the one hand, and New
Diamond and its Subsidiaries, on the other hand, may reasonably request in order to complete and
file all Tax Returns which they may be required to file or to respond to audits by any Tax
Authorities, and to otherwise enable them or their Affiliates to satisfy their respective
accounting, Tax and other legitimate requirements. Each of SV, New Diamond, the New Diamond
Entities, Onyx, its Designated Affiliates and the Retained Entities shall make their employees and
facilities available on a mutually convenient basis to provide explanation of any documents or
information provided hereunder. Onyx shall, and shall cause its Designated Affiliates, the
Retained Entities and their respective Subsidiaries to, take all actions reasonably necessary to
facilitate New Diamond&#146;s and SV&#146;s exercise of their rights under this Article&nbsp;IV in
</DIV>


<P align="center" style="font-size: 10pt">34
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">respect of the Retained Entities, including preparing and filing Tax Returns, and conducting Tax Proceedings. New
Diamond shall, and shall cause the New Diamond Entities to, take all actions reasonably necessary
to facilitate Onyx&#146;s and the Company&#146;s exercise of their rights under this Article&nbsp;IV in respect of
the New Diamond Entities, including conducting Tax Proceedings.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;For a period of ten (10)&nbsp;years after the Closing Date, New Diamond, Onyx, its Designated
Affiliates and the Retained Entities shall retain all Tax Returns, books and records of, or with
respect to, the Retained Entities, the Retained Assets or the Retained Business for all taxable
periods ending on or prior to the Closing Date to the extent such items are in such person&#146;s
possession after the Closing. Thereafter, neither New Diamond, Onyx, any of its Designated
Affiliates nor any of the Retained Entities shall dispose of any such Tax Returns, books or records
unless it first offers such Tax Returns, books and records to New Diamond or Onyx, as applicable
and New Diamond or Onyx, as applicable fails to accept such offer within 60&nbsp;days of its being made.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;SV, New Diamond, Onyx, its Designated Affiliates and the Retained Entities shall, and
shall cause their respective Subsidiaries to, cooperate in the preparation of all Tax Returns
relating in whole or in part to taxable periods ending on or before the Closing Date that are
required to be filed after such date and all Tax Returns for Straddle Periods.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.4 <U>Tax Proceedings</U>. (a)&nbsp;Each of SV, New Diamond and its Subsidiaries, on the
one hand, and Onyx, its Designated Affiliates, the Retained Entities and their respective
Subsidiaries, on the other hand, shall provide prompt notice to the other party of any claim,
assessment or dispute of which it becomes aware related to Taxes for which it is indemnified by the other party under Section
4.1. Such notice shall attach copies of the pertinent portion of any written communication from a
Tax Authority and contain factual information (to the extent known) describing any asserted Tax
liability in reasonable detail and shall be accompanied by copies of any notice and other documents
received from any Tax Authority in respect of any such matters.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the case of any Tax Proceeding, the Controlling Party shall have the sole right to
control, contest, resolve and defend the Tax Proceeding (including having the right to determine
whether and when to settle the Tax Proceeding); <U>provided</U>, <U>however</U><I>, </I>that, except in
the case of Exclusive Tax Proceedings, in the case of any Tax Proceeding relating to any
Pre-Closing Period or Straddle Period in which the outcome would reasonably be expected to result
in an increase in liability for Taxes with respect to which the Non-Controlling Party or any
Affiliate thereof is liable under this Separation Agreement or with respect to which such
Non-Controlling Party or Affiliate is liable at law and with respect to which such Non-Controlling
Party or Affiliate is not entitled to indemnification under this Separation Agreement, (i)&nbsp;the
Controlling Party shall provide the Non-Controlling Party with a timely and reasonably detailed
account of each phase of such Tax Proceeding, (ii)&nbsp;the Non-Controlling Party shall be entitled to
receive copies of all correspondence and documents related to such Tax Proceeding, (iii)&nbsp;the
Controlling Party shall consult with the Non-Controlling Party before taking any significant action
in connection with such Tax Proceeding, (iv)&nbsp;the Controlling Party shall consult with the
Non-Controlling Party and offer the Non-Controlling Party an opportunity to comment before
submitting any written materials prepared or furnished in connection with such
</DIV>

<P align="center" style="font-size: 10pt">35
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Tax Proceeding, (v)&nbsp;the Controlling Party shall defend such Tax Proceeding diligently and in good faith as if it were
the only party in interest in connection with such Tax Proceeding, (vi)&nbsp;except in the case of a Tax
Proceeding in respect of a Tax Return of a Retained Entity on which are reportable Taxes for which
only SV and New Diamond are responsible under Section&nbsp;4.1, the Non-Controlling Party shall be
entitled to participate in (but not control) such Tax Proceeding, at its own expense, and (vii)&nbsp;the
Controlling Party shall not settle such Tax Proceeding without the consent of the Non-Controlling
Party which shall not be unreasonably withheld.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">For purposes of this Section&nbsp;4.4(b):
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) New Diamond shall be the &#147;Controlling Party&#148; with respect to any Tax Proceeding in
respect of (A)&nbsp;a Tax Return referred to in Section&nbsp;4.4(c) (and any adjustment to a state or
local Income Tax Return required as a result of the outcome of any Tax Proceeding with
respect to such a Tax Return), (B) (except in the case of a Non-Income Tax Return on which
Taxes for which Onyx is responsible under Section&nbsp;4.1 are reportable) any Tax Return of New
Diamond or a New Diamond Entity (such Tax Proceedings described in clauses (A)&nbsp;or (B),
collectively, the &#147;<U>Exclusive Diamond Proceedings</U>&#148;) and there shall be no
&#147;Non-Controlling Party&#148; in respect of such a Tax Proceeding,
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Onyx shall be the &#147;Controlling Party&#148; with respect to any Tax Proceeding in
respect of a Tax Return referred to in Section&nbsp;4.4(d) (the &#147;Exclusive Onyx Proceedings,&#148;
and, together with the Exclusive Diamond Proceedings, the &#147;Exclusive Tax Proceedings&#148;) and there shall be no &#147;Non-Controlling Party&#148; in respect of such a
Tax Proceeding,
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) except in the case of Exclusive Tax Proceedings, in the case of any Tax
Proceeding in respect of (A)&nbsp;any Income Tax Return of a Retained Entity for a Straddle
Period, (B)&nbsp;any Tax Return of a Retained Entity on which are reportable only Taxes for which
SV and New Diamond are responsible under Section&nbsp;4.1 or (C)&nbsp;a Non-Income Tax Return on which
are reportable Non-Income Taxes for which both SV and New Diamond, on the one hand, and Onyx
and the Company, on the other hand, are responsible under this Separation Agreement, if Onyx
and the Company are responsible under this Separation Agreement for more than half the Taxes
reported on the Tax Return, then Onyx shall be the &#147;Controlling Party&#148; and New Diamond shall
be the &#147;Non-Controlling Party&#148;; otherwise New Diamond shall be the &#147;Controlling Party&#148; and
Onyx the &#147;Non-Controlling Party&#148; with respect to such Tax Proceeding,
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Notwithstanding any other provision of this Separation Agreement, neither Onyx, its
Designated Affiliates, the Retained Entities nor any of their respective Subsidiaries or Affiliates
shall be entitled to participate in any Tax Proceeding with respect to any Tax Return of the
Affiliated Group or any United States consolidated federal Income Tax Return which includes New
Diamond or SV or any other consolidated, combined or unitary Tax Return which includes New Diamond,
any New Diamond Entity or any member of the New Diamond Seller Group, nor shall Onyx, its
Designated Affiliates, the Retained Entities nor any of their respective Subsidiaries or Affiliates
be entitled to any information (except to the extent relating solely to
</DIV>

<P align="center" style="font-size: 10pt">36
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any Retained Entity, the Retained Business, or any Retained Asset, which may include pro forma information relating solely
to the Retained Entities, the Retained Business or a Retained Asset) regarding any such Tax Return
(or any Tax Returns of New Diamond).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Notwithstanding any other provision of this Separation Agreement, neither SV, New Diamond,
any New Diamond Entity nor any of their respective Subsidiaries or Affiliates shall be entitled to
participate in any Tax Proceeding with respect to any Tax Return of any Retained Entity for a
Post-Closing Period other than a Straddle Period (or any consolidated, combined or unitary Tax
Return for a Post-Closing Period, other than a Straddle Period, which includes any Retained
Entity), unless such Tax Return includes New Diamond or a New Diamond Entity, nor shall SV, New
Diamond, any New Diamond Entity nor any of their respective Subsidiaries or Affiliates be entitled
to any information (except to the extent relating solely to any Retained Entity, the Retained
Business or any Retained Asset which may include pro forma information relating solely to the
Retained Entities, the Retained Business, or a Retained Asset) regarding any such Tax Return.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.5 <U>Tax Sharing Agreements</U>. Anything in any other agreement to the contrary
notwithstanding, all liabilities and obligations between New Diamond, any New Diamond Entity or any
member of the New Diamond Seller Group, on the one hand, and the Retained Entities, on the other
hand, under any Tax allocation or Tax sharing agreement in effect prior to the Closing Date (other
than this Separation Agreement) shall cease and terminate as of the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.6 <U>Tax Benefits</U>. New Diamond and SV shall be entitled to any Tax Benefit
arising from any deduction that results from any payment, loss, obligation, Tax or Liability
arising from a Section&nbsp;4.6 Liability. Neither Onyx, its Designated Affiliates, the Company nor any
of their respective Subsidiaries shall claim any such deduction in respect of a Section&nbsp;4.6
Liability on any Tax Return that Onyx, its Designated Affiliates or the Company are responsible for
preparing under Section&nbsp;4.2(b); <U>provided</U>, <U>however</U><I>, </I>that if any deduction arising in
respect of a payment, loss, obligation, Tax or Liability arising from a Section&nbsp;4.6 Liability is
not permitted by law or administrative practice to be reported on a Tax Return for which New
Diamond has filing responsibility under Section&nbsp;4.2(a) (or another Pre-Closing Period Tax Return)
and is permitted by law or administrative practice to be reported on a Tax Return for which Onyx,
its Designated Affiliates or the Company has filing responsibility under Section&nbsp;4.2(b), then, at
New Diamond&#146;s request, Onyx, its Designated Affiliates, the Retained Entities or their respective
Subsidiaries shall claim such deduction and pay to New Diamond the amount of any Tax Benefit
actually realized in cash from such deduction (less any Tax Detriment that results from such
deduction) no later than thirty (30)&nbsp;days after the Tax Return in which such Tax Benefit is
realized or utilized is filed; <U>provided</U>, <U>however</U>, that New Diamond shall repay such
amount to the extent that subsequent events occur that result in the loss or reduction of such Tax
Benefit no later than thirty (30)&nbsp;days after Onyx notifies New Diamond, in writing as provided
below, of the loss or reduction of such Tax Benefit. For purposes of this Section&nbsp;4.6, such
subsequent events include, but are not limited to, audit adjustments, realization of any Tax
Detriment, and the recognition of a net operating loss that could have been carried over to offset
income in the absence of the deduction that results from the payment, loss, obligation, Tax or
Liability arising from a Section&nbsp;4.6 Liability. For purposes of this Section&nbsp;4.6, an increase (or
reduction) in Taxes as a result of any Tax Benefit or Tax Detriment shall be deemed to be
</DIV>


<P align="center" style="font-size: 10pt">37
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">realized by a party to the extent the Tax liability of such party exceeds (or is less than) the Tax
liability such party would have incurred without taking into account any Tax Item relating to such
Tax Benefit or Tax Detriment. Any payment in respect of a net Tax Benefit or notice of a loss or
reduction of such Tax Benefit shall be accompanied by a schedule prepared by Onyx in good faith
setting forth in reasonable detail the amount of such Tax Benefit or such loss or reduction of Tax
Benefit and the calculation of that amount. Nothing in this Section&nbsp;4.6 shall require Onyx or any
Retained Entity to disclose to any person any Tax Return filed by it or any material information
Onyx or such Retained Entity otherwise deems confidential.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.7 <U>Transfer Taxes</U>. Notwithstanding anything to the contrary in this
Separation Agreement, other than with respect to the Standalone Drug Sale, New Diamond and Onyx
agree that New Diamond shall bear 50% of all documentary, sales, use, registration, value added,
transfer, recordation stamp and similar Taxes (collectively, &#147;<U>Transfer Taxes</U>&#148;) imposed on
the Reorganization or the transactions set forth in Section&nbsp;2.1(a), and Onyx shall bear 50% of any
such Transfer Taxes. New Diamond and Onyx, and their respective Subsidiaries and Affiliates, agree
to timely sign and deliver any affidavits, certificates or forms as may be necessary or appropriate
to establish an exemption from (or otherwise reduce), or file Tax Returns or any other documents
with respect to, such Transfer Taxes. Any party shall have the right to seek a refund of any and
all Transfer Taxes paid by it for which it is responsible pursuant to this Section&nbsp;4.7 at its own
expense. If so requested, the other party shall use reasonable efforts to cooperate with the party
seeking such refund.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.8 <U>Taxes Governed by Article&nbsp;IV</U>. Claims for indemnification with respect to
Taxes shall be governed by this Article&nbsp;IV and Section&nbsp;5.8 but not by any other provision of
Article&nbsp;V or Article&nbsp;VI. For the absence of doubt, any obligations to make indemnification
payments with respect to Taxes imposed under Section&nbsp;4999 of the Code shall be governed by the
provisions of Article&nbsp;VIII addressing allocation of Liabilities under Company Plans.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.9 <U>Survival</U>. All rights and obligations under this Article&nbsp;IV shall survive
the Closing Date and continue until 60&nbsp;days after the expiration of all applicable statutes of
limitation (including all periods of extension, whether automatic or permissive).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.10 <U>Post-Closing Dispositions</U>. For the avoidance of doubt, the covenants of
Onyx, its Designated Affiliates and the Retained Entities set forth in this Article&nbsp;IV shall apply
to Onyx, its Designated Affiliates and the Retained Entities regardless of any post-Closing
disposition of the Retained Entities by Onyx, its Designated Affiliates or any of their respective
Subsidiaries or Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.11 <U>Reorganization Treatment</U>. The parties agree (a)&nbsp;to treat the acquisition
by New Diamond of all of the issued and outstanding Equity Interests of the Company for stock of
New Diamond and the subsequent conversion of the Company into a Delaware limited liability company,
taken together, as a mere change in identity or form of the Company qualifying as a reorganization
under Section&nbsp;368(a)(1)(F) of the Code and (b)&nbsp;to treat the Company as a &#147;disregarded&#148; entity
within the meaning of Treasury Regulation&nbsp;Section&nbsp;301.7701-3 for the period from and after the time
of the conversion of the Company into a Delaware limited liability company and for so long as the
Company is wholly owned by New
</DIV>


<P align="center" style="font-size: 10pt">38
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Diamond, in each case, for all Tax purposes, unless required to do
otherwise as a result of a Determination. The parties agree not to take any position on any Tax
Return or in any Tax Proceeding inconsistent with such treatment described in the immediately
preceding sentence.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.12 <U>&#091;Intentionally Omitted&#093;</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.13 <U>Tax Treatment of Payments</U>. The parties agree to treat any indemnity
payments pursuant to this Article&nbsp;IV, for Tax purposes, as an adjustment to the Retained Business
Price or as payments that are deductible by the payor, as appropriate, unless otherwise required by
applicable Tax Law.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE V
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>INDEMNIFICATION</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.1 <U>SV&#146;s and New Diamond&#146;s Agreement to Indemnify</U>. In addition to any other
indemnification provided hereunder, subject to the terms and conditions set forth in this
Separation Agreement, from and after the Closing Date, each of SV and New Diamond shall, and New Diamond shall cause each of the New Diamond Entities to, indemnify,
defend and hold harmless Onyx, the Company, the other Retained Entities and each of their
respective directors, officers, partners, members, employees and other representatives, advisors
and agents (collectively, &#147;<U>Representatives</U>&#148;), Subsidiaries and Affiliates (collectively,
the &#147;<U>Company Indemnitees</U>&#148;) from and against any and all Indemnifiable Losses of the Company
Indemnitees arising out of or resulting from, directly or indirectly, the New Diamond Liabilities
and the matters contemplated as being Indemnifiable Losses by Section&nbsp;2.6 of this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.2 <U>Onyx&#146;s and the Company&#146;s Agreement to Indemnify</U>. In addition to any other
indemnification provided hereunder, subject to the terms and conditions set forth in this
Separation Agreement, from and after the Closing Date, each of Onyx and the Company shall, and
shall cause each of the Retained Entities to, indemnify, defend and hold harmless SV, New Diamond
and the New Diamond Entities, and each of their respective Representatives, Subsidiaries and
Affiliates (collectively, the &#147;<U>New Diamond Indemnitees</U>&#148;) from and against any and all
Indemnifiable Losses of the New Diamond Indemnitees arising out of or resulting from, directly or
indirectly, the Retained Liabilities and the matters contemplated as being Indemnifiable
Losses by Section&nbsp;2.6 of this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.3 <U>Reduction of Indemnifiable Losses for Insurance Benefits Received</U>. For
purposes of this Article&nbsp;V, Section&nbsp;8.2 and Section&nbsp;8.7, the calculation of any Indemnifiable Loss
will reflect the amount of any insurance proceeds or indemnification payments received by the
Indemnitee in respect of such Indemnifiable Loss (net of all reasonable costs and expenses incurred
by the Indemnitee in recovering such insurance proceeds). Each Indemnitee shall use its
commercially reasonable efforts to recover from its insurers or other sources of reimbursement or
recovery the maximum portion of any Indemnifiable Loss that is recoverable from such sources.
</DIV>


<P align="center" style="font-size: 10pt">39
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.4 <U>Procedure for Indemnification</U>. (a)&nbsp;If an Indemnitee shall receive notice
of the assertion by a person who is not a party to this Separation Agreement of any claim or of the
commencement by any such person of any Action (a &#147;<U>Third Party Claim</U>&#148;) with respect to which
an Indemnifying Party may be obligated to provide indemnification under Section&nbsp;5.1 or Section&nbsp;5.2,
such Indemnitee shall give such Indemnifying Party prompt notice thereof after becoming aware of
such Third Party Claim; <U>provided</U>, that the failure of any Indemnitee to give notice as
provided in this Section&nbsp;5.4 shall not relieve the related Indemnifying Party of its obligations
under this Article&nbsp;V, except to the extent that such Indemnifying Party is actually and materially
prejudiced by such failure to give notice. Such notice shall describe the Third Party Claim in
reasonable detail, and, if practicable, shall indicate the estimated amount of the Indemnifiable
Loss that has been or may be sustained or asserted by such Indemnitee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;If an Indemnitee gives notice of a Third Party Claim to an Indemnifying Party, the
Indemnifying Party shall have 30&nbsp;days after receipt of notice to elect, at its option, to take
responsibility for resolving, and assume and control the defense of, at its own expense and by its
own counsel, any such Third Party Claim and shall be entitled to assert any
and all defenses available to the Indemnitee to the fullest extent permitted by Law. If the
Indemnifying Party shall undertake to defend and resolve any such Third Party Claim, it shall
promptly notify the Indemnitee of its intention to do so, and the Indemnitee agrees to cooperate as
reasonably requested by the Indemnifying Party and its counsel in the resolution of, or defense
against, any such Third Party Claim; <U>provided</U>, <U>however</U>, that the Indemnifying Party
shall not admit any liability with respect to such Third Party Claim without the prior written
consent of the Indemnitee, and shall not resolve, settle, compromise or discharge any such Third
Party Claim without the prior written consent of the Indemnitee (which consent will not be
unreasonably withheld or delayed) unless the relief consists solely of the payment of money and
includes a provision whereby the plaintiff or claimant in the matter releases the Indemnitees from
all liability with respect thereto. Notwithstanding the foregoing, the Indemnitee shall have the
right to defend (but not admit liability, compromise, settle or otherwise resolve such Third Party
Claim without the prior written consent of the Indemnifying Party) any Third Party Claim as to
itself by its own separate counsel, and the Indemnifying Party shall pay the reasonable fees, costs
and expenses of such separate counsel, as incurred, if the Indemnitee shall have determined in good
faith that an actual or potential conflict of interest makes representation by the same counsel or
the counsel selected by the Indemnifying Party inappropriate. Further, the Indemnitee shall have
the right to employ separate counsel and to participate in the defense of any Third Party Claim
(though such separate counsel shall not appear of record), at the expense of the Indemnitee (unless
the Indemnifying Party agrees to pay the fees and expenses of such separate counsel). In any
event, the Indemnitee and Indemnifying Party and their counsel shall cooperate in the defense of
any Third Party Claim and keep such persons informed of all developments relating to any such Third
Party Claim, and provide copies of all relevant correspondence and documentation relating thereto
consistent with applicable rules of privilege and legal ethics. All costs and expenses incurred in
connection with the Indemnitee&#146;s cooperation shall be paid by the Indemnifying Party, as incurred.
If the Indemnifying Party receiving a notice of Third Party Claim does not elect timely to take
responsibility for resolving, and defend, such Third Party Claim or does not defend such Third
Party Claim in good faith, the Indemnitee shall have the right, in addition to any other right or
remedy it may have hereunder, at the Indemnifying Party&#146;s expense, to defend such Third Party
Claim; <U>provided</U>, <U>however</U>, that (1)&nbsp;the Indemnitee shall not have any obligation to
participate in the defense of, or defend, any such Third Party Claim; (2)
</DIV>

<P align="center" style="font-size: 10pt">40
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Indemnitee&#146;s defense of or participation in the defense of any such claim shall not in any way diminish or lessen the
obligations of the Indemnifying Party under this Article&nbsp;V; and (3)&nbsp;the Indemnitee shall not
resolve, settle, compromise or discharge any such Third Party Claim without the prior written
consent of the Indemnifying Party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.5 <U>Pending Litigation; New Litigation</U>. Following the Closing Date, (a)&nbsp;Onyx
and/or one or more if its Designated Affiliates shall have exclusive authority and control over the
investigation, prosecution, defense and appeal of (1)&nbsp;all Actions brought against the Company or
its Subsidiaries listed on <U>Schedule&nbsp;1.12</U> of this Separation Agreement and all pending
Actions brought against the Company or its Subsidiaries exclusively relating to the Retained
Business and (2)&nbsp;all Actions brought against the Company or its Subsidiaries brought after the date
hereof that primarily relate to the Retained Business (the Actions described in the foregoing
clauses (1)&nbsp;and (2)&nbsp;each, a &#147;<U>Retained Action</U>&#148;), and may settle or compromise, or consent to
the entry of any Judgment with respect to, any such Action without the consent of any other party,
<U>provided</U>, that in the event that such Retained Action involves the potential
indemnification of an Indemnified Director or Officer, Onyx or one or more of its Designated
Affiliates, as applicable, shall not settle, compromise or consent to the entry of any judgment in
any actual or threatened claim, demand, action, suit, proceeding, inquiry or investigation in
connection with a Retained Action in respect of which indemnification has been or could be sought
by such Indemnified Director or Officer under the Transaction Agreements unless such settlement,
compromise or judgment includes an unconditional release of such Indemnified Director or Officer
from all liability arising out of such claim, demand, action, suit, proceeding, inquiry or
investigation or such Indemnified Director or Officer otherwise consents thereto, and (b)&nbsp;New
Diamond and/or one or more of its Designated Affiliates shall have exclusive authority and control
over the investigation, prosecution, defense and appeal of (1)&nbsp;all pending Actions brought against
the Company or its Subsidiaries listed on <U>Schedule&nbsp;1.13</U> of this Separation Agreement, (2)
all of the Actions brought against the Company or its Subsidiaries as of the date hereof that are
not Retained Actions (the Actions described in the foregoing clauses (1)&nbsp;and (2)&nbsp;each, a &#147;<U>New
Diamond Action</U>&#148;) (3)&nbsp;all Shared Transaction Litigation Liabilities, (4)&nbsp;all Unallocated Actions
(as defined below) and (5)&nbsp;all Actions that constitute Specified Standalone Drug Liabilities, and
may settle or compromise, or consent to the entry of any Judgment with respect to, any such Action
without the consent of any other party; <U>provided</U>, that, notwithstanding anything to the
contrary, neither Onyx nor New Diamond (nor any of their respective Subsidiaries or Affiliates) may
settle or compromise, or consent to the entry of any Judgment with respect to, any Retained Action,
New Diamond Action, Unallocated Action, Shared Transaction Litigation Liability or any Action that
constitutes a Specified Standalone Drug Liability, without the prior written consent of the other
party if such settlement, compromise or consent to such Judgment (i)&nbsp;includes any form of relief
binding upon such other party or its Affiliates or their respective businesses or assets, (ii)&nbsp;does
not include as an unconditional term thereof the giving by the claimant or plaintiff to such other
party (and any Affiliate of such other party subject to such Action) of a full and final release
from all Liability in respect of such claim or litigation or (iii)&nbsp;in the case of a Shared
Transaction Litigation Liability, requires any cash payment for damages or otherwise by any party
to this Separation Agreement other than the settling party. If, after the date hereof, any Action
other than those Retained Actions, New Diamond Actions and Shared Transaction Litigation
Liabilities as described above shall be brought against the Company or any of its Subsidiaries,
such Action
</DIV>


<P align="center" style="font-size: 10pt">41
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">shall be deemed to be &#147;<U>Unallocated Actions</U>&#148; for purposes of this Separation
Agreement unless such Action shall constitute a Specified Standalone Drug Liability.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.6 <U>Remedies Exclusive</U>. From and after the Closing and except as otherwise
specifically provided herein (including Articles IV and VIII), the rights to indemnification
provided in this Article&nbsp;V shall be the exclusive monetary remedy for any New Diamond Liabilities
or Retained Liabilities; <U>provided</U> that nothing herein shall preclude assertion by any
Indemnitee of any other rights or the seeking of any and all other remedies against any
Indemnifying Party in the event of fraud or in the event of an Indemnifying Party&#146;s failure to
comply with its indemnification obligations hereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.7 <U>Retained Business Price Adjustment</U>. The parties agree to treat any
indemnity payments pursuant to this Separation Agreement for Tax purposes, as an
adjustment to the Retained Business Price, as applicable, or as payments that are deductible
by the payor, as appropriate, unless otherwise required by applicable Tax Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.8 <U>Exclusion of Tax Indemnities</U>. Notwithstanding anything to the contrary in
this Article&nbsp;V or in Article&nbsp;VI, the provisions of Article&nbsp;V and Article&nbsp;VI shall not apply to Tax
indemnification matters and indemnification shall not be provided under Article&nbsp;V or Article&nbsp;VI for
Taxes, all such matters and any such indemnification being governed by Article&nbsp;IV.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VI
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>CERTAIN ADDITIONAL MATTERS</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.1 <U>Further Assurances; Subsequent Transfers</U>. (a)&nbsp;Each of the parties hereto
will execute and deliver such further instruments of transfer, distribution and assumption and will
take such other actions as the other parties hereto may reasonably request in order to effectuate
the purposes of this Separation Agreement and to carry out the terms hereof. Without limiting the
generality of the foregoing, at any time and from time to time after Closing, at the request of any
party the other party will execute and deliver such other instruments of transfer and distribution,
and take such action as the requesting party may reasonably deem necessary or desirable in order to
more effectively transfer, convey and assign to such requesting party (or any of its Subsidiaries
and/or Designated Affiliates) and to confirm such requesting party&#146;s (or any of its Subsidiaries
and/or Designated Affiliates, as the case may be) right, title to or interest in, all of the New
Diamond Assets or Equity Interests in the New Diamond Entities, the Retained Assets or Equity
Interests in the Retained Entities, as applicable, to put the requesting party (or any of its
Subsidiaries and/or Designated Affiliates, as the case may be) in actual possession and operating
control thereof and to permit the requesting party (or any of its Subsidiaries and/or Designated
Affiliates, as the case may be) to exercise all rights with respect thereto (including rights under
contracts and other arrangements as to which the consent of any third party to the transfer thereof
shall not have previously been obtained) and to properly assume and discharge the related New
Diamond Liabilities, or the Retained Liabilities, as applicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) In furtherance of the foregoing, in the event and to the extent that a transferring party
is unable to obtain any consents required to transfer and assign to the other
</DIV>

<P align="center" style="font-size: 10pt">42
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">party (or such other party&#146;s Designated Affiliate), and a release of a transferor from, any agreements, licenses and
other rights included in the New Diamond Assets or Retained Assets, as applicable, such transferor
(1)&nbsp;shall continue to be bound thereby pending assignment to the other party or its Designated
Affiliate and (2)&nbsp;shall, at the direction and expense of the other party, pay, perform and
discharge fully all of its obligations thereunder from and after the Closing and prior to
assignment to the other party or its Designated Affiliate, and the other party will indemnify the
transferor for any Liabilities of the transferor arising out of such Assets or its compliance with
the documentation and agreement relating to, any reasonable out-of-pocket expenses associated with
any attempt to transfer or failure to transfer such Asset or any Liabilities arising out of or
resulting from the transferor&#146;s actions taken in accordance with any
such directions of the other party or its Designated Affiliate. The transferor shall, without
further consideration therefor, pay, assign and remit to the other party or its Designated
Affiliate promptly all monies, rights and other consideration received in respect of such
agreements. Following the Closing, the transferor shall exercise or exploit its rights and options
under all such agreements, leases, licenses and other rights and commitments referred to in this
Section&nbsp;6.1(b) when and only as reasonably directed by, and at the expense of, the other party or
its Designated Affiliate. If and when any such consent shall be obtained or such agreement, lease,
license or other right shall otherwise become assignable, the transferor shall promptly assign all
its rights and obligations thereunder to the other party or its Designated Affiliate without
payment of further consideration and the other party or its Designated Affiliate shall, without the
payment of any further consideration therefor, assume such rights and obligations. Notwithstanding
the foregoing, if the arrangement described in this Section&nbsp;6.1(b) is impracticable or will cause
(or is likely to cause) a default under any real estate lease (whether due to the intended change
of the store brand under which such property will be operated or for other reasons), then the
parties will work in good faith to establish a mutually satisfactory arrangement for the operation
of such leased real property during the period subsequent to the Closing and pending receipt of the
required consent, including a fair and equitable arrangement (under the applicable circumstances)
for allocating income and expenses with respect to such property during such period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In the event that, subsequent to the Closing Date, the Company or Onyx shall either (1)
receive written notice from New Diamond that certain specified Assets of the Company or any
Subsidiary of the Company which properly constitute New Diamond Assets were not transferred to New
Diamond on or prior to the Closing Date or (2)&nbsp;determine that certain Assets of the Company or any
Subsidiary of the Company which properly constitute New Diamond Assets were not transferred to New
Diamond on or prior to the Closing Date, then (assuming the accuracy of such notice or demand) as
promptly as practicable thereafter, the Company or Onyx, as appropriate, shall take all steps
reasonably necessary to transfer and deliver any and all of such Assets to New Diamond without the
payment by New Diamond of any further consideration therefor. In the event that, subsequent to the
Closing Date, New Diamond shall either (i)&nbsp;receive written notice from the Company or Onyx that
certain specified Assets which properly constitute Retained Assets were transferred to New Diamond
or included with the New Diamond Entities or (ii)&nbsp;determine that certain Assets of New Diamond
which properly constitute Retained Assets were transferred to New Diamond or included with the New
Diamond Entities, then (assuming the accuracy of such notice or demand) as promptly as practicable
thereafter, New Diamond shall, and shall cause its Subsidiaries to, take all steps reasonably
necessary to transfer and deliver any and all of such Assets to the Company or its
</DIV>

<P align="center" style="font-size: 10pt">43
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiaries in each case without the payment by Onyx, the Company of any further consideration therefor.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Without limiting the provisions of this Section&nbsp;6.1 or any other provision of this
Separation Agreement, each of the parties for itself and its respective Subsidiaries and
Affiliates, as appropriate, agrees to execute, acknowledge and deliver all documents and to take
all actions reasonably necessary to effectuate the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Each Transferred Real Property shall be conveyed by means of a warranty deed and/or
assignment of lease with warranties, in recordable form (as modified as appropriate in the particular jurisdiction in which the real property
is located (each a &#147;<U>Transfer Document</U>&#148;), and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Each Transfer Document executed by a party transferring or otherwise assigning
Transferred Real Property that conveys Transferred Real Property to any other party shall
state on the face thereof the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) In the case of any breach of any transferor (each, a &#147;<U>Grantor</U>&#148;)
warranties herein contained, whether expressed or implied, the liability of Grantor
shall be limited to its interest in the real property hereby conveyed and all
amounts (collectively, &#147;<U>Indemnified Amounts</U>&#148;) which are recovered from the
prior non-affiliated transferors in the chain of title (&#147;<U>Prior Transferors</U>&#148;)
or pursuant to any real property title policies existing prior to the date of this
instrument (&#147;<U>Pre-Existing Title Policy</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Grantor irrevocably assigns to each transferee (each, a &#147;<U>Grantee</U>&#148;)
all of Grantor&#146;s right, title and interest in and to all Indemnity Amounts including
without limitation all claims, actions, rights of recovery and indemnity, losses,
damages, expenses and fees (including reasonable attorneys&#146; fees and court costs),
at law, in equity or by contract, which Grantor may now or hereafter have against
any and all Prior Transferors or under any Pre-Existing Title Policy, and Grantor
hereby irrevocably designates and appoints the transferee its attorney in fact,
coupled with an interest, with respect to all Indemnity Amounts.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The warranties and covenants contained herein shall be solely for the
benefit of and enforceable by Grantee hereunder and for no other party including
heirs, successors and assigns of Grantee and under no circumstances shall such
warranties and covenants be deemed to run with the real property conveyed by this
instrument.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Without limiting the foregoing provisions of this Section&nbsp;6.1(d), if any
claim is made by Grantee against Grantor as the result of any alleged breach of any
covenants or warranties in any Transfer Document, upon Grantee&#146;s written notice
Grantor shall either (A)&nbsp;make and diligently pursue all claims against the Prior
Transferors, and against any title insurance company under any applicable
Pre-Existing Title Policy, or (B)&nbsp;permit Grantee, in the name of Grantor, to make
any or all such claims, in all cases at the sole cost and expense of Grantee,
including counsel selected and retained by Grantee as is
</DIV>

<P align="center" style="font-size: 10pt">44
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">reasonably acceptable to
Grantor. If Grantor shall be named by any third-party in any proceeding in
connection with any such claim, Grantee (at Grantee&#146;s sole cost) shall with counsel
reasonably acceptable to Grantor defend and procure the dismissal of Grantor
(subject to the requirements of law in connection with pursuing the claims against
the Prior Transferors and the title insurance company, as applicable).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.2 <U>Use of Names; Cross-License</U>. (a)&nbsp;Following the Closing Date, the Company
and the other Retained Entities shall have the sole and exclusive ownership of and right to use, as
between the Company and the other Retained Entities, on the one hand, and New Diamond and its
Subsidiaries, on the other hand, each of the names that are (1)&nbsp;set forth in <U>Schedule&nbsp;1.14</U>
of this Separation Agreement or (2)&nbsp;used solely in connection with the Retained Business (the
&#147;<U>Retained Names</U>&#148;), and each of the trade marks, trade names, trade dress, service marks,
banners, logos and other proprietary rights related to such Retained Names (the &#147;<U>Retained
Proprietary Name Rights</U>&#148;). Following the Closing Date, New Diamond and its Subsidiaries shall
have the sole and exclusive ownership of and right to use, as between New Diamond and its
Subsidiaries, on the one hand, and the Company and the other Retained Entities, on the other hand,
all names used by the Company and its Subsidiaries other than the Retained Names (the &#147;<U>New
Diamond Names</U>&#148;), and all other trade marks, trade names, trade dress, service marks, banners,
logos and other proprietary rights related to such New Diamond Names (the &#147;<U>New Diamond
Proprietary Name Rights</U>&#148;). In connection with the Separation, the Company shall use its
reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done,
all things necessary, proper or advisable to vest New Diamond and it Subsidiaries with full and
undivided ownership in the New Diamond Proprietary Name Rights. Notwithstanding the foregoing,
following the Closing, neither the Company and the other Retained Entities, nor New Diamond and its
Subsidiaries, shall use any names that are confusingly similar to the Retained Names or the New
Diamond Names, as applicable, without the prior written consent of the other party,
<U>provided</U> that the parties agree that none of the names set forth on <U>Schedule&nbsp;1.14</U>,
on the one hand, and the New Diamond Names, on the other hand, shall be deemed to be &#147;confusingly
similar.&#148; As promptly as practicable following the Closing Date but in no event later than one
hundred eighty (180)&nbsp;days following the Closing Date, the parties hereto shall, and shall cause
their respective Subsidiaries and other Affiliates to, take all action necessary to cease using,
and change (including by amending any charter documents), any corporate or other names which are
the same as or confusingly similar to any of the New Diamond Names and the New Diamond Proprietary
Name Rights or the Retained Names and the Retained Proprietary Name Rights, as the case may be.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding the foregoing, on the Closing Date, the Company and New Diamond shall
enter into a Cross-Licensing Agreement (the &#147;<U>Cross-Licensing Agreement</U>&#148;),
reasonably acceptable to both parties, which shall provide for, among other things, the grant of a
limited, royalty-free cross-license to each of the Company and its Subsidiaries, on the one hand
and to each of New Diamond and its Subsidiaries, on the other hand, to use certain Retained
Proprietary Name Rights and New Diamond Proprietary Name Rights, in each case, for so long as and
to the extent that each of the Company and its Subsidiaries, on the one hand, and New Diamond and
its Subsidiaries, on the other hand, own the Retained Assets or the New Diamond Assets,
respectively. The Cross-Licensing Agreement shall also provide for the grant of a limited,
royalty-free, license to the Company and its Subsidiaries of the Lucky New
</DIV>

<P align="center" style="font-size: 10pt">45
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Diamond Proprietary Name Rights set forth on Schedule&nbsp;1.16 of this Separation Agreement (collectively, the &#147;<U>Lucky
Proprietary Name Rights</U>&#148;) for use in Northern California and Nevada for a period of three years
from the Closing Date. The exclusive right of the Company and its Subsidiaries to use the Lucky
Proprietary Name Rights in Northern California and Nevada shall continue and shall become perpetual
if the Company or its Subsidiaries (or their transferees) use any of the Lucky Proprietary Name
Rights in Northern California and Nevada during such three-year period. If the Company or its
Subsidiaries (or their transferees) do not use any of the Lucky Proprietary Name Rights in Northern
California and Nevada during any portion of such three-year period, the license to use the Lucky
Proprietary Name Rights shall cease and all right, title and interest in and to the Lucky Proprietary Name Rights shall revert to New Diamond and its
Subsidiaries. The Cross-Licensing Agreement shall further provide that, except as provided above
with respect to the Lucky Proprietary Name Rights if such rights are used during the three-year
period from the Closing Date, in the event that Retained Assets or the New Diamond Assets, as the
case may be, are transferred or assigned to a third party, such third party shall obtain the
benefit of the license contained therein for up to one hundred eighty (180)&nbsp;days following the
transfer of such Assets to such third party; <U>provided</U>, <U>however</U>, that if such third
party is a national competitor of the New Diamond Business the expiration of such license for such
third party&#146;s benefit shall expire no later than ninety (90)&nbsp;days following the transfer of such
Assets to such third party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.3 <U>Settlement of Intercompany Accounts</U>. All intercompany leases,
receivables, payables, loans and other accounts (collectively, &#147;<U>Intercompany Accounts</U>&#148;) in
existence immediately prior to the Separation between the Company or the other Retained Entities,
on the one hand, and New Diamond or the New Diamond Entities, on the other hand, shall be
contributed, distributed or otherwise transferred or assumed at or prior to the Closing such that,
as of the Closing, there are no Intercompany Accounts outstanding between New Diamond or any New
Diamond Entity, on the one hand, and any Retained Entity, on the other hand.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.4 <U>Merger Agreement Provisions</U>. (a)&nbsp;Each of the parties hereto that is also
a party to the Merger Agreement shall provide Onyx with as much prior written notice as is
reasonably practicable (which, if the circumstances permit, shall be not less than two Business
Days&#146; notice) of any proposed agreement or consent by any or all of them to any modifications of
the terms and conditions of, or proposed delivery by both or either of them of any consent or
waiver or any exercise of any right of termination under, the Merger Agreement. Each of the
parties hereto that is also a party to the Merger Agreement shall (1)&nbsp;allow Onyx to participate
directly in any negotiations or discussions relating to any such proposed modification, consent,
waiver or termination unless such action would not reasonably be expected to have a material
adverse effect on the Retained Business, Retained Assets or Retained Liabilities and (2)&nbsp;keep Onyx
reasonably informed of the status and any developments with respect to any such proposed
modification, consent, waiver or termination. None of the parties hereto that is also a party to
the Merger Agreement shall, without the prior written consent of Onyx, terminate the Merger
Agreement pursuant to Section&nbsp;8.1(a) thereof or agree to any modification of any of the terms or
conditions of, or give any consent or waiver under, any provision of the Merger Agreement if such
modification, consent or waiver would reasonably be expected to have an adverse effect on the
Retained Business, Retained Assets or Retained Liabilities. SV shall not, without the prior
written consent of Onyx, terminate the Merger Agreement pursuant to Section&nbsp;8.1(e)(2)(B).
</DIV>


<P align="center" style="font-size: 10pt">46
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Prior to the Closing, each party hereto will promptly notify each other party hereto in
the event that such party becomes aware of (1)&nbsp;the occurrence or nonoccurrence of any event the
occurrence or nonoccurrence of which could reasonably be expected to cause (i)&nbsp;any representation
or warranty of any party to the Merger Agreement to be untrue or inaccurate or (ii)&nbsp;any covenant,
condition or agreement of any party to the Merger Agreement contained in the Merger Agreement to
not be complied with or satisfied and (2)&nbsp;any failure of any party to the Merger Agreement to comply with or satisfy any covenant, condition
or agreement to be complied with or satisfied by it under the Merger Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;During the period from the date of this Separation Agreement through the earlier of the
termination of this Separation Agreement pursuant to its terms and the Closing Date, the Company
shall, and shall cause each Company Subsidiary to, subject to reasonable restrictions imposed from
time to time upon advice of counsel respecting applicable Law or the Confidentiality Agreement,
afford representatives of Onyx and its Designated Affiliates, following notice from Onyx to the
Company in accordance with this Section&nbsp;6.4(c), reasonable access during normal business hours to
all properties, offices, books, contracts, commitments and records and such financial (including
all working papers) and operating data of the Company and the Company Subsidiaries and all other
information concerning its business, properties, personnel, vendors, landlords/sublandlords,
tenants, licensees and franchisees as Onyx or its Designated Affiliates may reasonably request,
including access to distribution centers and stores to conduct field audits at Onyx&#146;s expense, and
shall instruct the employees, counsel, financial advisors and auditors of the Company to cooperate
with Onyx in connection with the foregoing. Onyx shall schedule and coordinate all inspections
with the Company and shall give the Company at least two Business Days prior notice thereof,
setting forth the inspection or materials that Onyx or its representatives intend to conduct. The
Company shall be entitled to have representatives present at all times during any such inspection.
Notwithstanding the foregoing, neither Onyx nor any of its representatives shall (i)&nbsp;contact or
have any discussions with any of the Company&#146;s employees below the level of division vice president
(or, if no such position exists with respect to any particular area of the Company, division leader
or its equivalent), agents, or representatives, unless in each case Onyx obtains the prior written
consent of the Company, which shall not be unreasonably withheld, conditioned or delayed, (ii)
contact or have any discussions with any of the vendors, licensees or franchisees of the Company or
the Company Subsidiaries, unless in each case Onyx obtains the prior written consent of the
Company, which shall not be unreasonably withheld, conditioned or delayed, (iii)&nbsp;contact or have
any discussions with any of the landlord/sublandlords, tenants/subtenants of the Company or the
Company Subsidiaries if, within two Business Days after receipt of notice from Onyx of its
intention to have such a discussion, the Company shall raise a reasonable objection to such contact
or discussion, (iv)&nbsp;damage any property or any portion thereof, or (v)&nbsp;perform any onsite procedure
or investigation (including any onsite environmental investigation or study) that involves physical
disturbance or damage to any property or any portion thereof. Within ten (10)&nbsp;Business Days after
the date hereof, the Company shall appoint a representative for the purpose of coordination of
inspections and providing approvals of contact with employees, vendors, landlords/sublandlords,
tenants/subtenants, licensees or franchisees of the Company or its Subsidiaries. Notwithstanding
the foregoing, neither the Company nor any Company Subsidiary shall be required to provide access
to or to disclose information where such access or disclosure would jeopardize the attorney-client
privilege of the Company or any Company Subsidiary or contravene any Law or binding
</DIV>

<P align="center" style="font-size: 10pt">47
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">agreement entered into prior to the date of this Separation Agreement. All information obtained pursuant to
this Section&nbsp;6.4(c) shall continue to be governed by the Confidentiality Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Onyx shall use its commercially reasonable efforts to obtain the Financing pursuant to the
terms and conditions set forth in the Financing Commitment. Onyx shall notify the Company if at
any time prior to the Closing Date the Financing Commitment shall expire or be terminated, modified
or amended for any reason. The Company shall (i)&nbsp;provide and shall cause the Company Subsidiaries to, and use commercially reasonable efforts
to cause the respective officers, employees and Representatives, including legal and accounting, of
the Company and its Subsidiaries to provide, all cooperation reasonably requested by Onyx in
connection with any debt financing that Onyx may determine to arrange (any such debt financing, a
&#147;<U>Future Debt Financing</U>&#148;), including providing such access and documentation and taking such
action as is customary for transactions such as the Financing or Future Debt Financing and
facilitating the production of any due diligence items that the prospective lenders may reasonably
request, including current Phase I Environmental Site Assessments, field audits, appraisals and
title insurance with respect to the real property, and (ii)&nbsp;satisfy the conditions in the Financing
Commitment or Future Debt Financing that require action by the Company. Onyx shall promptly, upon
request by the Company, reimburse the Company for all reasonable out-of-pocket third party costs
incurred by the Company or any of the Company Subsidiaries in connection with such cooperation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;During the period from the date of this Separation Agreement through the earlier of the
termination of this Separation Agreement pursuant to its terms and the Closing Date, Onyx shall,
and shall cause each Subsidiary of Onyx to, subject to reasonable restrictions imposed from time to
time upon advice of counsel respecting applicable Law or the Confidentiality Agreement, afford
representatives of the Company and its Subsidiaries such information as they may reasonably require
concerning the capitalization, liquidity and financial resources of Onyx and its Subsidiaries after
giving effect to the transactions contemplated by this Separation Agreement. Notwithstanding the
foregoing, neither Onyx nor any Onyx Subsidiary shall be required to provide access to or to
disclose information where such access or disclosure would jeopardize the attorney-client privilege
of Onyx or any Subsidiary of Onyx or contravene any Law or binding agreement entered into prior to
the date of this Separation Agreement. The Company shall hold, and shall cause its officers,
employees, agents, consultants, advisors and other Representatives to hold, in strict confidence,
unless compelled to disclose by judicial or administrative process or at the direction of any
Authority or, in the opinion of its counsel, by other requirements of Law, all non-public
information concerning Onyx furnished it pursuant to this Section&nbsp;6.4(e) or its Representatives or
otherwise in its possession (except to the extent that such information can be shown to have been
(x)&nbsp;in the public domain through no fault of the party to which it was furnished or (y)&nbsp;later
lawfully acquired on a nonconfidential basis from other sources by the party to which it was
furnished), and the Company shall not, without the prior written consent of the party that
furnished such information, release or disclose such information to any other person, except its
auditors, attorneys, financial advisors, financing sources, bankers and other consultants, advisors
and other representatives who have a need to know such information and who agree to be bound by the
provisions of this sentence. The Company shall be deemed to have satisfied its obligation to hold
confidential information concerning or supplied by any other party if it exercises the same care as
it takes to preserve confidentiality for its own similar confidential information.
</DIV>

<P align="center" style="font-size: 10pt">48
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.5 <U>Further Action; Reasonable Best Efforts</U>. (a)&nbsp;Subject to the terms and
conditions of this Separation Agreement, each of the parties hereto will use its reasonable best
efforts to take, or cause to be taken, all actions and to do, or cause to be done, and assist and
cooperate with the other parties in doing, all things necessary, or desirable under applicable Law
and regulations to consummate, in the most expeditious manner practicable, the transactions
contemplated by this Separation Agreement. In furtherance of the foregoing, from the date hereof until Closing
(and except as contemplated by the Cub Sale Agreement), Onyx agrees, and shall cause each of its
Affiliates and each holder of its Equity Interests, not to enter into any transaction which would
impair or delay the parties&#146; ability to receive approval of the transactions contemplated hereby
under the HSR Act, including, without limitation, any acquisition of or merger with any entity that
derived revenues in the following NAICS Codes: 44561, 44611 and any NAIC codes that begin with
44511 or 44611. Onyx hereby represents that no person that is the ultimate parent entity of Onyx
derives any revenues in such NAICS Codes, otherwise than as a result of the Cub Sale Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company and Onyx will use reasonable best efforts to: (i)&nbsp;prepare, as soon as
practicable, all filings and other presentations in connection with seeking any regulatory
approval, exemption or other authorization from any Authority necessary to consummate the
transactions contemplated hereby; (ii)&nbsp;prosecute such filings and other presentations with
diligence; and (iii)&nbsp;oppose any objections to, appeals from or petitions to reconsider or reopen
any such approval by persons not party to this Agreement. The Company and Onyx will use reasonable
best efforts to facilitate obtaining any final order or orders approving such transactions,
consistent with this Separation Agreement and/or to remove any impediment to the consummation of
the transactions contemplated hereby. The Company and Onyx will use reasonable best efforts to
furnish all information in connection with the approvals of or filings with any Authority and will
promptly cooperate with and furnish information in connection with any such requirements imposed
upon Onyx or any of its Affiliates in connection with this Agreement and the transactions
contemplated hereby. Subject to Sections&nbsp;6.5(c) and 6.5(d), Onyx will use reasonable best efforts
to obtain any consent, authorization, order or approval of, or any exemption by, and to remove any
impediment imposed by any Authority to allow the consummation of the transactions contemplated
hereby. Onyx and the Company will each advise the other party promptly of any material
communication received by such party or any of its Affiliates from the FTC, DOJ, any state attorney
general or any other Authority regarding any of the transactions contemplated hereby, and of any
understandings, undertakings or agreements (oral or written) such party proposes to make or enter
into with the FTC, DOJ, any state attorney general or any other Authority in connection with the
transactions contemplated hereby. Onyx and the Company will each consult with the other in advance
of any material meetings with the FTC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In furtherance and not in limitation of Sections&nbsp;6.5(a) and (b), each of Onyx and the
Company shall make an appropriate filing of a Notification and Report Form pursuant to the HSR Act
with respect to the transactions contemplated hereby as promptly as practicable and thereafter make
any other required submissions with respect to the transactions contemplated hereby under the HSR
Act and shall take all other actions reasonably necessary, proper or advisable to cause the
expiration or termination of the applicable waiting periods under the HSR Act as soon as
practicable.
</DIV>

<P align="center" style="font-size: 10pt">49
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;In furtherance and not in limitation of Sections&nbsp;6.5(a) and (b), Onyx shall, in order to
consummate the Retained Business Purchase contemplated by this Separation Agreement, use its
reasonable best efforts (i)&nbsp;to secure the expiration or termination of any applicable waiting
period under the HSR Act, (ii)&nbsp;to resolve any objections asserted with respect to the Retained
Business Purchase contemplated hereby under any antitrust law or the
Federal Trade Commission Act raised by any governmental authority (&#147;<U>Objections</U>&#148;), and
(iii)&nbsp;to prevent the entry of, and to have vacated, lifted, reversed or overturned, any decree,
judgment, injunction or other order that would prevent, prohibit, restrict or delay Closing. For
purposes of this Section&nbsp;6.5(d), &#147;reasonable best efforts&#148; include (A)&nbsp;executing settlements,
undertakings, consent decrees, stipulations or other agreements, (B)&nbsp;selling, divesting or
otherwise conveying particular assets or categories of assets or businesses of Onyx, (C)&nbsp;agreeing
to sell, divest or otherwise convey any particular assets or categories of assets or businesses of
the Company contemporaneously with or subsequent to the Closing, and (D)&nbsp;permitting the Company to
sell, divest or otherwise convey any particular assets or categories of assets or businesses of the
Company prior to the Closing; <U>provided</U>, that in no event shall Onyx be required (or shall
the Company be permitted pursuant to this Section&nbsp;6.5(d)) to take any actions pursuant to this
Section&nbsp;6.5(d) that, individually or when aggregated with all other actions taken pursuant to this
Section&nbsp;6.5(d), could reasonably be expected to have a material adverse effect on Onyx and the
Company, taken as a whole, after giving effect to the consummation of the Retained Business
Purchase. No actions taken pursuant to this Section&nbsp;6.5(d) shall be considered for purposes of
determining whether a Company Material Adverse Effect has occurred. Onyx shall respond to and seek
to resolve any Objection as promptly as practicable after such Objection is raised.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Subject to the terms and conditions of the Merger Agreement, each of the Company and SV
shall comply with their obligations under Section&nbsp;6.6(a)-(d) of the Merger Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Notwithstanding the foregoing or any other provision of this Separation Agreement, nothing
in this Section&nbsp;6.5 shall limit a party&#146;s right to terminate this Separation Agreement pursuant to
Section&nbsp;9.2 so long as such party has up to then complied in all material respects with its
obligations under this Section&nbsp;6.5.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.6 <U>Ancillary Agreements</U>. On the Closing Date, the parties shall execute
(and/or cause their respective Subsidiaries party thereto to execute) the Ancillary Agreements; it
being agreed that (i)&nbsp;Onyx may request that the schedules to the Transition Services Agreement
include any service that the Company Headquarters currently provides to the Retained Business and
(ii)&nbsp;prior to the Closing Date, SV and Onyx shall review and negotiate in good faith to agree upon
the appropriate service levels to be set forth in the Transition Services Agreement with respect to
services to be provided under the Transition Services Agreement to Onyx after the Closing Date.
Notwithstanding anything to the contrary contained in this Separation Agreement, (i)&nbsp;the
nonperformance by any party with the agreements and covenants set forth in Section&nbsp;6.2(b) or this
Section&nbsp;6.6 (including any related failure of any party to certify as to the performance thereof)
shall not constitute a failure of any condition to the obligation of any party to consummate the
transactions contemplated by this Separation Agreement to be satisfied or grounds for any party to
terminate this Separation Agreement and (ii)&nbsp;if and to the extent of a conflict between the terms
and provisions of this Separation Agreement and any Ancillary Agreement, the terms of the Ancillary
Agreement shall govern.
</DIV>


<P align="center" style="font-size: 10pt">50
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.7 <U>Sharing of Certain Payments</U>. In the event that SV receives a Company
Termination Fee (as defined in the Merger Agreement), SV and Onyx shall share in such fee (a)
first, in an amount equal to each party&#146;s actual out-of-pocket third party expenses incurred in connection with
this Separation Agreement and the Merger Agreement and (b)&nbsp;second, on a 85%/15% basis. Such amount
shall be paid within five (5)&nbsp;Business Days of the receipt by SV of such Company Termination Fee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.8 <U>Certain Restrictions Pending the Closing</U>. (a)&nbsp;Each of Onyx and SV agrees
that, from and after the date hereof and prior to the Closing, except (1)&nbsp;as otherwise expressly
permitted by this Separation Agreement or the Merger Agreement, (2)&nbsp;for any action that constitutes
an exercise of their respective rights under Section&nbsp;6.4, Section&nbsp;9.1 or Section&nbsp;9.2 or (3)&nbsp;as
agreed in writing by the other parties hereto, each of Onyx and SV shall not, and shall not permit
any of its Subsidiaries to, take or agree, in writing or otherwise, to take any action which could
reasonably be expected to materially impair its ability to perform its obligations under this
Separation Agreement or to prevent, impede or materially delay the consummation of the transactions
contemplated under this Separation Agreement or result in the failure to satisfy any condition to
the consummation of the transactions hereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company agrees that, from and after the date hereof and prior to the Closing, except
(1)&nbsp;as otherwise expressly permitted by this Separation Agreement or the Merger Agreement, (2)&nbsp;for
any action that constitutes an exercise of the Company&#146;s rights under Section&nbsp;9.1 or Section&nbsp;9.2 of
this Separation Agreement or (3)&nbsp;as agreed in writing by the other parties hereto, the Company
shall not, and shall not permit any of its Subsidiaries to, take or agree, in writing or otherwise,
to take any action which could reasonably be expected to materially impair the Company&#146;s ability to
perform its obligations under this Separation Agreement or to prevent, impede or materially delay
the consummation of the transactions contemplated under this Separation Agreement or result in the
failure to satisfy any condition to the consummation of the transactions hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In furtherance, and not limitation of the foregoing, Section&nbsp;6.1(a) (Conduct of Business
Prior to the Closing) of the Merger Agreement is incorporated herein by reference (<I>mutatis
mutandis</I>); <U>provided</U>, <U>however</U>, for purposes of this Section&nbsp;6.8(c) of the Separation
Agreement (1) &#148;Onyx&#148; shall be substituted for any reference to &#147;Parent&#148; contained in such section,
(2) &#147;this Separation Agreement&#148; shall be substituted for any reference to &#147;this Agreement&#148; in such
section, (3)&nbsp;the references to &#147;(in each case, with respect to the New Diamond Business or to the
extent affecting New Diamond and/or the New Diamond Entities in a non-de minimis respect)&#148; shall be
deemed to read &#147;(in each case, in relation to the Retained Business, the Retained Assets and the
Retained Liabilities),&#148; (4)&nbsp;Section&nbsp;6.1(a)(v)(D)(2) shall be deemed to read &#147;any Real Property
Lease (other than any amendment or termination in connection with the disposition of the
Springfield Stores) which provides for monthly base rental payments over the primary term of the
lease in excess of $10,000, on average or which provides for a term in excess of two years,&#148;, (5)
Section&nbsp;6.1(a)(v)(E) shall be deemed to read &#147;vary capital expenditures upward or downward in any
material respect from the capital expenditure budget insofar as it relates to the Retained Business
as set forth on Section&nbsp;6.8(c) of the Company Disclosure Letter authorize, or enter into, any new
capital expenditures which are in the aggregate, in excess of the Company&#146;s capital expenditure
budget insofar as it relates to the Retained Business or authorize, or enter into any commitment to
make any capital expenditures
</DIV>

<P align="center" style="font-size: 10pt">51
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">that related to the Retained Business which are, individually, in
excess of $2,500,000.&#148;, and (6)&nbsp;the following shall be inserted at the end of Section&nbsp;6.1(a)(vi) as a new number (9): &#147;(9)
hire (except in the case of replacing a departing executive or employee) any executive officer (as
defined by Rule&nbsp;3b-7 of the Exchange Act) or other employee earning annual compensation in excess
of $250,000, or terminate more than two such executive officers or employees earning in excess of
$250,000 in any 6&nbsp;month period, other than termination for cause.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.9 <U>Payments by Onyx to the Exchange Fund</U>. Under the Merger Agreement, SV has
agreed to deposit in trust (the &#147;<U>Exchange Fund</U>&#148;) with the Paying Agent (as defined in the
Merger Agreement) any amounts payable under Article&nbsp;III of the Merger Agreement. In furtherance of
the foregoing and Onyx&#146;s obligations under Section&nbsp;2.4(c) of this Separation Agreement, Onyx and/or
one or more of its Designated Affiliates shall pay, or cause to be paid, by wire transfer of
immediately available funds to the account designated by the Paying Agent as the Exchange Fund, an
amount without duplication equal to the Retained Business Price (which amount New Diamond intends
to treat as having been loaned from New Diamond to SV).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.10 <U>Settlement of Appraisal Proceedings </U>. In the event any appraisal
proceeding brought under Section&nbsp;262 of the DGCL results in the payment of an amount per share in
respect of shares of the Common Stock (as defined in the Merger Agreement) of the Company
outstanding prior to the Effective Time that is less than the Per Share Merger Consideration (after
taking into account the costs and expenses of defending such Action), the difference between the
amount of such payment and the Per Share Merger Consideration shall be split between the Company
and New Diamond on a 15%/85% basis. Each of Onyx and SV shall, or shall cause the Company or New
Diamond, respectively, to make such payments when and if due.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.11 <U>Certain Standalone Drug Sale Matters</U>. (a)&nbsp;The Company shall not,
without the prior written consent of the other parties hereto, voluntarily terminate the Standalone
Drug Sale Agreement or agree to any modification of any of the terms or conditions of, or give any
consent or waiver under, or enter into any settlement of any Action or dispute under any provision
of the Standalone Drug Sale Agreement, if such modification, consent, waiver, settlement or
termination would reasonably by expected to adversely affect, or impose any cost or liability on,
Onyx or its Subsidiaries (including their interests following the consummation of the transactions
contemplated by the Standalone Drug Sale Agreement) or adversely affect the ability to consummate
the transactions contemplated hereby in a timely manner. The Company shall comply with the terms
of the Standalone Drug Sale Agreement in all material respects. The Company will use reasonable
best efforts to cause the conditions to the consummation of the Standalone Drug Sale Agreement to
be satisfied (or waived by the other party thereto).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Prior to the Closing, the Company will promptly notify each other party hereto in the
event that the Company becomes aware of (1)&nbsp;the occurrence or nonoccurrence of any event the
occurrence or nonoccurrence of which could reasonably be expected to cause (i)&nbsp;any representation
or warranty of any party to the Standalone Drug Sale Agreement to be untrue or inaccurate or (ii)
any covenant, condition or agreement of any party to the Standalone Drug Sale Agreement contained in the Standalone Drug Sale Agreement to not be
</DIV>

<P align="center" style="font-size: 10pt">52
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">complied with or satisfied or (2)&nbsp;any failure of any party to the Standalone Drug Sale Agreement to
comply with or satisfy any covenant, condition or agreement to be complied with or satisfied by it
under the Standalone Drug Sale Agreement, in each case, to the extent that any of the foregoing
matters would reasonably be expected to result in the failure of a closing condition to the
Standalone Drug Sale Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.12 <U>Proxy Statement</U>. Onyx will cooperate with SV and the Company in the
preparation of the Proxy Statement/Prospectus and Form S-4. Each of Parent and the Company will
provide Onyx with a reasonable opportunity to review drafts of, and revisions to, the Proxy
Statement/Prospectus and Form S-4 prepared by such party, and Onyx shall use its reasonable best
efforts to furnish to SV and the Company information relating to it and its affiliates as necessary
to prepare the Proxy Statement/Prospectus and Form S-4. Onyx agrees that none of the information
supplied or to be supplied by it for inclusion or incorporation by reference in the Proxy
Statement/Prospectus or the Form S-4 will, at the date such document is first mailed to the
stockholders of the relevant party and at the time of such party&#146;s meeting of stockholders relating
to the Merger, contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they are made, not misleading. For purposes of the foregoing, it is
understood and agreed that information concerning or related to Onyx or any of its Designated
Subsidiaries will be deemed to have been supplied by Onyx.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.13 <U>Merger Agreement Termination Fee</U>. In the event that (i)&nbsp;SV is required
to make a payment to the Company pursuant to Section&nbsp;8.2(d)(i) of the Merger Agreement or (ii)(A)
SV is required to make a payment to the Company pursuant to Section&nbsp;8.2(d)(ii) of the Merger
Agreement and (B)&nbsp;the board of directors of SV shall have failed to include or make or shall have
publicly withdrawn, modified or changed, in a manner adverse to the Company, the Parent Board
Recommendation for reasons primarily related to antitrust concerns, Onyx shall be responsible for
the payment to the Company of (or shall reimburse SV for) an amount equal to $70,000,000 of such
$250,000,000 payment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.14 <U>Springfield Stores Sale</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Onyx shall act in good faith and use its reasonable best efforts to sell the Springfield
Stores to a third party (other than SV) prior to the date that is the one year anniversary of the
Closing Date (the &#147;<U>Springfield Stores Date</U>&#148;) and shall consider in good faith any
prospective purchaser of the Springfield Stores proposed to Onyx by SV; <U>provided</U>, that such
one year limitation shall be extended if Onyx is in discussions with any third party to sell the
Springfield Stores on the Springfield Stores Date until such discussions have terminated in good
faith.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the extent Onyx shall have entered into an agreement to sell one or both of the
Springfield Stores within the timeline contemplated by paragraph (a)&nbsp;above, it shall, upon the
closing of such sale, pay to Jewel Food Stores, Inc. eighty per cent (80%), and shall be entitled
to keep twenty percent (20%), of the consideration (net of tax and costs of sale)
for such store or stores. Any such payment to Jewel Food Stores, Inc. shall be allocable to
the Springfield Stores.
</DIV>

<P align="center" style="font-size: 10pt">53
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;SV shall be entitled to see, at its request, all documentation with respect to the sales
or prospective sales contemplated by this Section&nbsp;6.14.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VII
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>ACCESS TO INFORMATION AND SERVICES</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.1 <U>Access to Information</U>. From and after the Closing (a)&nbsp;each of the parties
hereto shall (1)&nbsp;afford to the other parties and their respective authorized accountants, counsel
and other designated Representatives reasonable access (including using reasonable efforts to give
access to persons or firms possessing Information) and duplicating rights during normal business
hours and upon reasonable advance notice to all records, books, contracts, instruments, computer
data and other data and information (collectively, &#147;<U>Information</U>&#148;) within the each other
party&#146;s possession insofar as such access is reasonably required by Onyx or SV, as the case may be,
or their respective Designated Affiliates and (2)&nbsp;at the request and expense of Onyx, SV or their
respective Designated Affiliates, as applicable, use its reasonable efforts to cooperate with the
other parties and their respective accountants and other Representatives in connection with the
preparation of any audits (and related financial statement preparation) and with the transition of
the Retained Business and the New Diamond Business to &#147;stand-alone&#148; businesses following the
Closing, including by assisting in connection with any efforts to obtain insurance coverage for the
Retained Business and the New Diamond Business, as applicable. Information may be requested under
this Section&nbsp;7.1 for, without limitation, audit, accounting, claims, litigation and tax purposes,
as well as for purposes of fulfilling disclosure and reporting obligations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.2 <U>Litigation Cooperation</U>. Following the Closing, with respect to any Action
that involves any of the parties to this Separation Agreement or any of the Retained Entities or
New Diamond Entities and relates to (a)&nbsp;the transactions contemplated by this Separation Agreement
or the Merger Agreement or (b)&nbsp;the Company or any current or former Subsidiary of the Company or
any Liabilities or current or former Assets, employees or businesses thereof, whether or not such
Action is subject to indemnification hereunder, each of the parties hereto shall, upon written
request by any other party hereto, and at the expense of the requesting party (subject to the
indemnification and expense-sharing provisions of this Separation Agreement, to the extent
applicable), provide all cooperation and assistance, and shall furnish such records and
information, as may be reasonably requested by the other in connection therewith, including, by
using reasonable efforts to make available to the other, its officers, directors, employees and
agents as witnesses and to attend such conferences, discovery proceedings, hearings, trials and
appeals as may be reasonably requested by the other in connection therewith. With respect to (1)
any such Action involving Shared Transaction Liabilities or (2)&nbsp;any Action initiated by any
Authority or private party pursuant to the HSR Act or any similar Law and relating to the
transactions contemplated by this Separation Agreement or the Merger Agreement, the parties agree,
consistent with applicable rules of privilege and legal ethics, to provide each other with
timely and reasonably detailed updates with respect to all material developments, consult with
each other before taking any significant actions in connection therewith and offer each other the
opportunity to comment before submitting to any Authority or adverse party any written materials
prepared or furnished in connection with such Action.
</DIV>


<P align="center" style="font-size: 10pt">54
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.3 <U>Retention of Records</U>. Except as otherwise required by Law or agreed to in
writing, the parties hereto and/or one or more of their Designated Affiliates shall each retain,
for a period of at least seven years following the Closing Date, all Information in their
possession relating to (a)&nbsp;in the case of New Diamond and its Affiliates, the Retained Assets, the
Retained Entities and the Retained Business, the Retained Liabilities, and (b)&nbsp;in the case of the
Company and its Affiliates, the New Diamond Assets, the New Diamond Entities, the New Diamond
Business and the New Diamond Liabilities. Notwithstanding the foregoing, except as otherwise
required by Law, any party may destroy or otherwise dispose of any of such Information at any time,
<U>provided</U>, that prior to such destruction or disposal, (1)&nbsp;such party provides no less than
90 or more than 120&nbsp;days&#146; prior written notice to the other parties, specifying the Information
proposed to be destroyed or disposed of and (2)&nbsp;if the other party shall request in writing prior
to the scheduled date for such destruction or disposal that any of the Information proposed to be
destroyed or disposed of be delivered to such party, the responsive party shall promptly arrange
for the delivery of such of the Information as was requested, at the expense of the requesting
party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.4 <U>Confidentiality</U>. From and after the Closing, each party shall hold, and
shall cause its officers, employees, agents, consultants, advisors and other Representatives to
hold, in strict confidence, unless compelled to disclose by judicial or administrative process or
at the direction of any Authority or, in the opinion of its counsel, by other requirements of Law,
all non-public Information concerning the other parties furnished it by any such other party or its
representatives or otherwise in its possession (except to the extent that such Information can be
shown to have been (a)&nbsp;in the public domain through no fault of the party to which it was furnished
or (b)&nbsp;later lawfully acquired on a nonconfidential basis from other sources by the party to which
it was furnished), and each party shall not, without the prior written consent of the party that
furnished such Information, release or disclose such Information to any other person, except its
auditors, attorneys, financial advisors, financing sources, bankers and other consultants, advisors
and other representatives who have a need to know such Information and who agree to be bound by the
provisions of this Section&nbsp;7.4. Each party shall be deemed to have satisfied its obligation to
hold confidential Information concerning or supplied by any other party if it exercises the same
care as it takes to preserve confidentiality for its own similar confidential Information.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.5 <U>Publicity</U>. The parties shall consult with each other before issuing any
press release or otherwise making any public statements with respect to this Separation Agreement
or the transactions contemplated hereby, except to the extent public disclosure is required by
applicable Law or the requirements of the NYSE or the PCX, in which case the issuing party shall
use its reasonable best efforts to consult with the other party before issuing any such release or
making any such public statement.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE VIII
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>EMPLOYEE BENEFITS; LABOR MATTERS</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.1 <U>Locus of Employees and Company Plans</U>. No later than immediately prior to
the Separation, the employment of any New Diamond Employees who are employed by a Retained Entity
shall be transferred to a New Diamond Entity, and the
</DIV>


<P align="center" style="font-size: 10pt">55
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">employment of any Retained Employees who are employed by a New Diamond Entity shall be transferred to a Retained Entity. The New Diamond
Employees who are employed by a New Diamond Entity immediately prior to the Separation shall be
retained as employees of such entity, and the Retained Employees who are employed by a Retained
Entity immediately prior to the Separation shall be retained as employees of such entity. Prior to
the Separation the Company shall cause the real estate leases and real property assets associated
with the Retained Business held in trust in a Company Plan to be removed from such trust.
Concurrently with the Separation, New Diamond shall assume or retain sponsorship of all Company
Plans (other than Assumed Benefit Plans), all assets held in trust (other than such real estate
leases and real property assets) to fund such plans and all insurance policies funding such plans
shall be New Diamond Assets, and the Retained Entities and Retained Employees shall cease to
actively participate in such plans as of the Closing Date (it being understood that Retained
Employees shall still be eligible for benefits in accordance with the terms of such plans, provided
that no additional rights or benefits shall accrue under any such plans in respect of service of
the Retained Employees subsequent to the Closing Date), and, except to the extent provided
elsewhere herein, New Diamond shall assume and be solely responsible for all Liabilities and
obligations whatsoever in respect of such plans. Without limiting the generality of Section&nbsp;9.5,
nothing in this Article&nbsp;VIII, express or implied, is intended to or shall confer upon any current
or former employee or service provider of New Diamond, the Company, and their respective Affiliates
any right, benefit or remedy of any nature whatsoever.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.2 <U>Employee Benefits</U>. After the Closing, each of the Company, Onyx and/or
one or more of its Designated Affiliates shall, and shall cause each Retained Entity to, as the
case may be, take such action as may be necessary to honor the applicable obligations under the
last sentence of Section&nbsp;6.8(c) and Section&nbsp;6.13(a), (c), (d)&nbsp;and (e)&nbsp;of the Merger Agreement with
respect to the Retained Employees (other than Former Retained Employees) as if the &#147;Surviving
Corporation&#148; as referenced therein was the Company and &#147;Parent&#148; as referenced therein was Onyx, and
including without limitation an obligation to establish and maintain as of the Effective Time such
plans, policies and arrangements in such form as Onyx may determine to provide such benefits. For
purposes of this Section&nbsp;8.2, the last sentence of Section&nbsp;6.13(a) of the Merger Agreement shall be
deemed to read: &#147;For purposes of this Section&nbsp;6.13 only, the term &#147;Company Employee&#148; shall be
deemed to refer to any current employee, officer, consultant, independent contractor or director of
the Company or any Subsidiary of the Company after giving effect to the Standalone Drug Sale and
the Separation.&#148;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.3 <U>Other Liabilities and Obligations</U>. As of the Closing Date, with respect
to claims relating to any employee Liability or obligations not otherwise allocated in this
Separation Agreement, (a)&nbsp;New Diamond shall assume, and be solely responsible for, all Liabilities
and obligations whatsoever of the Company and its Affiliates for such claims made by all New Diamond Employees
and (b)&nbsp;the Company shall retain or assume, and be solely responsible for, all Liabilities and
obligations whatsoever for claims made by all Retained Employees whether arising out of events,
occurrences or services performed before or following the Closing Date. As of the Closing Date,
the Company shall assume (subject to the definition of Shared Transaction Litigation Liabilities)
and be solely responsible for all Liabilities and obligations whatsoever in respect of Assumed
Benefit Plans, and all assets held in trust to fund such plans and all insurance policies funding
such plans shall be Retained Assets. Without limiting the generality of the foregoing, as of the
Closing Date, New Diamond shall assume and

<P align="center" style="font-size: 10pt">56
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">be solely responsible for any collective bargaining agreement or obligation covering New Diamond Employees as of the Closing Date and the Company shall
retain or assume and be solely responsible for any collective bargaining agreement or obligation
covering Retained Employees as of the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.4 <U>Welfare Plans</U>. Effective as of the Closing Date, Retained Employees shall
cease to participate in plans providing for the type of benefits described in Section&nbsp;3(1) of ERISA
(other than retiree medical plans under which Former Retained Employees shall continue to
participate (but not to actively accrue credit for service) following the Closing Date)
(&#147;<U>Welfare Plans</U>&#148;) that are sponsored by the New Diamond Entities (&#147;<U>Old Welfare
Plans</U>&#148;) and shall commence participation in Welfare Plans sponsored by Retained Entities
(&#147;<U>New Welfare Plans</U>&#148;). New Diamond will provide administrative services and support to the
New Welfare Plans following the Closing Date, as set forth in the Transition Services Agreement.
Effective as of the Closing Date, the Company shall assume all responsibility for, and all
Liabilities in respect of, accrued but unused vacation days of Retained Employees, and New Diamond
shall assume all responsibility for, and all Liabilities in respect of, accrued but unused vacation
days of New Diamond Employees. As of the Closing Date, (a)&nbsp;New Diamond shall assume or retain
liability for all workman&#146;s compensation claims with respect to New Diamond Employees and Retained
Employees that arose directly out of injuries or illness that occurred prior to the Closing Date
and disability claims with respect to New Diamond Employees and Retained Employees that arose prior
to the Closing Date, (b)&nbsp;New Diamond shall assume or retain liability for all workman&#146;s
compensation claims with respect to New Diamond Employees that arise out of injuries or illness
that arise on or after the Closing Date and disability claims with respect to New Diamond
Employees that arise on or after the Closing Date and (c)&nbsp;the Company shall assume or retain
liability for all workman&#146;s compensation claims with respect to Retained Employees that arise
directly out of injuries or illness that arise on or after the Closing Date and disability claims
with respect to Retained Employees that arise on or after the Closing Date. For purposes of the
preceding sentence, under no circumstances will a workman&#146;s compensation claim be deemed to have
arisen out of an injury occurring prior to the Closing Date or will a claim for disability benefits
be deemed to have arisen prior to the Closing Date, in each case, if the applicable claim is not
filed prior to, or within 180&nbsp;days following, the Closing Date.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.5 <U>Retirement Plans; Savings Plans</U>. (a)&nbsp;At Closing New Diamond and its
Affiliates shall assume or retain sponsorship of, and responsibility for all Liabilities in respect
of, Company Plans (other than Assumed Benefit Plans) that are qualified or nonqualified retirement,
retiree medical, or deferred compensation plans, whether with respect to New Diamond Employees,
Retained Employees or Standalone Drug Employees. All assets held in trust to fund such plans (other
than the real estate leases and real property assets associated with the Retained Business which
shall be removed from any such trust prior to the Separation and shall be Retained Assets) and all
insurance policies funding such plans shall be New Diamond Assets.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As soon as practicable after the Closing Date, New Diamond shall cause the account
balances of all employees of the Company (other than New Diamond Employees and Former Retained
Employees) in the Company Plans that are account balance plans qualified under Section 401(a) of
the Code to be available for distribution in accordance
</DIV>

<P align="center" style="font-size: 10pt">57
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with the terms of such plans, and the Company shall permit Retained Employees (other than Former Retained Employees) who are participants
in such plans to rollover such distributions (including a rollover of outstanding participant
loans) into a defined contribution plan established by the Company that satisfies the qualification
requirements of Section 401(a) of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.6 <U>Preservation of Rights to Amend or Terminate Plans</U>. No provision of this
Separation Agreement shall be construed as a limitation on the right of the Company or New Diamond
to amend any plan or terminate its participation therein which the Company or New Diamond would
otherwise have under the terms of such plan or otherwise, and no provision of this Separation
Agreement shall be construed to create a right in any employee or beneficiary of such employee
under a plan that such employee or beneficiary would not otherwise have under the terms of such
plan itself.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.7 <U>Reimbursement; Indemnification</U>. New Diamond and the Company acknowledge
that the Company, on the one hand, and New Diamond, on the other hand, and their respective
Subsidiaries, may incur costs and expenses (including contributions to plans and the payment of
insurance premiums) pursuant to any of the employee benefit or compensation plans, programs or
arrangements which are, as set forth in this Separation Agreement, the responsibility of the other.
Accordingly, the Company and New Diamond agree to reimburse each other, as soon as practicable but
in any event within five Business Days of receipt from the other party of appropriate verification,
for all such costs and expenses reduced by the amount of any Tax reduction or recovery of Tax
benefit realized by the Company or New Diamond or any such Subsidiary, as the case may be, in
respect of the corresponding payment made by it. Liabilities retained, assumed or indemnified by
New Diamond pursuant to this Article&nbsp;VIII shall in each case be deemed to be New Diamond
Liabilities, and Liabilities retained, assumed or indemnified by the Company pursuant to this
Article&nbsp;VIII shall in each case be deemed to be Retained Liabilities, and, in each case, shall be
subject to the indemnification provisions set forth in Article&nbsp;V.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.8 <U>Change In Control</U>. The parties hereto will treat the consummation of the
Transactions, both individually and collectively, and regardless of the order in which they
actually occur, as a &#147;change in control,&#148; &#147;change of control&#148; or similar event under each of the
Company Plans (to the extent such Company Plans contain provisions relating to &#147;change in control,&#148;
&#147;change of control&#148; or similar event).
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">ARTICLE IX
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><U>MISCELLANEOUS</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.1 <U>Conditions to Closing</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;<U>Mutual Conditions to Consummate the Separation Agreement</U>. The respective
obligations of each party to consummate the transactions contemplated by this Separation Agreement
shall be subject to the satisfaction or waiver at or prior to the Closing of the following
conditions:
</DIV>

<P align="center" style="font-size: 10pt">58
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) each of the conditions to the Merger, as set forth in Article&nbsp;VII of the Merger
Agreement (other than the condition that the Standalone Drug Sale, the Separation and the
Retained Business Purchase shall have occurred), and each of the conditions of the
Standalone Drug Sale, as set forth in Article&nbsp;IX of the Standalone Drug Sale Agreement,
shall have been satisfied or waived (excluding conditions of the Merger Agreement and the
Standalone Drug Sale Agreement that, by their terms, cannot be satisfied until the closing
of the Merger Agreement or the Standalone Drug Sale Agreement, as applicable);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) the waiting period (and any extension thereof) applicable to the transactions
contemplated by this Separation Agreement under the HSR Act shall have been terminated or
shall have expired; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) no Law, temporary restraining order, preliminary or permanent injunction or other
legal restraint shall have been enacted, entered, promulgated or enforced and no action or
decision shall have been taken and remain in effect by any Authority which prohibits,
restrains or enjoins the consummation of the transactions contemplated by this Separation
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Conditions to Obligations of Onyx</U>. The obligations of Onyx to consummate the
transactions contemplated hereby shall be further subject to the satisfaction or waiver at or prior
to the Closing of the following conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The representations and warranties of the Company contained in Section&nbsp;3.2(a) of
this Separation Agreement (disregarding any Company Material Adverse Effect, materiality or
similar qualifiers therein) shall be true and correct as of the date hereof and the Closing
Date as though made on and as of such date (unless any such representation or warranty is
made only as of a specific date, in which event such representation and warranty shall be
true and correct as of such specified date), except where any failure of any such
representation or warranty to be so true and correct has not had and would not reasonably be
expected to have a Company Material Adverse Effect, <U>provided</U>, <U>however</U>, that
the representations and warranties of the Company in Section&nbsp;4.2 of the Merger Agreement
(Authority, Enforceability), as modified pursuant to Section&nbsp;3.2(a) of this Separation
Agreement, shall be true in all but <I>de minimis </I>respects;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The Company shall have performed in all material respects the obligations, and
complied in all material respects with the agreements and covenants, required to be
performed by or complied with by it under this Separation Agreement at or prior to the
Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) The representations and warranties of SV and its Designated Affiliates set forth in
this Separation Agreement (disregarding any Parent Material Adverse Effect, materiality or
similar qualifiers therein) shall be true and correct as of the date hereof and the Closing
Date as though made on and as of such date (unless any such representation or warranty is
made only as of a specific date, in which event such representation and warranty shall be
true and correct as of such specified date),
</DIV>

<P align="center" style="font-size: 10pt">59
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">except where any failure of such representation or warranty to be so true and correct has not had and would not reasonably be expected to
have a Parent Material Adverse Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Each of SV and its Designated Affiliates shall have performed in all material
respects the material obligations, and complied in all material respects with the material
agreements and covenants, required to be performed by or complied with by it under this
Separation Agreement at or prior to the Closing; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Onyx shall have received a certificate of an executive officer of (i)&nbsp;the Company,
certifying that the conditions set forth in Sections&nbsp;9.1(b)(1) and (2)&nbsp;have been satisfied
and (ii)&nbsp;SV, certifying that the conditions set forth in Section&nbsp;9.1(b)(3) and (4)&nbsp;have been
satisfied.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) Notwithstanding the foregoing, Onyx shall not, without the prior written consent of
SV, amend, modify or waive any provision of this Separation Agreement if such amendment,
modification or waiver would reasonably be expected to have an adverse effect on the New
Diamond Business, New Diamond Assets or New Diamond Liabilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Conditions to the Obligations of the Company and SV</U>. The obligations of each of
the Company and SV to consummate the transactions contemplated hereby shall be further subject to
the satisfaction or waiver at or prior to the Closing of the following conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The representations and warranties of Onyx and its Designated Affiliates set forth
in this Separation Agreement shall be true and correct in all material respects, in each
case as of the date hereof and the Closing Date as though made on and as of such date
(unless any such representation or warranty is made only as of a specific date, in which
event such representation and warranty shall be true and correct in all material respects as
of such specified date);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Each of Onyx and its Designated Affiliates shall have performed in all material
respects the material obligations, and complied in all material respects with the material
agreements and covenants, required to be performed by or complied with by it under this
Separation Agreement at or prior to the Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Each of the Company and SV shall have received a certificate of an executive
officer of Onyx, certifying that the conditions set forth in Sections&nbsp;9.1(c)(1) and (2)&nbsp;have
been satisfied.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Additional Conditions to the Obligation of the Company</U>. The obligations of the
Company to consummate the transactions contemplated hereby shall be further subject to the Company
having received, at Onyx&#146;s expense, an opinion in form and substance reasonably acceptable to the
Company, of a nationally recognized independent valuation firm reasonably acceptable to the
Company, addressed to the Company&#146;s Board of Directors and dated as of the Closing Date, to the
effect that immediately after giving effect to the transactions contemplated by this Separation
Agreement, the Standalone Drug Sale Agreement and the Merger Agreement, including the Financing,
any alternative financing, any other repayment or
</DIV>

<P align="center" style="font-size: 10pt">60
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">refinancing of debt contemplated in this Separation Agreement, payment of all amounts required to be paid in connection with the
consummation of the transactions contemplated by the Separation Agreement, the Standalone Drug Sale
Agreement and the Merger Agreement, and payment of all related fees and expenses, each of Onyx and
the Company are Solvent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.2 <U>Termination Prior to the Closing</U>. (a) <U>Termination by Mutual
Consent</U>. This Separation Agreement may be terminated at any time prior to the Closing upon the
mutual written consent of the Company, SV and Onyx.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;<U>Automatic Termination</U>. This Separation Agreement shall terminate automatically
upon any termination of the Merger Agreement or the Standalone Drug Sale Agreement in accordance
with the terms thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;<U>Termination by Onyx</U>. This Separation Agreement may be terminated at any time
prior to the Closing by written notice from Onyx to each other party if the Closing shall not have
been consummated by the Termination Date (as defined in the Merger Agreement).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;<U>Termination by Any Party</U>. This Separation Agreement may be terminated at any time
prior to the Closing by written notice from any party to each other party if (1)&nbsp;any Authority of
competent jurisdiction shall have issued a final order, decree or ruling or taken any other action
permanently enjoining, restraining or otherwise prohibiting the consummation of the transactions
contemplated by this Separation Agreement and such order, decree or ruling or other action shall
have become final and nonappealable or (2)&nbsp;there shall have been a material failure of any
representation or warranty of any other party to be true or a material breach of any covenant or
agreement of another party contained in this Separation Agreement such that the conditions set
forth in Section&nbsp;9.1(b) or (c)&nbsp;would not be satisfied, and such breach or failure to be true is not
cured (if curable) prior to the earlier of (i)&nbsp;20 Business Days following notice of such breach (it
being understood that such 20 Business Day period shall not be applicable to covenants or
agreements that by their terms are intended to be satisfied at Closing) and (ii)&nbsp;the Termination
Date; <U>provided</U> that the right to terminate this Separation Agreement pursuant to this
Section&nbsp;9.2(d)(2) shall not be available to the party seeking to terminate if any action of such
party or the failure of such party to perform any of its obligations under this Separation
Agreement required to be performed at or prior to the Closing has been the cause of, or resulted in, the failure of the Closing to occur on or before the Termination
Date and such action or failure to perform constitutes a breach of this Separation Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.3 <U>Effect of Termination</U>. (a)&nbsp;Except as provided below, in the event of the
termination of this Separation Agreement pursuant to Section&nbsp;9.2, this Separation Agreement shall
forthwith become void and there shall be no liability or obligation on the part of any party
hereto, except with respect to this Article&nbsp;IX and Section&nbsp;6.7, which shall survive such
termination; <U>provided</U>, <U>however</U>, that nothing herein shall relieve any party from
liability for any willful or intentional material breach of this Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Onyx agrees that, if the Company, New Diamond or SV shall terminate this Separation
Agreement pursuant to Section&nbsp;9.2(d)(2) on account of a breach of this Separation Agreement by Onyx
then Onyx shall be liable for damages equal in the aggregate to
</DIV>

<P align="center" style="font-size: 10pt">61
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">$100,000,000 (one hundred million dollars) (the &#147;<U>Onyx Termination Fee</U>&#148;), two-thirds of which shall be paid to the Company and
one-third of which shall be paid to SV. The Onyx Termination Fee shall be paid promptly in
immediately available funds no later than two Business Days after such termination by the Company,
New Diamond or SV. Subject to the rights of the Company and SV as third-party beneficiaries under
the Financing Commitment in respect of the Onyx Termination Fee, the obligation of Onyx to make
such payment to SV and the Company shall be the sole remedy and recourse of the Company, New
Diamond or SV arising out of such breach by Onyx of this Separation Agreement. The Company and SV
agree that any claim that SV has or may have against Onyx or the Sponsor relating to the Onyx
Termination Fee or otherwise under the Financing Commitment shall be subordinated in right of
payment to the payment in full of any claim that the Company has or may have against Onyx or the
Sponsor under the Financing Commitment relating to the payment of the Onyx Termination Fee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.4 <U>No Survival</U>. None of the representations and warranties in this
Separation Agreement or in any instrument delivered pursuant to this Separation Agreement, and the
other agreements and documents contemplated to be delivered in connection herewith, including any
rights arising out of any breach of such representations and warranties shall, in the event Closing
occurs, survive the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.5 <U>Entire Agreement; Third Party Beneficiaries</U>. This Separation Agreement
(together with the documents and instruments referred to herein, including the Merger Agreement,
the Ancillary Agreements, including the Transition Services Agreement) (a)&nbsp;constitutes the entire
agreement and supersedes all other prior agreements and understandings, both written and oral,
among the parties with respect to the subject matter hereof, and (b)&nbsp;is not intended to confer upon
any person other than the parties hereto and thereto any rights or remedies; <U>provided</U>,
<U>however</U>, that the Indemnified Directors or Officers and the Indemnitees are intended to be
third party beneficiaries of the provisions of Articles IV and V and each of such persons shall
have the right to enforce such provisions as if they were parties hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.6 <U>Fees and Expenses</U>. Except as otherwise specifically provided in this
Separation Agreement, all costs, expenses incurred by the parties hereto in connection with this Separation Agreement, the
Merger Agreement and the transactions contemplated hereunder and thereunder shall be paid by the
party hereto or thereto incurring such costs or expenses.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.7 <U>No Waiver</U>. No waiver by any party hereto of any breach of any covenant,
agreement, representation or warranty hereunder shall be deemed a waiver of any preceding or
succeeding breach of the same. The exercise of any right granted to any party in this Separation
Agreement shall not operate as a waiver of any default or breach on the part of the other parties
hereto. Each and all of the several rights and remedies of any party hereto under this Separation
Agreement shall be construed as cumulative and no one right as exclusive of the others.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.8 <U>Amendments</U>. No change, modification, alteration, amendment or agreement
to discharge in whole or in part, or waiver of, any of the terms and conditions of this Separation
Agreement, shall be binding upon any party, unless the same shall be made by a written instrument
signed and executed by the authorized representatives of each party, with the same formality as the
execution of this Separation Agreement.
</DIV>


<P align="center" style="font-size: 10pt">62
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.9 <U>Governing Law</U>. This Separation Agreement shall be governed by, and
construed in accordance with, the laws of the State of Delaware (without giving effect to choice of
law principles thereof).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.10 <U>Notices</U>. (a)&nbsp;All notices, requests and demands to or upon the
respective parties hereto, and all statements and accountings given or required to be given
hereunder, shall be made by personal service, or sent by certified mail, return receipt requested,
postage prepaid, or by facsimile addressed as follows, or to such other address as may hereafter be
designated in writing by the respective parties hereto, and shall be deemed received when delivered
to the designated address (and only if confirmed if delivered by facsimile):
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="0%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="53%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">(1</TD>
    <TD nowrap valign="top">)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">if to the Company, to
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Albertson&#146;s, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">250 East Parkcenter Boulevard</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Boise, ID 83706</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attn: Corporate Secretary</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile: (208)&nbsp;395-6349</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">with a copy to</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jones Day</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">North Point</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">901 Lakeside Avenue</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Cleveland, OH 44114</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attn: Lyle G. Ganske, Esq.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile: (216)&nbsp;579-0212</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">and</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jones Day</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">2727 North Harwood Street</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Dallas, TX 75201</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attn: Mark E. Betzen, Esq.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile: (214)&nbsp;969-5100</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">and</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">(2</TD>
    <TD nowrap valign="top">)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">if to Onyx, to</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">AB Acquisition LLC</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">c/o Cerberus Capital Management, L.P.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">299 Park Avenue</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York, NY 10171</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attn: Lenard Tessler</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile: (212)&nbsp;755-3009</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">63
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="15%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="0%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="53%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="24%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">with a copy to</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Schulte Roth &#038; Zabel LLP</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">919 Third Avenue</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York, NY 10022</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attn: Stuart D. Freedman, Esq.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile: (212)&nbsp;593-5955</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">and</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">(3</TD>
    <TD nowrap valign="top">)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">if to SV, to</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SUPERVALU, Inc.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">11840 Valley View Road</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Eden Prairie, MN 55344</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attn: Corporate Secretary</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile: (952)&nbsp;828-8900</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">with a copy to</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Wachtell, Lipton, Rosen &#038; Katz</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">51 West 52nd Street</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">New York, NY 10019</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Attn: Andrew R. Brownstein, Esq.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Igor Kirman, Esq.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Facsimile: (212)&nbsp;403-2393</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the extent not otherwise to be provided under the Merger Agreement, each of SV and the
Company agrees to deliver to each of Onyx and New Diamond copies of all notices, requests and demands to or from the parties to the Merger Agreement,
and all certificates, statements and accountings delivered or given or required to be delivered or
given under the Merger Agreement, each such delivery to be made in accordance with the procedures
set forth in Section&nbsp;9.10(a); <U>provided</U>, <U>however</U>, that if SV or the Company elects
to deliver any such notice, request, demand or certificate, statement or accounting by certified
mail as permitted by Section&nbsp;9.10(a), a copy thereof will also be delivered to each of Onyx and New
Diamond by personal service or by confirmed facsimile in accordance with Section&nbsp;9.10(a).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.11 <U>Interpretation</U>. The headings contained in this Separation Agreement are
for reference purposes only and shall not affect in any way the meaning or interpretation of this
Separation Agreement. In this Separation Agreement, unless a contrary intention appears, (a)&nbsp;the
words &#147;herein,&#148; &#147;hereof&#148; and &#147;hereunder&#148; and other words of similar import refer to this Separation
Agreement as a whole and not to any particular Article, Section, Schedule, Exhibit or other
subdivision, (b)&nbsp;whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this
Separation Agreement, they shall be deemed to be followed by the words &#147;without limitation,&#148; (c)
reference to any Article, Section, Schedule or Exhibit is reference to such Article or Section of,
or Schedule or Exhibit to, this Separation Agreement, (d) &#147;days&#148; means calendar days, (e)&nbsp;all
defined terms in this Separation Agreement have the defined meaning when used in any certificate or
other document made or delivered pursuant to this
</DIV>


<P align="center" style="font-size: 10pt">64
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Separation Agreement, unless otherwise indicated therein, (f)&nbsp;all defined terms in this Separation Agreement are applicable to the singular as well
as the plural forms of such terms and to the masculine as well as to the feminine and neuter
genders of such term, and in each case, vice versa, (g)&nbsp;references in this Separation Agreement to
specific Laws (such as the Code, HSR Act and ERISA) or to specific provisions of Laws include all
rules and regulations promulgated thereunder, (h) &#147;person&#148; means any natural person or any
corporation, association, partnership, joint venture, limited liability, joint stock or other
company or trust, (i)&nbsp;references to the &#147;Company and each of its Subsidiaries,&#148; the &#147;Subsidiaries
of the Company,&#148; and other similar phrases, with respect to any time prior to the Closing, shall be
deemed to include reference to each of the Subsidiaries of the Company without giving effect to the
transfer of ownership of the New Diamond Entities at Closing, (j)&nbsp;items listed or included within a
definition are so listed or included without duplication, (k)&nbsp;any statute defined or referred to
herein or in any agreement or instrument referred to herein means such statute as from time to time
amended, modified or supplemented, including by succession of comparable successor statutes, and
(l)&nbsp;if and to the extent any party designates a Designated Affiliate pursuant to the terms hereof,
such Designated Affiliate shall be deemed to be a party to this Separation Agreement and to have
made any representations and warranties contained in this Separation Agreement as of the time of
such designation, and any action or undertaking required of such Designated Affiliate pursuant to
the terms of this Separation Agreement shall become an obligation of such Designated Affiliate as
of the time of such designation. No provisions of this Separation Agreement shall be interpreted
or construed against any party hereto solely because such party or its legal representative drafted
such provision.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.12 <U>Counterparts</U>. This Separation Agreement may be executed simultaneously
in any number of counterparts, each of which shall be deemed an original but all of which together
shall constitute one and the same instrument.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.13 <U>Specific Performance</U>. The parties agree that if for any reason any of
the provisions of this Separation Agreement are not performed in accordance with their specific
terms or are otherwise breached, immediate and irreparable harm or injury would be caused for which
money damages would not be an adequate remedy. Accordingly, each party agrees that, in addition to
any other available remedy at law or equity, each party shall be entitled to an injunction
restraining any violation or threatened violation of the provisions of this Separation Agreement
without the necessity of posting a bond or other form of security. In the event that any Action
should be brought in equity to enforce the provisions of this Separation Agreement, no party will
allege, and each party hereby waives the defense, that there is an adequate remedy at law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.14 <U>Successors and Assigns</U>. (a)&nbsp;This Separation Agreement shall inure to
the benefit of and be binding upon the respective successors and permitted assigns of the parties
hereto, but any such assignment by any party hereto shall not relieve such assigning party of any
of its obligations or agreements hereunder unless expressly agreed to in writing by each other
party hereto in its sole discretion; <U>provided</U>, <U>however</U>, that no party may assign,
delegate or otherwise transfer any of its rights or obligations under this Separation Agreement
without the consent of each other party hereto, except that from and after the Closing Date this
Separation Agreement may be assigned to a lender of a party as collateral for indebtedness,
provided that the party making such assignment shall not be released from its obligations hereunder
and the
</DIV>


<P align="center" style="font-size: 10pt">65
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">non-assigning party shall have no obligation to pursue remedies against any assignee before
proceeding against assignor for any breach of any of its obligations hereunder; <U>provided</U>,
<U>further</U>, that nothing contained in this Section&nbsp;9.14(a) shall prevent Onyx, New Diamond,
SV or the Company (but, in the case of the Company, only after the Effective Time) from assigning
from transferring or assigning this Separation Agreement or its rights and obligations hereunder to
a Designated Affiliate, in either case, so long as such assignment or transfer does not purport to
relieve the assignee of its obligations hereunder. Any attempted assignment in violation of the
foregoing shall be null and void.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;To the extent that the Company, Onyx and/or one of more its Designated Affiliates or any
of their respective Subsidiaries, directly or indirectly, whether by merger, transfer of assets,
transfer of stock, operation of law, license or otherwise, transfers, licenses or otherwise
disposes of, in one or more transactions, to any other person all or substantially all of the
Retained Assets each owns immediately after the Closing or the Retained Business, Onyx or such
Designated Affiliate or such Subsidiary will cause the transferee of such Retained Assets to assume
specifically such transferor&#146;s and the Company&#146;s obligations under this Separation Agreement with
respect thereto. Such assumption will not relieve the transferor of its obligations in respect
thereof. To the extent that New Diamond and/or one or more of their Designated Affiliates or any
of their respective Subsidiaries, directly or indirectly, whether by merger, transfer of assets,
transfer of stock, operation of law, license or otherwise, transfers, licenses or otherwise
disposes of, in one or more transactions, to any other person all or substantially all of the New
Diamond Assets or the New Diamond Business, the transferor will cause the transferee of such New
Diamond Assets or New Diamond Business to assume specifically its obligations under this Separation
Agreement with respect thereto. Such assumption will not relieve the transferor of its obligations
in respect thereof. The parties agree that such transferee may exercise all of the transferring party&#146;s rights hereunder, as the
case may be, with respect to such Assets or businesses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.15 <U>Severability</U>. If any term or other provision of this Separation
Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of
being enforced, all other terms and provisions of this Separation Agreement shall nevertheless
remain in full force and effect. Upon such determination that any term or other provision is
invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith
to modify this Separation Agreement so as to effect the original intent of the parties as closely
as possible in a mutually acceptable manner.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.16 <U>Jurisdiction; Venue; Consent to Service of Process</U>. (a)&nbsp;Except as
otherwise provided in Section&nbsp;2.7, 2.8 or 4.9, each of the parties hereto (a)&nbsp;consents to submit
itself to the exclusive personal jurisdiction of the Delaware Court of Chancery and any Federal
court located in the State of Delaware in the event of any Action arising out of or relating to
this Separation Agreement or any of the transactions contemplated by this Separation Agreement, (b)
agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other
request for leave from any such court, and (c)&nbsp;agrees that it will not bring any Action arising out
of or relating to this Separation Agreement or any of the transactions contemplated by this
Separation Agreement in any court other than the Delaware Court of Chancery or a Federal court
sitting in the State of Delaware. In any Action arising out of or relating to this Separation
Agreement or any of the transactions contemplated by this Separation Agreement, each party

<P align="center" style="font-size: 10pt">66
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">irrevocably and unconditionally waives and agrees not to assert by way of motion, as a defense or
otherwise any claims that it is not subject to the jurisdiction of the above courts, that such
Action is brought in an inconvenient forum or that the venue of such Action is improper. Each of
the parties also hereby agrees that any final and unappealable Judgment against a party in
connection with any such Action shall be conclusive and binding on such party and that such award
or Judgment may be enforced in any court of competent jurisdiction, either within or outside of the
United States. A certified or exemplified copy of such Judgment shall be conclusive evidence of
the fact and amount of such Judgment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each party hereto irrevocably consents to service of process in the manner provided for
the giving of notices pursuant to Section&nbsp;9.10 of this Separation Agreement. Nothing in this
Section&nbsp;9.16 shall affect the right of any party to serve process in any other manner permitted by
applicable Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.17 <U>Waiver of Jury Trial</U>. To the fullest extent permitted by Law, each of
the parties irrevocably waives all right to trial by jury in any Action or counterclaim arising out
of or relating to this Separation Agreement or any of the transactions contemplated by this
Separation Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.18 <U>Company Disclosure Letter</U>. There may have been included in the Company
Disclosure Letter and may be included elsewhere in this Separation Agreement items which are not
&#147;material,&#148; and such inclusion shall not be deemed to be an acknowledgment or agreement by the
Company that such items are &#147;material&#148; or to affect the interpretation of such term for
purposes of this Separation Agreement. Disclosures included in any Section of the Company
Disclosure Letter shall be considered to be made for purposes of all other Sections of the Company
Disclosure Letter to the extent that the relevance of any such disclosure to any other Section of
the Company Disclosure Letter is reasonably apparent from the text of such disclosure. The
inclusion of any items or information in the Company Disclosure Letter shall not be construed as an
admission that such item or information (or any non-disclosed item or information of comparable or
greater significance) is material or otherwise required to be scheduled as an exception from any
representation, warranty or covenant. Matters reflected in the Company Disclosure Letter are not
necessarily limited to matters required by the Agreement to be disclosed in the Company Disclosure
Letter.
</DIV>



<P align="center" style="font-size: 10pt">67
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties have caused this Separation Agreement to be signed by their
respective officers thereunto duly authorized as of the date first written above.
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ALBERTSON&#146;S, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/  John R. Sims
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John R. Sims&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President and General Counsel&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">NEW ALOHA CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">SUPERVALU, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/
Jeff Noodle</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Jeff Noodle</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Chairman &amp; CEO</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AB ACQUISITION LLC<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/
Lenard Tessler</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Lenard Tessler</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Authorized Signatory</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.03
<SEQUENCE>4
<FILENAME>l18113aexv2w03.htm
<DESCRIPTION>EX-2.03 ASSET PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-2.03 Asset Purchase Agreement</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit 2.03</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ASSET PURCHASE AGREEMENT</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">dated as of
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">January&nbsp;22, 2006
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">among
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>CVS CORPORATION</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>CVS PHARMACY, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>ALBERTSON&#146;S, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>SUPERVALU INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>NEW ALOHA CORPORATION</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt">and
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>THE SELLERS LISTED ON ANNEX A ATTACHED HERETO</B>
</DIV>


<P align="center" style="font-size: 10pt">
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>TABLE OF CONTENTS</B></U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 1 Purchase and Sale</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.01. Purchase and Sale</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.02. Excluded Assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">3</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.03. Assumed Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.04. Excluded Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">6</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.05. Consents; Assignment of Contracts and Rights</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">7</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.06. Purchase Price</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">8</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.07. Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.08. Prorations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.09. Removal of Equipment and Signage</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;1.10 La Habra Inventory Adjustment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 2 Representations and Warranties of Albertson&#146;s</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.01. Organization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">11</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.02. Authority; Enforceability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.03. Non-Contravention; Assigned Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.04. Governmental Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.05. Litigation;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.06. Compliance with Law</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">13</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.07. Real Property</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.08. Title to the Purchased Assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.09. IT Systems</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">14</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.10. Sufficiency of Assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.11. Labor Relations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.12. Environmental Compliance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">15</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.13. Financial Schedules</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">16</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.14. No Undisclosed Liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.15. Absence of Certain Changes or Events</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.16. Finders&#146; Fees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;2.17. Healthcare Regulatory</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 3 Representations and Warranties of Parent and Buyer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;3.01. Organization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;3.02. Authority; Enforceability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;3.03. Non-Contravention</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">ii
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;3.04. Governmental Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;3.05. Financing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;3.06. Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 4 Representations and Warranties of SUPERVALU</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;4.01. Organization</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;4.02. Authority; Enforceability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;4.03. Non-Contravention</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;4.04. Governmental Consents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;4.05. Brokers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 5 Covenants of The Sellers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.01. Conduct of the Standalone Drug Business</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">21</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.02. Access to Information; Confidentiality</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">23</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.03. Notices of Certain Events</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.04. Noncompetition; Cooperation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">25</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.05. Prescription Files</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.06. Casualty and Condemnation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">26</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.07. Assistance in Transfer of Licenses, Permits and Registrations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">27</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.08. Controlled Substances Inventory</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.09. Updated Store List</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.10. Financial Reports; Audited Financials</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">28</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.11. Intercompany Leases</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;5.12. Merger Agreement; Separation Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 6 Covenants of Buyer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;6.01. Confidentiality</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">29</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;6.02. Access</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;6.03. Guarantee Releases under Certain Contracts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;6.04. Contractual Overpayments</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;6.05. Medicare And Medicaid Provider Numbers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 7 Covenants of Buyer and the Sellers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.01. Reasonable Best Efforts; Further Assurances</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.02. HSR Clearance</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">31</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.03. Certain Filings</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.04. Public Announcements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">32</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">iii
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.05. Trademarks; Tradenames</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">33</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.06. Accounts Receivables; Gift Cards and Gift Certificates; Prepaid
Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.07. Transition Services Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.08. HIPAA Privacy Standards</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.09. Solicitation of Employees</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.10. Kodak and Qualex Photo Processing Equipment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">34</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.11. &#147;As Is&#148; Condition; Waiver and Release</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.12. Payments for Pharmacy Services</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;7.13. Confidentiality Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">35</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 8 Tax Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;8.01. Tax Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;8.02. Tax Cooperation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 9 Employee Benefits</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;9.01. ERISA Representations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">37</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;9.02. Employees and Offers of Employment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;9.03. The Sellers&#146; Employee Benefit Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">38</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;9.04. Buyer Benefit Plans</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;9.05. Labor Agreements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">39</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;9.06. Employee Compensation</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">41</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;9.07. Employee Indemnity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;9.08. No Third Party Beneficiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 10 Conditions to Closing</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;10.01. Conditions to Each Party&#146;s Obligations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">42</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;10.02. Conditions to Obligation of Buyer</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;10.03. Conditions to Obligation of the Sellers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 11 Survival; Indemnification</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;11.01. Survival</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">43</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;11.02. Indemnification</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">44</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;11.03. Procedures</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">45</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 12 Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;12.01. Grounds for Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">47</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;12.02. Effect of Termination</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">iv
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">ARTICLE 13 Miscellaneous</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.01. Definitions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">48</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.02. Notices</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">54</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.03. Amendments and Waivers</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.04. Expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.05. Successors and Assigns</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.06. Governing Law</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.07. Specific Performance; Jurisdiction</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.08. WAIVER OF JURY TRIAL</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">56</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.09. Counterparts; Effectiveness; Third Party Beneficiaries</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.10. Other Definitional and Interpretative Provisions</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.11. Entire Agreement</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.12. Severability</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.13. Bulk Transfer Laws</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">57</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Section&nbsp;13.14. Guaranty</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">58</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="13%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="82%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Annex A
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sellers</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;A
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">List of Owned Stores</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;B
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">List of Ground Lease Stores</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;C
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">List of Leased Stores</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;D
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Assignment and Assumption Agreement</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;E
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Forms of Lease Assignment and Assumption Agreement</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;F
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Form of Standalone Drug Business Transition Services Agreement</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Exhibit&nbsp;G
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Distribution Center Transition Services Agreement Term Sheet</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="34%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="61%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;1.01(f)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assumed Labor Agreements</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;1.01(g)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assigned Contracts</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;1.02(a)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Excluded Equipment</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.01(b)(i)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Lease Optional Extensions to be Exercised</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.01(b)(ii)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Stores to be Closed</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;5.02(a)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transition Planning Related Activities</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;7.09</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employees Buyer May Solicit</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;9.02(a)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Offers of Employment</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Schedule&nbsp;9.02(b)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Divisional Pharmacy Managers</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">v

</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ASSET PURCHASE AGREEMENT</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT dated as of January&nbsp;22, 2006, among CVS Pharmacy, Inc., a Rhode Island corporation
(&#147;<B>Buyer</B>&#148;), CVS Corporation, a Delaware corporation (&#147;<B>Parent</B>&#148;), Albertson&#146;s, Inc., a Delaware
corporation (&#147;<B>Albertson&#146;s</B>&#148;), New Aloha Corporation, a Delaware corporation and wholly owned
subsidiary of Albertson&#146;s (&#147;<B>New Diamond</B>&#148;), SUPERVALU INC., a Delaware corporation (&#147;<B>SUPERVALU</B>&#148;),
and the entities listed on Annex A, each of which is directly or indirectly wholly owned by
Albertson&#146;s as of the date hereof (such entities listed on Annex A together with Albertson&#146;s, the
&#147;<B>Sellers</B>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>W I T N E S S E T H :</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Sellers conduct retail drug store and pharmacy businesses in freestanding Stores
(as defined below) through the operation of the Owned Stores, the Ground Lease Stores, the Leased
Stores and the Distribution Center (as each term is defined below) (such business, the &#147;<B>Standalone
Drug Business</B>&#148;; for the avoidance of doubt, the parties acknowledge and agree that the Standalone
Drug Business excludes Seller&#146;s retail drug store and pharmacy businesses located in the same
building as, and with common entrances to, grocery stores (the &#147;<B>Retained Combo Drug Stores</B>&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Buyer desires to purchase the Purchased Assets (as defined below) relating to the
Standalone Drug Business from the Sellers and to assume certain related liabilities, and the
Sellers desire to sell such Purchased Assets to Buyer, upon the terms and subject to the conditions
set forth herein; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Sellers (i)&nbsp;own the drug stores and the real property associated with the drug
stores listed on Exhibit&nbsp;A hereto (the &#147;<B>Owned Stores</B>&#148;); (ii)&nbsp;own the drug stores and lease the real
property associated with the drug stores listed on Exhibit&nbsp;B hereto (the &#147;<B>Ground Lease Stores</B>&#148;);
(iii)&nbsp;lease the drug stores listed on Exhibit&nbsp;C hereto (the &#147;<B>Leased Stores</B>&#148; and collectively with
the Owned Stores and the Ground Lease Stores, the &#147;<B>Stores</B>&#148; and each individually, a &#147;<B>Store</B>&#148;); and
(iv)&nbsp;own the Distribution Center (collectively with the Stores, the &#147;<B>Facilities</B>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and the mutual covenants and agreements
herein contained, and intending to be legally bound hereby, the parties hereto agree as follows:
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 1</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Purchase and Sale</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.01. <I>Purchase and Sale</I>. Except as otherwise provided below, upon the terms and
subject to the conditions of this Agreement, Buyer agrees to purchase from the Sellers and the
Sellers agree to sell, convey, transfer, assign and deliver, or cause to be sold, conveyed,
transferred, assigned and delivered, to Buyer at the Effective Time, all of the Sellers&#146; right,
title and interest in, to and under the assets primarily related to the Standalone Drug Business
including the following assets and properties, wherever located, real, personal or mixed, tangible
or intangible, as the same shall exist at the Effective Time, including all such assets acquired by
</DIV>

<P align="center" style="font-size: 10pt">
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Sellers between the date hereof and the Effective Time (the &#147;<B>Purchased Assets</B>&#148;), but
excluding the Excluded Assets:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the real property owned by the Sellers and associated with the Owned Stores or the
Distribution Center (the &#147;<B>Owned Real Property</B>&#148;) and the tenants&#146; interests in the ground
leases associated with the Ground Lease Stores (the real property associated with the Ground
Lease Stores being referred to as the &#147;<B>Ground Leased Real Property</B>&#148;), together with all
buildings, structures, installations, fixtures, trade fixtures, building equipment and other
improvements owned by the Sellers located on or attached to the Owned Real Property or
Ground Leased Real Property (and all title documents, surveys, related construction plans
and documents and related real estate files with respect to the Owned Real Property and
Ground Leased Real Property);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the Store Leases (the real property leased pursuant to the Store Leases is referred
to collectively as the &#147;<B>Leased Real Property</B>&#148; and together with the Owned Real Property and
the Ground Leased Real Property, the &#147;<B>Real Property</B>&#148;), and all Store Lease documents,
related construction plans and documents and related real estate files;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) all fixed assets and tangible personal property (other than the Inventory) at the
Facilities and owned by the Sellers, including fixtures, trade fixtures, building equipment,
fittings, furniture, computer hardware, office equipment, and other tangible property, but
excluding the Excluded Equipment;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) all pharmaceutical and non-pharmaceutical inventories at the Facilities and owned
by the Sellers (including private label inventory) and supplies (including containers,
labels and packaging items) (collectively, the &#147;<B>Inventory</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) except to the extent prohibited by Law, all prescription files owned and used by
the Sellers that are associated with the Stores (it being understood that Sellers will
retain the prescription files that are associated with the Retained Combo Drug Stores) (the
&#147;<B>Prescription Files</B>&#148;) and all customer data and information derived from branded customer
loyalty promotions, co-branded credit card programs and other similar programs related to
customer purchases at the Stores;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) the Labor Agreements set forth on Schedule&nbsp;1.01(f) (such Labor Agreements, the
&#147;<B>Assumed Labor Agreements</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) all Real Property Documents, Construction Contracts, and all contracts, agreements,
leases, licenses, commitments, sales and purchase orders and other instruments listed on
Schedule&nbsp;1.01(g) (collectively with the Assumed Labor Agreements, the &#147;<B>Assigned Contracts</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) to the extent assignable or transferable, all guarantees and warranties of third
parties to the extent that they relate to the ownership or operation of the Standalone Drug
Business or the Purchased Assets;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) subject to Section&nbsp;7.06(c), all of the Sellers&#146; security deposits, prepaid rent and
prepaid expenses previously paid by the Sellers to fulfill the Sellers&#146; obligations
</DIV>

<P align="center" style="font-size: 10pt">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">under the Store Leases and the Ground Leases where (if and to the extent such consent
is expressly required by the applicable Store Lease or Ground Lease) the landlord thereunder
has consented in writing to the transfer of the deposits to Buyer and, to the extent
transferable, all vendor, utility and other deposits relating to the Facilities (&#147;<B>Prepaid
Expenses</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) all transferable or assignable telephone and facsimile numbers associated with
phone lines terminating at the Facilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) all transferable or assignable licenses, permits or other governmental
authorizations that are exclusively related to the Facilities or the Purchased Assets,
including pharmacy, liquor, tobacco and similar licenses (&#147;<B>Licenses</B>&#148;; for the avoidance of
doubt the parties acknowledge and agree that &#147;Licenses&#148; shall not include any licenses,
permits or other governmental authorizations that relate to operation of Retained Combo Drug
Stores);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) cash in cash registers at each Store in an amount equal to $2,000 for each Store
(&#147;<B>Petty Cash</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) all forklifts and motor vehicles (trucks, vans, and autos) primarily related to the
Distribution Center and all motor vehicles exclusively used by field management transferred
to Buyer immediately following the Closing (the &#147;<B>Transferred Vehicles</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) all trailers and tractors relating to the Distribution Center and the distribution
centers located at Brea, California and Irvine, California (approximately 845 trailers, 117
tractors) will be equitably assigned to these three facilities based on mutually agreed upon
operating metrics;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) all reimbursements on account of Prorated Charges (as defined herein) due and owing
to Buyer pursuant to Section&nbsp;1.08; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) all books, records, files and papers, whether in hard copy or computer format,
located at the Facilities or relating primarily to the Purchased Assets (and copies of any
other relevant books, records, files and papers to the extent relating to the Purchased
Assets).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.02. <I>Excluded Assets</I>. Buyer and the Sellers expressly understand and agree that,
notwithstanding anything to the contrary contained herein, the following assets and properties of
the Sellers prior to the Closing (the &#147;<B>Excluded Assets</B>&#148;) shall be excluded from the Purchased
Assets and, except as otherwise provided in the Separation Agreement, shall be assets and
properties of New Diamond following the Closing:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all (i)&nbsp;motor vehicles (trucks, vans, and autos) and rail, truck and sea containers
other than the Transferred Vehicles or as otherwise allocated pursuant to Section&nbsp;1.01(m)
and (ii)&nbsp;all other fixed assets and tangible personal property set forth on Schedule&nbsp;1.02(a)
(collectively, the &#147;<B>Excluded Equipment</B>&#148;);
</DIV>

<P align="center" style="font-size: 10pt">3
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) all of the cash and cash equivalents of the Sellers on hand (including all cash,
cash equivalents and working funds in cash registers at each Store) and in banks other than
Petty Cash;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) all accounts receivable relating to the Standalone Drug Business owed to the
Sellers or any of their Affiliates prior to the Effective Time, including delinquent rent
payments, tenant reimbursements and refunds of insurance premiums accruing to, or held for,
the benefit of the Sellers (the &#147;<B>Accounts Receivable</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) except as provided under Section&nbsp;5.06, all insurance policies relating to the
Standalone Drug Business or the Purchased Assets;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) any refund or credit of Taxes to the extent attributable to any Pre-Closing Tax
Period or to any Taxes for which Sellers, New Diamond or SUPERVALU are responsible;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) all equipment owned by third parties who are not affiliated with Sellers and all
leased equipment located at or used in the Facilities, in each case in such categories of
excluded equipment as are set forth in Schedule&nbsp;1.02(a);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) all computer software owned or used by the Sellers or their Affiliates;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) all contracts, agreement, leases, licenses, commitments, sales and purchase orders
and other instruments (which may include tax indemnity agreements) other than the Assigned
Contracts;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) all trademarks, service marks, trade names, logos, patents and similar intangibles
owned by the Sellers or used in connection with the operation of the Facilities;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) all rebates and refunds arising from the operation of the Facilities prior to the
Effective Time;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) all undeposited or uncollected checks and food stamps held by the Sellers prior to
the Effective Time;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) all signs or personal property that contain the name (or trade derivative thereof),
trademarks, servicemarks, trade names or logo of the Sellers or any of their Affiliates,
including all uniforms supplied to the Sellers&#146; employees;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) any Purchased Assets sold or otherwise disposed of without violating any provisions
of this Agreement during the period from the date hereof until the Effective Time;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) all world wide web or other internet addresses, sites and domain names and internet
protocol address spaces;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) the Sellers&#146; phone networks, internet mail and computer networks;
</DIV>

<P align="center" style="font-size: 10pt">4
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) all customer data and information derived from branded customer loyalty promotions,
co-branded credit card programs and other similar programs other than such customer data and
information relating to customer purchases at the Stores;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(q) all provider agreements for the Medicare and Medicaid programs, including all
applicable provider numbers;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(r) any lease, sublease, license, sublicense or other contract relating to the
installation, use or operation of ATM&#146;s or similar banking machines, in-store banking
facilities, or slot machines or other gaming devices located at the Stores (and any interest
of the Sellers in such equipment), except to the extent assignment to Buyer is required by
the applicable agreement; <I>provided</I>, <I>however</I>, that Buyer shall allow each bank operating
ATM&#146;s or other in-store banking facilities and licensees of any kind to continue to operate
in the relevant Store for up to 180&nbsp;days (or such greater time as required by Law) after
receipt of notice from the Sellers informing each such bank or licensee of the transfer of
the relevant Store to Buyer;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(s) all assets primarily related to the sale of inventory conducted through any website
operated by or on behalf of Albertson&#146;s or any of its Affiliates;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(t) all reimbursements on account of Prorated Charges (as defined herein) due and owing
to Sellers pursuant to Section&nbsp;1.08;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(u) all books and records to the extent relating to any Excluded Asset; <I>provided,
however, </I>that Buyer will be entitled to copies of any other relevant books, records, files
and papers to the extent relating to the Purchased Assets or to the extent relevant for
normal course accounting after the Closing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) all firearms or any merchandise related to firearms, ammunition or similar items,
in each case to the extent non-transferable under applicable Law; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(w) all audiotapes, videotapes or DVDs available for rental and not owned by Sellers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.03. <I>Assumed Liabilities</I>. Upon the terms and subject to the conditions of this
Agreement, Buyer hereby assumes, effective at the Effective Time, and shall thereafter pay, perform
or otherwise discharge when due, the following liabilities and obligations (the &#147;<B>Assumed
Liabilities</B>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all liabilities and obligations of the Sellers under each Store Lease, Ground Lease
and Assigned Contract;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) all amounts allocated to Buyer under Section&nbsp;1.08 and all Apportioned Obligations
and Transfer Taxes allocated to Buyer pursuant to Section&nbsp;8.02;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) all liabilities or obligations for Taxes with respect to the Standalone Drug
Business or the Purchased Assets related to a Post-Closing Tax Period (except for Taxes set
forth in Section&nbsp;1.04(iv)(B) below);
</DIV>

<P align="center" style="font-size: 10pt">5
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) all liabilities and obligations expressly assumed by Buyer under Article&nbsp;9;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) liabilities and obligations directly arising from, or in connection with, the
validity of the real estate interest in any Owned Real Property or from or in connection
with the right to occupy any Owned Real Property (excluding for avoidance of doubt any
personal injury tort liability, any liability arising from operation of the Standalone Drug
Business, or any liability or amount prorated under Section&nbsp;1.08); and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) all Environmental Liabilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.04. <I>Excluded Liabilities</I>. Notwithstanding any provision in this Agreement or any
other writing to the contrary, Buyer is assuming only the Assumed Liabilities and is not assuming
any other liability or obligation of any Seller of whatever nature (fixed or contingent, known or
unknown), whether presently in existence or arising hereafter. All such other liabilities and
obligations shall be retained by and remain obligations and liabilities of the Sellers (all such
liabilities and obligations not being assumed being herein referred to as the &#147;<B>Excluded
Liabilities</B>&#148;). For the avoidance of doubt (but without overriding the Assumed Liabilities in
Section&nbsp;1.03), Excluded Liabilities include the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any liability or obligation resulting from or arising out of the conduct of
the supermarket business of the Sellers (including the operation of pharmacy
counters in supermarkets), any other business of the Sellers other than the
Standalone Drug Business, or any Excluded Asset;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) all amounts allocated to Sellers under Section&nbsp;1.08 and all Apportioned
Obligations and Transfer Taxes allocated to Sellers pursuant to Section&nbsp;8.02;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) all accounts payable arising prior to Closing with respect to the
Standalone Drug Business or the Purchased Assets;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) (A)&nbsp;any liability or obligation for Taxes with respect to the Standalone
Drug Business or the Purchased Assets related to a Pre-Closing Tax Period, and (B)
any liability or obligation for Taxes of any Seller, or any member of any
consolidated, affiliated, combined or unitary group of which any Seller is or has
been a member, for Taxes (if any) attributable to the transactions, occurring on or
prior to the Closing Date, pursuant to this Agreement, the Merger Agreement or the
Purchase and Separation Agreement (including the Reorganization as defined therein);
<I>provided </I>that Transfer Taxes incurred in connection with the transfer of the
Purchased Assets pursuant to this Agreement and Apportioned Obligations shall be
allocated and paid in the manner set forth in Section&nbsp;8.02 hereof;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) all liabilities and obligations relating to or arising with respect to (A)
any Employee, that arise, exist, accrue or are attributable to the period as of or
prior to Closing, other than any liability or obligation expressly assumed by Buyer
pursuant to Article&nbsp;9, or (B)&nbsp;any employee of any Seller or any of its Affiliates
who is not an Employee; and
</DIV>

<P align="center" style="font-size: 10pt">6
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) all other liabilities and obligations (other than any Assumed Liabilities)
of any kind, fixed or contingent, known or unknown, resulting from or arising out of
the conduct of the Standalone Drug Business, the use, non-use or ownership (whether
by leasehold or fee) of the Purchased Assets, or the operation of the Facilities, in
each case under this clause (vi), only to the extent such other liabilities and
obligations arise during, accrue during, or are attributable to the period prior to
Closing or as of the Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.05. <I>Consents; Assignment of Contracts and Rights</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Sellers shall use: (i)&nbsp;commercially reasonable efforts to obtain all material
consents of third parties that are identified in writing by Buyer to the transfer of the
Purchased Assets; and (ii)&nbsp;reasonable best efforts to obtain consents from landlords under
those Leases that require a landlord&#146;s consent to an assignment that are identified in
writing by Buyer; <I>provided, however</I>, neither Sellers nor Buyer shall be required to pay any
consideration or incur any additional liability in order to obtain such consents, subject to
the provisions of Section&nbsp;1.05(d).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Subject to Section&nbsp;1.05(a), Sellers agree, in connection with requests for consents
to landlords for assignments of Leases requiring the same, to make requests as soon as
practicable after the date hereof and to pursue such requests in a good faith and diligent
manner. Sellers further agree to provide Buyer with detailed progress reports on such
requested consents on at least a weekly basis. Buyer agrees to cooperate with Sellers&#146;
efforts and to use reasonable best efforts to obtain such consents, by supplying any
commercially reasonable information requested by the landlords who are considering such
requests. In addition, in connection with those Leases that merely require that the tenant
provide notices before or after an assignment, Sellers agree to send such notices to those
landlords identified in writing by Buyer in the form prepared by Buyer and within the
timeframes identified by Buyer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Notwithstanding anything in this Agreement to the contrary, this Agreement shall
not constitute an agreement to assign any Assigned Contract or any claim or right or any
benefit arising thereunder or resulting therefrom if and for so long as such assignment,
without the consent of a third party thereto, would constitute a breach or other
contravention of such Assigned Contract or in any way adversely affect the rights of Buyer
or the Sellers thereunder. If such consent is not obtained, or if an attempted assignment
thereof would be ineffective or would adversely affect the rights of any Seller thereunder
so that Buyer would not in fact receive all such rights, Buyer and each Seller will
cooperate in a mutually agreeable arrangement under which Buyer would obtain the benefits
and perform and discharge the obligations thereunder in accordance with this Agreement, or
under which such Seller would enforce for the benefit of Buyer at Buyer&#146;s sole cost and
expense, with Buyer being responsible for the performance and discharge of such Seller&#146;s
obligations, any and all rights of the Sellers against a third party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) If any landlord that has the right to consent to an assignment of a Lease refuses
or fails to give its consent to the assignment of such Lease, or if any right of sublease,
recapture or termination by any landlord would be triggered by the request for
</DIV>

<P align="center" style="font-size: 10pt">7
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">consent to assignment (collectively, &#147;<B>Landlord Rights</B>&#148;) and Sellers or any of its
Affiliates are permitted to sublease, license or otherwise arrange for Buyer to occupy the
premises demised by the Lease for the permitted use under such Lease (an &#147;<B>Occupancy
Agreement</B>&#148;), then in all such cases upon the written request of Buyer, Seller shall enter
into a sublease, license or Occupancy Agreement with Buyer for such Store on a fully net
basis and on such terms as will generally confer and impose on Buyer all of Sellers&#146; rights
and obligations under the Lease for such Store until such landlord consents to the
assignment of the Lease to Buyer and Buyer will indemnify Sellers for any and all
liabilities, costs and expenses of Sellers arising out of the respective Lease and any
related Occupancy Agreement, any reasonable out-of-pocket expenses associated with any
attempt to transfer or failure to transfer such Lease or any other liabilities, costs and
expenses arising out of or resulting from the Sellers&#146; actions taken in accordance with any
reasonable directions of Buyer in connection with such Lease. If and when any such consent
shall be obtained or such Lease shall otherwise become assignable, the respective Occupancy
Agreement shall be terminated with no further obligations of the Sellers, Sellers shall
promptly assign all their rights and obligations under the respective Lease to the Buyer
without payment of further consideration (subject to the foregoing indemnity by Buyer of
Sellers) and the Buyer shall, without the payment of any further consideration therefor,
assume such all rights and obligations. Notwithstanding the foregoing, if the arrangement
described in the immediately preceding clauses of this Section&nbsp;1.05(d) is impracticable or
will cause (or is likely to cause) a default under any Lease or the triggering of any
Landlord Rights (whether due to the change or intended change of the store brand under which
such property will be operated or for other reasons), then the parties will work in good
faith to establish a mutually satisfactory arrangement for the operation by Buyer of such
leased real property during the period subsequent to the Closing and pending receipt of the
required consent, including a fair and equitable arrangement (under the applicable
circumstances) to ensure that Sellers are fully reimbursed for all costs and expenses with
respect to such Lease during such period. Sellers shall not be obligated to take or refrain
from taking any actions which could reasonably be expected to trigger or cause the exercise
of any Landlord Rights, subject to the further provisions of this Section&nbsp;1.05(d). In the
event a landlord wrongfully refuses or fails to consent to an assignment or a request for an
assignment would trigger any Landlord Rights, and a sublease, license or Occupancy Agreement
is not permitted under the terms of the applicable Lease, Seller agrees, upon written
request from Buyer and at Buyer&#146;s sole cost and expense, to institute litigation against
such landlord with counsel selected by Buyer (and reasonably acceptable to Seller) to
enforce Sellers&#146; rights under such Lease and Buyer agrees to indemnify and hold harmless
Seller with respect to all such litigation and all costs, expenses, losses and damages
resulting therefrom under or in connection with any affected Lease. The Standalone Drug
Transition Services Agreement shall provide that in the event that Sellers&#146; rights under any
Leases have been transferred to New Diamond or any Affiliate through the Merger Agreement or
otherwise, that the obligations of Sellers under this paragraph shall be assumed by New
Diamond or its relevant Affiliate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.06. <I>Purchase Price</I>. The purchase price for the Purchased Assets is $3,930,000,000
in cash (the &#147;<B>Purchase Price</B>&#148;). The Purchase Price shall be subject to adjustment as provided in
Section&nbsp;1.08.
</DIV>

<P align="center" style="font-size: 10pt">8
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.07. <I>Closing</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <I>Closing</I>. The closing (the &#147;<B>Closing</B>&#148;) of the purchase and sale of the Purchased
Assets and the assumption of the Assumed Liabilities hereunder shall take place at the
offices of Jones Day, at 222 East 41<SUP style="font-size: 85%; vertical-align: text-top">st</SUP> Street, New York, New York 10017, at 9:00
a.m. local time, as soon as practicable, but in no event later than the second Business Day
after the satisfaction or waiver of the conditions set forth in Article&nbsp;10 (excluding
conditions that, by their terms, cannot be satisfied until the Closing, but the Closing
shall be subject to the satisfaction of those conditions), or at such other time or place as
Buyer and Albertson&#146;s may agree (the &#147;<B>Closing Date</B>&#148;). On the Closing Date:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Buyer shall pay, in immediately available funds by wire transfer, an amount
equal to the Purchase Price.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Buyer and the Sellers, as applicable (and Parent, SUPERVALU and their
Affiliates where applicable in the relevant agreements or instruments) shall execute
and deliver to the other the following documents:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Quitclaim deeds (or equivalent deeds without covenants or
warranties) necessary to convey fee simple title to the Owned Real Property
to Buyer;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) one or more deeds, bills of sale, endorsements, assignments and
other instruments of conveyance and assignment (without covenant or warranty
except as provided hereunder) as the parties and their respective counsel
shall deem reasonably necessary or appropriate to vest in Buyer all right,
title and interest in, to and under the Purchased Assets in form and
substance reasonably satisfactory to Albertson&#146;s and Buyer;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) one or more Assignment and Assumption Agreement substantially in
the form attached hereto as Exhibit&nbsp;D (the &#147;<B>Assignment and Assumption
Agreements</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D) instruments of assignment and assumption (the &#147;<B>Lease Assignment and
Assumption Agreements</B>&#148;) substantially in the forms attached hereto as
Exhibit&nbsp;E, pursuant to which the Sellers shall assign the Leases to Buyer
and Buyer shall assume all obligations thereunder and Parent will guarantee
to New Diamond, Albertson&#146;s and their respective Affiliates all obligations
of Buyer thereunder in a separate agreement with SUPERVALU; <I>provided </I>that
there shall be no liability of or to Sellers under the Assignment and
Assumption Agreements except as provided hereunder;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(E) subject to Section&nbsp;7.07, a Transition Services Agreement
substantially in the form attached hereto as Exhibit&nbsp;F (the &#147;<B>Standalone Drug
Business Transition Services Agreement</B>&#148;), providing for the provision by
SUPERVALU or its Affiliates to Buyer of transition services relating to the
Standalone Drug Business after Closing;
</DIV>

<P align="center" style="font-size: 10pt">9
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(F) subject to Section&nbsp;7.07, a Transition Services Agreement
substantially on the terms set forth on Exhibit&nbsp;G (the &#147;<B>Distribution Center
Transition Services Agreement</B>&#148;), providing for the provision by Buyer to New
Diamond, SUPERVALU or their respective Affiliates of transition services
relating to the Distribution Center after Closing; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 9%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(G) a certificate from each Seller (or, if such Seller is a
&#147;disregarded entity&#148; within the meaning of Section&nbsp;1.1445-2(b)(2)(iii) of
the Treasury Regulations promulgated under the Code, the Seller that is
treated as the transferor of property for U.S. tax purposes) stating that
such Seller is not a &#147;foreign person&#148; as defined in Section&nbsp;1445 of the
Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Risk of Loss; Title</I>. Risk of loss to the Purchased Assets will transfer to Buyer
at the Effective Time. Transfer of title to the Purchased Assets will be deemed to have
occurred at the Effective Time. All sales at a Store after the Effective Time shall be for
the account of Buyer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <I>Purchased Assets Are Indivisible</I>. Subject to Section&nbsp;1.05, the rights to purchase
and sell the Purchased Assets are indivisible. Such Purchased Assets may not be
individually purchased or sold without all of the others, unless expressly permitted or
required pursuant to the provisions of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.08. <I>Prorations</I>. (a)&nbsp;On the Closing Date all rent, common area charges, utility
charges, real estate taxes, sales taxes on rent and other obligations under the Leases transferred
at the Closing shall be prorated as of the Effective Time (collectively, the &#147;<B>Prorated Charges</B>&#148;).
Whenever possible, such prorations shall be based on actual, current payments by the Sellers or
their Affiliates and to the extent such actual amounts are not available, such prorations shall be
estimated as of the Effective Time based on actual amounts for the most recent comparable billing
period. When the actual amounts become known, such prorations shall be recalculated by Buyer and
the Sellers, and Buyer or the Sellers, as the case may be, promptly (but not later than 10 Business
Days after notice of payment due and delivery of reasonable supporting documentation with respect
to such amounts) shall make any additional payment or refund so that the correct prorated amount is
paid by each of Buyer and the Sellers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Percentage rent payable under each Lease shall be prorated at the end of the
current lease year for each Lease, and the percentage rent payable, if any, shall be paid by
Buyer when due and the Sellers shall promptly reimburse Buyer a portion thereof determined
by multiplying (A)&nbsp;a fraction, the numerator of which is the amount of the Sellers&#146; or their
Affiliates&#146; gross annual sales at such Store from the first day of such lease year to (and
excluding) the Closing Date, and the denominator of which is the sum of Buyer&#146;s and its
Affiliates&#146; and the Sellers&#146; and their Affiliates&#146; gross annual sales at such Store for the
entire lease year, times (B)&nbsp;the amount of percentage rent actually due under the Lease for
such Store. The Sellers, upon the request of Buyer, shall promptly provide Buyer with such
information as Buyer shall be required to submit to landlords under the Leases in connection
with the payment of percentage rent with respect to the Stores.
</DIV>

<P align="center" style="font-size: 10pt">10
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Buyer and the Sellers shall cooperate in good faith to resolve any dispute with respect
to prorations. In the event Buyer and the Sellers are unable to resolve such
dispute within 20 Business Days after the date such dispute arose, Buyer and the Sellers
shall submit the items remaining for resolution in writing, together with such written
evidence as Buyer or the Sellers may elect to include, to an Independent Accounting Firm.
The Independent Accounting Firm shall, within 20 Business Days of such submission, resolve
any differences between Buyer and the Sellers and such resolution shall, in the absence of
manifest error, be final, binding and conclusive upon each of the parties. The costs, fees
and expenses of the Independent Accounting Firm shall be borne equally by Buyer and New
Diamond. For purposes of this Agreement the &#147;<B>Independent Accounting Firm</B>&#148; means a
nationally recognized accounting firm agreed upon by Buyer and the Sellers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.09. <I>Removal of Equipment and Signage. </I>Within the applicable time periods specified
in Section&nbsp;7.05, Buyer shall remove at its expense all of the Sellers&#146; signage and equipment that
are not Purchased Assets and are located at the Facilities; <I>provided, however, </I>if requested by the
Sellers, Buyer shall arrange transportation of such signage and equipment to a location designated
by the Sellers at the Sellers&#146; expense.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.10. <I>La Habra Inventory Adjustment. </I>Buyer (through RGIS Inventory Specialists
(&#147;<B>RGIS</B>&#148;)) will conduct a physical count of the inventory at the La Habra warehouse as of a time as
close as possible to the Closing. Representatives of Buyer and SUPERVALU will be permitted to be
present during the count. Sellers will cooperate and give access to representatives of Buyer and
SUPERVALU for this purpose. For purposes of this count, the inventory will be valued at cost using
Albertson&#146;s cost method then in effect. SUPERVALU will be entitled to receive a copy of the
electronic UPC item-level physical inventory file for the inventory taken by RGIS. Buyer, Parent
and SUPERVALU agree that, absent manifest error, the physical inventory counts of RGIS shall be
final and binding on each of the parties. SUPERVALU will be entitled to an economic credit equal
to 30% of such inventory value so counted, and Buyer and SUPERVALU will in good faith mutually
determine the manner in which such credit will be transferred to SUPERVALU.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 2</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Representations and Warranties of Albertson&#146;s</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the exceptions set forth in the corresponding sections of the letter from
Albertson&#146;s, dated as of the date of this Agreement, addressed to Buyer (the &#147;<B>Disclosure Letter</B>&#148;),
to the extent such exceptions are reasonably apparent, Albertson&#146;s represents and warrants to Buyer
that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.01. <I>Organization</I>. Each Seller is duly organized, validly existing and in good
standing under the laws of its respective jurisdiction of organization, and has the requisite
corporate power and authority to own its properties and to carry on its business as presently
conducted and is duly qualified to do business and is in good standing (where such concept exists)
as a foreign corporation in each jurisdiction in which the nature of its business or the ownership
or leasing of its properties makes such qualification necessary, except where the failure to be so
qualified or in good standing as a foreign corporation or have such power or
</DIV>

<P align="center" style="font-size: 10pt">11
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">authority would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect. Complete and correct copies of the certificate of incorporation and
by-laws of each Seller as currently in effect have been made available to Parent and, as so made
available, are in full force and effect, and no other organizational documents are applicable to or
binding upon any Seller.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.02. <I>Authority; Enforceability</I>. Each Seller has all necessary corporate power and
authority to execute and deliver this Agreement and the Ancillary Agreements to which it is a
party, to perform its obligations hereunder and thereunder and to consummate the transactions
contemplated hereby and thereby. The execution, delivery and performance by each Seller of this
Agreement and the Ancillary Agreements to which it is a party and the consummation by each Seller
of the transactions contemplated hereby and thereby have been duly and validly authorized by all
necessary corporate action on the part of each Seller and no other corporate proceedings on the
part of any Seller are necessary pursuant to its governing documents or the laws of its
jurisdiction of incorporation to authorize this Agreement or the Ancillary Agreements to which it
is a party or to consummate the transactions contemplated hereby or thereby. Each Seller&#146;s Board
of Directors has (i)&nbsp;approved this Agreement and the transactions contemplated hereby, (ii)
determined that the terms of this Agreement are fair to and in the best interests of such Seller
and its stockholders, and (iii)&nbsp;declared the advisability of this Agreement. This Agreement has
been duly executed and delivered by the Sellers, and each Ancillary Agreement will be duly executed
and delivered by each Seller party thereto, and, assuming due authorization, execution and delivery
by the other parties hereto and thereto, constitutes or will constitute a legal, valid and binding
agreement of each Seller enforceable against each Seller in accordance with its terms, subject to
the effects of bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other
similar Laws relating to or affecting creditors&#146; rights generally and general equitable principles
(whether considered in a proceeding in equity or at law).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.03. <I>Non-Contravention; Assigned Contracts</I>. (a)&nbsp;The execution, delivery and
performance by each Seller of this Agreement and the Ancillary Agreements to which it is a party
does not and will not (i)&nbsp;conflict with or violate such Seller&#146;s governing documents, (ii)&nbsp;assuming
that all consents, approvals and authorizations contemplated by Section&nbsp;2.04 have been obtained and
all filings described therein have been made, conflict with or violate any Law applicable to any
Seller or by which any Seller or any of their respective properties are bound, or (iii)&nbsp;result in
any breach or violation of or constitute a default (or an event which with notice or lapse of time
or both would become a default) or result in the loss of a benefit under, or give rise to any right
of termination, cancellation, recapture, amendment or acceleration of, or performance under, any
note, bond, mortgage, indenture, contract, agreement, lease, license, permit or other instrument or
obligation (which, in any case, is not a contract, agreement or other arrangement pursuant to which
Sellers or any Subsidiary leases real property, including the Leases) to which such Seller is a
party or by which such Seller or any of its properties are bound, except, in the case of clauses
(ii)&nbsp;and (iii)&nbsp;of this Section&nbsp;2.03(a), for any such conflict, violation, breach, default, loss,
right or other occurrence which would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;(i)&nbsp;The Sellers are not (and, to the Sellers&#146; Knowledge, no other party is) in default
under any Assigned Contract, (ii)&nbsp;each of the Assigned Contracts is in full force and
</DIV>

<P align="center" style="font-size: 10pt">12
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">effect, and is the valid, binding and enforceable obligation of the Sellers, and to the
Seller&#146;s Knowledge, of the other parties thereto, and (iii)&nbsp;the Sellers have performed all
respective obligations required to be performed by them to date under the Assigned Contracts and
are not (with or without the lapse of time or the giving of notice, or both) in breach thereunder,
except, in the case of clauses (i), (ii)&nbsp;and (iii)&nbsp;of this Section&nbsp;2.03(b), for any such default,
failure, invalidity, unenforceability, non-performance, breach or other occurrence which would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.04. <I>Governmental Consents</I>. The execution, delivery and performance by each Seller
of this Agreement and the Ancillary Agreements to which it is a party and the consummation by each
Seller of the transactions contemplated hereby and thereby does not and will not require any
consent, approval, authorization or permit of, action by, filing with or notification to, any
Governmental Authority, except as required under or pursuant to (a)&nbsp;the HSR Act, (b)&nbsp;consents or
approvals in connection with the transfer of Licenses, and (c)&nbsp;any other consent, approval,
authorization, permit, action, filing or notification the failure of which to be made or obtained
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.05. <I>Litigation</I>. There are no Actions pending or, to the Knowledge of Albertson&#146;s,
threatened against the Sellers or, to the Knowledge of Albertson&#146;s, any officer, director or
employee of any Seller in such capacity, which would reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect. No Seller is a party or subject to or in default
under any Governmental Order which would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.06. <I>Compliance with Law</I>. (a)&nbsp;The Sellers and their Affiliates are not (and have
not been since February&nbsp;3, 2005) in violation of any Law, and have not received any written notice
of any violation of Law, in each case except for any violation or possible violation that would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. The
Sellers and their Affiliates are (and have been since February&nbsp;3, 2005) in compliance with, all
permits, licenses, authorizations, exemptions, orders, consents, approvals and franchises from
Governmental Authorities required to conduct their respective businesses as now being conducted,
except for any such permit, license, authorization, exemption, order, consent, approval or
franchise the absence of, or the non-compliance, with which would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Albertson&#146;s has designed and maintains a system of internal control over financial
reporting (as defined in Rules&nbsp;13a-15(f) and 15d-15(f) of the Exchange Act) sufficient to provide
reasonable assurances regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with GAAP. Albertson&#146;s (i)&nbsp;has designed
and maintains disclosure controls and procedures (as defined in Rules&nbsp;13a-15(e) and 15d-15(e) of
the Exchange Act) that provides reasonable assurance that material information required to be
disclosed by Albertson&#146;s in the reports that it files or submits under the Exchange Act is
recorded, processed, summarized and reported within the time periods specified in the Securities
and Exchange Commission&#146;s rules and forms, and (ii)&nbsp;has disclosed and reported, based on its most
recent evaluation of its internal controls over financial reporting prior to the date hereof, to
Albertson&#146;s auditors and the audit committee of the Albertson&#146;s Board of
</DIV>

<P align="center" style="font-size: 10pt">13
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Directors (A)&nbsp;any significant deficiencies and material weaknesses in the design or operation
of its internal control over financial reporting that are reasonably likely to adversely affect in
any material respect Albertson&#146;s ability to record, process, summarize and report financial
information and (B)&nbsp;any fraud, whether or not material, that involves management or other employees
who have a significant role in Albertson&#146;s internal control over financial reporting. Albertson&#146;s
has heretofore furnished to Buyer complete and correct copies of Albertson&#146;s final report to the
audit committee of Albertson&#146;s Board of Directors for fiscal 2004 and all subsequent quarterly
updates, in each case in respect of the matters in clause (ii)&nbsp;of the immediately preceding
sentence.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.07. <I>Real Property</I>. The Real Property is all of the real property which the Sellers
own, lease, operate or sublease in connection with the Standalone Drug Business. Except as would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Sellers have good and marketable fee simple title to all Owned Real Property
and valid leasehold estates in all Leased Real Property free and clear of all Liens, except
Permitted Liens. The Sellers or one of their respective Subsidiaries has exclusive use and
possession of each Leased Real Property and Owned Real Property, other than any use or
occupancy rights granted to third-party owners, tenants or licensees pursuant to agreements
with respect to such real property entered in the ordinary course of business (each
agreement, including all amendments thereto, a &#147;<B>Third Party Use and Occupancy Agreement</B>&#148;),
none of which would reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Except as would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, each Ground Lease and Store Lease and each Third Party
Use and Occupancy Agreement is in full force and effect and is valid and enforceable in
accordance with its terms, and there is no material default under any Ground Lease or Store
Lease or any Third Party Use and Occupancy Agreement either by the Sellers party thereto or,
to the Sellers&#146; Knowledge, by any other party thereto, and no event has occurred that, with
the lapse of time or the giving of notice or both, would constitute a default by any Seller
thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Except as would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect, there are no pending or, to any Seller&#146;s Knowledge,
threatened condemnation or eminent domain proceedings that affect any Owned Real Property or
Leased Real Property, and no Seller has received any written notice of the intention of any
Governmental Authority or other Person to take any Owned Real Property or Leased Real
Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.08. <I>Title to the Purchased Assets</I>. Sellers have valid title to all of the Purchased
Assets that are owned by Sellers free and clear of all Liens except for Permitted Liens. Sellers
have a valid leasehold interest or valid rights to use all of the other Purchased Assets, except
where the failure to have a valid leasehold interest or valid rights have not had and would not
reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
</DIV>

<P align="center" style="font-size: 10pt">14
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.09. <I>IT Systems</I>. (a)&nbsp;Except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;the IT Systems of the Sellers are
adequate for the operation of the Standalone Drug Business as presently conducted and (ii)&nbsp;there
has not been any material malfunction with respect to any of the material IT Systems of the Sellers
since January&nbsp;31, 2002 that has not been remedied or replaced in all material respects.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect, (i)&nbsp;the use of the information and data that is used or held for use in
the operation of the Standalone Drug Business or that is otherwise material to or necessary for the
operation of the Standalone Drug Business (the &#147;<B>Data</B>&#148;) by the Sellers does not infringe or violate
the privacy rights of any Person or otherwise violate any Law or regulation, (ii)&nbsp;the Sellers have
taken reasonable and customary measures consistent with generally accepted industry practices to
protect the privacy of the Data of their respective customers, and (iii)&nbsp;to the Sellers&#146; Knowledge,
since January&nbsp;31, 2002 there have been no security breaches with respect to the privacy of such
Data.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.10. <I>Sufficiency of Assets. </I>Assuming the due execution of and performance under the
Standalone Drug Transition Services Agreement, the continued employment of all Employees
immediately after the Effective Time and other than with respect to the Excluded Assets, and
subject to the provisions of Section&nbsp;1.05(d), the Purchased Assets immediately after the Effective
Time shall constitute assets sufficient in all material respects to conduct the Standalone Drug
Business as conducted immediately prior to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.11. <I>Labor Relations</I>. Except as would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect, no Seller has received notice during
the past two years of the intent of any Governmental Authority responsible for the enforcement of
labor, employment, occupational health and safety or workplace safety and insurance/workers
compensation laws to conduct an investigation of or affecting any Seller with respect to any
Facility and, to the Knowledge of any Seller, no such investigation is in progress. Except as
would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, there are no (and have not since March&nbsp;30, 2004 been any) labor disputes, strikes,
organizing activities or work stoppages against any Seller pending, or to the Knowledge of any
Seller, threatened with respect to any Facility. No labor organization or group of 50 or more
employees of any Seller has made a pending formal demand for recognition or certification, and
there are no representation or certification proceedings or petitions seeking a representation
proceeding presently pending or, to the knowledge of any Seller, threatened to be brought with
respect to any Facility.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.12. <I>Environmental Compliance</I>. (a) (i)&nbsp;In connection with or relating to the
Facilities or Purchased Assets, except as would not reasonably be expected individually or in the
aggregate to have a Material Adverse Effect, to the Sellers&#146; Knowledge, the Sellers and their
Affiliates comply and have complied with all applicable Environmental Laws (as defined below), and
possess and comply, and have complied, with all applicable Environmental Permits (as defined below)
required under such laws to operate as it currently operates, in each case in connection with or
relating to the Facilities or Purchased Assets; (ii)&nbsp;except as would not reasonably be expected
individually or in the aggregate to have a Material Adverse Effect, to the Sellers&#146; Knowledge,
there are no, and there have not been any, Materials of Environmental
</DIV>

<P align="center" style="font-size: 10pt">15
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Concern (as defined below) at any of the Facilities or Purchased Assets under circumstances
that have resulted in or are reasonably likely to result in liability of the Sellers or any of
their Affiliates under any applicable Environmental Laws; (iii)&nbsp;in connection with or relating to
the Facilities or Purchased Assets, except as would not reasonably be expected to have a Material
Adverse Effect, none of the Sellers or their Affiliates has received any written notification
alleging that it is liable for, or request for information pursuant to section 104(e) of the
Comprehensive Environmental Response, Compensation and Liability Act or similar foreign, state or
local Law concerning, any release or threatened release of Materials of Environmental Concern at
any location except, with respect to any such notification or request for information concerning
any such release or threatened release, to the extent such matter has been fully resolved such that
no further action is required with the appropriate foreign, federal, state or local regulatory
authority or otherwise; and (iv)&nbsp;the reports of environmental assessments, audits and similar
investigations previously made available to Parent are all material such reports in the possession
of the Sellers and conducted since January&nbsp;30, 2003 in connection with or relating to the
Facilities or Purchased Assets. There are no Actions arising under Environmental Laws pending or,
to the Knowledge of the Sellers, threatened against the Sellers or any of their Affiliates which
would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
In connection with or relating to the Facilities or Purchased Assets, except as would not
reasonably be expected to have a Material Adverse Effect, at each property where
Asbestos-Containing Material (&#147;<B>ACM</B>&#148;) has been identified, all ACM is non-friable, encapsulated or
abated and no ACM is present in any property where the Sellers have not implemented an Asbestos
Operation and Management Plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding any other representations and warranties in this Agreement, the
representations and warranties in this Section&nbsp;2.12 are the only representations and warranties in
this Agreement with respect to Environmental Laws, Environmental Permits or Materials of
Environmental Concern.
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;<B>Materials of Environmental Concern</B>&#148; means: any hazardous, acutely hazardous, or toxic material,
substance or waste defined or regulated as such under Environmental Laws, including the federal
Comprehensive Environmental Response, Compensation and Liability Act and the federal Resource
Conservation and Recovery Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.13. <I>Financial Schedules</I>. Set forth in Section&nbsp;2.13(a) of the Disclosure Letter are
(i)&nbsp;unaudited selected results of operations data for each of the New Diamond Business (as defined
in the Separation Agreement), the Standalone Drug Business and the Retained Business (as defined in
the Separation Agreement) for the 52&nbsp;weeks ended January&nbsp;29, 2004, the 53&nbsp;weeks ended February&nbsp;3,
2005 and the 39&nbsp;weeks ended November&nbsp;3, 2005 (collectively, the &#147;<B>Separate Operations Data</B>&#148;) and
(ii)&nbsp;unaudited selected balance sheet data for Albertson&#146;s and each of Albertson&#146;s operating
regions as of February&nbsp;3, 2005 ( the &#147;<B>Separate Balance Sheet Data</B>&#148;). The Separate Operations Data
and the Separate Balance Sheet Data have been compiled from source books, records and financial
reports of Albertson&#146;s and its Subsidiaries. Such source books, records and financial reports were
prepared by Albertson&#146;s in the ordinary course of its business, are accurate in all material
respects and were subject to Albertson&#146;s internal controls. The allocations of the Separate
Operations Data among the New Diamond Business, the Standalone Drug Business and the Retained
Business are consistent with Section&nbsp;2.13(a)(i) of the Disclosure Letter and the allocations of the
Separate Balance Sheet Data are allocated in the
</DIV>

<P align="center" style="font-size: 10pt">16
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">manner described in Section&nbsp;2.13(a)(ii) of the Disclosure Letter. The Separate Balance Sheet
Data and the Separate Operations Data reconcile to Albertson&#146;s historical financial statements
filed with the SEC and, in Albertson&#146;s opinion, present fairly, in all material respects, the
information presented in the Separate Balance Sheet Data and the Separate Operations Data,
respectively. Subject to the changes in accounting principles and methodologies effected by
Albertson&#146;s as described in the Company SEC Reports (as defined in the Merger Agreement), the
accounting principles and methodologies used in the preparation of the Separate Operations Data
were applied on a consistent basis, in all material respects, for each of the periods presented
therein. Set forth in Section&nbsp;2.13(a)(iii) of the Disclosure Letter are selected assets and
liabilities included in the Purchased Assets and Assumed Liabilities, which schedule was prepared
by Sellers and was compiled from source books, records and financial reports of Albertson&#146;s and its
Subsidiaries. Such source books, records and financial reports were prepared by Albertson&#146;s in the
ordinary course of its business, are accurate in all material respects and were subject to
Albertson&#146;s internal controls.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.14. <I>No Undisclosed Liabilities</I>. No Seller has any liabilities, claims or
indebtedness related to the Standalone Drug Business of any kind whatsoever, whether accrued,
contingent, absolute, determined, determinable or otherwise, whether due or to become due, in each
case, that are required by GAAP to be set forth, reserved against, disclosed or otherwise reflected
in a consolidated balance sheet or the notes thereto, except liabilities that (i)&nbsp;are set forth in
the financial schedules set forth in Section&nbsp;2.13 of the Disclosure Letter or disclosed in the
notes thereto, (ii)&nbsp;were incurred in the ordinary course of business and consistent with past
practice since the date of the financial schedules set forth in Section&nbsp;2.13 of the Disclosure
Letter and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect, (iii)&nbsp;are incurred pursuant to the transactions contemplated by this Agreement,
(iv)&nbsp;have been discharged or paid in full prior to the date of this Agreement in the ordinary
course of business consistent with past practice or (v)&nbsp;were incurred outside the ordinary course
of business since the date of the financial schedules set forth in Section&nbsp;2.13 of the Disclosure
Letter, but which are, and would reasonably be expected to be, individually or in the aggregate,
immaterial in amount or nature.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.15. <I>Absence of Certain Changes or Events</I>. Since November&nbsp;3, 2005, except as
expressly contemplated by this Agreement, the Sellers have conducted their businesses in the
ordinary course in all material respects consistent with past practice, and, since such date, there
has not been any change, event or occurrence which has had or would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect. Except as set forth in Section&nbsp;2.15
of the Seller Disclosure Letter, since November&nbsp;3, 2005, the Sellers have not taken any action
that, if taken after the date of this Agreement, would constitute a breach of Sections&nbsp;5.01(a),
(b), (d), (g)&nbsp;or (j)&nbsp;hereof, other than with respect to Real Property.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.16. <I>Finders&#146; Fees</I>. Except for Goldman, Sachs &#038; Co., Houlihan Lokey Howard &#038; Zukin
and The Blackstone Group, L.P., there is no investment banker, broker, finder or other intermediary
which has been retained by or is authorized to act on behalf of the Sellers who is entitled to any
fee or commission in connection with the transactions contemplated by this Agreement.
</DIV>

<P align="center" style="font-size: 10pt">17
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.17. <I>Healthcare Regulatory</I>. (a)&nbsp;Sellers are qualified for participation in the
Medicare and Medicaid programs. No Seller has received any notice indicating that such
qualification may be terminated or withdrawn nor has any reason to believe that such qualification
may be terminated or withdrawn. Sellers have timely filed all claims or other reports required to
be filed with respect to the purchase of products or services by third-party payors (including,
without limitation, Medicare and Medicaid), except where the failure to file such claims and
reports would not, individually or in the aggregate, be reasonably likely to have a Material
Adverse Effect, and all such claims or reports are complete and accurate in all material respects.
Sellers have no material liability to any payor with respect thereto, except for liabilities
incurred in the ordinary course of business consistent with past practice.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Sellers have complied in all material respects with all applicable
&#147;Healthcare Laws&#148;, i.e., The Social Security Act, as amended, Sections&nbsp;1128, 1128A and
1128B, 42 U.S.C. Sections&nbsp;1320a-7, 7(a) and 7(b), including, without limitation, Criminal
Penalties Involving Medicare or State Health Care Programs, commonly referred to as the
&#147;Federal Anti-Kickback Statute&#148; and The Social Security Act, as amended, Section&nbsp;1877, 42
U.S.C. Section&nbsp;1395nn (Prohibition Against Certain Referrals), commonly referred to as the
&#147;Stark Statute,&#148; the statute commonly referred to as the &#147;Federal False Claims Act,&#148; the
Health Insurance Portability and Accountability Act of 1996, and the regulations issued
pursuant thereto and all statutes and regulations relating to the possession, distribution,
maintenance and documentation of controlled substances.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) No personnel of the Sellers during such person&#146;s employment with Sellers
have been convicted of, charged with or investigated for a Medicare, Medicaid or other
Federal Health Care Program (as defined in 42 U.S.C. &#167; 1320a-7b(f)) related offense, or
convicted of, charged with or investigated for a violation of federal or state law relating
to fraud, theft, embezzlement, breach of fiduciary responsibility, financial misconduct,
obstruction of an investigation or controlled substances. No personnel of the Sellers
during such person&#146;s employment with Sellers have been excluded or suspended from
participation in Medicare, Medicaid or any other Federal Health Care Program, or have been
debarred, suspended or are otherwise ineligible to participate in federal programs. No
personnel of the Sellers during such person&#146;s employment with Sellers has, to Sellers&#146;
Knowledge, committed any offense which may reasonably serve as the basis for any such
exclusion, suspension, debarment or other ineligibility. The Sellers, to their Knowledge,
have not arranged or contracted with any individual or entity that is suspended, excluded or
debarred from participation in, or otherwise ineligible to participate in, a Federal Health
Care Program or other federal program.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Except as specifically excluded hereunder or not legally permitted to be
transferred to Buyer, the Purchased Assets include all permits, licenses, provider numbers,
authorizations, exemptions, orders, consents, approvals, registrations, franchises or the
like held by the Sellers and necessary for the lawful conduct of the Standalone Drug
Business under and pursuant to all applicable statutes, laws, ordinances, rules and
regulations of all Governmental Authorities having, asserting or claiming jurisdiction over
it or any part of the Standalone Drug Business (&#147;<B>Permits</B>&#148;). All Permits have been legally
obtained and maintained and are valid and in full force and effect. The
</DIV>

<P align="center" style="font-size: 10pt">18
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">Sellers are in compliance in all material respects with all of the terms and conditions of
the Permits. No outstanding material violations are or have been recorded in respect of any
of the Permits. No proceeding is pending or, to the Sellers&#146; knowledge, threatened, to
suspend, revoke, withdraw, modify or limit any of the Permits, and, to the Sellers&#146;
knowledge, there is no fact, error or admission relevant to any Permit that would permit the
suspension, revocation, withdrawal, modification or limitation or result in the threatened
suspension, revocation, withdrawal, modification or limitation, or any loss of any Permit.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 3</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Representations and Warranties of Parent and Buyer</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent and Buyer hereby jointly and severally represent and warrant to the Sellers that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.01. <I>Organization</I>. Each of Parent and Buyer is duly organized, validly existing and
in good standing under the laws of the state of its organization, and has the requisite corporate
or similar power and authority to own its properties and to carry on its business as presently
conducted and is duly qualified to do business and is in good standing (where such concept exists)
as a foreign corporation in each jurisdiction in which the nature of its business or the ownership
or leasing of its properties makes such qualification necessary. Complete and correct copies of
the certificate of incorporation and by-laws (or equivalent organizational documents) of Parent and
Buyer as currently in effect, have been made available to Albertson&#146;s, and as so made available,
are in full force and effect and no other organizational documents are applicable to or binding
upon Parent and Buyer. Buyer is a direct or indirect wholly owned subsidiary of Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.02. <I>Authority; Enforceability</I>. Each of Parent and Buyer has the corporate or other
power and authority to execute and deliver this Agreement and the Ancillary Agreements to which it
is a party and to perform its obligations hereunder and thereunder and to consummate the
transactions contemplated hereby and thereby. The execution and delivery by each of Parent and
Buyer of this Agreement and the Ancillary Agreements to which it is a party and the consummation by
each of Parent and Buyer of the transactions contemplated hereunder and thereunder have been duly
authorized by all necessary action on the part of each of Parent and Buyer and the holders of any
equity interests thereof. This Agreement and each Ancillary Agreement to which each is a party has
been or will be duly executed and delivered by each of Parent and Buyer and, assuming due
authorization, execution and delivery by the other parties hereto and thereto, constitutes or will
constitute a legal, valid and binding agreement of each of Parent and Buyer, enforceable against
each of them in accordance with its terms, subject to the effects of bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other similar Laws relating to or affecting
creditors&#146; rights generally and general equitable principles (whether considered in a proceeding in
equity or at law).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.03. <I>Non-Contravention</I>. The execution, delivery and performance by each of Parent
and Buyer of this Agreement and the Ancillary Agreements to which each is a party does not and will
not (a)&nbsp;conflict with or violate its certificate of incorporation or by-laws or comparable
governing documents, (b)&nbsp;assuming that all consents, approvals and authorizations
</DIV>

<P align="center" style="font-size: 10pt">19
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">contemplated by Section&nbsp;3.04 have been obtained and all filings described therein have been
made, conflict with or violate any Law applicable to Parent or Buyer or by which Parent or Buyer or
any of their respective properties are bound or (c)&nbsp;result in any breach or violation of or
constitute a default (or an event which with notice or lapse of time or both would become a
default) or result in the loss of a benefit under, or give rise to any right of termination,
cancellation, recapture, amendment or acceleration of, or performance under, any note, bond,
mortgage, indenture, contract, agreement, lease, license, permit or other instrument or obligation
to which Parent or Buyer is a party or by which Parent or Buyer or any of their respective
properties are bound, except, in the case of clauses (b)&nbsp;and (c), for any such conflict, violation,
breach, default, loss, right or other occurrence which would not, individually or in the aggregate,
prevent or materially delay the consummation of the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.04. <I>Governmental Consents</I>. The execution, delivery and performance by Parent and
Buyer of this Agreement and the Ancillary Agreements to which each is a party and the consummation
by each of Parent and Buyer of the transactions contemplated hereby and thereby do not and will not
require any consent, approval, authorization or permit of, action by, filing with or notification
to, any Governmental Authority, except (a)&nbsp;as required under or pursuant to the HSR Act and (b)&nbsp;any
other consent, approval, authorization, permit, action, filing or notification the failure of which
to be made or obtained would not, individually or in the aggregate, prevent or materially delay the
consummation of the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.05. <I>Financing</I>. As of Closing, Buyer will have sufficient cash, available lines of
credit or other sources of immediately available funds to enable it to make payment of the Purchase
Price and any other amounts to be paid by it hereunder. At and after the Closing, Buyer will have
cash in an aggregate amount sufficient for Buyer to perform all of its obligations hereunder and
with respect to the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.06. <I>Brokers</I>. No agent, broker, finder or investment banker is entitled to any
brokerage, finder&#146;s or other fee or commission in connection with the transactions contemplated by
this Agreement based upon arrangements made by or on behalf of Parent or Buyer for which any Seller
could have any liability.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 4</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Representations and Warranties of Supervalu</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SUPERVALU hereby represents and warrants to the Buyer that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.01. <I>Organization</I>. SUPERVALU is duly organized, validly existing and in good
standing under the laws of its jurisdiction of organization, and has the requisite corporate or
similar power and authority to own its properties and to carry on its business as presently
conducted and is duly qualified to do business and is in good standing (where such concept exists)
as a foreign corporation in each jurisdiction in which the nature of its business or the ownership
or leasing of its properties makes such qualification necessary.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.02. <I>Authority; Enforceability</I>. SUPERVALU has the corporate or other power and
authority to execute and deliver this Agreement and to perform its obligations hereunder.
</DIV>

<P align="center" style="font-size: 10pt">20
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The execution and delivery by SUPERVALU of this Agreement have been duly authorized by all
necessary action on the part of SUPERVALU. This Agreement has been duly executed and delivered by
SUPERVALU and, assuming due authorization, execution and delivery by the other parties hereto,
constitutes or will constitute a legal, valid and binding agreement of SUPERVALU, enforceable
against it in accordance with its terms, subject to the effects of bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other similar Laws relating to or affecting
creditors&#146; rights generally and general equitable principles (whether considered in a proceeding in
equity or at law).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.03. <I>Non-Contravention</I>. The execution, delivery and performance by SUPERVALU of this
Agreement does not and will not (a)&nbsp;conflict with or violate its organizational documents, (b)
assuming that all consents, approvals and authorizations contemplated by Section&nbsp;4.04 have been
obtained and all filings described therein have been made, conflict with or violate any Law
applicable to SUPERVALU or by which SUPERVALU or its respective properties are bound, or (c)&nbsp;result
in any breach or violation of or constitute a default (or an event which with notice or lapse of
time or both would become a default) or result in the loss of a benefit under, or give rise to any
right of termination, cancellation, recapture, amendment or acceleration of, or performance under,
any note, bond, mortgage, indenture, contract, agreement, lease, license, permit or other
instrument or obligation to which SUPERVALU is a party, except in the case of clauses (b)&nbsp;and (c),
for any such conflict, violation, breach, default, loss, right or other occurrence which would not,
individually or in the aggregate, prevent or materially delay the consummation of the transactions
contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.04. <I>Governmental Consents</I>. The execution, delivery and performance by SUPERVALU of
this Agreement and the Ancillary Agreements to which it is a party and the consummation by
SUPERVALU of the transactions contemplated hereby and thereby do not and will not require any
consent, approval, authorization or permit of, action by, filing with or notification to, any
Governmental Authority, except (a)&nbsp;as required under or pursuant to the HSR Act and (b)&nbsp;any other
consent, approval, authorization, permit, action, filing or notification the failure of which to be
made or obtained would not, individually or in the aggregate, prevent or materially delay the
consummation of the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.05. <I>Brokers</I>. No agent, broker, finder or investment banker is entitled to any
brokerage, finder&#146;s or other fee or commission in connection with the transactions contemplated by
this Agreement based upon arrangements made by or on behalf of SUPERVALU for which Buyer could have
any liability.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 5</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Covenants of The Sellers</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Sellers agree that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.01. <I>Conduct of the Standalone Drug Business</I>. From the date hereof until the
Effective Time, the Sellers shall conduct the Standalone Drug Business in the ordinary course
consistent with past practice, including using commercially reasonable efforts to (i)&nbsp;maintain
Inventory of a quantity (including seasonal variations), quality and mix consistent with past
</DIV>

<P align="center" style="font-size: 10pt">21
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">practices, (ii)&nbsp;maintain employment of employees (including pharmacists and store managers) at
levels consistent with the needs of the business of each Store consistent with past practices at
the posted hours of the Store and its pharmacy as of the date of this Agreement, (iii)&nbsp;maintain the
Real Property in a physical condition consistent with past practice, (iv)&nbsp;maintain the validity of
existing pharmacy and other federal, state or local licenses, permits or registrations,
certifications and Medicare and Medicaid provider status, including any renewals or extensions
thereof, consistent with past practices and (v)&nbsp;preserve intact the business organizations and
relationships with third parties. Without limiting the generality of the foregoing, subject to
applicable Law and Section&nbsp;5.01 of the Disclosure Letter, from the date hereof until the Effective
Time, the Sellers will not (in each case, to the extent it relates to the Standalone Drug
Business), without the prior written consent of Buyer, which consent shall not be unreasonably
withheld, conditioned or delayed (in each case, to the extent it relates to the Standalone Drug
Business):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) sell, lease, license, purchase or enter into a contract to sell, remove or
otherwise dispose of any Purchased Assets except (i)&nbsp;pursuant to existing contracts or
commitments disclosed to Buyer in writing prior to the date hereof, (ii)&nbsp;sales of inventory
in the ordinary course consistent with past practice or (iii)&nbsp;purchases, lease-related
expenditures and equipment leases in the ordinary course of business consistent with the
levels contemplated in the capital expenditure budget set forth in Section&nbsp;5.01(a) of the
Disclosure Letter (the &#147;<B>Capex Budget</B>&#148;);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) unless required by the terms of the applicable Store Lease or Ground Lease, modify
materially, renew, extend or terminate any of the Store Leases or Ground Leases; <I>provided</I>
that optional extensions of lease terms provided for in Store Leases or Ground Leases may be
exercised by Sellers in the ordinary course of business consistent with past practices and
<I>provided further </I>that, notwithstanding anything to the contrary herein, the Sellers (i)
shall exercise any existing optional extensions for and/or renew (in accordance with the
applicable time periods) (or, in the case of Stores subject to month-to-month lease
arrangements, use reasonable best efforts to continue those arrangements for) those Store
Leases or Ground Leases listed in Schedule&nbsp;5.01(b)(i) and (ii)&nbsp;have advised Buyer that they
are to close or sell the Stores listed in Schedule&nbsp;5.01(b)(ii);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) terminate or permit termination or expiration of, any existing pharmacy or other
federal, state or local licenses, permits, registrations, certifications and Medicare and
Medicaid provider numbers, except in the ordinary course of business, consistent with past
practices;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) incur, assume or guarantee any indebtedness for borrowed money with respect to the
Purchased Assets, or mortgage or pledge any Purchased Asset or create or suffer to exist any
Lien other than Permitted Liens on any Purchased Assets, other than in the ordinary course
of business consistent with past practices; <I>provided, however</I>, no Lien on Real Property
securing indebtedness will be created;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) enter into any (i)&nbsp;employment, deferred compensation, severance, retirement or
other similar agreement with any officer or employee of the Standalone Drug Business (or
amend any such existing agreement), (ii)&nbsp;grant any severance or termination pay to any
officer or employee of the Standalone Drug Business (other than
</DIV>

<P align="center" style="font-size: 10pt">22
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">any severance or termination pay that is required to be paid under any of Albertson&#146;s
or its Affiliates&#146; severance plans as in effect on the date hereof) or (iii)&nbsp;increase any
compensation or other benefits payable to any officer or employee of the Standalone Drug
Business, other than any compensation increases that are in the ordinary course of business
consistent with past practice;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) make or commit to any capital expenditure for additions or improvements to any
plant, property or equipment relating primarily to the Standalone Drug Business in excess of
the Capex Budget, except to the extent that such excess does not exceed $1,000,000 in the
aggregate;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) enter into, modify, extend or cancel any third-party payor contracts (which
contracts are for amounts in excess of $250,000 per annum), except in the ordinary course of
business consistent with past practices;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) make any material changes in accounting policies or procedures other than as
required by GAAP or a Governmental Authority;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) enter into any real estate lease or lease commitment (or change the status of any
commitment), enter into or materially modify any Construction Contract, or purchase or
acquire or enter into any agreement to purchase or acquire any real estate, in each case
relating primarily to the Standalone Drug Business, other than as expressly contemplated
hereby or in the ordinary course of business consistent with past practice as determined in
accordance with Section&nbsp;5.01 of the Disclosure Letter;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) in any material respect, amend, waive, modify, supplement, extend, terminate, allow
to lapse, assign, encumber or otherwise transfer, in whole or in part, its rights and
interests in or under any Assigned Contracts, other than as expressly contemplated hereby or
in the ordinary course of business consistent with past practice as determined in accordance
with Section&nbsp;5.01 of the Disclosure Letter; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) agree or commit to do any of the foregoing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.02. <I>Access to Information; Confidentiality</I>. (a)&nbsp;From the date hereof until the
Effective Time, Albertson&#146;s will (i)&nbsp;give Buyer, its counsel, financial advisors, auditors and
other authorized representatives reasonable access during normal business hours and upon reasonable
notice to the offices, properties, books, records and personnel of the Sellers relating to the
Facilities and the Purchased Assets, (ii)&nbsp;furnish to Buyer, its counsel, financial advisors,
auditors and other authorized representatives such financial and operating data and other
information relating to the Facilities and the Purchased Assets as Buyer may reasonably request
(including affording Buyer and its representatives access to the Stores and the Distribution Center
during the pre-Closing period to enable Buyer, at Buyer&#146;s expense, to conduct a physical count of
all inventory at such locations, (iii)&nbsp;co-operate and prioritize and allocate its resources as
reasonably necessary to construct a data bridge and the data file transfers to ensure that Sellers
will commence providing, immediately as of Closing, the information technology services to Buyer as
specified in the Standalone Drug Transition Services Agreement, (iv)&nbsp;deliver to Buyer (in
electronic form where available) commencing promptly after the date hereof the data reasonably
</DIV>

<P align="center" style="font-size: 10pt">23
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">requested by Buyer in order to commence and progress item match and other transition related
planning activities as specified in Schedule&nbsp;5.02(a) and (v)&nbsp;instruct the employees, counsel,
financial advisors and auditors of the Sellers to cooperate with Buyer in connection with the
foregoing; <I>provided </I>that (x)&nbsp;Buyer and its representatives shall not have the right, without the
prior approval of Albertson&#146;s (which shall not be unreasonably withheld, delayed or conditioned, so
long as Buyer provides Sellers with an appropriate indemnity), to perform any investigative
procedures that involve physical disturbance or damage to the Facilities, the real property upon
which the Facilities are situated or any of the Purchased Assets or Excluded Assets and (y)&nbsp;it is
understood and agreed that Buyer has informed Sellers that the access and conduct that is required
by this Section&nbsp;5.02(a) is critical to its ability to operate the Stores, and to conduct business
and service customers at the Stores, at Closing, but that such access and conduct must be provided
or performed in a form or manner or pursuant to a process that complies with applicable Law and any
medical privacy policy of Albertson&#146;s maintained for the benefit of third parties that imposes a
legally binding obligation on Albertson&#146;s or is required to be complied with order to be in
accordance with applicable Law. Accordingly, to the extent that providing access to certain
information or personnel or taking certain action under this Section&nbsp;5.02(a) would not so comply in
a given form or manner or pursuant to a given process, the parties shall agree on a form or manner
of access or conduct that will both enable Buyer to operate the Stores, and conduct business and
service customers at the Stores, at Closing and will comply with applicable Law and any such policy
(<I>e.g., </I>pricing information may be redacted from the item files and pharmacy reimbursement rates may
be redacted from third party plan information). To the extent that any Seller incurs any
incremental out-of-pocket costs in processing, retrieving or transmitting any such information
pursuant to this Section&nbsp;5.02(a), the Buyer shall reimburse the appropriate Seller for the
reasonable out-of-pocket costs thereof promptly upon the submission to the Buyer of an invoice
therefor accompanied by supporting documentation in reasonable detail.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) During the period preceding the Closing Date, the Sellers shall permit Buyer access
to each Facility after normal business hours (unless other times are permitted by the
Sellers) in order to (i)&nbsp;prepare as-built surveys, and (ii)&nbsp;install wiring for communication
devices and other store systems (including computers and other systems) and take other
similar action at such Facility, all at Buyer&#146;s cost and without causing damage to such
Facility; <I>provided </I>that Buyer shall not be permitted to install any equipment in the
Facilities until immediately following the Effective Time. Buyer agrees to repair any
damage which may be caused due to the exercise of its rights pursuant to this Section
5.02(b) and to indemnify, defend and hold harmless the Seller Indemnitees from any and all
Damages arising out of or in any way connected with Buyer&#146;s exercise of its rights pursuant
to this Section&nbsp;5.02(b). The Sellers&#146; obligation to provide the foregoing access shall be
conditioned on the requirement that Buyer shall not unreasonably interfere with the Sellers&#146;
Standalone Drug Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) After the Effective Time, the Sellers and their Affiliates will hold, and will use
their commercially reasonable efforts to cause their respective officers, directors,
employees, accountants, counsel, consultants, advisors and agents to hold, in confidence,
unless required to disclose by judicial or administrative process or by other requirements
of Law or by the rules, regulations or policies of any United States or foreign securities
exchange, all documents and information concerning the Purchased Assets and Assumed
Liabilities, except to the extent that such information can be shown to have been (i)&nbsp;in the
</DIV>

<P align="center" style="font-size: 10pt">24
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">public domain prior to the Effective Time, (ii)&nbsp;in the public domain at or after the
Effective Time through no fault of the Sellers or their Affiliates or (iii)&nbsp;later lawfully
acquired by the Sellers from sources other than those related to its prior ownership of the
Standalone Drug Business; <I>provided </I>that the Sellers may disclose such information to their
officers, directors, employees, successors, accountants, counsel, consultants, advisors and
agents in connection with the transactions contemplated by this Agreement so long as such
Persons are informed by the Sellers of the confidential nature of such information and are
directed by the Sellers to treat such information confidentially. The obligation of the
Sellers and their Affiliates to hold any such information in confidence shall be satisfied
if Sellers exercise the same care with respect to such information as they would take to
preserve the confidentiality of their own similar information. For so long as such
information remains subject to the foregoing confidentiality obligations, the Sellers shall
not use the same for any purpose other than tax, accounting and regulatory and other
compliance purposes and evaluating, enforcing and performing their rights and obligations
under this Agreement and the Ancillary Agreements or otherwise in connection with the
transactions contemplated hereby and thereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Subject to Section&nbsp;8.02(a), after the Effective Time, the Sellers will afford
promptly to Buyer and its agents reasonable access (with an opportunity to make copies)
(subject, however, to confidentiality and similar non-disclosure obligations) during normal
business hours and upon reasonable notice, to the Sellers&#146; properties, books, records
(whether in hard copy or computer format), workpapers, contracts, commitments, Tax Returns,
personnel and records relating to the Facilities or the Purchased Assets as Buyer shall
reasonably request for any reasonable business purpose relating to the Facilities or the
Purchased Assets; <I>provided </I>that any such access by Buyer shall not unreasonably interfere
with the conduct of the business of the Sellers. Buyer shall bear all of the out-of-pocket
costs and expenses (including attorneys&#146; fees, but excluding reimbursement for general
overhead, salaries and employee benefits) reasonably incurred in connection with the
foregoing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.03. <I>Notices of Certain Events</I>. From the date hereof until the Closing Date, each
party shall promptly notify the other party of:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) any written notice or other written communication from any Person alleging that the
consent of such Person is or may be required in connection with the transactions
contemplated by this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any written notice or other written communication from any Governmental Authority
in connection with the transactions contemplated by this Agreement; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) any change or fact of which it is aware that will or is reasonably likely to result
in any of the conditions set forth in Article&nbsp;10 becoming incapable of being satisfied.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.04. <I>Noncompetition; Cooperation. </I>(a)&nbsp;SUPERVALU agrees that neither it nor any of
its controlled Affiliates shall:
</DIV>

<P align="center" style="font-size: 10pt">25
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) until eighteen months after the Closing Date, either directly or
indirectly, for its own account or jointly with others, open any freestanding drug
store within a 2.5-mile radius of any of the Stores;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) (X)&nbsp;until six months after the Closing Date, open any new pharmacy counter
in any supermarket owned or operated either directly or indirectly for its own
account or jointly with others by any Seller or any of its Affiliates within a
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.25-mile radius of any of the Stores or (Y)&nbsp;for the following twelve months after
such initial six month period, open more than five new pharmacy counters in a
supermarket within a .25-mile radius of any of the Stores.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Notwithstanding anything to the contrary contained in this Section&nbsp;5.04,
neither SUPERVALU nor any of its controlled Affiliates shall be prohibited from (X)
entering into or consummating any agreement or transaction providing for the
acquisition or disposition of any assets, securities or businesses so long and to
the extent that such acquisitions or dispositions are not specifically intended to
circumvent the restrictions set forth in this Section&nbsp;5.04 or (Y)&nbsp;the purchase,
acquisition or possession of 5% or less of any class of securities of any Person in
the ordinary course of SUPERVALU&#146;s or any of its Affiliates&#146; passive investment
activities.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) SUPERVALU agrees that, until 18&nbsp;months after the Closing Date, neither it nor any
of its controlled Affiliates, on the one hand, and Parent agrees that neither it nor any of
its controlled Affiliates, on the other hand, shall solicit any prescription drug customer
of the other party to the extent that such customer&#146;s prescription file is associated with a
store of the other party; <I>provided </I>that the foregoing shall not be deemed to prohibit
generalized solicitations through media advertisements that are not targeted at such
customers. For the avoidance of doubt, nothing in this Section&nbsp;5.04(b) shall limit any
party&#146;s ability to solicit any customer whose name independently appears on such party&#146;s
prescription files.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) For a period of 180&nbsp;days from the Closing Date, SUPERVALU and Parent agree not to
disparage each other or to communicate that a prescription file has been &#147;transferred&#148; or
&#147;transferred away&#148; (or a message using similar language) from the other&#146;s branded store in
communications with prescription drug customers.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.05. <I>Prescription Files</I>. Commencing on the Closing Date and in accordance with a
schedule to be provided by Buyer, the Sellers will deliver the Prescription Files to Buyer in an
electronic format mutually agreeable to Buyer and the Sellers in accordance with all applicable
state board of pharmacy regulations; <I>provided </I>that Sellers shall preserve and maintain original
hard copies of the Prescription Files at the applicable Stores in accordance with all applicable
state board of pharmacy regulations; <I>provided further</I>, the cost of any conversion into such
mutually agreed upon electronic format shall be at Buyer&#146;s sole cost and expense.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.06. <I>Casualty and Condemnation</I>. (a)&nbsp;In the event that, after the execution of this
Agreement, but prior to the Effective Time, any Facility is subject to loss, destruction or
</DIV>

<P align="center" style="font-size: 10pt">26
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">damage to the building or other improvements thereon (a &#147;<B>Casualty</B>&#148;) or the exercise of eminent
domain by a Governmental Authority (a &#147;<B>Condemnation</B>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Subject to Section&nbsp;5.06(a)(ii), at the Closing the Sellers shall assign to Buyer
all proceeds the Sellers have received from any third party insurance claims, condemnation
awards, compensation or other reimbursements relating to such Casualty or Condemnation
(except as to business interruption insurance to the extent that such proceeds are used or
intended to be used to reimburse Seller for any out-of-pocket costs, expenses, damages or
losses suffered or incurred by Seller up to and including the Effective Time) to the extent
such proceeds have not already been used by a Seller to repair any such loss, destruction or
damage (or are required to reimburse any Seller for any such repair), and shall assign to
Buyer the right to receive any future proceeds of such Casualty or Condemnation receivable
after the Effective Time, including as to business interruption insurance.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) If any such Casualty is not covered under the Sellers&#146; insurance policies and in
the event of a Leased Store that has suffered a Casualty where the landlord is responsible
for such repairs, loss or destruction pursuant to the terms of the relevant Lease, the
applicable Seller shall assign the applicable Lease to Buyer at the Closing and, without any
additional payment from the Sellers, the Sellers shall assign to Buyer any claim they have
under such Lease with respect thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Any party receiving a notice of Casualty or Condemnation shall notify all other parties in
accordance with Section&nbsp;12.02. Notwithstanding anything to the contrary contained in this
Agreement, in no event will any Casualty or Condemnation constitute the breach of any
representation, warranty or covenant of the Sellers contained in this Agreement if the Sellers
comply with this Section&nbsp;5.06.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Notwithstanding anything to the contrary in this Agreement, under no circumstances shall
(i)&nbsp;SUPERVALU, New Diamond, Sellers or any of their respective Affiliates be responsible for any
retention or deductible payable with respect to any Casualty or Condemnation and (ii)&nbsp;any payments
on account of a Casualty or Condemnation or any other loss be required from Beryl American
Corporation, or any other Subsidiary or Affiliate of SUPERVALU or the Sellers that has underwritten
an insurance policy with respect to any Purchased Asset.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.07. <I>Assistance in Transfer of Licenses, Permits and Registrations</I>. (a)&nbsp;The Sellers
will use commercially reasonable efforts to assist Buyer in obtaining the transfer of the Licenses,
including directing its employees to cooperate with such transfer and making any notifications
required to be sent by the Sellers to the U.S. Drug Enforcement Administration (&#147;<B>DEA</B>&#148;) and
applicable state pharmacy boards prior to the Effective Time. It is understood that Buyer is
responsible for any expenses associated with any of the foregoing transfers or assignments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) With respect to any liquor license or liquor or other alcoholic beverage inventory
conveyed hereunder, the parties shall comply with applicable Law, including the creation of
any necessary escrow and the disbursement or release of any funds held in
</DIV>

<P align="center" style="font-size: 10pt">27
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">such escrow, with the related escrow fees being paid by Buyer; <I>provided, however, </I>if a
state liquor control authority refuses to consent to the transfer or issuance of a liquor
license with respect to any Store to Buyer, the liquor inventory at such Store shall be
deemed Excluded Inventory. The parties shall cooperate in executing and delivering any
documentation necessary to effect the foregoing. Buyer or a designee of Buyer will file, or
cause to be filed, all necessary pharmacy and liquor permit applications with the
appropriate governmental authorities and will use its commercially reasonable efforts to
obtain such permits as soon as practicable (including any controlled substance licenses
required under state law and DEA numbers). In the event that any liquor, alcoholic
beverage, pharmacy, controlled substances, DEA, Medicare, Medicaid or other permit, license,
registration, provider number, approval, consent, certification or the like issued by any
Governmental Authority necessary for the Buyer&#146;s ownership and/or operation of the Purchased
Assets, Standalone Drug Business or any Store shall not have been issued or transferred to
Buyer as of the Closing, at the request of Buyer and without any additional consideration,
the Sellers shall execute such powers of attorney, instruments and agreements as are
reasonably necessary to allow Buyer to utilize the Sellers&#146; liquor, alcoholic beverage,
pharmacy, controlled substances, DEA, Medicare, Medicaid or other permits, licenses,
registrations, provider numbers, approvals, consents, certifications or the like, to the
extent permitted under applicable Law, in Buyer&#146;s ownership and/or operation of the
Purchased Assets, Standalone Drug Business or any Store, until the issuance of such liquor,
alcoholic beverage, pharmacy, controlled substances, DEA, Medicare, Medicaid or other
permits, licenses, registrations, provider numbers, approvals, consents, certifications or
the like to Buyer; provided that as a condition precedent to the Sellers&#146; execution of any
such power of attorney, instrument or agreement, Buyer shall also agree that (i)&nbsp;during the
period of Buyer&#146;s use of the Sellers&#146; liquor, alcoholic beverage, pharmacy, controlled
substances, DEA, Medicare, Medicaid or other permits, licenses, registrations, provider
numbers, approvals, consents, certifications or the like thereunder, Buyer shall own and/or
operate the Purchased Assets, Standalone Drug Business or any Store in accordance with
applicable Law and (ii)&nbsp;Buyer shall indemnify the Sellers against all losses arising out of
Buyer&#146;s use of such power of attorney, instrument or agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.08. <I>Controlled Substances Inventory</I>. To the extent required by applicable Law or
DEA regulations in context of the transactions contemplated by this Agreement, the Sellers will
undertake and deliver to Buyer at each Store an inventory of &#147;controlled substances&#148; located at
such Store, as close as practicable prior to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.09. <I>Updated Store List</I>. No later than thirty Business Days prior to the Closing,
Sellers shall provide to Buyer updated copies of Exhibits A, B and C to this Agreement (the
&#147;<B>Updated Store List</B>&#148;), which shall set forth the final and definitive list of the Stores, and which
shall be identical to the Exhibits A, B and C attached to this Agreement except for, in accordance
with Section&nbsp;5.01 (i)&nbsp;the addition of new or replacement retail drug stores associated with the
Standalone Drug Business which are opened by Sellers between the date of this Agreement and the
date of Sellers&#146; delivery of the Updated Store List to Buyer, and (ii)&nbsp;the removal of any Stores
due to operational closings consistent with past practice or expirations of Store Leases or Ground
Leases in accordance with their terms. The Updated Store List shall be
</DIV>

<P align="center" style="font-size: 10pt">28
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">deemed to be Exhibits A, B and C to this Agreement for all purposes under this Agreement as of
the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.10. <I>Financial Reports; Audited Financials</I>. (a)&nbsp;Between the date of this Agreement
and the Closing Date, subject to applicable Law, Sellers shall deliver to Buyer on a monthly basis
interim, unaudited financial reports for the Standalone Drug Business, prepared by Sellers in the
ordinary course of business consistent with past practices and in accordance with Sellers&#146;
customary reporting format for Sellers&#146; internal use in overseeing and managing the operations of
the Standalone Drug Business and the Stores.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Sellers will cooperate and use commercially reasonable efforts to prepare for
Parent (and in the event required to be obtained by Parent under Regulation&nbsp;S-X under the
Exchange Act, shall prepare for Parent), commencing promptly after the date hereof, audited
financial statements for the Standalone Drug Business, the Purchased Assets and the Assumed
Liabilities for Albertson&#146;s then most recently completed and reported fiscal year (and
unaudited reviewed financial statements for any historical or subsequent fiscal quarter
required to be obtained by Parent under such Regulation&nbsp;S-X) in each case fairly presented
in accordance with GAAP on a basis consistent with Albertson&#146;s historical financial
statements. Sellers shall deliver all such financial statements to Parent at least 30&nbsp;days
prior to the latest time such financial statements are required to be filed by Parent with
the Securities and Exchange Commission under the Exchange Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.11. <I>Intercompany Leases</I>. On or prior to the Closing Date, the Sellers shall deliver
the Purchased Assets free and clear of any lease or sublease agreements between any Seller or any
Affiliate of a Seller, on the one hand, and Albertson&#146;s or any Affiliate of Albertson&#146;s, on the
other hand.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.12. <I>Merger Agreement; Separation Agreement</I>. Neither Albertson&#146;s nor SUPERVALU
shall, without the prior written consent of Buyer agree to any modification of any of the terms or
conditions of, or give any consent or waiver under, any provision of the Merger Agreement or
Separation Agreement if such modification, consent or waiver would reasonably be expected to have a
material and adverse effect on the Standalone Drug Business, Purchased Assets or Assumed
Liabilities.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 6</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Covenants of Buyer</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Buyer agrees that:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.01. <I>Confidentiality</I>. Prior to the Effective Time and after any termination of this
Agreement, Buyer and its Affiliates will hold, and will use their commercially reasonable efforts
to cause their respective officers, directors, employees, accountants, counsel, consultants,
advisors and agents to hold, in confidence, unless compelled to disclose by judicial or
administrative process or by other requirements of Law or by the rules, regulations or policies of
any United States or foreign securities exchange, all documents and information concerning the
Standalone Drug Business that the Sellers have furnished to Buyer or any of its Affiliates in
</DIV>

<P align="center" style="font-size: 10pt">29
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">connection with the transactions contemplated by this Agreement, except to the extent that
such information can be shown to have been (i)&nbsp;in the public domain through no fault of Buyer or
any of its Affiliates or (ii)&nbsp;later lawfully acquired by Buyer or any of its Affiliates from
sources other than the Sellers; <I>provided </I>that Buyer may disclose such information to its officers,
directors, employees, accountants, counsel, consultants, advisors and agents in connection with the
transactions contemplated by this Agreement so long as such Persons are informed by Buyer of the
confidential nature of such information and are directed by Buyer to treat such information
confidentially. The obligation of Buyer and its Affiliates to hold any such information in
confidence shall be satisfied if they exercise the same care with respect to such information as
they would take to preserve the confidentiality of their own similar information. If this
Agreement is terminated, Buyer and its Affiliates will, and will use their commercially reasonable
efforts to cause their respective officers, directors, employees, accountants, counsel,
consultants, advisors and agents to, destroy or deliver to the Sellers, upon request, all documents
and other materials, and all copies thereof, obtained by Buyer or any of its Affiliates or on their
behalf from the Sellers in connection with this Agreement that are subject to such confidence.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.02. <I>Access</I>. After the Effective Time, Buyer will afford promptly to each of the
Sellers and New Diamond and their agents reasonable access (with an opportunity to make copies)
(subject, however, to confidentiality and similar non-disclosure obligations) during normal
business hours and upon reasonable notice, to Buyer&#146;s properties, books, records (whether in hard
copy or computer format), workpapers, contracts, commitments, Tax Returns, personnel and records
relating to the Facilities or the Purchased Assets as the Sellers and/or New Diamond shall
reasonably request for any reasonable business purpose relating to the Facilities or the Purchased
Assets; <I>provided </I>that any such access by the Sellers and/or New Diamond, as applicable, shall not
unreasonably interfere with the conduct of the business of Buyer. Each of the Sellers and New
Diamond shall bear all of the out-of-pocket costs and expenses (including attorneys&#146; fees, but
excluding reimbursement for general overhead, salaries and employee benefits) reasonably incurred
in connection with the foregoing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.03. <I>Guarantee Releases under Certain Contracts</I>. Following the Effective Time, the
Buyer will use its reasonable best efforts to procure the release by the applicable counterparty of
any guarantee of Albertson&#146;s or their respective Affiliates in place with respect to any Store
Lease, Ground Lease or Assigned Contract by offering a replacement guarantee of Buyer or its
Affiliates, but Buyer shall have no further obligation to procure such release. If and to the
extent that Buyer shall be unable to procure any such release, Buyer and its Affiliates shall
jointly and severally indemnify and hold harmless the Sellers, New Diamond or their respective
Affiliates, as applicable, against any damages, losses, liabilities and expenses (including
reasonable attorneys&#146; fees) suffered or incurred by any of them with respect to any such Store
Lease, Ground Lease or Assigned Contract.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.04. <I>Contractual Overpayments</I>. If at any time in the one-year period following the
Effective Time, the Buyer or any of its Affiliates receives a refund amount or a reduction in an
amount payable from a vendor that relates to a contractual overpayment under any of the Assigned
Contracts, Store Leases or Ground Leases by the Sellers or their Affiliates prior to the Effective
Time, the Buyer shall promptly pay to New Diamond an amount equal to the amount of such refund or
reduction.
</DIV>

<P align="center" style="font-size: 10pt">30
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.05. <I>Medicare And Medicaid Provider Numbers</I>. The Buyer shall promptly make (and
thereafter diligently pursue) all filings, notifications and applications required for
participating as a provider in Medicare and Medicaid reimbursement programs with respect to the
Stores.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 7</FONT>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 0pt"><FONT style="font-variant: SMALL-CAPS">Covenants of Buyer and the Sellers</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.01. <I>Reasonable Best Efforts; Further Assurances</I>. (a)&nbsp;Subject to the terms and
conditions of this Agreement (including, but not limited to, Section&nbsp;7.2), Buyer and the Sellers
will use their reasonable best efforts to take, or cause to be taken, all actions and to do, or
cause to be done, and assist and cooperate with the other parties in doing, all things necessary or
desirable under applicable Laws and regulations to consummate, in the most expeditious manner
practicable, the transactions contemplated by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Buyer and the Sellers will use reasonable best efforts to: (i)&nbsp;prepare, as soon as
practicable, all filings and other presentations in connection with seeking any regulatory
approval, exemption or other authorization from any Governmental Authority necessary to
consummate the transactions contemplated hereby; (ii)&nbsp;prosecute such filings and other
presentations with diligence; and (iii)&nbsp;oppose any objections to, appeals from or petitions
to reconsider or reopen any such approval by Persons not party to this Agreement. Buyer and
the Sellers will use reasonable best efforts to facilitate obtaining any final order or
orders approving such transactions, consistent with this Agreement and/or to remove any
impediment to the consummation of the transactions contemplated hereby. Buyer and the
Sellers will use reasonable best efforts to furnish all information in connection with the
approvals of or filings with any Governmental Authority and will promptly cooperate with and
furnish information in connection with any such requirements imposed upon Buyer or any of
its Affiliates in connection with this Agreement and the transactions contemplated hereby.
Subject to Section&nbsp;6.02, Buyer will use reasonable best efforts to obtain any consent,
authorization, order or approval of, or any exemption by, and to remove any impediment
imposed by any Governmental Authority to allow the consummation of the transactions
contemplated hereby. Buyer and the Sellers will each advise the other party promptly of any
material communication received by such party or any of its Affiliates from the Federal
Trade Commission, Department of Justice, any state attorney general or any other
Governmental Authority regarding any of the transactions contemplated hereby, and of any
understandings, undertakings or agreements (oral or written) such party proposes to make or
enter into with the Federal Trade Commission, Department of Justice, any state attorney
general or any other Governmental Authority in connection with the transactions contemplated
hereby. Buyer and Sellers will each consult with the other in advance of any material
meetings with the Federal Trade Commission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.02. <I>HSR Clearance</I>. (a)&nbsp;In furtherance and not in limitation of Section&nbsp;7.01, each
of Buyer and Albertson&#146;s shall make an appropriate filing of a Notification and Report Form
pursuant to the HSR Act with respect to the transactions contemplated hereby as promptly as
practicable and thereafter make any other required submissions with respect to the transactions
contemplated hereby under the HSR Act and to take all other appropriate actions
</DIV>

<P align="center" style="font-size: 10pt">31
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">reasonably necessary, proper or advisable to cause the expiration or termination of the
applicable waiting periods under the HSR Act as soon as practicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Notwithstanding the foregoing, Buyer shall promptly take, in order to consummate
the transactions contemplated hereby, all actions necessary to (A)&nbsp;secure the expiration or
termination of any applicable waiting period under the HSR Act (the &#147;<B>HSR Clearance</B>&#148;) and (B)
to resolve any objections asserted with respect to the transactions contemplated under this
Agreement under any antitrust Law or the Federal Trade Commission Act, raised by any
Governmental Authority, and to prevent the entry of any court order and to have vacated,
lifted, reversed or overturned any decree, judgment, injunction or other order that would
prevent, prohibit, restrict or delay Closing, including (i)&nbsp;executing settlements,
undertakings, consent decrees, stipulations or other agreements with any Governmental
Authority (or with any private party, but only in this latter case, in order to vacate,
lift, reverse, overturn, settle or otherwise resolve any decree, judgment, injunction or
other order that prevents, prohibits, restricts or delays Closing that may be issued by any
court or other Governmental Authority in favor of that third party), (ii)&nbsp;selling, divesting
or otherwise conveying particular assets or categories of assets or businesses of Parent and
its Affiliates, (iii)&nbsp;agreeing to sell, divest or otherwise convey any particular assets or
categories of assets or businesses of the Purchased Assets contemporaneously with or
subsequent to the Closing, and (iv)&nbsp;permitting the Sellers to sell, divest or otherwise
convey any particular assets or categories of assets or businesses of the Purchased Assets
prior to the Closing. All such efforts shall be unconditional and shall not be qualified by
best efforts and no actions taken pursuant to this Section&nbsp;7.02 shall be considered for
purposes of determining whether a Material Adverse Effect has occurred. Buyer shall respond
to and seek to resolve as promptly as reasonably practicable any objections asserted by any
Governmental Authority with respect to the transactions contemplated under this Agreement.
In the event in connection with such efforts Buyer or Seller sell or otherwise dispose of
any of the Purchased Assets and the Closing occurs, the Buyer will be entitled to retain all
net proceeds received from the applicable sale or disposition to a third party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.03. <I>Certain Filings</I>. Buyer and the Sellers shall cooperate with one another (a)&nbsp;in
determining whether any action by or in respect of, or filing with, any Governmental Authority is
required, or any actions, consents, approvals or waivers are required to be obtained from parties
to any material contracts, in connection with the consummation of the transactions contemplated by
this Agreement, and (b)&nbsp;in taking such actions or making any such filings, furnishing information
required in connection therewith and seeking timely to obtain any such actions, consents, approvals
or waivers. Each of Buyer and the Sellers shall use their respective reasonable best efforts to
obtain Tax clearance certificates (pursuant to Laws with respect to bulk transfers) from any state
in which failure to obtain such certificate may result in Buyer or any of its Affiliates being
liable for Taxes as transferee in connection with the consummations of the transactions
contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.04. <I>Public Announcements</I>. From the date hereof through the Closing Date, no public
release or announcement concerning the transactions contemplated hereby shall be issued by Parent,
SUPERVALU or Albertson&#146;s (or their respective Affiliates or representatives) without the prior
consent of each of the other such parties (which consent shall not be
</DIV>

<P align="center" style="font-size: 10pt">32
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">unreasonably withheld or delayed), except, in each case, as such release or announcement may
be required by Law or the rules, regulations or policies of any United States or foreign securities
exchange, in which case the party required to make the release or announcement shall use its
commercially reasonable efforts to allow the other parties reasonable time to comment on such
release or announcement in advance of such issuance; <I>provided </I>that SUPERVALU, Parent and Sellers
may make internal announcements to their respective employees after reasonable prior notice to, and
consultation with, the other; <I>provided, however</I>, that no prior notice or consultation will be
required for communications concerning status or other factual matters concerning the transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.05. <I>Trademarks; Tradenames</I>. Except as otherwise set forth in this Section&nbsp;7.05,
after the Effective Time, Buyer and its Affiliates shall not use the Tradenames and Trademarks.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Buyer agrees to use commercially reasonable efforts to re-brand (including changing
signage), and Sellers agree, at Buyer&#146;s expense, to use commercially reasonable efforts to
assist Buyer in re-branding, each Store in the greater Chicago metropolitan area and
Southern California (San Diego and Orange County) markets within 90&nbsp;days after the Closing
Date (and each other Store within 180&nbsp;days after the Closing Date), and Buyer and its
Affiliates shall have the right to use the &#147;Albertson&#146;s&#148; (to the extent used for private
label product), &#147;Osco&#148; or &#147;Sav-on&#148; names (the &#147;<B>Tradenames and Trademarks</B>&#148;) in connection
with each Store until such Store has been re-branded; <I>provided </I>that such time periods shall
be extended to the extent necessary if such re-branding is not permitted by Law before the
expiration of such period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) After the Effective Time, Buyer and its Affiliates and its resellers shall have the
right to sell existing inventory and to use existing packaging, labeling, containers,
supplies, advertising materials and any similar materials bearing the Tradenames and
Trademarks for 180&nbsp;days following the Closing Date. Buyer and its Affiliates and resellers
shall have the right to use the Tradenames and Trademarks in advertising that cannot be
changed by Buyer or its Affiliates or resellers using commercially reasonable efforts for a
period not to exceed 180&nbsp;days after the applicable Effective Time. Buyer and its Affiliates
and resellers shall comply with all applicable Laws or regulations in any use of packaging
or labeling containing the Tradenames and Trademarks. Buyer and its Affiliates and resellers
shall not be obligated to change the Tradenames and Trademarks on goods in the hands of
dealers, distributors and customers at the time of the expiration of the time period set
forth herein.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.06. <I>Accounts Receivables; Gift Cards and Gift Certificates; Prepaid Expenses</I>. (a)
Buyer shall promptly deposit in one or more accounts designated by New Diamond within 10&nbsp;days of
receipt any monies paid to Buyer with respect to Accounts Receivable and shall furnish the
information that New Diamond may reasonably request from time to time with respect to such Accounts
Receivable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Following the Closing Date for a period of four months thereafter, with respect to
each Store, Buyer shall (i)&nbsp;accept in full any original proprietary gift cards
</DIV>

<P align="center" style="font-size: 10pt">33
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">issued by Sellers for use at their retail locations from customers who present gift
cards at such Store and (ii)&nbsp;Buyer shall redeem at full face value any original proprietary
gift certificates issued by Sellers for use at their retail locations to customers who
present such gift certificates at such Store.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Buyer shall reimburse New Diamond at the Closing for the full amount of all
documented Prepaid Expenses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.07. <I>Transition Services Agreement</I>. Buyer and SUPERVALU and its Affiliates shall
cooperate and use their respective best efforts to enter into at Closing the Standalone Drug
Business Transition Services Agreement and the Distribution Center Transition Services Agreement;
provided, however, in no event shall the execution and delivery of the Standalone Drug Business
Transition Services Agreement or the Distribution Center Transition Services Agreement pursuant to
Section&nbsp;1.07 be a condition to Closing.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.08. <I>HIPAA Privacy Standards</I>. (a)&nbsp;After the Effective Time, Buyer shall make the
Prescription Files available for access and amendment to individuals in accordance with the Health
Insurance Portability and Accountability Act of 1996 privacy standards (the &#147;<B>HIPAA Privacy
Standards</B>&#148;) and other applicable Laws. Buyer shall respond to individuals&#146; requests for
accountings of disclosures of protected health information for periods prior to the Effective Time
in accordance with the HIPAA Privacy Standards.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) In addition, Buyer shall maintain the Prescription Files and all protected health
information transferred by the Sellers in accordance with the Health Insurance Portability
and Accountability Act of 1996 security standards governing electronic protected health
information.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) All inquiries and responses by Buyer relating to patient rights under HIPAA Privacy
Standards relating to uses or disclosures of health information made prior to the Effective
Time shall be forwarded to the Sellers and New Diamond pursuant to Section&nbsp;12.02.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.09. <I>Solicitation of Employees</I>. Each of Parent and SUPERVALU mutually agree that (i)
neither it nor any of its Affiliates shall, until the end of the 18&nbsp;month period immediately
following the Closing Date, except as contemplated in Article&nbsp;9 and except with respect to any
employees listed on Schedule&nbsp;7.09, solicit the services of any personnel at the level of field
management or above (i.e., not including any pharmacist or store managers) that is employed by the
other party or its Affiliates pertaining to a drug store (including a pharmacy counter in a
supermarket) and (ii)&nbsp;until six months after the Closing Date, solicit any pharmacist that is
employed in a drug store (including a pharmacy counter in a supermarket) by the other party, in
each case, in any market which the Sellers operate a Store immediately prior to the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.10. <I>Kodak and Qualex Photo Processing Equipment</I>. The Sellers and Buyer shall each
use commercially reasonable efforts, and shall reasonably cooperate with each other in such
efforts, to obtain the consent of each of Kodak and Qualex to the (a) (i)&nbsp;transfer of the photo
processing equipment leased by the Sellers or their Affiliates from Kodak and Qualex and
</DIV>

<P align="center" style="font-size: 10pt">34
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">located at the Stores (the &#147;<B>Photo Equipment</B>&#148;) to Buyer and (ii)&nbsp;the assumption by Buyer of the
obligations of the Sellers with respect to such Photo Equipment, or (b)&nbsp;buyout by Buyer of the
Photo Equipment.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.11. <I>&#147;As Is&#148; Condition; Waiver and Release</I>. Except for the express representations
and warranties contained in this Agreement (and without limiting the conditions to Closing in
Article&nbsp;10), the Purchased Assets to be transferred hereunder will be transferred &#147;as is, where
is,&#148; in their present condition and state of repair, with all faults, limitations and defects
(hidden and apparent). Without limitation, each of Buyer and Parent, on the one hand, and the
Sellers and New Diamond, on the other hand, acknowledge that, except as specifically set forth to
the contrary in this Agreement, no warranties or representations, expressed or implied, of any kind
whatsoever (including any implied warranty of merchantability or fitness for a particular purpose)
have been made by the other party, any of its Affiliates or any other Person, or will be relied
upon.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.12. <I>Payments for Pharmacy Services</I>. Buyer agrees to forward to New Diamond any sums
of money received by Buyer for pharmacy services rendered by the Sellers prior to the Effective
Time. New Diamond and the Sellers agree to forward to Buyer any sums of money received by New
Diamond or the Sellers, as applicable, for pharmacy services rendered by Buyer following the
Effective Time. Further, upon reasonable notice from New Diamond and/or the Sellers, Buyer agrees
to afford reasonable access to allow New Diamond and the Sellers access to the Prescription Files
for the sole purpose of third party rebilling and reconciliation with respect to periods prior to
the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.13. <I>Confidentiality Agreement. </I>Parent and Albertson&#146;s agree that the terms and
provisions of the Confidentiality Agreement (as amended by this Section&nbsp;7.13) shall continue to
bind the parties; <I>provided, however</I>, that, in the event the Closing occurs, the Confidentiality
Agreement (as amended by this Section&nbsp;7.13) will terminate on the Closing Date except that the
confidentiality obligations therein will continue in effect in accordance with the terms thereof
with respect to information of Albertson&#146;s not related to the Standalone Drug Business, the
Purchased Assets or the Assumed Liabilities. Parent and Albertson&#146;s further agree that, until the
earlier of the Closing and the termination of Section 6(c) of the Confidentiality Agreement in
accordance with its terms, the scope of Section 6(c) of the Confidentiality Agreement (No
Solicitation) shall be expanded to apply reciprocally to each of Parent and its Affiliates, on the
one hand, and Albertson&#146;s and its Affiliates, on the other hand, and the terms in that Section 6(c)
shall be expanded to apply to their respective directors, officers, management level employees,
in-store managers and in-store pharmacists (and will not be limited by any reference to the
evaluation or discussions described in that Section&nbsp;6(c)); <I>provided </I>that in no event shall anything
in the foregoing or the Confidentiality Agreement prohibit or limit in any way the ability of
Parent and its affiliates to solicit, or make offers of employment to, Kevin Tripp, the Employees
and/or the individuals who are described in Section&nbsp;9.02, but only in relation to post-Closing
employment with Parent or its affiliates (which solicitations and offers shall, for the sake of
clarity, be conditioned on the Closing occurring).
</DIV>

<P align="center" style="font-size: 10pt">35
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 8</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Tax Matters</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.01. <I>Tax Matters</I>. Except as specified in Section&nbsp;8.01 of the Disclosure Letter, or
as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, Albertson&#146;s hereby represents and warrants to Buyer that the Sellers have timely paid, or
made provision to pay, all Taxes that include or relate to the Standalone Drug Business and the
Purchased Assets that will have been required to be paid on or prior to the date hereof, the
non-payment of which would (a)&nbsp;result in a Lien on any Purchased Asset, (b)&nbsp;otherwise adversely
affect the Standalone Drug Business or (c)&nbsp;result in Buyer becoming liable or responsible therefor.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.02. <I>Tax Cooperation</I>. (a)&nbsp;Notwithstanding any other provision in this Agreement,
this Section&nbsp;8.02 shall govern cooperation with respect to Tax matters. Buyer, the Sellers, New
Diamond and SUPERVALU agree to furnish or cause to be furnished to each other, upon request, as
promptly as practicable, such information and assistance relating to the Standalone Drug Business
and the Purchased Assets (including access to books and records) as is reasonably necessary for the
filing of all Tax Returns, the making of any election relating to Taxes, the preparation for any
audit by any Taxing Authority, and the prosecution or defense of any Action relating to any Tax.
Except with respect to information that is generally available to the public, the party requesting
such information shall treat such information so obtained in a manner consistent with the way in
which it treats its own records. Buyer, the Sellers, New Diamond and SUPERVALU shall retain all
books and records with respect to Taxes pertaining to the Purchased Assets for a period of at least
seven years following the Effective Time. Buyer, the Sellers, New Diamond and SUPERVALU shall
cooperate with each other in the conduct of any audit or other proceeding relating to Taxes
involving the Purchased Assets or the Standalone Drug Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) All real property taxes (other than real estate Taxes referred to in Section&nbsp;1.08),
personal property taxes and similar ad valorem obligations (other than Transfer Taxes, which
shall be governed by Section&nbsp;8.02(c)) levied with respect to the Purchased Assets for a
Straddle Tax Period (collectively, the &#147;<B>Apportioned Obligations</B>&#148;) shall be apportioned
between the Sellers and Buyer based on the number of days of such taxable period included in
the Pre-Closing Tax Period and the number of days of such taxable period included in the
Post-Closing Tax Period. The Sellers shall be liable for the proportionate amount of such
taxes that is attributable to the Pre-Closing Tax Period, and Buyer shall be liable for the
proportionate amount of such taxes that is attributable to the Post-Closing Tax Period.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) All excise, sales, use, value added, registration stamp, recording, documentary,
conveyancing, franchise, property, transfer, gains, transaction privilege tax and similar
Taxes, levies, charges and fees (collectively, &#147;<B>Transfer Taxes</B>&#148;) incurred in connection with
the transfer of the Purchased Assets pursuant to this Agreement shall be borne equally by
Buyer on the one hand, and Sellers, on the other hand. Buyer and the Sellers shall
cooperate in providing each other with any appropriate resale exemption certifications and
other similar documentation.
</DIV>

<P align="center" style="font-size: 10pt">36
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Apportioned Obligations and Transfer Taxes described in this Section&nbsp;8.02 shall be
timely paid, and all applicable Tax Returns shall be filed, as provided by applicable Law.
The paying party shall provide to the non-paying party drafts of all Tax Returns described
in the preceding sentence and a statement setting forth the amount of reimbursement to which
the paying party is entitled under Section&nbsp;8.02(b) and Section&nbsp;8.02(c), as the case may be,
together with appropriate supporting information and schedules at least 30 calendar days
prior to the due date for the filing of such Tax Return (including extensions), or such
shorter period as is necessary to allow for the timely filing of such Tax Return. The
non-paying party shall have the right, at its expense, to review all work papers and
procedures used to prepare any such Tax Return. If the non-paying party, within 10 Business
Days after delivery of any such Tax Return, notifies the paying party in writing that it
objects to any items in such Tax Return, the parties will use their reasonable best efforts,
acting in good faith, to resolve such disputed items between themselves. If the parties
fail to resolve such disputed items within 5 Business Days, such disputed items shall be
resolved (within a reasonable time, taking into account the deadline for filing such Tax
Return) by the Independent Accounting Firm. Upon resolution of all such items, the relevant
Tax Return shall be adjusted, if necessary, to reflect such resolution and shall be binding
upon the parties without further adjustment. The costs, fees and expenses of the
Independent Accounting Firm shall be borne equally by the parties. The non-paying party
shall make reimbursement promptly pursuant to this Section&nbsp;8.02(d) but in no event later
than 10&nbsp;days after the resolution of the relevant Tax Return. Any payment not made within
such time shall bear interest at the Applicable Rate until paid.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 9</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Employee Benefits</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.01. <I>ERISA Representations</I>. Albertson&#146;s hereby represents and warrants to Buyer that
Section&nbsp;9.01 of the Disclosure Letter contains a correct and complete list identifying each
material &#147;employee benefit plan,&#148; as defined in Section&nbsp;3(3) of ERISA, each material employment,
severance or similar contract, plan, arrangement or policy and each other material plan or
arrangement (written or oral) providing for compensation, bonuses, profit-sharing, stock option or
other stock-related rights or other forms of incentive or deferred compensation, vacation benefits,
insurance (including any self-insured arrangements), health or medical benefits, employee
assistance program, disability or sick leave benefits, workers&#146; compensation, supplemental
unemployment benefits, severance benefits and post-employment or retirement benefits (including
compensation, pension, health, medical or life insurance benefits) which is maintained,
administered or contributed to by the Sellers or any of their ERISA Affiliates and covers any
Employee as of the date hereof. Copies of such plans (and, if applicable, related trust or funding
agreements or insurance policies) and all amendments thereto (other than the Taft Hartley Plan
Documents) have been made available to Buyer together with, if applicable, the most recently filed
annual report (Form&nbsp;5500 including, if applicable, Schedule&nbsp;B thereto) and tax return (Form&nbsp;990)
prepared in connection with any such plan or trust. Such plans are referred to collectively herein
as the &#147;<B>Employee Plans</B>.&#148; Albertson&#146;s agrees to use its commercially reasonable efforts to furnish
Buyer with a copy of each Taft Hartley Plan Document prior to the Closing Date. Except as would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect,
each Employee Plan which is intended to be qualified
</DIV>

<P align="center" style="font-size: 10pt">37
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">under Section 401(a) of the Code is so qualified and has received a determination letter to
that effect from the IRS and, to the Knowledge of any Seller, no circumstances exist which would
reasonably be expected to materially adversely affect such qualification or exemption. With
respect to any Surviving Plan (as defined below) (i)&nbsp;Sellers have not incurred any withdrawal
liability under Subtitle E of Title IV of ERISA (&#147;<B>Withdrawal Liability</B>&#148;) that remains unsatisfied,
as would reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, and (ii)&nbsp;Sellers have not received any notification, that any such Surviving Plan is in
reorganization or has been terminated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.02. <I>Employees and Offers of Employment</I>. Effective as of the Effective Time, Buyer
shall (i)&nbsp;offer employment to each Employee, at a base salary or wage that is at least equal to
that provided the applicable Employee immediately prior to the Effective Time; (ii)&nbsp;have the right
to offer employment to each Albertson&#146;s corporate employee, field manager, field-based marketing
manager and divisional pharmacy manager, in each case to the extent dedicated solely to the
Standalone Drug Business, including, without limitation, those employees specified in Schedule
9.02(a) (so long as they are so dedicated) at a base salary or wage that is at least equal to that
provided to such Albertson&#146;s corporate employee, field manager, field-based marketing manager or
divisional pharmacy manager immediately prior to the Effective Time and (iii)&nbsp;have a right to hire
certain of the category managers, real estate personnel, field-based marketing managers and
divisional pharmacy managers in each case who have shared responsibilities between the Standalone
Drug Business and the New Diamond Business (as defined in the Separation Agreement) (collectively,
the &#147;<B>Shared Personnel</B>&#148;) to the extent specified in Schedule&nbsp;9.02(b) as determined in cooperation
between Sellers and Buyer by allocating a proportionate number of Shared Personnel to Buyer based
on the ratio of (x)&nbsp;the total number of pharmacy counters in Stores covered by such Shared
Personnel to (y)&nbsp;the total number of pharmacy counters in Stores and grocery stores operated by
Sellers collectively covered by such Shared Personnel as set forth on such Schedule&nbsp;9.02(b).
Sellers may update, and deliver to Buyer, Schedule&nbsp;9.02(a) and Schedule&nbsp;9.02(b) within fourteen
days following the date of this Agreement. SUPERVALU and Buyer shall cooperate in good faith to
determine the accuracy of Schedule&nbsp;9.02(a) and Schedule&nbsp;9.02(b) and agree to update each such
Schedule as appropriate. The term &#147;<B>Employee</B>&#148; includes any Person who, immediately prior to the
Effective Time, is actively employed by any Seller at a Facility or who is on short-term disability
leave, authorized leave of absence, military service or lay-off with recall rights as of the
Effective Time (such inactive employees shall be offered employment by Buyer as of the date they
return to active employment but only if such employee returns to active service within 180&nbsp;days
after the Effective Time or such later time as their reemployment rights are protected by
applicable Laws), but shall exclude any other inactive or former employee including any Person who
is on long-term disability leave or unauthorized leave of absence as of the Effective Time. The
employees who accept and commence employment with Buyer (including the employees described in this
Section&nbsp;9.02 and the employees set forth on Schedule&nbsp;7.09) are hereinafter collectively referred to
as the &#147;<B>Transferred Employees</B>.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.03. <I>The Sellers&#146; Employee Benefit Plans</I>. Except as expressly set forth herein, no
assets or liabilities of any Employee Plan shall be transferred to Buyer or any of its Affiliates
or to any plan of Buyer or any of its Affiliates. Buyer shall agree to assume the obligations
under any agreement providing for the grant of any restricted stock units or any cash awards to the
Transferred Employees or Employees (but only to the extent they remain eligible for such
</DIV>

<P align="center" style="font-size: 10pt">38
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">awards) which are granted to such Transferred Employees or Employees following the date hereof
but prior to the Effective Time, but solely with respect to the Employees, only to the extent such
awards are set forth and described in Section&nbsp;9.03 of the Disclosure Letter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.04. <I>Buyer Benefit Plans</I>. Buyer will cause all plans and programs of Buyer and its
Affiliates to recognize all service of the Transferred Employees with the Sellers or any of their
Affiliates prior to the Closing Date for purposes of vesting and eligibility and for purposes of
determining the amount of benefits under Buyer&#146;s applicable sick leave, vacation, severance or
other welfare plan. Buyer will assume, and be solely responsible for, all sick leave, vacation or
other paid time off accrued by Employees prior to the Effective Time; <I>provided, however</I>, that Buyer
will not assume any accrued sick leave, vacation or other paid time off to the extent Sellers are
required by Law to pay any Transferred Employee the appropriate accrued amounts of sick leave,
vacation or other paid time off, but will instead reimburse and hold harmless Sellers and their
Affiliates in respect of any such payments. Buyer shall or shall cause its Affiliates to offer
enrollment in, effective as of the Effective Time, all health and welfare and 401(k) plans of the
Buyer and its Affiliates to each Transferred Employee who participates in an equivalent type of
plan of Sellers or their Affiliates immediately prior to the Effective Time, and, so long as such
Transferred Employees remain employed by Buyer shall continue such enrollment for no less than 12
months following the Effective Time (so long as the applicable employee remains eligible under the
terms of the program, except that solely for purposes of Buyer&#146;s health care plans such eligibility
will be determined without regard to minimum number of hour requirements during the first 90&nbsp;days
following the Closing Date). Buyer shall (i)&nbsp;cause to be waived all limitations as to preexisting
condition limitations, exclusions and waiting periods with respect to participation and coverage
requirements applicable to the Transferred Employees under any plan of Buyer or its Affiliates that
is a healthcare plan, to the extent such limitation or exclusion was waived or such waiting period
was satisfied as of the Effective Time under any healthcare plan maintained for such employees
immediately prior to the Effective Time and (ii)&nbsp;cause applicable healthcare plans of Buyer or its
Affiliates to provide each Transferred Employee with credit for any co-payments, deductibles and
any other out-of-pocket expenses paid during the plan year or other appropriate period commencing
immediately prior to the Effective Time in satisfying any applicable deductible or out-of-pocket
requirements under any healthcare plan(s) of Buyer or its Affiliates for such plan year (so long as
Buyer is provided the applicable information). If within 12&nbsp;months following the Closing Date
Buyer terminates the employment of any Transferred Employee without cause, Buyer shall provide the
Transferred Employee severance benefits in an amount no less than the severance benefits the
Transferred Employee would have been entitled to under Albertson&#146;s applicable severance plans (but
excluding any individual employment or change in control agreements).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.05. <I>Labor Agreements</I>. (a)&nbsp;Buyer shall (i)&nbsp;assume the Assumed Labor Agreements, (ii)
recognize and comply with any legal duty to bargain or negotiate with any labor organization
lawfully entitled to represent any Transferred Employees, (iii)&nbsp;fully comply with Sections&nbsp;9.02 and
9.04 of this Agreement with respect to such Transferred Employees and credit such Transferred
Employees with full seniority gained while employed by Sellers and their Affiliates, and (iv)
indemnify the Seller Indemnitees against and hold each of them harmless from any and all damages,
losses, liabilities and expenses (including reasonable attorneys&#146; fees and expenses, indirect,
consequential, incidental, exemplary or special damages, punitive damages, lost profits, lost
revenues and diminution in value or benefits) arising out of or in any
</DIV>

<P align="center" style="font-size: 10pt">39
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">way connected with Buyer&#146;s failure to assume and comply with the terms of the Labor Agreements
(or Seller&#146;s failure to require Buyer to assume the Labor Agreements) or recognize and comply with
any legal duty to bargain or negotiate with any labor organizations lawfully entitled to represent
any Transferred Employees, including any such damages arising from any claims, including but not
limited to grievances, unfair labor practice charges, lawsuits, injunction actions or contractual,
administrative or legal actions of any kind, alleging a breach of a Labor Agreement or the
violation of any labor law, or any action by a labor organization at any location as a result
thereof. Buyer may seek before Closing to modify the terms of the Labor Agreements; <I>provided,
however</I>, that such modification shall not be a condition to Closing under this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) It is expressly agreed and understood that neither Buyer nor any Seller has any
right, power or authority to control, direct or regulate the labor relations and human
resources policies and procedures of the other, that neither is deemed to constitute the
agent or representative of the other, and that neither is liable in any manner whatsoever
for the acts or omissions of the other, its agents, representatives or employees.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) At all times prior to the Effective Time, the Sellers shall have sole and exclusive
responsibility for the operation and management of the Facilities and the Purchased Assets
related thereto, for the employment and control of the Employees, for compliance with all
Laws governing the employment relationship, and for compliance with the terms of any Labor
Agreement, employment contract or employee benefit plan covering the Employees or any of
Sellers&#146; former employees. At all times subsequent to the Effective Time, Buyer shall have
sole and exclusive responsibility for the operation and management of the Facilities and the
Purchased Assets related thereto, for the employment and control of its employees, for
compliance with all Laws governing the employment relationship, and for compliance with the
terms of any collecting bargaining agreement, employment contract or employee benefit plan
covering its employees.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) With respect to any Multiemployer Plan for which contributions were required to be
made pursuant to a Labor Agreement (the &#147;<B>Surviving Plans</B>&#148;), Buyer and Sellers shall take all
steps necessary under Section&nbsp;4204 of ERISA so that the transaction contemplated by this
Agreement will not constitute a partial or complete withdrawal under Section&nbsp;4201 of ERISA.
The parties hereto acknowledge and agree that the sale of assets under this Agreement
constitutes a bona fide, arm&#146;s length sale of assets between unrelated parties, and the
parties intend that this Agreement be covered by and satisfy all of the requirements of
Section&nbsp;4204 of ERISA. With respect to the Surviving Plans, Buyer and Sellers agree to the
following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <I>Contributions</I>. Buyer agrees to contribute to the Surviving Plans, with
respect to the covered operations, for substantially the same number of contribution
base units for which Seller had an obligation to contribute to the Surviving Plans.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <I>Security</I>. Buyer agrees that, if it does not qualify for an exemption
pursuant to PBGC Regulation&nbsp;Section&nbsp;4204.11(a), it will provide a bond or place an
amount in escrow in accordance with Section&nbsp;4204(a)(1)(B) of ERISA.
</DIV>

<P align="center" style="font-size: 10pt">40
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <I>Seller&#146;s Secondary Liability</I>. In the event Buyer withdraws from the
Surviving Plans in a complete withdrawal, or a partial withdrawal with respect to
the covered operations, during the five plan years commencing with the first plan
year beginning after the Closing Date, Seller shall be secondarily liable, but only
to the extent required by Section&nbsp;4204 of ERISA with respect to the covered
operations if Buyer&#146;s primary liability to the Surviving Plans is not paid. If
Buyer withdraws from the Surviving Plans before the last day of the fifth plan year
beginning after the Closing Date, and fails to make any withdrawal liability payment
when due, then Seller shall pay to the Surviving Plans an amount determined in
accordance with the requirements of Section&nbsp;4204 of ERISA and the law, reduced, as
permitted under the law, by the amounts paid by the Buyer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) <I>Reduction of Liability</I>. The liability of a party furnishing a bond or
escrow shall be reduced, upon payment of any bond or escrow to the Surviving Plans,
by the amount thereof in accordance with Section&nbsp;4204(a)(4) of ERISA.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) <I>Buyer&#146;s Indemnification</I>. Buyer agrees that, to the extent Buyer is
required to contribute to the Surviving Plans pursuant to this Agreement and, with
respect to the Surviving Plans, for the five plan years beginning after the Closing
Date, Buyer will make such contributions on a timely basis. Buyer further agrees
that it shall be liable to Seller and shall defend, indemnify, and hold Seller and
its shareholders, officers, directors, employees and agents harmless from any
withdrawal liability, claims, costs, damages, expenses, taxes, penalties or fines
arising solely out of any failure by the Buyer to satisfy the requirements of this
Section and with respect to any actions Buyer may take after the Closing Date which
results in any Withdrawal Liability under any Multiemployer Plan for which Buyer has
a contribution obligation. Seller agrees to provide Buyer with reasonable advance
notice of any action or event which could result in the imposition of withdrawal
liability by the Surviving Plans against Seller and for which Seller asserts Buyer
may be liable. In any event Seller shall immediately furnish Buyer with a copy of
any notice of withdrawal liability it may receive with respect to the Surviving
Plans, together with all the pertinent details. If any such withdrawal liability
shall be assessed against Seller, Seller further agrees to provide Buyer with
reasonable advance notice of any intention on the part of Seller not to make full
payment of any withdrawal liability when the same shall become due. For purposes of
this Section&nbsp;9.05(d)(v), the term Seller shall include Seller Indemnitees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.06. <I>Employee Compensation</I>. No later than 15&nbsp;days after the date hereof, Albertson&#146;s
shall provide Buyer with, or cause to be provided to Buyer, a true and complete list, organized by
Facility, of the name, title, position pay rate, position effective date, full-time/part-time
status, continuous service date, all paid time off eligibility and balances, status under the Fair
Labor Standards Act, benefit eligibility and enrollment status (including defined contribution plan
information) of each Employee as of the date hereof. Such list shall be updated as necessary to
reflect new hires or other personnel changes occurring between the date delivered to Buyer and the
Effective Time.
</DIV>

<P align="center" style="font-size: 10pt">41
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.07. <I>Employee Indemnity</I>. In addition to and not in limitation of any of the
foregoing provision of this Article&nbsp;9, from and after the Effective Time, Buyer shall indemnify the
Seller Indemnitees against and hold each of them harmless from any and all damages, losses,
liabilities and expenses (including reasonable attorneys&#146; fees and expenses), incurred or suffered
by the Sellers or any of their Affiliates arising from the failure to hire or the employment or
termination of any Employee or Transferred Employee by Buyer or any of its Affiliates (or as a
result of non-acceptance of an offer, to the extent any such non-acceptance results in severance
payments under the applicable Sellers&#146; severance plan) on or after the Effective Time pursuant to
the applicable Albertson&#146;s severance plans (but excluding any individual employment or change in
control agreements) or pursuant to the Worker Adjustment and Retraining Notification Act or any
similar state Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.08. <I>No Third Party Beneficiaries</I>. No provision of this Article&nbsp;9 shall create any
third party beneficiary or other rights in any employee or former employee (including any
beneficiary or dependent thereof) of the Sellers, New Diamond or of any of their respective
Subsidiaries in respect of continued employment (or resumed employment) with either Buyer or any of
its Affiliates or the Standalone Drug Business and no provision of this Article&nbsp;9 shall create any
such rights in any such Persons in respect of any benefits that may be provided, directly or
indirectly, under any Employee Plan or any plan or arrangement which may be established by Buyer or
any of its Affiliates. No provision of this Agreement shall constitute a limitation on rights to
amend, modify or terminate after the Effective Time any such plans or arrangements of Buyer or any
of its Affiliates.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 10</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Conditions to Closing</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;10.01. <I>Conditions to Each Party&#146;s Obligations</I>. The obligations of each party hereto
to consummate the transactions contemplated hereby are subject to the satisfaction or waiver of the
following conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Any applicable waiting period under the HSR Act relating to the transactions
contemplated hereby shall have expired or been terminated.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) No provision of any applicable Law or regulation and no judgment, injunction, order
or decree shall prohibit the consummation of the transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) (i)&nbsp;The satisfaction or waiver at or prior to the Closing of the conditions to the
Merger (as defined in that certain Agreement and Plan of Merger, dated as of the date hereof
(the &#147;<B>Merger Agreement</B>&#148;), by and among Albertson&#146;s, New Aloha Corporation, SUPERVALU, New
Diamond Sub, Inc. and Emerald Acquisition Sub, Inc.), shall have occurred as set forth in
Article&nbsp;VII of the Merger Agreement (other than the condition that the Standalone Drug Sale
and Retained Business Purchase (each as defined in the Merger Agreement) shall have
occurred); and (ii)&nbsp;the satisfaction or waiver at or prior to the Closing of the conditions
to closing to the Retained Business Purchase shall have occurred.
</DIV>

<P align="center" style="font-size: 10pt">42
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;10.02. <I>Conditions to Obligation of Buyer</I>. The obligation of Buyer to consummate the
transactions contemplated hereby are subject to the satisfaction or waiver of the following further
conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) (i)&nbsp;The Sellers shall have performed in all material respects all of their
obligations hereunder required to be performed by them on or prior to the Closing Date, (ii)
the representations and warranties of Albertsons&#146; or SUPERVALU contained in this Agreement
(disregarding any Material Adverse Effect, materiality or similar qualifiers therein) shall
be true and correct as of the date hereof and Closing Date as though made on and as of such
date (unless any such representation or warranty is made only as of a specific date, in
which event such representation and warranty shall be true and correct as of such specified
date), except where any failure of such representations or warranties to be so true and
correct, individually or in the aggregate, has not had and would not reasonably be expected
to have a Material Adverse Effect, and (iii)&nbsp;Buyer shall have received a certificate signed
by an officer of Albertson&#146;s or SUPERVALU, as applicable, to the foregoing effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The applicable Sellers shall have duly executed and delivered each of the Ancillary
Agreements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;10.03. <I>Conditions to Obligation of the Sellers</I>. The obligation of the Sellers to
consummate the transactions contemplated hereby is subject to the satisfaction or waiver of the
following further conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) (i)&nbsp;Buyer shall have performed in all material respects all of its obligations
hereunder required to be performed by it at or prior to the Closing Date, (ii)&nbsp;the
representations and warranties of Buyer contained in this Agreement and in any certificate
or other writing delivered by Buyer pursuant hereto shall be true in all material respects
at and as of the Closing Date, as if made at and as of such date (except to the extent that
any representation or warranty speaks as of an earlier date, in which case it must be true
and correct only as of that earlier date) and (iii)&nbsp;the Sellers shall have received a
certificate signed by an officer of each of Parent and Buyer to the foregoing effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Buyer shall have duly executed and delivered each of the Ancillary Agreements.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 11</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Survival; Indemnification</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;11.01. <I>Survival</I>. All representations and warranties in this Agreement of any party or
in any instrument delivered pursuant to this Agreement shall terminate at the Effective Time. The
covenants and agreements of the parties hereto contained in this Agreement or in any certificate or
other writing delivered pursuant hereto or in connection herewith shall survive the Closing Date
indefinitely or for the shorter period explicitly specified therein, except that to the extent any
covenant provides for performance prior to Closing, such covenant to such extent shall not survive
Closing.
</DIV>

<P align="center" style="font-size: 10pt">43
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;11.02. <I>Indemnification</I>. (a)&nbsp;From and after the Closing Date, SUPERVALU shall
indemnify Buyer and its Affiliates (each, a &#147;<B>Buyer Indemnitee</B>&#148; and collectively, the &#147;<B>Buyer
Indemnitees</B>&#148;) against and agrees to hold each of them harmless from any and all damage, loss,
liability and expense (including reasonable attorneys&#146; fees and expenses in connection with any
Action whether involving a third-party claim or a claim solely between the parties hereto)
(&#147;<B>Damages</B>&#148;) incurred or suffered by Buyer or any of its Affiliates arising out of:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any breach after the Closing of any covenant or agreement of SUPERVALU or
its Affiliates contained in this Agreement or a breach by SUPERVALU or its
applicable Affiliates of Section&nbsp;1.07(a)(ii)(E);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) any Excluded Liability;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">regardless of whether such Damages arise as a result of the negligence, strict liability or any
other liability under any theory of Law or equity.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) From and after the Closing Date, Parent shall indemnify the Sellers, New Diamond
and their respective Affiliates (each, a &#147;<B>Seller Indemnitee</B>&#148; and collectively, the &#147;<B>Seller
Indemnitees</B>&#148;) against and hold each of them harmless from any and all Damages incurred or
suffered by the Sellers, New Diamond or any of their respective Affiliates arising out of:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any breach after the Closing of any covenant or agreement of Buyer or its
Affiliates contained in this Agreement or a breach by Buyer or its applicable
Affiliates of Section&nbsp;1.07(a)(ii)(F);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the conduct of the Standalone Drug Business by Buyer after the Closing
Date or the ownership, operation, occupancy or use by Buyer after the Closing Date
of the Facilities or Purchased Assets; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) any Assumed Liabilities;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">regardless of whether such Damages arise as a result of the negligence, strict liability or any
other liability under any theory of Law or equity.
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Following the Closing, except as to injunctive relief, the sole and exclusive
remedy for each of the Indemnified Parties with respect to any and all claims relating to a
breach of this Agreement shall be pursuant to the indemnification provisions set forth in
this Article&nbsp;11. In furtherance of the foregoing, each of the Indemnified Parties hereby
waives, to the fullest extent permitted under applicable Law, any and all rights, claims and
causes of action it may have against the other parties hereto, arising under or based upon
any Federal, state, local or foreign Law, other than the right to seek indemnity pursuant to
this Article&nbsp;11. Notwithstanding the foregoing, the provisions of this Article&nbsp;11 shall in
no way limit any other express indemnification rights of any party set forth in this
Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) The amount of any Damages subject to indemnification hereunder shall be calculated
net of any insurance proceeds or other third-party payments received by the
</DIV>

<P align="center" style="font-size: 10pt">44
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">Indemnitee on account of such Damages. In the event that the Indemnitor reimburses the
Indemnitee for any Damages prior to the receipt or realization of any proceeds, payments or
benefits referred to in the immediately preceding sentence, the Indemnitee shall remit to
the Indemnitor an amount equal to the amount of such proceeds, payments or benefits, as the
case may be. In the event any payment is made in respect of Damages pursuant to this
Article&nbsp;11, the Indemnitor who made such payment shall be subrogated to the extent of such
payment to any related rights of recovery of the Indemnitee receiving such payment against
any third party.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Without limitation of their respective rights and obligations as set forth
elsewhere in this Article&nbsp;11, and subject to the procedures for indemnification claims set
forth in this Article&nbsp;11, the Indemnitee shall act in good faith, shall use commercially
reasonable efforts to mitigate any Damages.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) All indemnity payments, except those in respect of Prorated Charges, shall be
treated as additional adjustments to the amount of the total consideration paid for the
Purchased Assets (or as amounts that are deductible by the payor, if in accordance with
applicable law) for all Tax purposes, except as otherwise required by applicable Tax law or
by a &#147;determination&#148; within the meaning of Section&nbsp;1313 of the Code.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Notwithstanding anything to the contrary contained herein, the indemnification
provided for in this Article&nbsp;11 shall not cover, and in no event shall any party hereto be
liable for, any indirect, consequential, incidental, exemplary or special damages, punitive
damages, lost profits, lost revenues or diminution in value.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;11.03. <I>Procedures</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <I>Third Party Claims</I>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) If any Indemnitee shall desire to assert any claim for indemnification
provided under this Article&nbsp;11 in respect of, arising out of or involving a claim or
demand made by any Person (other than a Buyer Indemnitee or a Seller Indemnitee)
against the Indemnitee (a &#147;<B>Third Party Claim</B>&#148;), such Indemnitee shall notify the
Indemnitor in writing, and in reasonable detail (taking into account the information
then available to such Indemnitee), of the Third Party Claim; <I>provided, however,</I>
that the failure of an Indemnitee to notify the Indemnitor shall relieve the
Indemnitor from its obligation to indemnify only to the extent that the Indemnitor
is actually prejudiced as a result of such failure. The Indemnitee shall deliver to
the Indemnitor, promptly after the Indemnitee&#146;s receipt thereof, copies of all
notices and documents (including court papers) received by the Indemnitee relating
to the Third Party Claim; <I>provided, however, </I>that the failure to deliver such copies
shall relieve the Indemnitor from its obligation to indemnify only to the extent
that the Indemnitor is actually prejudiced as a result of such failure.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Upon receipt of notification of a Third Party Claim, the Indemnitor shall
be entitled to participate in the defense of the Third Party Claim and, if it so
</DIV>

<P align="center" style="font-size: 10pt">45
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">chooses, to assume the defense thereof with counsel selected by the Indemnitor
and reasonably satisfactory to the Indemnitee. Should the Indemnitor so elect to
assume the defense of a Third Party Claim, the Indemnitor shall not be liable to the
Indemnitee for legal expenses subsequently incurred by the Indemnitee in connection
with the defense thereof, unless the Third Party Claim involves potential conflicts
of interest or substantially different defenses for the Indemnitee and the
Indemnitor. If the Indemnitor assumes such defense, the Indemnitee shall have the
right to participate in defense thereof and to employ counsel, at its own expense
(except as provided in the immediately preceding sentence), separate from the
counsel employed by the Indemnitor, it being understood that the Indemnitor shall
control such defense. The Indemnitor shall be liable for the fees and expenses of
counsel employed by the Indemnitee for any period during which the Indemnitor has
not assumed the defense thereof and as otherwise contemplated by the two immediately
preceding sentences. If the Indemnitor chooses to defend any Third Party Claim, all
the parties hereto shall cooperate in the defense or prosecution thereof. Such
cooperation shall include the retention and (upon the Indemnitor&#146;s request) the
provision to the Indemnitor of records and information that are reasonably relevant
to such Third Party Claim, and the use of commercially reasonable efforts to make
employees available on a mutually convenient basis to provide additional information
and explanation of any material provided thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Whether or not the Indemnitor shall have assumed the defense of a Third
Party Claim, the Indemnitee shall not admit any liability with respect to, or
settle, compromise or discharge, such Third Party Claim without the Indemnitor&#146;s
prior written consent, which shall not be unreasonably withheld or delayed. The
Indemnitor may settle, compromise or discharge such Third Party Claim with the
written consent of the Indemnitee, which shall not be unreasonably withheld or
delayed, or without such consent if such settlement, compromise or discharge (A)
includes an unconditional release of the Indemnitee from all liability in respect of
such Third Party Claim, (B)&nbsp;does not subject the Indemnitee to any injunctive relief
or other equitable remedy, and (C)&nbsp;does not include a statement or admission of
fault or culpability on the part of any Indemnitee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Notwithstanding the foregoing, (A)&nbsp;if a Third Party Claim relates to
Apportioned Obligations, Buyer shall be entitled to control the defense of such
Third Party Claim and (B)&nbsp;if a Third Party Claim relates to Transfer Taxes, New
Diamond and SUPERVALU shall be entitled to control the defense of such Third Party
Claim (any Third Party Claim referred to above in this clause (iv), a &#147;<B>Tax Claim</B>&#148;).
In the case of any Tax Claim, the party not entitled to control such Tax Claim (the
&#147;<B>Non-Controlling Party</B>&#148;) shall be entitled to participate fully (at the
Non-Controlling Party&#146;s sole expense) in the conduct of such Tax Claim and the party
controlling the defense of such Tax Claim shall not settle such Tax Claim without
the consent of the Non-Controlling Party (which consent shall not be unreasonably
withheld). The costs and expenses of conducting the defense of such Tax Claim shall
be reasonably apportioned in the same manner as the Apportioned Obligations or the
Transfer Taxes or other Taxes, as the case may
</DIV>

<P align="center" style="font-size: 10pt">46
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">be, to which the Tax Claim relates. Notwithstanding any other provision, New
Diamond and SUPERVALU shall be entitled to control in all respects any proceedings
relating to Taxes based on or related to income (<B>&#147;Income Taxes&#148;</B>) of Sellers, New
Diamond, SUPERVALU, Albertsons or any of their Affiliates and, except as provided
above in this Section&nbsp;11.03(a)(iv), all other proceedings relating to Taxes of
Sellers, New Diamond, SUPERVALU, Albertsons or any of their Affiliates, and Buyer
shall be entitled to control in all respects any proceedings relating to Income
Taxes of Buyer or any of its Affiliates and, except as provided above in this
Section&nbsp;11.03(a)(iv), all other proceedings relating to Taxes of Buyer or any of its
Affiliates.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Direct Claims</I>. If any Indemnitee shall desire to assert any claim for
indemnification provided for under this Article&nbsp;11 other than a claim in respect of, arising
out of or involving a Third Party Claim, such Indemnitee shall notify the Indemnitor in
writing, and in reasonable detail (taking into account the information then available to
such Indemnitee), of such claim promptly after becoming aware of the existence of such
claim; <I>provided, however, </I>that the failure of an Indemnitee to notify the Indemnitor shall
relieve the Indemnitor from its obligation to indemnify only to the extent that the
Indemnitor is actually prejudiced as a result of such failure.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 12</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Termination</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;12.01. <I>Grounds for Termination</I>. This Agreement may be terminated at any time prior to
the Closing Date:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) by mutual written agreement of Albertson&#146;s and Buyer;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) by either Albertson&#146;s or Buyer if the Closing shall not have been consummated on or
before September&nbsp;22, 2006 (the &#147;<B>Termination Date</B>&#148;); <I>provided </I>that the right to terminate
this Agreement pursuant to this Section&nbsp;12.01(b) shall not be available to the party seeking
to terminate if any action of such party or the failure of such party to perform any of its
obligations under this Agreement required to be performed at or prior to the Closing has
been the cause of, or resulted in, the failure of the Closing to occur on or before the
Termination Date and such action or failure to perform constitutes a breach of this
Agreement; <I>provided, further, </I>that the right to terminate this Agreement pursuant to this
Section&nbsp;12.01(b) shall not be available to Albertson&#146;s if neither Albertson&#146;s nor SUPERVALU
shall have exercised its termination right under Section&nbsp;8.1(c) of the Merger Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) by either Albertson&#146;s or Buyer if there shall be any Law, regulation or
nonappealable final order, decree or judgment of any court or governmental body having
competent jurisdiction that would make the consummation of the transactions contemplated
hereby illegal or otherwise prohibited;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) by Albertson&#146;s if there shall have been a material breach of any representation,
warranty, covenant or agreement on the part of Buyer contained in this
</DIV>

<P align="center" style="font-size: 10pt">47
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">Agreement such that the condition set forth in Section&nbsp;10.03(a) would not be satisfied
and which shall not have been cured prior to the earlier of (i)&nbsp;20 Business Days following
notice of such breach and (ii)&nbsp;the Termination Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) by Buyer if there shall have been a material breach of any representation,
warranty, covenant or agreement on the part of any Seller contained in this Agreement such
that the condition set forth in Section&nbsp;10.02(a) would not be satisfied and which shall not
have been cured prior to the earlier of (i)&nbsp;20 Business Days following notice of such breach
and (ii)&nbsp;the Termination Date; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) by Albertson&#146;s or Buyer if the Merger Agreement is terminated.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The party desiring to terminate this Agreement pursuant to clauses 12.01(b), (c), (d), (e)&nbsp;or
(f)&nbsp;shall give notice of such termination to the other party.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;12.02. <I>Effect of Termination</I>. If this Agreement is terminated as permitted by Section
12.01, such termination shall be without liability of either party (or any stockholder, director,
officer, employee, agent, consultant or representative of such party) to the other party to this
Agreement; <I>provided </I>that nothing herein shall relieve any party from liability for any willful and
material breach hereof. The provisions of Section&nbsp;6.01, 7.13, 12.01, 13.02, 13.03, 13.04, 13.05,
13.06, 13.07 and 13.08 shall survive any termination hereof pursuant to Section&nbsp;11.01.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><FONT style="font-variant: SMALL-CAPS">ARTICLE 13</FONT><BR>
<FONT style="font-variant: SMALL-CAPS">Miscellaneous</FONT>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.01. <I>Definitions</I>. (a)&nbsp;The following terms, as used herein, have the following
meanings:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Action</B>&#148; means any claim, action, suit, proceeding or investigation by or before any
Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Affiliate</B>&#148; means, with respect to any Person, any other Person directly or indirectly
controlling, controlled by, or under common control with such other Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Ancillary Agreements</B>&#148; means the Assignment and Assumption Agreements to be dated as of the
Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Applicable Rate</B>&#148; means a rate per annum equal to the &#147;prime rate&#148; as set forth on the Closing
Date in <I>The Wall Street Journal </I>&#147;Money Rates&#148; column.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Business Day</B>&#148; means a day, other than Saturday, Sunday or other day on which commercial
banks in New York, New York are authorized or required by Law to close.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Code</B>&#148; means the Internal Revenue Code of 1986, as amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Confidentiality Agreement</B>&#148; means the Confidentiality Agreement, dated September&nbsp;27, 2005,
between Albertson&#146;s and Parent, as amended by Section&nbsp;7.13 hereof.
</DIV>

<P align="center" style="font-size: 10pt">48
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Construction Contracts</B>&#148; means all construction contracts, architectural contracts,
engineering contracts, and fixture purchase orders primarily related to the Standalone Drug
Business (a Schedule of all material contracts of such types will be provided to Buyer within 45
days after the date hereof) and any contracts and purchase orders approved under Section&nbsp;5.01.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Distribution Center</B>&#148; means the distribution center owned by Sellers and located at 777 South
Harbor Boulevard, La Habra, CA 90631, including building No.&nbsp;1111 and all real estate and
improvements associated therewith.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Effective Time</B>&#148; means 12:01&nbsp;a.m., local time on the Closing Date.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Environmental Laws</B>&#148; means any federal, state, local or foreign Law (including common law),
treaty, judicial decision, regulation, rule, judgment, order, decree, injunction, permit or
governmental restriction or any agreement with any Governmental Authority or other third party,
whether now or hereafter in effect, relating to the environment, human health and safety or to
pollutants, contaminants, wastes or chemicals or any toxic, radioactive, ignitable, corrosive,
reactive or otherwise hazardous substances, wastes or materials.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Environmental Liabilities</B>&#148; means any and all liabilities arising in connection with or in any
way relating to the Facilities, the Purchased Assets or any activities or operations occurring or
conducted at the Real Properties (including offsite disposal), whether accrued, contingent,
absolute, determined, determinable or otherwise, which arise under or relate to any applicable
Environmental Law, including any matter disclosed or required to be disclosed in Section&nbsp;2.12 of
the Disclosure Letter and any and all litigation arising out of or in any way related to any such
matter.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Environmental Permits</B>&#148; means all permits, licenses, franchises, certificates, approvals and
other similar authorizations of Governmental Authorities relating to or required by applicable
Environmental Laws and affecting, or relating in any way to, the operation of the Facilities or the
Purchased Assets.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>ERISA</B>&#148; means the Employee Retirement Income Security Act of 1974, as amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>ERISA Affiliate</B>&#148; of any entity means any other entity which, together with such entity, would
be treated as a single employer under Section&nbsp;414 of the Code.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934 and the rules and regulations
promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>GAAP</B>&#148; means United States generally accepted accounting principles.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Governmental Authority</B>&#148; means any federal, state, local or foreign government (including any
political or other subdivision or judicial, legislative, executive or administrative branch,
agency, commission, authority or other body of any of the foregoing).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Governmental Order</B>&#148; means any order, writ, judgment, injunction, decree or award entered by
or with any Governmental Authority.
</DIV>

<P align="center" style="font-size: 10pt">49
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Ground Lease</B>&#148; means any lease or sublease of, or any other interest in, real property
occupied by a Ground Lease Store.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>HSR Act</B>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Indemnitee</B>&#148; means a Seller Indemnitee or a Buyer Indemnitee, as the case may be.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Indemnitor</B>&#148; means any Person required to provide indemnification under Article&nbsp;11 of this
Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>IT Systems</B>&#148; means all electronic data processing, information, recordkeeping, communications,
telecommunications, account management, inventory management and other computer systems (including
all computer programs, software, databases, firmware, hardware and related documentation) and
Internet websites.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Knowledge</B>&#148; means the actual knowledge, with respect to any Seller, of any person listed in
Section&nbsp;13.01 of the Disclosure Letter, and with respect to Buyer, of any officer of Buyer or
Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Labor Agreements</B>&#148; mean any and all union contracts, collective bargaining agreements and
other labor agreements relating to persons employed at, or in connection with, the Facilities to
the extent they relate to the Facilities or the operation of the Standalone Drug Business.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Law</B>&#148; means any statute, law, ordinance, regulation, rule, code or other requirement of law of
a Governmental Authority or any Governmental Order.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Lease</B>&#148; means a Store Lease or a Ground Lease.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Lien</B>&#148; means any security interest, pledge, mortgage, lien, charge, hypothecation, option to
purchase or lease or otherwise acquire any interest, conditional sales agreement, adverse claim of
ownership or use, title defect, easement, right of way, or other encumbrance of any kind, other
than any obligation to accept returns of inventory in the ordinary course of business and other
than those arising by reason of restrictions on transfers under federal, state and foreign
securities Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Material Adverse Effect</B>&#148; means any effect that (a)&nbsp;is materially adverse to the business,
financial condition or results of operations of the Standalone Drug Business, other than any effect
to the extent resulting proximately from (i)&nbsp;general economic conditions or developments or changes
therein, (ii)&nbsp;conditions in the industries in which the Standalone Drug Business operates or
developments or changes therein, except to the extent that such conditions, developments or changes
impact the Standalone Drug Business in a materially disproportionately adverse manner relative to
similarly situated competitors of the Standalone Drug Business, (iii)&nbsp;conditions in the stock
markets or other capital markets or developments or changes therein, (iv)&nbsp;the announcement of this
Agreement or the transactions contemplated hereby, (v)&nbsp;the performance by the Sellers of their
obligations pursuant to this Agreement (except the obligations of the Sellers to obtain the
consents contemplated by Section&nbsp;2.04), (vi)&nbsp;the
</DIV>

<P align="center" style="font-size: 10pt">50
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">announcement, consummation, termination or abandonment of the Merger Agreement, (vii)&nbsp;any
actions taken or omitted to be taken by or at the request or with the written consent of Parent or
Buyer, (viii)&nbsp;any changes in any Laws or any accounting regulations or principles, or (b)&nbsp;would
prevent or materially delay the consummation of the transactions contemplated by this Agreement. A
failure by Albertson&#146;s to meet any projections, estimates or budgets for any period prior to, on or
after the date of this Agreement shall not in itself constitute a Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Multiemployer Plan</B>&#148; means any &#147;multiemployer plan,&#148; as defined in Section&nbsp;3(37) of ERISA.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Permitted Liens</B>&#148; means (i)&nbsp;Liens that relate to taxes, assessments and governmental charges
or levies imposed upon the Purchased Assets that are not yet due and payable or that are being
contested in good faith by appropriate proceedings, (ii)&nbsp;Liens imposed by Law that relate to
obligations that are not yet due and have arisen in the ordinary course of business and consistent
with past practice, (iii)&nbsp;pledges or deposits to secure obligations under workers&#146; compensation
laws or similar legislation or to secure public or statutory obligations, (iv)&nbsp;mechanics&#146;,
carriers&#146;, workers&#146;, repairers&#146; and similar Liens imposed upon the Purchased Assets arising or
incurred in the ordinary course of business and consistent with past practice, (v)&nbsp;other Liens on
assets which, in the case of each of clause (iv)&nbsp;and (v)&nbsp;above are, either individually or in the
aggregate, not material in amount and would not reasonably be expected to materially impair the
continued use, utility or value of the property to which they relate in the conduct of the business
currently conducted thereon.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Person</B>&#148; means an individual, corporation, partnership, limited liability company,
association, trust or other entity or organization, including a Governmental Authority.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Pre-Closing Tax Period</B>&#148; means a taxable period or portion thereof that ends on or prior to
the Effective Time; if a taxable period begins on or prior to the Effective Time and ends after the
Effective Time, then the portion of the taxable period that ends on and includes the Effective Time
shall constitute a Pre-Closing Tax Period.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Post-Closing Tax Period</B>&#148; means any taxable period that begins after the Effective Time; if a
taxable period begins on or prior to the Effective Time and ends after the Effective Time, then the
portion of the taxable period that begins immediately after the Effective Time shall constitute a
Post-Closing Tax Period.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Real Property Documents</B>&#148; means easements, reciprocal easements, assignments, leases,
subleases, termination agreements, subordination agreements, nondisturbance agreements, estoppel
certificates, declarations of covenants, conditions and restrictions, municipal development
agreements, agreements with local planning or zoning authorities, and amendments or supplements to
any of the foregoing, and recorded memoranda of any of the foregoing, all with respect to the
Facilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Sellers</B>&#148; has the meaning set forth in the Recitals; <I>provided, however, </I>that following the
Closing (i)&nbsp;any right of Sellers hereunder shall be deemed to be the right of New Diamond and (ii)
any obligation of Sellers hereunder shall be deemed to be the obligation of New Diamond or
</DIV>

<P align="center" style="font-size: 10pt">51
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Sellers, as applicable, to the extent that such obligation is within the control of New
Diamond or the Sellers, respectively.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Separation Agreement</B>&#148; means that certain Purchase and Separation Agreement, dated as of the
date hereof, by and between Albertson&#146;s, New Aloha Corporation, SUPERVALU INC. and AB Acquisition
LLC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Store Lease</B>&#148; means any lease or sublease of, or any other interest in, real property occupied
by a Leased Store.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Straddle Tax Period</B>&#148; means any taxable period that begins before the Effective Time and ends
after the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Subsidiaries</B>&#148; of a Person means any and all corporations, partnerships, limited liability
companies, trusts and other entities, whether incorporated or unincorporated, with respect to which
such Person, directly or indirectly, legally or beneficially, owns (i)&nbsp;a right to a majority of the
profits of such entity or (ii)&nbsp;securities having the power to elect a majority of the board of
directors or similar body governing the affairs of such entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Taft-Hartley Plan Documents</B>&#148; means each Employee Plan which is identified on Section&nbsp;9.01(a)
of the Disclosure Letter as being formed under the Taft-Hartley Labor Act of 1947, and all
amendments and other documents related thereto.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Tax</B>&#148; means all taxes, fees, levies or other assessments, imposed by any Governmental
Authority responsible for the administration or imposition of any Tax (a &#147;<B>Taxing Authority</B>&#148;),
including income, gross receipts, excise, real and personal property, municipal, capital, sales,
use, transfer, license, payroll and franchise taxes and including Taxes imposed on a consolidated,
combined, unitary or affiliated group, and such term shall include any interest, penalties, or
additions to tax attributable to such taxes, fees, levies or other assessments.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<B>Tax Returns</B>&#148; means any return, report or other information required to be supplied to any
Taxing Authority in connection with Taxes.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each of the following terms is defined in the Section set forth opposite such term:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="80%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Term</B></TD>
    <TD>&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD nowrap align="right" style="border-bottom: 1px solid #000000"><B>Section</B></TD>
    <TD>&nbsp;</TD>

</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Accounts Receivable
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Albertson&#146;s
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Introduction
</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Apportioned Obligations
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Assigned Contracts
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Assignment and Assumption Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.07</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Assumed Labor Agreements
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Assumed Liabilities
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.03</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Buyer
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Introduction
</TD>
    <TD>&nbsp;</TD>

</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Buyer Indemnitee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Capex Budget
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">52
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="80%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Term</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Section</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Casualty
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.06</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Closing
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.07</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Closing Date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.07</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Condemnation
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.06</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Damages
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">DEA
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.07</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Data
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2.09</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Disclosure Letter
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Article&nbsp;2
</TD>
    <TD>&nbsp;</TD>

</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Distribution Center
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>

</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Distribution Center Transition Services Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.07</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Employee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Employee Plans
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Excluded Assets
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Excluded Equipment
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Excluded Liabilities
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.04</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Facilities
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ground Lease Stores
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Ground Leased Real Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">HIPAA Privacy Standards
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7.08</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">HSR Clearance
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Income Taxes
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11.03</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Independent Accounting Firm
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.08</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Inventory
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Landlord Rights
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.05</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Lease Assignment and Assumption Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.07</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Leased Real Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Leased Stores
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Licenses
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Materials of Environmental Concern
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2.12</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Merger Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10.03</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Non-Controlling Party
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11.03</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Occupancy Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.05</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Owned Real Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Owned Stores
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>

</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Parent
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Introduction
</TD>
    <TD>&nbsp;</TD>

</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Permits
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2.17</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Petty Cash
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Photo Equipment
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7.10</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Prepaid Expenses
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Prescription Files
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Prorated Charges
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.08</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Purchase Price
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.06</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Purchased Assets
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Real Property
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Retained Combo Drug Stores
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">53
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="80%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Term</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="3" style="border-bottom: 1px solid #000000"><B>Section</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">RGIS
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.10</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Seller Indemnitee
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Sellers
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Introduction
</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Shared Personnel
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Standalone Drug Business
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Standalone Drug Business Transition Services Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.07</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Stores
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">SUPERVALU
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>

    <TD nowrap align="right" valign="top">Recitals
</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Surviving Plans
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9.05</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Tax Claims
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11.03</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Termination Date
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">12.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Third Party Claim
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11.03</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Third Party Use and Occupancy Agreement
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2.07</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Tradenames and Trademarks
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7.05</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Transfer Taxes
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Transferred Employees
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9.02</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Transferred Vehicles
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">1.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Updated Store List
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">5.09</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Withdrawal Liability
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="right" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9.01</TD>
    <TD nowrap valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.02. <I>Notices</I>. All notices, requests and other communications to any party hereunder
shall be in writing (including facsimile transmission) and shall be given,
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if to Buyer or Parent, to:
</DIV>
<DIV align="right">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="92%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="100%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">CVS Corporation</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">One CVS Drive</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Woonsocket, RI 02895</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Attention: Douglas A. Sgarro</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Fax: 401-770-3663</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with a copy to:
</DIV>
<DIV align="right">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="92%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="100%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Davis Polk &#038; Wardwell</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">450 Lexington Avenue</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">New York, NY 10017</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Attention: Louis Goldberg</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Fax: 212-450-3539</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">54
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if to the Sellers, to:
</DIV>
<DIV align="right">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="92%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="100%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Albertson&#146;s</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">P.O. Box 20</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">250 Parkcenter Boulevard</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Boise, Idaho 83726 (street zip &#150; 83706)</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Attention: Corporate Secretary</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Facsimile No.: (208)&nbsp;395-6575</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with a copy to:
</DIV>
<DIV align="right">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="92%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="100%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Jones Day</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">2727 North Harwood Street</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Dallas, Texas 75201</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Attention: Mark V. Minton</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Phone: (214)&nbsp;969-3763</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Facsimile: (214)&nbsp;969-5100</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;if to SUPERVALU, to:
</DIV>
<DIV align="right">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="92%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="100%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">SUPERVALU Inc.</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">11840 Valley View Road</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Eden Prairie, Minnesota 55344</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Attention: Corporate Secretary</DIV></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Facsimile No.: (952)&nbsp;828-8900</DIV></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or such other address or facsimile number as such party may hereafter specify for the purpose by
notice to the other parties hereto. All such notices, requests and other communications shall be
deemed received on the date of receipt by the recipient thereof if received prior to 5:00 p.m. in
the place of receipt and such day is a Business Day in the place of receipt. Otherwise, any such
notice, request or communication shall be deemed not to have been received until the next
succeeding Business Day in the place of receipt.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.03. <I>Amendments and Waivers</I>. (a)&nbsp;Any provision of this Agreement (including the
Exhibits and Schedules hereto) may be amended or waived if, but only if, such amendment or waiver
is in writing and is signed, in the case of an amendment, by each party to this Agreement, or in
the case of a waiver, by the party against whom the waiver is to be effective.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) No failure or delay by any party in exercising any right, power or privilege
hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof
preclude any other or further exercise thereof or the exercise of any other right, power or
privilege. The rights and remedies herein provided shall be cumulative and not exclusive of
any rights or remedies provided by Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.04. <I>Expenses</I>. (a) <I>General</I>. Except as otherwise provided herein, all costs and
expenses incurred in connection with this Agreement shall be paid by the party incurring such cost
or expense.
</DIV>

<P align="center" style="font-size: 10pt">55
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 3%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <I>Closing Costs</I>. Costs incurred in connection with the Closing will be allocated as
follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) The Sellers shall pay the Sellers&#146; attorneys&#146; fees;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 6%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Buyer shall pay (A)&nbsp;Buyer&#146;s attorneys&#146; fees and (B)&nbsp;the cost of updating
any existing survey or obtaining any new surveys of the Real Property or the
Facilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.05. <I>Successors and Assigns</I>. The provisions of this Agreement shall be binding upon
and inure to the benefit of the parties hereto and their respective successors and assigns;
<I>provided </I>that no party may assign, delegate or otherwise transfer any of its rights or obligations
under this Agreement without the consent of each other party hereto; except that Buyer may transfer
or assign, in whole or from time to time in part, to one or more of its Affiliates the right to
purchase all or a portion of the Purchased Assets, but no such transfer or assignment will relieve
Buyer or Parent of its obligations hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.06. <I>Governing Law</I>. This Agreement shall be governed by and construed in accordance
with the law of the State of Delaware, without regard to the conflicts of law rules of such state.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.07. <I>Specific Performance; Jurisdiction</I>. The parties agree that irreparable damage
would occur in the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached. It is accordingly agreed that the
parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and
to enforce specifically the terms and provisions of this Agreement in the Court of Chancery of the
State of Delaware, this being in addition to any other remedy to which such party is entitled at
law or in equity. In addition, each of the parties hereto (i)&nbsp;consents to submit itself to the
personal jurisdiction of the Court of Chancery of the State of Delaware (and, with respect to
claims in which the exclusive subject matter jurisdiction of such claims is federal, the federal
district court for the District of Delaware) in the event any dispute arises out of this Agreement
or any of the transactions contemplated by this Agreement, (ii)&nbsp;agrees that it will not attempt to
deny or defeat such personal jurisdiction by motion or other request for leave from such court,
(iii)&nbsp;agrees that it will not bring any action relating to this Agreement or any of the
transactions contemplated by this Agreement in any court other than the Court of Chancery of the
State of Delaware (or, with respect to claims in which the exclusive subject matter jurisdiction of
such claims is federal, the federal district court for the District of Delaware) and (iv)&nbsp;to the
fullest extent permitted by Law, consents to service being made through the notice procedures set
forth in Section&nbsp;13.02. Each party hereto hereby agrees that, to the fullest extent permitted by
Law, service of any process, summons, notice or document by U.S. registered mail to the respective
addresses set forth in Section&nbsp;13.02 shall be effective service of process for any suit or
proceeding in connection with this Agreement or the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.08. <I>WAIVER OF JURY TRIAL</I>. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY
AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY.
</DIV>

<P align="center" style="font-size: 10pt">56
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.09. <I>Counterparts; Effectiveness; Third Party Beneficiaries</I>. This Agreement may be
signed in any number of counterparts, each of which shall be an original, with the same effect as
if the signatures thereto and hereto were upon the same instrument. The facsimile transmission of
any signed original counterpart of this Agreement shall be deemed to be the delivery of an original
counterpart of this Agreement. This Agreement shall become effective when each party hereto shall
have received a counterpart hereof signed by all of the other parties hereto. Until and unless
each party has received a counterpart hereof signed by the other party hereto, this Agreement shall
have no effect and no party shall have any right or obligation
hereunder (whether by virtue of any other oral or written agreement or other communication).
No provision of this Agreement is intended to confer any rights, benefits, remedies, obligations or
liabilities hereunder upon any Person other than the parties hereto, their respective successors
and assigns and the Indemnitees.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.10. <I>Other Definitional and Interpretative Provisions</I>. The words &#147;hereof&#148;, &#147;herein&#148;
and &#147;hereunder&#148; and words of like import used in this Agreement shall refer to this Agreement as a
whole and not to any particular provision of this Agreement. The captions herein are included for
convenience of reference only and shall be ignored in the construction or interpretation hereof.
References to Articles, Sections, Exhibits, Annexes and Schedules are to Articles, Sections,
Exhibits, Annexes and Schedules of this Agreement unless otherwise specified. Any singular term in
this Agreement shall be deemed to include the plural, and any plural term the singular. Whenever
the words &#147;include&#148;, &#147;includes&#148; or &#147;including&#148; are used in this Agreement, they shall be deemed to
be followed by the words &#147;without limitation&#148;, whether or not they are in fact followed by those
words or words of like import. &#147;Writing&#148;, &#147;written&#148; and comparable terms refer to printing, typing
and other means of reproducing words (including electronic media) in a visible form.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.11. <I>Entire Agreement</I>. This Agreement and the Ancillary Agreements constitute the
entire agreement between the parties with respect to the subject matter of this Agreement and
supersede all prior agreements and understandings, both oral and written, between the parties with
respect to the subject matter of this Agreement, including, at the Closing (to the extent set forth
in Section&nbsp;7.13), the Confidentiality Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.12. <I>Severability</I>. Whenever possible, each provision of this Agreement will be
interpreted so as to be effective and valid under applicable law, but if any provision or portion
of any provision of this Agreement is held invalid, illegal or unenforceable in any respect under
any applicable law in any jurisdiction, then such invalidity, illegality or unenforceability will
not affect the validity, legality or enforceability of any other provision or portion of any
provision of this Agreement, and this Agreement will be re-formed, construed and enforced in such
jurisdiction in such manner as will effect as nearly as lawfully possible the purposes and intent
of such invalid, illegal or unenforceable provision.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.13. <I>Bulk Transfer Laws</I>. The Sellers and Buyer waive the requirements of any Laws
(including Tax Laws, it being understood that Sellers and Buyer shall use their respective
reasonable best efforts to obtain Tax clearance certificates as provided in Section&nbsp;8.03) with
respect to bulk transfers, and the Sellers agree to pay and discharge when due all claims of
creditors which could be asserted against Buyer by reason of such waiver. The Sellers jointly and
severally shall indemnify, defend and hold harmless Buyer from any and all Damages
</DIV>

<P align="center" style="font-size: 10pt">57
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">resulting from
the claims of creditors of the Sellers arising out of or connected with their failure to comply
with the requirements of any Laws relating to bulk transfers or the failure of the Sellers to
discharge such claims.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;13.14. <I>Guaranty</I>. Parent hereby guarantees to each of the Sellers and New Diamond the
prompt and full discharge by Buyer of all of Buyer&#146;s payment and performance obligations under this
Agreement in accordance with the terms hereof. SUPERVALU hereby guarantees to Parent the prompt
and full discharge by each Seller controlled by SUPERVALU
and by New Diamond of all their payment and performance obligations under this Agreement in
accordance with the terms hereof.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;REMAINDER OF PAGE INTENTIONALLY LEFT BLANK&#093;
</DIV>


<P align="center" style="font-size: 10pt">58
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">CVS PHARMACY, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/
Tom Ryan</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Tom Ryan</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President &amp; CEO</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">CVS CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/
Tom Ryan</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Tom Ryan</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President &amp; CEO</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ALBERTSON&#146;S, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ John R. Sims
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John R. Sims&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President and
General Counsel&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">SUPERVALU, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>

<TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/
Jeff Noodle</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Jeff Noodle</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Chairman &amp; CEO</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">NEW ALOHA CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ABS FINANCE CO., INC. <BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ABS PROCUREMENT CO.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President &#038; Assistant Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ACME MARKETS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ADVANTAGE STORES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ALBERTSONS ASSIST, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ John F. Boyd
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John F. Boyd&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President &#038; Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ALBERTSONS STORES CHARITABLE FOUNDATION, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ John F. Boyd
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John F. Boyd&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Treasurer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN DRUG STORES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN FOOD AND DRUG, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN PARTNERS, L.P.<BR>

<BR></TR>
<TR>
    <TD align="left">&nbsp;</TD>
<TD valign="top">By:&nbsp;&nbsp;</TD>
<TD valign="top" colspan="2">AMERICAN
DRUG STORES, INC., its Managing General Partner
&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
</TR>

<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN PROCUREMENT AND LOGISTICS COMPANY<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN STORES CHARITABLE FOUNDATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN STORES COMPANY, LLC<BR>
<BR>
<BR></TD></TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2">ALBERTSON&#146;S INC., its sole Member<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ John R. Sims
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John R. Sims&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President &#038; General<BR>
Counsel&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN STORES PROPERTIES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>

<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">AMERICAN STORES REALTY COMPANY, LLC<BR>
<BR></TD></TR>
<TR>
    <TD align="left">&nbsp;</TD>
<TD valign="top">By:&nbsp;&nbsp; </TD>
<TD valign="top" colspan="2">AMERICAN STORES COMPANY, LLC, its sole Member<BR>
<BR></TD></TR>
<TR>
    <TD align="left">&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
<TD valign="top" colspan="3">By:&nbsp;&nbsp;&nbsp;ALBERTSON&#146;S INC., its sole Member,<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2"  style="border-bottom: 0px solid #000000" align="left">/s/ John R. Sims</TD>

</TR>
<TR style="font-size: 1px">

    <TD align="left">&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
    <TD align="left">&nbsp;</TD>
<TD colspan="1" style="border-bottom: 1px solid #000000" align="left">&nbsp;</TD></TR>

<TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">John R. Sims&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Executive Vice President &#038; Executive Vice<BR>
President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">APLC PROCUREMENT, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ASC MEDIA SERVICES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">BERYL AMERICAN CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President &#038; Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">HEALTH &#145;n&#146; HOME CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Vice President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">JETCO PROPERTIES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">JEWEL FOOD STORES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Vice President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">JEWEL OSCO SOUTHWEST, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">KASCO AUTOMOTIVE PRODUCTS<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2"  align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD  valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">LUCKY STORES PROPERTIES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD  valign="top">Title:&nbsp;&nbsp;</TD>
    <TD  colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">LUCKY STORES, INC. (DE)<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD  colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD  colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">LUCKY STORES, INC. (FL)<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">MFC-LIVONIA PROPERTIES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">OAKBROOK BEVERAGE CENTERS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">OSCO DRUG OF MASSACHUSETTS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">OSCO DRUG OF TEXAS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">SAV-ON REALTY, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">SCOLARI&#146;S STORES, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">SUNRICH MERCANTILE CORP.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">U.S. SATELLITE CORPORATION<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Paul G. Rowan
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">Paul G. Rowan&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>

    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD colspan="2" align="left">President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<P align="center" style="font-size: 10pt">
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SUBMISSION>
